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Lung cancer is the leading cause of cancer death in the UK and whilst lung 
resection, in appropriate cases, offers the best chance of cure it is associated with 
significant post-operative morbidity and mortality. Post-operative right 
ventricular dysfunction, secondary to an increase in afterload, has long been 
hypothesised to contribute to this morbidity although this has not been well 
demonstrated. Previous studies have used echocardiography and volumetric 
pulmonary artery catheters to assess changes in right ventricular function and 
afterload. These studies, however, are undermined by the reliability of the 
methods utilised and by their incomplete assessment of afterload. To better 
evaluate this our research group has undertaken a cardiac magnetic resonance 
study and demonstrated right ventricular dysfunction following lung resection. 
This thesis details investigation of right ventricular strain and afterload as 
potential mechanisms of this dysfunction. 
The introduction (Chapter 1) reviews the management of lung resection and the 
right ventricle, detailing its anatomy and physiology, with a particular focus on 
the pathophysiology and assessment of right ventricular failure secondary to 
increases in afterload. In Chapter 2, a literature review of studies investigating 
changes in right ventricular function and afterload following lung resection is 
presented. These studies have failed to demonstrate a significant change in 
afterload quantified by measurement of pulmonary artery pressure and/or 
pulmonary vascular resistance. These indices, however, only assess global 
impedance to steady flow and overlook impedance to pulsatile flow.  
Chapter 3 details the aims and the investigations performed in this thesis. The 
rationale, design, methodology and generic results of the first sequential cardiac 
magnetic resonance study to investigate right ventricular dysfunction are 
presented in Chapter 4. Additionally, the previous results from this study 
(reported prior to this thesis) are presented, the main finding of which is a post-
operative reduction in right ventricular ejection fraction. All subsequent 
investigations presented in this thesis are performed on the cardiac magnetic 
resonance images collected within this study.  
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The first investigation (Chapter 5) utilises CMR right ventricular strain analysis to 
assess changes in right ventricular function following lung resection. A review of 
strain analysis, measurement and changes in states of increased right ventricular 
afterload is presented followed by a review of three prior, but contradictory 
echocardiographic strain investigations in patients undergoing lung resection. This 
investigation demonstrates that there is no immediate change, but a delayed 
reduction in global and free wall right ventricular longitudinal strain evident at 2-
months following lung resection.  
Chapters 6 and 7 investigate changes in right ventricular afterload, focusing on 
assessment of the pulsatile components of afterload. As lung resection is a 
unilateral insult to the pulmonary vasculature, indices that allow assessment of 
unilateral changes of afterload are described. Assessment is therefore performed 
in the main pulmonary artery and the branch (right or left) supplying the resected 
lung (termed the operative pulmonary artery) and the non-resected lung (non-
operative pulmonary artery). 
Chapter 6 assesses pulmonary artery flow, acceleration time and distensibility 
following lung resection. It demonstrates, for the first time, an increase in right 
ventricular pulsatile afterload following lung resection. Post-operatively, pulsatile 
afterload is increased along with an altered distribution of cardiac output away 
from the operative pulmonary artery. On post-operative day two, indices of 
afterload in the non-operative pulmonary artery are associated with a reduction 
in right ventricular ejection fraction.  
The first use of wave intensity analysis in a lung resection cohort is presented in 
Chapter 7. Wave intensity analysis combines flow and area measurements in the 
time domain to calculate wave intensity, a measure of the rate of transport of 
wave energy, and assesses pulsatile afterload by calculation of wave reflection 
index. This investigation again demonstrates a post-operative increase in pulsatile 
afterload and the presence of early wave reflection in the operative pulmonary 
artery. 
Finally, Chapter 8 investigates the relationship between changes in right 
ventricular function (ejection fraction and strain) and changes observed in 
pulsatile afterload. This is the first evidence linking a reduction in right ventricular 
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function to an increase in afterload following lung resection. At 2-months 
postoperatively, increased wave reflection is strongly associated with a reduction 
in right ventricular free wall strain. The increase in pulsatile afterload observed 
in the operative pulmonary artery is associated with an increase in the percentage 
of cardiac output travelling in the non-operative pulmonary artery which, in turn, 
is associated with the reduction in both right ventricular ejection fraction and 
strain at 2-months. 
The investigations presented in this thesis demonstrate, for the first time, the 
widely hypothesised increase in right ventricular afterload occurring following 
lung resection and its association with a decrease in right ventricular function. 
The thesis concludes with a discussion of future work describing the design and 
successful funding of two studies building on the results from this thesis; a pilot 
study investigating the right ventricular response to exercise following lung 
resection and a cardiac magnetic resonance investigation of right ventricular 
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Chapter 1 Introduction 
This chapter will provide an overview of the surgical management of lung cancer, 
specifically highlighting the significant cardiopulmonary morbidity faced by 
patients even after a “successful” lung resection. It will focus on the hypothesised 
role of right ventricular (RV) dysfunction and highlight potential 
pathophysiological mechanisms.  
1.1 Lung cancer 
1.1.1 Incidence and mortality of lung cancer 
It is easy to understand the burden that lung cancer places on the health of the 
United Kingdom and in particular Scotland by looking at local and national 
statistics provided by Cancer Research UK. Whilst lung cancer is the third most 
common cancer in the UK, it is the leading cause of cancer deaths (22% of all 
cancer deaths)1. This burden is even greater in Scotland and in particular Glasgow. 
European age-standardised rates (incidence per 100,000 person-years at risk) 
reveal that, compared to England, Scotland has a higher incidence of lung cancer 
106.7 vs 76.6, this increases to 143.6 within Greater Glasgow and Clyde, Figure 






Figure 1-1 Lung cancer incidence in Scottish regions 
Each box represents the ranked incidence and 95% confidence intervals of lung cancer in a 
Scottish region. Greater Glasgow and Clyde highlighted in top right demonstrating the markedly 
increased lung cancer incidence of the population. Image from Cancer Research UK1. 
Public health campaigns have sought to decrease smoking habits since the link 
between cigarette smoking and lung cancer was demonstrated in the 1950’s2, 3. 
Rates of cigarette smoking have decreased in both sexes, with a greater relative 
decrease in males, subsequently lung cancer rates in males have decreased but 
increased in females1. This has resulted in largely static lung cancer incidence 
over the last 20 years. One year survival (32.1% in 2011) has consistently improved 
since the 1970’s however there has only been modest improvements in five (9.5% 
in 2011) and ten year (4.9% in 2011) survival1, Figure 1-2. In comparison, the five 




Figure 1-2 Trend in lung cancer survival rates  
Trend in percentage survival over time for lung cancer. Note significant increase in one-year 
survival (black solid line) and gradual improvement in five-year (red dashed line) and ten-year (blue 
dotted line) survival. Plot constructed with data from Cancer Research UK1. 
1.1.2 Management of lung cancer 
National Institute for Health and Care Excellence guidelines recommend surgical 
resection, where appropriate, as the first-choice treatment for lung cancer with 
chemotherapy and radiotherapy as additional or alternative treatments5. In 2011 
Coleman et al. highlighted that the UK had lower one and five-year survival than 
Denmark, Norway, Sweden, Canada or Australia (data from 1995-2007)6. 
Historically, the UK rates of surgical resection have lagged behind other 
comparative countries. A British Medical Journal editorial titled ‘Thoracic surgery 
in crisis’ summarised the troubling 2001 report of a joint Working Group of The 
British Thoracic Society and The Society of Cardiothoracic Surgeons of Great 
Britain and Ireland. With only 40 purely thoracic surgeons operating in the UK, 
resection rates were less than 10% compared to 25% in the USA7, 8. Since this time 
rates have rapidly increased, Figure 1-3, particularly in elderly patients, Figure 
1-4, resulting in patients who previously would have been ineligible for surgery 




Figure 1-3 Lung cancer resection rates, 1980-2015 
Resection numbers have doubled from the 1980-2005 plateau to 2015. 
Image from the Society for Cardiothoracic Surgery in Great Britain & Ireland ‘Blue Book’ 20189.  
 
Figure 1-4 Lung cancer resection rates per age group, 1998-2008 
Data from England, 1998-2008, Resection rates are increasing over time predominantly in the older 
groups. Image from Riaz et al10. 
Analysis of geographical variation across the UK demonstrates significant 
inequality in rates of resection. This variation was demonstrated in studies 
covering 1998-200811-13, prior to the increases demonstrated in Figure 1-3. Analysis 
of 2010-2013 English lung cancer registers show that geographical variation 
persists with resection rates ranging from 9.3% to 17.2%, with similar variation for 
rates of chemotherapy and radiotherapy. Comparison of the quintile of highest 
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resection rates of treatment to the lowest gives an adjusted (age, sex and cancer 
stage) hazard ratio for survival of 0.80 [95% CI 0.75-0.84]14.  
An increase in the rate of surgical resection has consistently been shown to be 
associated with reduced mortality11-14 highlighting the potential for improvement 
in UK practice. A caveat to this argument is that there is limited randomised 
control trial evidence that specifically investigate which patients actually benefit 
from surgery4. Drives to increase resection rates must be balanced by appropriate 
evidence driven patient selection. 
1.1.2.1 Methods of lung resection  
Lung resection has developed in line with other surgical specialties towards a 
minimal size of resection by a minimally invasive approach. This equates to 
preferentially performing lobar resection in favour to pneumonectomy and 
utilising video-assisted thoracic surgery (VATS). Nationally pneumonectomy rates 
have fallen from 40% in 1980 to 5% in 2015 having been superseded by lobectomy 
and wedge/segmentectomy resectiona 9. The 2015 European Society of Thoracic 
Surgeons Database Annual Report demonstrated that the UK now lead the way 
within Europe in both minimal resection and minimally invasive approach to lung 
resection; 84.9% of UK lung resection by lobectomy vs 71.2% average with 55.3% 
of cases performed by VATS vs an average of 22%15. Interestingly the increase in 
lung resections described in section 1.1.2, is predominantly due to an increase in 
the number of VATS lobectomies9.  
1.1.2.2 Mortality following lung resection 
In-hospital mortality rate following lung resection is relatively low given the 
degree of surgical insult in a population with multiple comorbidities16, 17. Crude 
mortality data for all lung resections from the European Society of Thoracic 
Surgeons reported a 30-day mortality following lung resection of 2% between 2011-
 
a As surgical practice continues the shift from pneumonectomy to lobectomy the generalisability of 
any research performed in a pneumonectomy population diminishes. As less than 5% of 
resections are pneumonectomies all further evidence presented in this thesis will relate to 
predominately lobectomy populations unless explicitly stated. Intuitively (and as demonstrated 
later in this thesis) any insult caused by lobectomy is generally lesser than pneumonectomy. In 
order to ensure that the work within the thesis remains relevant to current practice the focus of 
investigation is lobectomy populations. 
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201415. This is in a population who are invariably current or ex-smokers with high 
levels of cardio-pulmonary co-morbidities16-18. Long-term survival is poor in 
contrast and is influenced by grade of tumour at time of resection19, Figure 1-5. 
 
Figure 1-5 Cancer specific survival following lung resection by cancer stage 
Note worsening survival with increasing stage of cancer (I, II and III from top to bottom), median 
follow up 28 months. Image from O’Dowd et al.19. 
Surgery specific mortality rates can be seen in the 2015 Thoracic Surgery Registry 
Brief Report produced by the Society for Cardiothoracic Surgery in Great Britain 
and Ireland9. They demonstrated a greater survival to discharge with VATS 
lobectomy (mortality 1%, 57/5838 patients) compared to open lobectomy (2.1%, 
356/16984), VATS pneumonectomy (2.9%, 1/34) and open pneumonectomy (5.3%, 
107/2034). Whilst these results follow the increasing surgical and physiological 
insults of VATS vs open and lobectomy vs pneumonectomy, they do not detail 
conversions from VATS to open or the cause of death. Any VATS procedure with 
intra-operative complications or increased difficulty may be converted to open, 
this may hide a true mortality difference in terms of planned approach. With 
regards to VATS pneumonectomy, the numbers are too low for any robust analysis 
to be performed. Additionally, there are obvious implications from patient 
selection for procedures; surgical approach will be determined by size, spread and 
location of tumour(s) and therefore more advanced cancers will require more 
extensive surgery. As such crude mortality rates may only represent the difference 
in patient baseline risk. 
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The evidence base supporting the rapid shift in practice from open to VATS lung 
resection is divided. There is consistent evidence of reduced complications and 
peri-operative morbidity following VATS lobectomy. It is associated with reduced 
arrhythmias, re-intubations, blood loss, blood transfusions, chest drain insertion, 
post-operative pain/analgesia and length of hospital stay compared to an open 
approach20, 21.  
Retrospective database cohort studies have not demonstrated a mortality 
difference between open and VATS lobectomies20, 22, 23. Paul et al. found no 
difference in mortality with two large database reviews, both including over 6000 
patients. Investigation of in-hospital mortality (2010)20 and long-term survival 
(2014) (median follow-up of 40 months) found no difference between VATS and 
open lobectomy24. More recently, Falcoz et al. (2016) demonstrated a lower 
mortality rate with VATS lobectomy vs open in a propensity matched analysis of 
5442 patients22. Their matching however did not include pathological cancer stage 
resulting in the VATS group having more stage 1 cancers than the open group, 
potentially limiting the validity of the result.  
Further investigation of post-operative physical function, safety and cost-
effectiveness is underway in the 500-patient study, Video Assisted Thoracoscopic 
Lobectomy Versus Conventional Open LobEcTomy for Lung Cancer (VIOLET). The 
primary outcome in this RCT is to determine a difference in self-reported physical 
function five weeks following surgery in open and VATS lobectomy groups. A 
secondary outcome of the study is survival to one year, whilst this study is not 
powered to detect survival differences it represents the largest VATS vs open RCT 
to date25. Without robust large RCTs specifically powered to detect mortality 
difference between surgical approaches it is impossible to definitively state 
whether this change in practice will convey a mortality benefit. 
1.1.2.3 Morbidity following lung resection 
The relatively low post-operative mortality rate is balanced against significant 
early and late post-operative morbidity. Early post-operative morbidity leads to 
increased in-hospital26 and long-term mortality27-29.  
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1.1.2.3.1 Early post-operative morbidity 
The incidence of early post-operative morbidity following lung resection ranges 
from 18.4%-47%27, 28. This variation is, at least in part, due to differing definitions 
of post-operative complications used in these studies. In 2015 The Society of 
Thoracic Surgeons (United Kingdom) and the European Society of Thoracic 
Surgeons produced a joint standardisation of variable definitions and terminology 
that defined cardiopulmonary complicationsb following lung resection, Table 1-1.  
Table 1-1 Major cardiopulmonary complications following lung resection 
Definitions by The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons 
general thoracic surgery databases: joint standardisation of variable definitions and terminology30.  
Major complications are increased in pneumonectomy vs lobectomy, open vs VATS 
approach, >75 vs <75 years, with vs without cardiac comorbidities and predicted 
post-operative forced expiratory volume in 1 second <70% vs >70%17. A meta-
analysis of 20,755 patients by Pucher et al. demonstrated reduced overall survival 
after post-operative infectious complication (HR 1.92 [95% CI 1.50, 2.35]) and 
after any post-operative complication (HR 1.28, [95% CI 1.21, 1.34])27. Lugg et al. 
showed, even after excluding early post-operative deaths, patients who 
specifically develop post-operative pulmonary complications have decreased 
survival (median survival 40 months vs 45.8 months)28, Figure 1-6. 
 
b Whilst complications directly related to the operation itself (haemorrhage, haemo-/pneumo- 
thorax, air leak, empyema, bronchopleural fistula, infection, etc) have significant impact on 
immediate post-operative morbidity and mortality, discussion will focus on non-surgical 
complications as they more closely relate to the underlying hypothesis of this thesis.  
Major cardiopulmonary complications 
Respiratory Acute respiratory distress syndrome/acute lung injury 
Respiratory failure 
Need for reintubation 
Prolonged mechanical ventilation >24 h 
Pneumonia 
Atelectasis requiring bronchoscopy 
Pulmonary oedema 
Pulmonary embolism 
Cardiovascular Arrhythmia requiring treatment 
Acute myocardial ischemia 
Acute cardiac failure 
Stroke/transient ischaemic attacks 




Figure 1-6 Survival of patients with and without a post-operative pulmonary complication 
Kaplan-Meyer plot of survival of patients who develop a post-operative pulmonary 
complication(bottom line) vs patients without a complication (top line), median survival 40 months, 
[95% CI 34.1, 43.8] vs 45.8 months [95% CI 44.3, 47.3], p=0.006. Early post-operative deaths 
excluded. Mean follow-up 40 months. Image from Lugg et al.28. 
Our research group has completed the largest cohort study (253 patients) of 
unplanned admission to the intensive care unit (ICU) following lung resection 
published to date31. We demonstrated an unplanned ICU admission rate of 2.3% 
with an ICU mortality of 29.0% [95% CI 23.2, 35.3%] vs a mortality of 0.03% [95% CI 
0.01, 0.10%] in patients not admitted to ICU (p < 0.001). The majority of patients 
were admitted with respiratory failure (68.1%) of which the main causes were; 
infection (27.3%), sputum retention (15.4%), persistent air leak/surgical 
emphysema (6.7%) and acute lung injury (6.3%). Alternative reasons for ICU 
admission were; bleeding (6.4%), airway compromise (6.0%), acute kidney injury 
(5.2%), cardiac arrest (4.8%) and sepsis (2.8%). Subsequent analysis of the patients 
admitted to ICU demonstrated that the requirement for both mechanical 
ventilation with renal replacement therapy (OR 2.04, [95% CI 1.07, 3.90]) and RV 
dysfunction (OR 3.93, 95% CI 1.71, 9.03) were predictive of ICU mortality, data 
unpublished at time of writing. 
1.1.2.3.2 Late post-operative morbidity 
Patients face significant long-term morbidity following lung resection with 
reduced pulmonary function32-36, impaired quality of life (QOL)37-40 and reduced 
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exercise tolerance34, 36, 41-46. Two-thirds of patients of who survive 5 years or more 
following lung resection report at least one pulmonary symptom with a third 
reporting dyspnoea47. 
Lung resection is associated with a post-operative reduction in physical 
components of quality of life (QOL) scoringc 37-40. Möller and Sartipy demonstrated 
the relationship between pre-operative and 6-month post-operative QOL and 
survival with the Short Form-36 (SF-36) questionnaire; a reduction in pre-operative 
and the post-operative change in the physical component of SF-36 summary 
scores, was associated with reduced survival (HR 0.932 [95% CI 0.932, 0.985] and 
0.82 [95% CI 0.692, 0.985]). Of note, a reduction in physical function had the 
strongest association with reduced survival (HR 0.72 [95% CI 0.606, 0.855]). 
Multiple studies have investigated changes in exercise tolerance from pre-
operative baseline following lung resection with 6MWT41, stair climbs36, 
cardiopulmonary exercise testing (CPET)34, 41-45 and volumetric flow catheters46, 48, 
49. Exercise capacity measured by maximal consumption of oxygen (VO2 max) has 
universally been shown to decrease following pneumonectomy by a range of 16.1-
28%42, 46, 50-54 however the changes following lobectomy are less clear with studies 
demonstrating no significant change in VO2 max42, 46, 55 with others demonstrating 
a significant fall of 13-20.8%34, 44, 50, 52.  
The two largest studies to assess exercise capacity give conflicting results for 
patients undergoing lobectomy. Brunelli et al. used stair climbing to predict VO2 
max in 200 patients36 and Win et al. performed shuttle walk testing measuring 
distance completed in 110 patients56. Brunelli et al. investigated exercise capacity 
pre-operatively, at discharge, 1 and 3 months post-operatively, they found a 
persistent decrease in VO2 max in the patients that had undergone 
pneumonectomy (11–17.6%) but only a transient reduction at discharge in patients 
who had undergone lobectomy (12%)36. Win et al. showed a similar pattern of a 
greater reduction in pneumonectomy but the 3 and 6-month lobectomy follow-up 
 
c Poghosyan et al.s' systematic review demonstrate a post-operative improvement in mental health 
QOL. This may purely represent the difference in mental health QOL scoring prior to major 
cancer surgery against post-operative testing in survivors.  
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had persistent reduction in distance covered (reduction of 75m (17%) and 68m 
respectively (16%))56. 
1.1.2.3.3 Factors affecting late post-operative morbidity 
There is a clear difference in post-operative exercise capacity between 
pneumonectomy and lobectomy although the relationship between the change in 
lung function and exercise capacity is relatively poor. A decrease in forced 
expiratory volume in one second (FEV1) only partially accounts for the decrease in 
exercise capacity (R2=30%)51 and a decrease in VO2 Max (R2=18%)50. This suggests 
that it may not be solely a decrease in respiratory function that causes a reduction 
in exercise capacity. 
Cardiovascular limitation may limit exercise capacity following lung resection34, 
56. Nezu et al. performed CPET of 82 patients (62 lobectomy) and demonstrated a 
post-operative reduction in exercise capacity. Patients only demonstrated a 
reduction of cardiac function on exercise (reduction in maximal heart rate (HR) 
and O2 pulse (VO2 max/HR)) without any reduction in respiratory function34. The 
hypothesis of cardiovascular limitation following lung resection is discussed later 
in this chapter and throughout the thesis.  
1.1.2.4 Summary of management of lung cancer 
Whilst surgical management has progressed towards a minimally invasive 
approach, there is no definitive evidence of a mortality benefit compared to an 
open approach, there is however evidence favouring VATS in terms of morbidity, 
as detailed above. Lobectomy (vs pneumonectomy) has reduced post-operative 
morbidity and a smaller reduction in post-operative exercise capacity, if present 
at all. 
It is apparent that the increasing rates of resection and ages of patients 
undergoing resection will present the thoracic anaesthetist with older, sicker, 
higher risk and ultimately more challenging patients. Whilst surgical advances 
have limited peri-operative complications, the anaesthetist must also endeavour 
to advance their peri-operative management of such patients. To do so they must 
understand the challenges lung resection poses to a patient, particularly in 
reference to the debilitating post-operative dyspnoea (“pulmonary disability”). Of 
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note, 2013 guidelines for the assessment of patient suitability for lung resection 
concluded that: 
“Ultimately though, the factors that contribute to long-term pulmonary 
disability, either individually or in concert, remain largely unknown. This makes 
predicting who exactly will suffer long-term pulmonary disability following 
lobectomy or pneumonectomy largely speculative.” 
Alessandro Brunelli (2013)57 
1.1.3 The hypothesis of right ventricular dysfunction following 
lung resection 
It seems intuitive that removal of lung parenchyma alone could result in 
pulmonary complications and a reduction in exercise capacity but there is 
evidence that the pathophysiological mechanism is multifactorial with 
cardiovascular limitation widely hypothesised to contribute. Previous work has 
focused on the role of RV dysfunction following lung resection48, 49, 58-77. Early work 
by Reed et al. and Okada et al. hypothesised that RV dysfunction occurred and 
that it was caused by an increase in RV afterload48, 49, 58-60. Although their results 
are questioned based on the design of the studies and the validity of the methods 
of assessment of RV function used, the hypothesis remains widely accepted 
without definitive evidence78, 79. This hypothesis is the basis of this thesis and the 
evidence base will be explored in detail in Chapter 2.  
It is the hypothesis of our research team that RV dysfunction contributes to this 
“pulmonary disability”. Before describing the conflicting evidence to date and the 
work our research group has undertaken to demonstrate RV dysfunction following 
lung resection, it is imperative to understand the normal structure, physiology and 




1.2 The right ventricular pulmonary vasculature unit 
The RV has long been overlooked and under-investigated. An early description of 
the RV from 1628 highlights the persisting view that it purely acts as a conduit of 
peripheral blood to the lungs: 
“... And I ask, as the lungs are so close at hand, and in continual motion, 
and the vessel that supplies them is of such dimensions, what is the use or 
meaning of this pulse of the right ventricle? And why was nature reduced to the 
necessity of adding another ventricle for the sole purpose of nourishing the 
lungs?” 
Sir William Harvey, 162880 
In the almost 400 years since this description there has been slow improvement in 
the understanding of the importance of the RV. In 2006 the National Heart, Lung, 
and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right 
Heart Failure produced the first of a series of reviews of the RV to be published in 
Circulation81. It was their conclusion that: 
“The consensus of the working group is that the role of the right ventricle 
in a spectrum of cardiovascular diseases has been relatively neglected 
proportionate to its central importance.” 
Voelkel et al.81 
Additionally, they highlighted the need for RV “awareness” and for research to 
focus on the RV.  
A further review titled “Assessment of Right Ventricular Function in the Research 
Setting: Knowledge Gaps and Pathways Forward” was published in 2018 by a group 
of twenty experts convened by the American Thoracic Society. Whilst it highlights 
the progress made in understanding of the RV there are clear gaps in basic 
knowledge regarding RV function and failure, in particular the method of assessing 
RV function and the specific mechanisms of RV failure82.  
Historically research has focused on the LV and to a lesser extent the pulmonary 
circulation. Much of the previous knowledge of the RV had been based on simple 
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translation of the LV literature83, 84. As this section will outline, the RV is very 
different to the LVd. 
1.2.1 Anatomy  
In understanding the structure and then physiology of the RV, it is again important 
to stress its differences and therefore its vulnerabilities compared to the LV. The 
two ventricles can be thought of as two pumps connected in series in a closed 
system. Both pumps must have the same (cardiac) output for the system to work. 
As both ventricles contract at the same (heart) rate they therefore must pump the 
same (stroke) volume. The differences between the work required of each pump 
is dictated by the structure of each circulation (pulmonary and systemic). The RV 
is only required to pump blood to the adjacent lungs whereas the LV must pump 
blood around the entire body. To achieve this the RV only needs to generate a 
small pressure compared to the LV. The nature of the pumps (muscular mass and 
ability to generate pressure) and of the vessels (structure, pressure and 
resistance) that form the circulations are matched to this requirement. A summary 
of the differences between the two ventricles and their circulations is included 
after further discussion, Table 1-2. 
1.2.1.1 Anatomy of the right ventricle 
The RV is the most anterior chamber of the heart and receives deoxygenated blood 
from the venous circulation via the right atrium (RA). The anatomy of the RV is 
again subsidiary to the LV as it wraps around the conical LV, Figure 1-7. This results 
in a triangular crescent shape curled around the LV with a shared interventricular 
septum between the two ventricular insertion points of the RV free wall. 
Additionally, there are encircling epicardial fibres linking the two ventricles81. The 
RV can be divided into three regions: inlet/sinus (tricuspid valve, chordae 
tendineae and papillary muscles), apex (trabeculated myocardium) and 
outlet/infundibulum (smooth muscle outflow tract to pulmonary valve)83.  
 
d This section will provide an overview of RV function and afterload. In subsequent chapters, there 






Figure 1-7 Structure of right ventricle and its relationship to the left ventricle 
Images formed from endocast of a normal heart. Right ventricle (RV) in blue/grey, left ventricle (LV) 
in red. A (view from anterior) RV blood flow travels from right atrium (RA) through the tricuspid 
valve (black dotted line) and out the RV outflow tract (black arrow) to pulmonary trunk (PT). Ao= 
aorta.  
B (view from apex) and C (3D model) RV wraps around the concentric LV. ICV= inferior vena cava. 
P= pulmonary valve. T= tricuspid valve. Images from Ho et al.85 and Sheehan et al.86 
As the pulmonary circulation is at a lower pressure than the systemic circulation 
the RV only performs 25% of the stroke work of the LV, this results in the RV having 
a thin musculature wall of 3-5mm in thickness (compared with 7-11mm in the LV)81 
and a lower overall muscle mass87. Within the RV myocardium, myofibres are 
predominately arranged longitudinally with some helical fibres that give torsion. 
The LV has an additional middle layer of circumferential myofibres that contract 
to decrease the cross-sectional diameter of the LV86. The musculature of the 
interventricular septum is predominantly LV fibres although there are some 
longitudinal RV83, 88. 
Contraction of the RV is by sequential contraction of the inlet, trabeculated 
myocardium and finally outlet88. The resultant contraction is formed through 
three movements; RV free wall toward septum (bellow movement), shortening 
(longitudinal fibres) and traction of RV free wall (from LV via insertion points)83. 
Due to the motion of the interventricular septum, ventricular insertion points and 
myofibre continuity between ventricles, LV contraction will lead to a degree of 
“passive” RV contraction. This is part of ventricular interdependence; the function 
of one ventricle is influenced by the other89. This dependence may be of particular 
importance in the lung resection population as isolated RV dysfunction may lead 
to LV dysfunction. 
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The blood supply to the RV is mainly by the right coronary artery in right-dominant 
coronary artery systems (80% of the population), with the anterior wall supplied 
by the left anterior descending artery88. Unlike the higher pressure LV the RV 
myocardium receives blood during systole and diastole although this is reduced in 
RV hypertrophy and/or pressure overload90.  
1.2.1.2 Anatomy of the pulmonary circulation 
The pulmonary circulation is described as a low pressure low resistance system in 
contrast to the high pressure high resistance systemic circulation91. The pulmonary 
vasculature is a series of bifurcations rapidly originating from the curved main 
pulmonary artery (PA), Figure 1-8. After bifurcating to right and left PA each 
subsequent division follows the corresponding conducting airways to the alveolar 
capillary beds92, 93. The majority of the surface area of the pulmonary vasculature 
is in the capillaries, 50-70m2 compared to 1.4m2 in the arteries and arterioles 
combined69, 93. The pulmonary arteries are elastic in nature with less smooth 
muscle than the systemic circulation. Whilst this ensures the vessels are compliant 
the low pulmonary artery pressure and resistance also limits its ability to control 
regional blood flow94, 95. 
 
Figure 1-8 Blood flow in pulmonary arteries 
4D cardiac magnetic resonance imaging of systolic flow in a healthy volunteer’s pulmonary arteries. 
A, venous blood returns to the right atrium (RA) from the inferior (IVC) and superior vena cava 
(SVC) but is blocked from entering the right ventricle (RV) by closed tricuspid valve. RV removed 
from image for clarity.  
B, RV propels blood through main pulmonary artery (MPA) to the bifurcation of into right (RPA) and 
left pulmonary arteries (LPA). Note the very short distance blood has to travel to the lungs.  
Image from Francois et al.96. 
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Table 1-2 Summary of right and left ventricle characteristics  
Data from Haddad et al.83 
1.2.2 Physiology  
The function of the RV is determined by its ability to eject blood by contraction 
and the loading conditions of the circulation it sits within, i.e. contractility, 
preload and afterload83.  
1.2.2.1 Contractility  
Contractilitye is: 
“the innate ability of the muscle to generate force.” 
Carabello 200297 
Contraction of the RV results in the pressure and flow changes demonstrated in 
Figure 1-9. There is a rapid increase in RV pressure (RVP) which will open the 
pulmonary valve once it exceeds pulmonary artery pressure (PAP) and lead to 
forward flow of blood in the MPA. Flow and pressure in the PA rapidly peak and 
fall with the pulmonary valve closing as the RV relaxes in diastole88, 98. Diastolic 
relaxation is caused by the energy dependent process of calcium re-uptake into 
the sarcoplasmic reticulum within the myocyte. The ability of the ventricle to 
relax in termed lusitropy99. 
 
e Contractility will be explored in greater detail in Chapter 5 
 
Right ventricle Left ventricle 
Shape Side: triangular 
Cross section: crescentic 
Elliptic 
Mass, g/m2 26±5 (17–34) 87±12 (64–109) 
Thickness of ventricular wall (mm) 2-5 7-11 
Ventricular pressures, (mmHg) 25/4 [(15–30)/(1–7)] 130/8 [(90–140)/(5–12)] 




Figure 1-9 Simultaneous right ventricle and pulmonary artery cardiac cycle 
Electrical stimulation of the right ventricle (RV) stimulates RV contraction following isovolumetric 
contraction/pre-ejection period (PEP). After the pulmonary valve opens a rapid increase in RV 
pressure (RVP) leads to increased pulmonary artery pressure (PAP) and flow. This coincides with 
peak rate of RV pressure development (RV dP/dt). Hangout interval (HOI) occurs when forward 
flow of blood in PA continues in spite of a negative pressure gradient between PA and RV. Image 
from Dell’Italia88. 
The period of RV contraction with a closed tricuspid valve prior to pulmonary valve 
opening is termed isovolumetric contraction (referred to as PEP in Figure 1-9). As 
the RV has a lower arterial pressure to overcome it has a shorter isovolumetric 
contraction time compared to the LV. At low pulmonary pressures there may be 
no isovolumetric contraction period with tricuspid closure and pulmonary valve 
opening simultaneously88. Timing of the closure of the pulmonary valve is more 
complex. Some authors argue that, under certain conditions, there is a “hangout 
interval” when PAP is greater than RVP, but the pulmonary valve remains open 
and there is still forward flow of blood, seemingly against a pressure gradient. It 
is thought this may be due to the momentum of blood through the outflow tract88. 
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Interestingly the hangout interval shortens with increasing pulmonary artery 
pressure suggesting this phenomena is reduced with an increase in afterload86, 98. 
The complex relationship between afterload and pulmonary blood flow will be 
discussed in detail in Chapter 7. 
1.2.2.2 Preload 
Preload is: 
“the load present before contraction”  
Haddad 200883 
Preload is dependent on intravascular volume status, passive/active RV filling, RV 
relaxation/compliance and factors external to the RV (pressures resultant of LV 
filling, respiration and pericardial constraint)100. Dell’Italia demonstrated the 
presence of RV Frank Starling mechanisms that link preload and contraction by 
measuring stroke volume following extrasystolic beats. The prolonged RV filling 
following an extrasystolic beat resulted in increased RV end-diastolic volume 
(RVEDV) and pressure (RVEDP), stroke volume (SV) and ejection fraction (RVEF) 
without a change in end-systolic volume or pressure, i.e. the RV increases its 
contractility in the presence of increased preload101. Excessive RV preload can 
impair cardiac output by overstretching of myocytes and impairment of LV filling 
by flattening the interventricular septum, an example of ventricular 
interdependence102. Additionally, volume overload of the RV can lead to tricuspid 
annular dilatation and tricuspid regurgitation reducing forward flow of blood to 
the lungs88. Classically the compliant RV is said to be tolerant of preload. 
1.2.2.3 Afterload 
Afterloadf is most accurately described as: 
“the load that the RV has to overcome during ejection.” 
Haddad 200883 
 
f Afterload will be discussed in detail later in this chapter and in Chapters 6 and 7. 
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It is easy to assume afterload is simply the opposing pressure in the pulmonary 
artery that the RV must exceed, i.e. to open the pulmonary valve and generate 
forward flow of blood, but this interpretation is overly simplistic. This can be seen 
in the hangout interval where forward flow of blood continues against a pressure 
gradient. In describing the hang-out interval Dell’Italia comments on the 
complexity of afterload: 
“The observation of continued forward flow in the presence of not only a 
declining pressure but also a negative pressure gradient emphasizes the inability 
of pressure measurements alone to define the mechanisms of right ventricular-
pulmonary artery coupling because total right ventricular afterload comprises 
resistive, capacitative, inertial, and pulse wave reflection properties of the 
pulmonary vasculature.” 
Dell’Italia 199188 
Afterload can therefore be considered to comprise of resistive (resistance to 
steady flow and inertia of blood) and pulsatile (absorption/storage and reflection 
of each pulse wave) components103. Given the highly compliant low resistance 
nature of the pulmonary vasculature it is unsurprising that the RV is intolerant to 
increases in afterload91. As the load resisting RV ejection increases the thin walled 
RV struggles to maintain its stroke volume and output102, Figure 1-10.  
 
Figure 1-10 Right and left ventricular response to increase in afterload 
Compared to the left, the right ventricle is unable to maintain its stroke volume in the face of small 
increases in afterload/pressure (P). Image from Chin et al.102 
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1.2.2.4 Relationship between contractility, preload and afterload  
Myocardial function can be pictured as a single myocyte contracting against a 
given load, Figure 1-11. On initial stimulation the myocyte will contract until it 
generates a tension greater than the opposing force (a-b in Figure 1-11), only at 
this point will myocyte shortening occur (b-c). Similarly, the myocyte maintains 
tension as it reverts to its original length (point c). The maximal velocity of 
shortening can be plotted as the maximal gradient of shortening after point b104. 
 
Figure 1-11 Isolated myocardium contraction 
Myocyte contraction against a given load generates an increase in tension (DT, top plot) and 
shortening (DL, bottom plot). Images from Cardiovascular Physiology Concepts by Klabunde104. 
As the load against which the myocyte contracts (afterload) increases a greater 
tension (DT) is required prior to shortening resulting in a reduction in myocyte 
shortening (DL) and the velocity at which the shortening occurs105, discussed later 
in section 5.2.3.1 page 150. Experimentation in skeletal106 and cardiac105 muscle 
has demonstrated that there is an inverse relationship between the force opposing 
myocyte contraction (afterload) and the velocity of myocardial shortening. This 
relationship is described as the force-velocity relationship, demonstrated by the 
red curves in Figure 1-12104.  
An increase in afterload decreases the velocity of shortening until the maximal 
force that the myocyte can generate (Fmax) is insufficient to overcome the 
opposing load and shortening does not occur. Conversely, as afterload decreases 
the velocity of shortening increases until a theoretical maximal velocity (Vmax), 





Figure 1-12 Change in force-velocity relationship with preload and inotropy  
Force-velocity relationship alteration with preload (A) and inotropy (B). Note inverse force-velocity 
relationship throughout and the change in maximal velocity (Vmax, y intercept) and force (Fmax, x 
intercept) with changes in preload and inotropy. Increased preload and inotropy will increase the 
velocity of shortening for the same afterload (increase in velocity at points c -> b -> a). Image 
annotated from Cardiovascular Physiology Concepts by Klabunde104. 
The force-velocity relationship of the myocyte is altered by preload and inotropy. 
As described by the length-tension relationship, an increase in preload will 
increase the starting tension of the myocyte allowing it to generate a greater 
tension (increase in Fmax) and a greater velocity of shortening for the same load, 
however, it will not change Vmax, left plot in Figure 1-12104. An increase in 
inotropy/contractility will lead to a right shift of the force-velocity relationship 
with an increase in Vmax and Fmax. As such the velocity of myocardial shortening 
is influenced by contractility, preload and afterload therefore an increase in 
afterload can be compensated by an increase in preload and/or contractility.  
1.2.2.5 Pressure volume loops 
The interaction between RV contractility, preload and afterload can also be 
demonstrated by pressure-volume loops103, Figure 1-13. Simultaneous 
measurement of intra-ventricular pressure and volume allow the calculation of 
elastance (the change in pressure for a given change in volume)107. Whilst this 
approach is predominately performed in animals as a research tool it gives a 
complete picture of RV physiology103, 108, 109. 
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1.2.2.5.1 Baseline function and definitions 
 
Figure 1-13 Right ventricular pressure volume loops 
Illustrative plots of simultaneous measurement of RV pressure and volume.  
A, RV volume increases from end systolic volume (ESV) without increase in pressure. At end 
diastolic volume (EDV) isovolumetric contraction occurs until the pulmonary valve (PV) opens. 
Ejection of the RV stroke volume occurs until the PV closes, followed by isovolumetric relaxation. 
B, Effective arterial elastance (EA) calculated from point joining (ESV, ESP) to (EDV, 0). 
C, End systolic elastance (EES) calculated as gradient to ESP of pressure volume loops of varying 
load. Images from Tedford103. 
Effective arterial elastance (EA) is described by Tedford as a “lumped measure 
of afterload” that accounts for resistive and pulsatile components103, 110. It is 
calculated from the gradient of a line joining end systolic pressure/volume to end 
diastolic volume111, see Figure 1-13C. A surrogate measurement of EA, calculated 
as mean PAP (MPAP) divided by SV, is markedly increased in pulmonary 
hypertension110, 112. 
End systolic or maximal elastance (EES or Emax) are load independent measures 
of contractility, they are often, somewhat inappropriately, used 
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interchangeably110, 113, 114. EES is calculated from the gradient of the end systolic 
pressure-volume relationship (ESPVR) of incrementally varied loading conditions, 
whilst Emax is calculated from the gradient of the line joining the points of maximal 
elastance of synchronised beats of varying load115, Figure 1-14. Often the two 
measures will give the same value although with the varying preloads used for 
calculation, subsequent changes in afterload can alter the time taken to reach 
maximal end-systole, i.e. it doesn’t occur at the corner of the pressure-volume 
loop. Frequently authors calculate EES but use the notation of Emax. 
In the RV, Emax has been demonstrated to be representative of changes in inotropy 
over a wide range of loading conditions and it may be superior to EES due to lack 
of isovolumetric relaxation period. Compared to the LV, RV pressure-volume loops 
tend to have a trapezoid shape due to the lack of a straight line of 
increasing/decreasing pressure at static volumes during isovolumetric 
contraction/relaxation. Measuring EES from the point of end-systolic point 
therefore may be inaccurate86.  
 
Figure 1-14 Comparison of end systolic and maximal elastance 
Demonstration of difference between end systolic elastance (EES) and maximal elastance (Emax), 
data from the left ventricle of a closed chest dog measured by conductance catheter. EES (solid 
line) joins the end-systolic pressure volume relationship (ESPVR) of varying load whereas Emax 
(dashed line) joins the points of maximal elastance for each loop (260ms in this example). Dotted 
lines represent Emax at 10, 40 and 60ms. Note steeper Emax than EES. Image from Kass and 
Maughan115. 
Coupling (Emax/Ea) is the ratio between ventricular and arterial elastance, i.e. the 
balance between contractility and afterload111. RV coupling varies on the method 
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used to calculate it and both Emax/Ea and Ea/Emax are used in literature103, 110-112, 
116, for consistency coupling will be calculated as Emax/Ea in this thesis. In a 
perfectly balanced system coupling would be assumed to equal 1, however a range 
of 1.5-2 is seen in normal human physiology109, 110.  
1.2.2.5.2 Right ventricular adaption  
The ventricular response to afterload demonstrates the adaption required to 
maintain coupling between the ventricle and the circulation. Leeuwenburgh et al. 
demonstrated the RV and LV response to increased RV afterload in lambs117, Figure 
1-15 and Figure 1-16. Five lambs were subjected to pulmonary artery banding and, 
after 8 weeks, conductance catheters were placed into the RV and LV. Preload 
reduction by gradual inferior vena cava compression allowed calculation of Emax. 
This was compared to five age matched control lambs. Additionally, a dobutamine 
infusion was administered to assess the ability of the ventricles to increase 
contractility, Figure 1-16. 
 
Figure 1-15 Right and left ventricular pressure volume loop in simulated pulmonary 
hypertension 
Lamb pressure-volume loops of the RV (left) and LV (right). Solids lines represent control lambs, 
dashed lines represent pulmonary artery banding lambs. Red lines depict Ea for the loop at 
maximal preload, i.e. baseline. Thick solid gradient line represents end-systolic elastance. Note 
increased RV pressure and volume in the banding group. Image annotated from Leeuwenburgh et 
al.s’ originals117. 
The adaption of the RV to chronic increase in afterload is apparent in the left pane 
Figure 1-15. To maintain the stroke volume and therefore cardiac output the RV 
must generate a far greater pressure, the increase in the height of the loop. This 
will increase the pressure at which the PV closes and so the angle of Ea (red dashed 
line). To achieve this increase in pressure generation the RV has to increase its 
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contractility (Emax) and its work (the area within the loop). In the experiment RV 
wall thickness increased in the banding group, this led to a reduced RVEDV 
potentially due to a decrease in compliance and therefore filling of the ventricle. 
The subsequent effect of the PA banding on the LV is shown in the right pane of 
Figure 1-15. The RV afterload increase reduces blood flow through the pulmonary 
vasculature (reduced stroke volume) and the higher pressure in the RV can 
compress the interventricular septum (reduced LVEDV and LVESV) leading to an 
underfilled LV, demonstrated by the dashed banding loops at a lower volume. As 
the systemic circulation is unchanged there is no change in Ea (afterload), no 




A dobutamine infusion predominately increases inotropyg and therefore 
contractility for the ventricles119. The banding group had a lower cardiac output 
both at rest and with dobutamine compared to the control group. The degree of 
increase in RV contractility in response to exercise is termed RV contractile 
reserve120 (RVCreserve, discussed further in 1.2.6.2). Under normal conditions the 
RV should be able to increase its contractility to meet increased demands, as seen 
in the control group response to dobutamine in the RV pane in Figure 1-16. The 
banding group has increased its contractility at rest to meet the demands and so 
has a lower relative increase its contractility with dobutamine, i.e. it has reduced 
contractile reserve. The relatively unaffected LV has reduced volume in the 
banding group but has a similar contractility at baseline and in response to 
dobutamine. 
 
Figure 1-16 Right and left ventricular response to dobutamine 
Illustrative pressure-volume loops of the right ventricle (RV) (left) and left ventricle (LV) (right). 
Solids lines represent baseline measures, dashed lines represent dobutamine infusion. Loop B= 
pulmonary artery banding lambs, C= control lambs. Images from Leeuwenburgh et al.117  
1.2.3 Right ventricular failure 
This section will review the mechanisms of RV failure (RVF) with particular focus 
on pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary 
hypertension (CTEPH) and pulmonary embolism (PE). Not only are these some of 
the most common mechanisms of RVF but they are also analogous to the 
 
g Dobutamine may also cause dilation of the pulmonary vasculature and reduced pulmonary 
vascular resistance at doses below 10mcg/kg/min but can increase PVR at higher doses 118. In 
Leeuwenburgh et al.s’ study the infusion was 2mcg/kg/min therefore there may be a slight 
degree of dobutamine induced reduction in PVR. 
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mechanism(s) of RVF following lung resection, discussed below. The specific 
methods of investigating RV function following lung resection will be explored 
later in 0, page 61.  
The hypothesised mechanism of RV failure following lung resection is secondary 
to an increase in afterload which may be; an acute intra-operative increase, a 
chronic post-operative increase, or a combination of the two. There is potentially 
an acute intra-operative increase in afterload secondary to one lung ventilation 
(OLV). Intra-operatively the patient is in the lateral position with the operative 
(non-dependent) lung raised. Institution of OLV leads to collapse of the non-
dependent lung and hypoxic pulmonary vasoconstriction (HPV) with the majority 
of blood flow diverted to the dependent lung121. The effect of HPV continues for 
hours into the post-operative period122 and there is multifactorial lung injury to 
the remaining operative lung and the non-operative lung123. These acute insults 
may increase RV afterload and are potentially analogous to the changes seen in a 
PE which may cause a complete occlusionh of the RPA/LPA or a lobar PA branch 
(similar to the arterial clamping in a pneumonectomy or lobectomy). Following 
lung resection there may be a chronic increase in afterload secondary to reduced 
lung volume. It is possible that both these mechanisms contribute to RV failure. 
Examination of the subtle distinctions between the response to acute and chronic 
afterload, may demonstrate the mechanisms of RV dysfunction following lung 
resection. 
1.2.3.1 Definition of right ventricular failure 
In 2018 two reviews were published on RVF. Ten experts in the field wrote a 
“state-of-the-art” paper for publication in Intensive Care Medicine124 and a 
multidisciplinary working group published an American Thoracic Society (ATS) 
Research Statement82. Prior to these publications there was no consensus 
definition of RVF. In the ATS review, “Assessment of Right Ventricular Function in 
the Research Setting: Knowledge Gaps and Pathways Forward” they defined RVF 
as, 
 
h Animal models of PE often use PA clamping to simulate an occlusive PE, a process almost 
identical to the anatomical change in lung resection.  
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“a complex clinical syndrome characterized by insufficient delivery of 
blood from the RV in the setting of elevated systemic venous pressure at rest or 
exercise.” 
Lahm et al.82 
Prior to the ATS definition, Haddad et al. had, separately to RVF, defined RV 
dysfunction as abnormalities of RV filling or contraction without signs of fluid 
retention, decreased systolic reserve and/or arrhythmia84. The ATS definition 
lowered the threshold for RVF and incorporated “dysfunction” into their definition 
of failurei. The authors stress that early recognition and early intervention may 
prevent the progression of the previously termed “RV dysfunction” to symptomatic 
RVF and that acute deterioration may occur at any stage82. Ultimately, RV 
dysfunction can be thought of as asymptomatic RVF under the definitions of both 
the ATS and Haddad et al. 
The RVF definition also covers multiple RVF phenotypes. The primary 
differentiation is between acute and chronic RVF, both have differing mechanisms 
of disease and likely different mechanisms of response. There is, however, 
considerable overlap between acute and chronic RVF and there is potential of 
acute deterioration in both82. 
1.2.3.2 Classification of right ventricular failure 
The American College of Cardiology Foundation/American Heart Association Task 
Force classify chronic RVF into four stages, A-D. Stages range from at risk of PAH 
and/or RVF (Stage A) to requiring circulatory support (Stage D), Figure 1-17. Whilst 
patients often progress through the stages, clinical deterioration may be 
prevented or even reversed with appropriate identification and management82. 
Acute deterioration may occur at any stage of RVF, often precipitated by 
infection, PE or disease progression. This may result in a cycle of reduced RV 
function leading to hypotension, impaired myocardial oxygen supply due to 
reduced coronary prefusion gradient (especially if increased RV pressures) and 
 
i As detailed in Chapter 2 the existing evidence base of RV response to lung resection is contested 
and predates this change in definition. Whilst it is the hypothesis of our research group that RV 
failure, as per the ATS definition, occurs following lung resection, the publication of our work 
and the bulk of this thesis predate this change. As such RV dysfunction will be used in this 
thesis to describe a reduction in RV function. 
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arrhythmias. In patients with PAH that require hospitalisation with RVF there is a 
14% in hospital and 35% 1 year mortality125. 
 
Figure 1-17 Classification of right ventricular failure 
Note the low threshold for Stage A and patients are asymptomatic until stage C. PAH= pulmonary 
artery hypertension. RVF= right ventricular failure. Image from Lahm et al.82. 
1.2.3.3 Mechanism of right ventricular failure in chronic pressure overload 
As the RV is subjected to chronic pressure overload (RVPO) it will maintain 
coupling by increasing contractility in parallel with the increase in afterload (Ees 
and Ea in Figure 1-18). Similarly, a reduction in Ea will cause a reduction in Ees 
(highlighting the therapeutic potential of afterload reduction). As disease 
progresses, the coupled state is initially maintained with a gradual increase in 
RV volume and decrease in stroke volume. Uncoupling occurs when the RV is no 
longer able to maintain increased contractility, leading to reduced Ees/Ea with 
further decreases in stroke volume and further dilation of the RV82, 126. 
Uncoupling is not necessarily triggered by an increase in afterload. The process 
of ventricular adaption to afterload leads to detrimental ventricular interactions 
and increased oxygen demand with impaired supply, discussed below, exhaustion 




Figure 1-18 Right ventricular adaption in pulmonary hypertension 
Ea= arterial elastance (afterload). Ees= end-systolic elastance (contractility). Ees/Ea= coupling. 
Contractility initially increases with afterload to maintain coupling until uncoupling at which point the 
RV dilates and stroke volume is reduced. mPAP= mean pulmonary artery pressure. Image from 
Vonk-Noordegraff et al.126 
The concept of impaired coronary blood flow to the RV in pulmonary arterial 
hypertension (PAH) has been elegantly demonstrated by van Wolferen et al. 
through comparing left and right coronary blood flow between patients with PAH 
and controls127. Under normal loading conditions the RV receives blood flow 
throughout systole and diastole (an even systolic/diastolic ratio) whilst the LV 
predominately receives flow during diastole due to the differences between wall 
tension and aortic pressure (a low systolic/diastolic ratio)83. As RV mass and 
pressure increase there is an inverse, proportional, reduction in systolic/diastolic 
ratio, leading to RV supply matching the pattern of the LV127. RV oxygen 
consumption also increases secondary to increased muscle mass, workload and 
decreased diastolic filling time (increased heart rate with reduced stroke volume). 
These factors ultimately result in an oxygen supply/demand imbalance126. 
As discussed in 1.2.1.1, the anatomical features of the RV and LV invariably leads 
ventricular interdependence. Interaction can either be thought of as in “series,” 
when reduced RV stroke volume leads to reduced LV preload or in “parallel” when 
geometric distortions of the RV and septum impairs filling of the LV128. Bowing of 
the interventricular septum into the LV can be caused by pressure and/or volume 
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overload of the RV89 and dyssynchrony in contraction/relaxation between the 
ventricles129, Figure 1-19. Increased RV afterload results in prolongation of the 
duration of RV contraction and asynchrony between contraction of the RV and the 
LV limiting LV early diastolic filling129. 
 
Figure 1-19 Right ventricular response to chronic increase in afterload 
Initial response of the right ventricle (RV) is to increase contractility and therefore muscle mass 
(coupling). Once this mechanism is exhausted, the RV dilates to maintain stoke volume causing 
bowing of septum into the LV. Finally, uncoupling occurs as the RV is unable to maintain cardiac 
output. Image from Vonk-Noordegraaf et al.126. 
The ATS review of RVF details that the molecular and pathogenic mechanisms 
responsible for RVF are poorly understood82. Angiogenesis occurs secondary to 
oxygen supply/demand imbalance and increased muscle mass with ventricular 
hypertrophy, an insufficient upregulation of these proangiogenic pathways may 
contribute to RV decompensation130. Additionally, altered contractile signalling 
and calcium handling has been demonstrated in chronic RVPO and is linked to 
myocyte stiffness and diastolic dysfunction131. Interestingly, this has been 
demonstrated following lung resection in pigs132. Understanding the multifactorial 
mechanisms responsible, would not only lead to better understanding of the 
development of RVF, but may provide targets for therapeutic interventions. 
1.2.3.4 Mechanism of right ventricular failure in acute pressure overload 
Whilst there is significant overlap in the acute and chronic response to RVPO, 
there are important distinctions. In contrast to global hypertrophy seen in 
response to chronic RVPO, a purely acute insult will result in thinning and scarring 
of the RV82, 133, Figure 1-20. A PE causes an acute occlusion of a pulmonary artery 




rapid increase in RV wall stress and exhaustion of myocyte energy resources. 
Within hours, a cascade of inflammatory chemokines, cytokines, cell infiltration 
and oxidative/nitrosative stress occurs that can lead to myocyte death within 
days82, 133. In rats, a simulated PE has been shown to cause acute RV myocardial 
inflammation (neutrophil infiltration) leading to myocardial fibrosis (macrophage 
infiltration) by 6 weeks following initial insult134, 135.  
There are regional differences in RV response to acute and chronic RVPO. Watts 
et al. demonstrated inflammation and scarring at the RV base and outflow tract 
following acute RVPO133-135. In chronic RVPO global hypertrophy occurs, CMR has 
demonstrated fibrosis in the area where the RV joins the septumj (RV insertion 
points)136 and that ischaemia predominately occurs in the RV free wall137. 
 
Figure 1-20 Comparison of right ventricular response to acute and chronic increases in 
afterload 
Left pane, an acute increase of afterload secondary to pulmonary embolism causes a rapid 
increase in right ventricular peak systolic pressure (RVPSP) (top) leading to thinning and scarring 
of the right ventricle (RV) (bottom). 
Right pane, in chronic pulmonary hypertension (PH) a gradual increase in RSPVP (top) leads to 
global RV hypertrophy of (bottom). 
Image from Watts et al.133. 
  
 
j  The inflammatory changes following PE demonstrated by Watts et al. are the basis for a 
subsequent study detailed in the future work section, 9.3.2 page 332 and Appendix 3.  
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1.2.4 Measures of right ventricular function 
As discussed in 1.2.3.1, a consensus definition of RVF was only established in 
201882. Of note, there is no agreed measure by which to define the term 
“insufficient delivery of blood from the RV” for this definition. The numerous 
methods and indices of quantifying RV function highlight the lack of a single ideal 
parameter.  
1.2.4.1 Contractility 
According to Carabello97, an ideal measure of contractility must be: 
• Sensitive to changes in inotropy  
• Independent of load  
• Independent of heart size and mass  
• Easy and safe to apply  
• Proven to be useful in the clinical setting 
Indices of contractility covered in this thesisk are summarised in Table 1-3. 
Ventricular elastance (Emax) is the most complete measure of RV contractility138, 
it is load independent and highly sensitive to changes in inotropy88, 139. It can be 
calculated from pressure volume loops as demonstrated above in 1.2.2.4 and 
Figure 1-13. The main limitations preventing widespread use is that conductance 
catheters are invasive, time consuming and expensive83. There are only a few 
studies of ventricular elastance in humans109, 140.  
Right ventricular ejection fraction (RVEF) and RV fractional area change 
(RVFAC) are the most widely used indices of RV function but both are dependent 
on loading conditions83. RVFAC is used as an estimate of RVEF in 2D imaging of the 
RV, although this can be inaccurate due to the complex 3D shape of the RV. They 
are however easily interpreted and are sensitive to changes in inotropy97.  
 
k Assessment of RV function within this thesis is performed predominately by CMR therefore 
indices that are measured by CMR are mainly discussed. 
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Tricuspid annular plane systolic excursion (TAPSE) is an echocardiographic 
measure of the distance the tricuspid valve annulus moves towards the apex 
during systole and S’ wave velocity is the velocity of this movement83. It is a single 
measure of longitudinal function taken from a 4-chamber view of the heart 
although it is influenced by loading conditions141. 
Strainl is a measure of myocardial shortening and measures deformation (change 
in shape of an object due to regional differences in velocities). It calculates the 
percentage reduction of the length of a region of the RV wall between systole and 
diastole142.  
Strain rate is the temporal derivative of strain and measures the rate of 
myocardial shortening. Both strain and strain rate correlate with RVEF/RVFAC143 
and contractility function as measured by sonomicrometry (insertion of 
piezoelectric crystals into pig myocardium)144. Impaired strain is predictive of 
adverse outcomes in pulmonary hypertension145. 
Table 1-3 Indices of right ventricular contractility  
RV= right ventricle. RVEF= RV ejection fraction. RVFAC= RV fractional area change. Interpretation 
from Haddad et al.83 
1.2.4.2 Afterload 
A complete understanding of RV function requires assessment of its loading 
conditions. There are numerous definitions and indices of right ventricular (RV) 
afterload but Haddad et al. state that it is most concisely described as: 
“the load that the RV has to overcome during ejection.” 
Haddad 200883 
 
l Strain analysis is described in detail and performed in Chapter 5. 
Functional parameters Load dependence Clinical utility 
Maximal RV elastance (mmHg/mL) + Most reliable index of contractility 
RVEF (%) + + + Clinical validation, wide acceptance.  
RVFAC (%) + + + Good correlation with RVEF  
Strain (%) + + + Correlates with stroke volume 
Strain rate (s−1) + + Correlates with contractility 
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If afterload is imagined in a single myofibre, the load it has to “overcome during 
ejection” can be pictured as a weight to be lifted. The force required to lift this 
is distributed over the cross-sectional area of the myofibre and can be measured 
as wall stress (force applied per unit area). With this definition, afterload can be 
depicted as the RV wall stress that occurs during ejection by LaPlace’s law, 
Equation 1-1. This definition is derived from the calculation of wall tension in a 
thin-walled sphere although as the RV is not spherical, this is only an estimate of 
stress and as the RV has a small radius and thin walls, RV wall stress is 
predominately influenced by RV pressure. 
!"##	%&'(%%	 ∝ 	*!"	+	,!"-!"
 
Equation 1-1 Right ventricular wall stress  
PEJ= pressure during ejection. REJ= radius of ventricle. HEJ= wall thickness. Equation form Tedford 
103. 
An ideal measure of afterload must assess the factors that determine RV pressure 
during ejection. Whilst numerous authors describe the factors that influence 
afterload83, 88, the most concise description is offered in Tedford’s review titled 
the "Determinants of right ventricular afterload”103 which states that afterload is 
determined by the sum of; 
• resistance to steady flow 
• compliance of the vessels 
• inertia of the blood 
• arterial wave reflections 
It can be argued that there is no single ideal/complete measure of afterload, there 
are however distinct approaches to its assessment. As detailed below and 
throughout this thesis there are numerous different methods of assessing 
afterload and each method only assesses a specific component of afterload103. 
Additionally, there is interdependence between these different components146. 
Throughout this thesis discussion of a change in afterload relates to the specific 
component(s) of afterload assessed by the measure discussed.  
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An important distinction between measures of afterload is if they assess resistance 
to steady flow (steady afterload) and/or impedance to pulsatile flow (pulsatile 
afterload)147. Conventional measures of afterload tend to rely on single 
measurements of flow or pressure, or a combination of such measurements and 
therefore they tend to only assess individual aspects. For example, pulmonary 
vascular resistance (PVR) only assesses resistance to steady flow as it is calculated 
from the means of PA pressure and flow (cardiac output over a minute), therefore 
it only accounts for steady afterload and fails to account for pulsatile afterload103, 
148, Equation 1-2. PVR is however, the mainstay of assessment of pulmonary artery 
hypertension and is predictive of both cardiac function and survival149, 150.  
*., = 	0*1* − 31*45  
Equation 1-2 Pulmonary vascular resistance 
PVR= pulmonary vascular resistance. MPAP= mean pulmonary artery pressure. LAP= left atrial 
pressure. CO= cardiac output.  
Afterload can also be assessed by combined interpretation of the changes in 
pressure and flow throughout the cardiac cycle by impedance analysis or wave 
intensity analysis (WIA). A comparison of the properties of the main methods of 
assessment of afterload is shown in Table 1-4, impedance analysis is discussed 
below and WIA is discussed in detail (and performed) in Chapter 7. 
Table 1-4 Overview of methods of afterload analysis 
PVR= pulmonary vascular resistance. MPAP= mean pulmonary artery pressure. WIA= wave 
intensity analysis. Table adapted from Su et al.151 
 PVR & MPAP Impedance analysis WIA 
Widely used in clinical practice Yes No No 
Easy to measure Yes No No 
Describes the steady state afterload Yes Yes Not directly 
Describes the pulsatile afterload No Yes Yes 
Provides information about the ventricle No No Yes 
Describes travelling waves No Yes Yes 
Wave separation possible -- Yes Yes 
Allows decompression waves -- No Yes 
Results presented in domain -- Frequency  Time  




RV end-diastolic volume (RVEDV) and pressure (RVEDP) can be used as surrogate 
measures for preload although both measures have limitations. RVEDP requires an 
invasive pulmonary artery catheter (PAC) for accurate measurement. RVEDV is 
challenging to measure as estimation of RV volumes is complicated by its shape, 
discussed below. Additionally, RVEDP and RVEDV do not have a linear relationship 
and therefore they cannot be used interchangeably83.  
1.2.5 Assessment modalities of right ventricular function 
Jiang et al. describe the challenges contributing to RV imaging due to the RV’s152: 
• complex geometry 
• heavily trabeculated myocardium 
• retrosternal position 
• marked load dependence 
Assessment of the RV can be performed invasively by catheterisation (conductance 
or PAC) or non-invasively by imaging (echocardiography, CT or CMR). Invasive 
modalities are superior at assessing pressure measurements, as they are measured 
directly and only are estimated by non-invasive imaging, whereas non-invasive 
modalities are superior at assessing structure, Table 1-5. Each approach has 
advantages/disadvantages but a truly complete assessment of RV function is only 
possible by a combination of invasive and non-invasive measures153, 154 . 
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Table 1-5 Comparison of common assessment modalities of the right ventricle  
−= not useful; += may be useful; ++= useful; +++= extremely useful 
Note CMR superior in all measures except for pressure assessment. PAC stroke volume calculated 
form cardiac output divided by heart rate. Conductance catheters not included due to limited clinical 
use. RV= right ventricle. RA= right atrium. PA= pulmonary artery. Interpretation from Benza et 
al.155. 
  






Volumes +++ ++ + 
Ejection fraction +++ ++ + 
Strain +++ ++ − 
Pressure −/+ ++ +++ 
Stroke volume +++ + +++ 
Mass ++ −/+ − 
Remodelling  +++ ++ − 
RA 
 
Assessment ++ + − 
Pressure − − +++ 
PA 
 
Dimensions +++ + + 
Distensibility +++ + −/+ 
Haemodynamics −/+ + +++ 
Quantitative lung flow +++ − − 
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The investigations carried out within this thesis will examine specific measures of 
RV/pulmonary vascular function. Each investigation will discuss measures and 
methods of assessing RV function in depth, so only a brief overview of assessment 
will be detailed in this sectionm.  
1.2.5.1 Non-invasive assessment of right ventricular function 
Echocardiography assessment of the RV is challenging due to its retrosternal 
position, complex geometry and difficulty in determining the endocardial border 
of the trabeculated myocardium141. Complete assessment requires imaging of the 
RV from numerous planes and isolated measures of RV function need cautious 
interpretation85, 141.  
Contractility can be estimated by numerous measures including; RVFAC, RVEF, 
TAPSE and strain imaging, section 1.2.4. Compared to CMR RVEF measurement, 
2D estimation of RVEF had a strong association in healthy volunteers (r=0.8, 
p<0.001)157 whereas TAPSE had poor correlation with CMR RVEF in a lung resection 
population (r=0.34, p<0.01)156. Continuous wave Doppler assessment of the 
tricuspid regurgitant jet can estimate pulmonary artery pressures. This method 
has been shown to underestimate SPAP, with almost half of patients having a 
difference of >10mmHg with direct PAC measurement (the gold standard in 
pressure measurement)158.  
Cardiac magnetic resonance (CMR) imaging is the gold standard in assessment of 
RV volumes80. Imaging of the ventricles will construct a series of cine images (a 
video of the full cardiac cycle divided into frames) of short axis sections from the 
apex of the heart to the valves. Tracing of the endocardium will allow calculation 
of end-systolic and end-diastolic ventricular volumes and therefore ejection 
fraction159. With post-processing using feature tracking analysis, strain and strain 
rate can be measured for both ventricles from short and long axis images160, 161. 
 
m A comprehensive comparison of echocardiographic and cardiac magnetic resonance imaging of 
the RV in a lung resection population has been published by a supervisor of this thesis, Dr 
McCall 156. This paper is from the same study that the analysis in this thesis is based upon. It is 
not discussed in this section, except where values differ greatly from previously published 
literature, in order to demonstrate why the study was required based on previous literature. 
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Imaging of the pulmonary arteries allows measurement of blood flow/velocity and 
assessment of the cross sectional area of the pulmonary arteries162. 
There are disadvantages to CMR; it has limited availability, is expensive, generates 
numerous artefacts and requires specialist interpretation. Additionally, it requires 
patients to lie in the long, narrow and noisy bore of the scanner for up to an hour. 
Only certain patients are suitable as any ferromagnetic objects can become 
projectiles or overheat in the magnetic field therefore patients with certain 
pacemakers or metallic foreign bodies are excluded159, 163. The disadvantages limit 
its use in the clinical setting, except in specialist centres, but the advantages 
make it an ideal research tool. In PAH trials, the lower variability of CMR RV 
analysis and therefore smaller required sample size for study design has shown 
that CMR is a more cost effective research tool than echocardiography164. 
1.2.5.2 Invasive assessment of right ventricular function  
Central vein cannulation allows passage of catheters into the right side of the 
heart and the pulmonary artery. These catheters can directly measure pressure 
throughout the insertion allowing direct measurement of central venous, right 
atrial, RV, pulmonary arterial and pulmonary capillary wedge pressures165. Flow 
and therefore cardiac output can be estimated by thermodilution166. Additional 
measurements can be made by conductance and volumetric catheters. Whilst the 
technique is safe, compared to non-invasive assessment there remains a slight 
morbidity and mortality risk. In a review by Hoeper et al. of 7218 catheterisations, 
2 patients died directly from catheter related complication (PA rupture and a 
another deemed related but cause of death unexplained at autopsy) while 76 
patients had serious adverse events (haematoma, pneumothoraces, arrhythmia, 
vasovagal events and hypotension)167.  
Conductance catheters are equipped with a micromanometer channel and 
multiple electrodes at regular intervals from the coiled tip80, 168, Figure 1-22. When 
placed in the RV, they measure pressure directly from a continual fluid column 
and estimate volume from the electrical conductance of blood168, 169. Electrodes 
are positioned between the apex and base of the ventricle and a current is 
generated between the two ends. The electrodes within the RV then measure the 
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conductance and derive the volume of each “slice” (level of the heart at which 
they sit) and the ventricular volume is calculated as the sum of the slices170.  
 
Figure 1-21 Right ventricular conductance catheterisation 
Left pane, position of conductance catheter. Note electrodes along the end. 
Right pane, pressure-volume loops are generated allowing complete assessment of right 
ventricular function. Note higher peak pressure and lower end-systolic elastance (thick black line) 
in late pulmonary artery hypertension (PAH). Image from Champion et al.80 
Whilst this expensive technique has been predominantly used in animals109 it has 
recently been utilised in a lung resection population to investigate the effect of 
thoracic epidural anaesthesia on RV function140. Either balloon insufflation 
(usually within the inferior vena cava) or Valsalva manoeuvres can be performed 
to generate pressure volume loops over varying loads80, Figure 1-21 and section 
1.2.2.4. 
Volumetric pulmonary artery catheters (VPAC) use thermodilution to derive 
RVEDV and ejection fraction168. The difference from conventional pulmonary 
artery catheters is the presence of a rapid response thermistor, a specialised RV 
injection port and two intra-cardiac electrodes for ECG measurement171. Ejection 
fraction, cardiac output and RVEDV are calculated using the decay constant of 
temperature changes of blood within the RV measured by the VPAC’s thermal 
component172-174, Equation 1-3. Modern VPACs utilise a heating element in the RV 
to induce temperature change168 but the method of injecting ice-cold saline, as 
originally described by Dhainaut174, is depicted in Figure 1-22. 
,.67. = 	 45-,	+	,.68 
Equation 1-3 Calculation of right ventricular end-diastolic volume (RVEDV) 
RVEDV= right ventricular end-diastolic volume. CO= cardiac output. HR= heart rate. RVEF= right 




Figure 1-22 Calculation of ejection fraction from thermodilution curve 
Ice cold saline injected, the temperature (T) difference with each beat from baseline (TB) is used to 
calculate the residual fraction (RF) and therefore ejection fraction (EF). Image from Dhainaut et 
al.174. 
In spite of the once established research use of VPACs, there is little evidence of 
accuracy in the derived measurements171. Particular concern has been raised over 
the RVEDV measurement, calculated as per Equation 1-3, as it has been shown to 
be a poor predictor of preload and fluid responsiveness175, 176. Two studies have 
compared VPACs with the gold standard measurements of RV volume in patients 
with pulmonary artery hypertension173 and induced RV ischaemia168, raising 
concerns that VPACs may be inaccurate in these conditions. 
Hoeper et al. performed CMR and VPAC assessment in 16 patients with PAH and 6 
healthy controls173. The differences in RVEDV, RVESV and RVEF were marked in 
terms of difference in value but also the large standard deviation within the VPAC 
measures. Against CMR, VPAC overestimated RVEDV (180±35 vs 412±168mL) and 
RVESV (120±32 vs 372±178mL) and underestimated RVEF (34±10% vs 12±8 %). The 
differences between the measures increased with the degree of tricuspid 
regurgitation. CMR measurements in 119 patients by van de Veerdonk177 et al. 
demonstrated RVEDV, RVESV and RVEF values in keeping with the CMR results from 
the study by Hoeper et al.173 
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Hein et al. performed an animal study in 7 pigs comparing VPAC with conductance 
catheters168 with induced RV ischaemia (temporary ligation of the RCA). Similar 
to the CMR studies, VPAC overestimated RVEDV and underestimated RVEF when 
compared to the conductance catheter, Figure 1-23. The mean difference in RVEF 
(REF in figure) showed a VPAC bias of -9.9% and a proportional bias of increasing 
underestimation at higher RVEF whilst RVEDV showed a bias of 31mL with 
systematic overestimation by VPAC. The VPAC RVEF and RVEDV had low sensitivity 
(57% and 43% respectively) and specificity (71% and 86% respectively) for detection 
of RV ischaemia compared to the conductance catheter. The area under receiver 
operating characteristics curve (AUROCC) for the VPAC did not reach statistical 




Figure 1-23 Comparison of volumetric pulmonary artery catheter and conductance catheters 
in measuring right ventricular function parameters 
Top row, Bland-Altman plots for volumetric pulmonary artery catheter (PAC in figure) and 
conductance catheter (CC) measurement of right ventricular ejection fraction (REF in figure, on left) 
and right ventricular end-diastolic volume (RVEDV, on right).  
Middle row, receiver operator curves for REF (REF in figure, on left) and RVEDV (on right). 
Bottom table, area under receiver operating characteristic (AUROCC) curves, sensitivity and 
specificity analysis.  
Note superior performance by conductance catheter in middle and bottom rows. Images from Hein 
et al.168 
The studies of Hoeper et al.173 and Hein et al.168 question the validity of VPAC 
assessment of RV dysfunction. Given that these studies demonstrate that the 
VPACs are inaccurate in both PAH and RV ischaemia the validity of VPAC is 
particularly questionable following lung resection as these are potential 
mechanisms of the RV dysfunction, as discussed in Section 1.2.3, page 50. The 
study of Hein et al. had an accompanying editorial, the name of which conveys 
the evidence for their use: 
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“Pulmonary artery catheter determined right ventricular ejection fraction 
and right ventricular end-diastolic volume: Another case of “The Emperor Has No 
Clothes” 
Leibowitz 2009178 
1.2.5.3 Biomarker assessment of right ventricular function 
In clinical practice natriuretic peptides (brain natriuretic peptide (BNP) or its pre-
cursor NT-pro-BNP) and troponins are used to detect or monitor for ventricular 
dysfunction. Release of neither BNP nor troponin are specific to the RV, although 
in the absence of LV dysfunction they may indicate RV dysfunction. 
Brain natriuretic peptide (and its precursor NT-proBNP) are released in response 
to myocardial stretch179 and enlarged cardiac chambers180. In a meta-analysis of 
studies investigating adverse outcome following PE, an elevated BNP was 
associated with RV dysfunction and 30-day mortality181. It has been shown as an 
effective screening tool for RV dysfunction in patients with PAH182. In lung 
resection cohorts, elevated pre-operative BNP has also been shown to be 
predictive of post-operative atrial fibrillation 183-185. 
Troponin (I or T) are contractile proteins released secondary to myocardial injury. 
They are primarily used in the diagnosis of myocardial infarction, although non-
specific troponin release occurs in numerous cardiac diseases and following non-
cardiac surgery180.  
1.2.5.4 Assessment of right ventricular function following lung resection  
In the ATS review, described above in section 1.2.3.1 page 51, the authors detail 
the challenges faced in assessing RV function in a research setting. According to 
Lahm et al.82 an ideal measure of RV function would be: 




• Easily obtained 
70 
 
In clinical practice, trans-thoracic echocardiography (TTE) is the main method of 
assessing RV function but is inferior to CMR for almost all parameters presented 
in Table 1-5. The low cost, widespread availability and relative ease of 
interpretation however mean echocardiography is predominantly used in clinical 
practice83. CMR has greater sensitivity and reproducibility than 
echocardiography82 therefore in a clinical trial the ability of CMR to accurately 
detect a small change in RVEF could allow a reduced study sample size and negate 
the additional costs of CMR164.  
In a study investigating RV volume changes following lung resection, VPAC may be 
of limited value. They have questionable accuracy in patients with raised 
pulmonary pressures173 and RV ischaemia168, both potential mechanisms of RV 
dysfunction following lung resection78. Additionally, serial assessment by VPAC or 
conductance catheters subjects the patient to the risk of complications with each 
insertion167. Whilst CMR and conductance catheters are both deemed “gold 
standard” in individual aspects of RV assessment, CMR has the advantages of being 
non-invasive, more readily available and established in clinical practice168.  
1.2.6 Assessment of right ventricular afterload 
This chapter, along with Chapter 2, will describe how PVR’s inability to measure 
the pulsatile components of afterload may result in underestimation of the 
changes in afterload following lung resection. Studies that have previously 
assessed the change in RV afterload following lung resection, described later in 
Chapter 2, have exclusively assessed the change in steady state afterload by 
measuring PVR and PAP. Lung resection results in a unilateral ligation and 
occlusion of a proximal PA. As detailed below and in Chapters 6 and 7, this may 
alter the distribution of cardiac output between the lungs and lead to a marked 
increase in pulsatile afterload with little or no change in PVR and PAP. Ultimately, 
these studies may have missed the hypothesised changes in afterload following 
lung resection by only assessing the steady afterload. 
1.2.6.1 Pulmonary vascular resistance 
Pulmonary vascular resistance is the most commonly used index of afterload but 
there have been longstanding concerns regarding its widespread use. Of note, the 
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topic has received two editorials in the leading intensive care journal, Intensive 
Care Medicine, both titled, “Pulmonary vascular resistance. A meaningless 
variable” published in 1984 by Versprille186 and in 2003 by Naeije187. In the years 
between these publications, 7,158 papers were published reporting PVR 
calculations187, highlighting its enduring use. Naeije details that PVR is dependent 
on flow and vasomotor tone of the pulmonary vasculature at the time of 
measurement and therefore a single measurement can be influenced by either of 
these factors. He concludes that PVR is best defined at multiple points of flow and 
pressure, this can be achieved by pharmacological intervention (i.e. a dobutamine 
infusion, Figure 1-16 page 50) or with exercise187. 
1.2.6.2 Assessment of pulmonary vascular reserve 
The ability of the pulmonary vasculature to accommodate an increase in cardiac 
output (CO) has been termed pulmonary vascular reserve (PVreserve). It has been 
demonstrated in a combined CMR and PAC investigation of patients with CTEPH, 
before and after pulmonary endarterectomy (PEA), and healthy subjects by 
Claessen et al.120, 188, Figure 1-24. PVreserve is measured by the gradient of the 
linear increase in MPAP with CO, an increase in the gradient of the MPAP-CO 
relationship is interpreted as a decrease in PVreserve. Following PEA, patients 
have a lower resting indices of afterload (MPAP and PVR) than the patients with 
CTEPH although exercise testing reveals a similar rate of increase in MPAP with 
CO on exercise, i.e. there is a persistent reduction in PVreserve. Additionally, the 
post-PEA have decreased RVCreserve as they are unable to increase RVEF on 
exercise (discussed in 1.2.2.5.2). Of note, PVR did not change on exercise in any 
of the three groups120. Exercise testing therefore can reveal an underlying 
pulmonary vascular disease and increase in afterload that is not apparent at rest 




Figure 1-24 Pulmonary vascular and right ventricular contractile reserve 
Normal pulmonary vascular (PVreserve, gradual increase in mean pulmonary artery pressure 
(MPAP) on exercise) and right ventricular contractile reserve (RVCreserve, increase in right 
ventricular ejection fraction (RVEF) on exercise) demonstrated in the healthy subjects (green line). 
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have markedly increased 
MPAP and reduced RVEF at rest. Exercise testing reveals reduced PVreserve (increased gradient 
of MPAP-cardiac output relationship) and reduced RVCreserve (lack of increase in RVEF on 
exercise). Patient post-pulmonary endarterectomy (PEA) however have resting MPAP and RVEF 
similar to healthy controls although exercise reveals a similar reduction in PVreserve and 
RVCreserve to the patients with CTEPH. Images from Claessen et al120. 
1.2.6.3 Impedance analysis 
Impedance analysis has been described as the most comprehensive description of 
RV afterload103, 189. Impedance analysis is complex to perform and interpret, 
although it assesses the four components of afterload described by Tedford103, 
1.2.4.2. The main distinction (and complexity) of impedance analysis from other 
methods of afterload analysis is that it is performed and interpreted in the 
frequency domain. Flow and pressure profiles are measured simultaneously at the 
same point in the pulmonary artery. The profiles are decomposed by Fourier 
analysis into a collection of sinusoidal waves of increasing frequencies (ƒ) that 
when combined form the original wave. ƒ represents the number of complete 
sinusoidal waves in the decomposition of a single heartbeat, as ƒ increases the 
amplitude of the sinusoidal wave decreases. ƒ=0 is the mean (0 sinusoidal waves) 
of pressure/flow, whilst ƒ=1 has the greatest amplitude and therefore represents 
the greatest contribution to pressure/flow of any of the frequencies190. The 
impedance spectra, example shown in Figure 1-25, is formed by the modulus of 







Equation 1-4 Impedance calculation 
Z= impedance. P= pressure. Q= flow. n=harmonic number. 
 
 
Figure 1-25 Pulmonary artery impedance spectra 
Schematic example of impedance spectra plotted as impedance modulus against frequency. Z0 is 
impedance measured at 0Hz, i.e. steady flow and therefore measures pulmonary vascular 
resistance. Z1= impedance at first harmonic, largely influenced by wave reflection in proximal 
vessels. ZC= characteristic impedance, represents “stiffness” and resistance in large proximal 
vessels to steady flow. ƒmin=frequency at first impedance minimum and relates to wave speed and 
timing of wave reflections. Image from Champion et al.80 
1.2.6.3.1 Interpretation of impedance analysis 
Interpretation of impedance analysis is performed from the graphical display 
generated, Figure 1-25. There are 2 main sections of the spectra to analyse, the 
zero harmonic (Z0) and the harmonic numbers. Each give information on separate 
components of the pulmonary vascular tree190. Z0 is the modulus of flow and 
pressure at a frequency of 0Hz. The resultant modulus is the mean flow divided 
by the mean pressure, it is therefore equivalent to PVR and representative of the 
resistance of distal vessels. The harmonic numbers are representative of the 
contribution of the first 5 divisions of the proximal pulmonary vasculature to 
overall afterload191. The harmonics can be split into the lower order harmonics (Z1 
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and Z2) and the higher order “reflectionless” harmonics (ZC). The impedance at a 
frequency of 1Hz (Z1) is influenced primarily by wave reflection of the proximal 
vessel; significant wave reflections will result in an increased impedance at Z1. ZC 
is the sum of the impedance at higher frequencies; it measures the ratio of blood 
mass inertia to proximal vessel compliance and equates to the impedance of 
proximal vessels to steady flow103, 189, 190. ƒmin is the frequency of the first minimum 
of impedance, measured as the minimum point of impedance following the initial 
rapid decrease (Figure 1-25). It allows calculation of the pulse wave velocity (c) 
and distance to reflection site(s)103. 
1.2.6.3.2 Performing impedance analysis 
Impedance analysis was first performed in man by Milnor et al. in 1969192, but has 
never been adopted into clinical practice and therefore there remain a limited 
number of studies reporting its use. It requires simultaneous pressure and flow 
measurement in the PA; pressure measurement is performed invasively with a 
pulmonary artery catheter (PAC), high fidelity data requires a sensor at the tip of 
the PAC whilst lower fidelity data can be acquired with a standard PAC189. 
Accurate measurement of flow has been the main limiting factor; flow can be 
estimated from velocity measurement192, measured with a specialised sensor on a 
PAC193-196 or measured non-invasively by echocardiography of the PA197-202. As 
described in 1.2.5.2, the insertion of an invasive PAC has an associated morbidity 
and mortality risk. Following lung resection there is also a theoretical risk of 
disruption of the newly ligated branch of the PA.  
In Milnor et al.s’ original study, flow measurements were computed from pressure 
differences, although the author recognised this as a fundamental limitation of 
the study192. The first time an impedance study was performed with a specialised 
multi-tip PAC was in 1984 by Murgo and Westerhof 193 and subsequently in further 
studies194-196. The flow tipped catheter approach has largely been superseded by 
combined PAC pressure measurement and echocardiography flow measurement.  
Impedance analysis is challenging to perform accurately. This has been 
investigated by a paediatric research team in Colorado who have performed 
validation studies of a PAC pressure measurement and Doppler flow analysis 
method of assessing impedance199-201. Errors in pulsed wave Doppler assessment 
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of flow creates large uncertainty in impedance analysis at higher harmonics. They 
caution the use of impedance analysis without specific investigation of and 
correction for such errors200.  
1.2.6.4 Windkessel models 
Development of “lumped parameter” models such as the 2- element or 3-element 
Windkesseln models may overcome some of the limitations of impedance 
analysis204. First described by Westerhof et al. in 1971, the 3-element Windkessel, 
models the pulmonary vasculature as an electrical circuit with a proximal resistor 
of characteristic impedance (ZC) with a capacitor (compliance (C)) and resistor 
(resistance (R)) arranged in parallel. Investigation of this method still 
predominately relies on invasive monitoring to obtain flow and pressure 
measurements for calculation of each the individual parameters. The 2-element 
Windkessel does not include the ZC component and has been described to provide 
more “accurate data” than the 3-element model205. 
 
Figure 1-26 Three element Windkessel model 
The 3-element Windkessel model is an electrical circuit analogous to the pulmonary circulation. 
ZC= characteristic impedance, C= compliance. R= resistor. Image from Tedford103. 
1.2.6.4.1 Resistance - compliance time constant 
Numerous different mathematical approaches to calculate C have been suggested 
(ZC and R can be calculated from impedance analysis)204, 206, 207. The simplest 
method of estimating C (stroke volume/pulse pressure) and R (PVR) have been 
validated in 2 studies by Lankhaar et al.147, 148. These and multiple further 
investigations have shown that there is an inverse hyperbolic relationship between 
R and C, with the product of R and C constant, described as the RC time constant, 
Figure 1-27. Whilst the position on the hyperbolic curve changes with compliance 
 
n The Windkessel analogy was originally described by Frank as a two-element Windkessel in 
1899203 Other variations on this include a four and five element Windkessel model.  
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(pulsatile afterload) and resistance (steady afterload), the nature of the 
relationship is unchanged in the presence of PAH, interstitial lung disease, age or 
with treatment of PAH147, 148 208, 209.  
  
Figure 1-27 Resistance-compliance relationship 
Plot demonstrating the relationship between resistance (R), compliance (C) and the time constant 
(!). Patient A has mild pulmonary artery hypertension (PAH) at baseline (A1) and patient B has 
severe PAH at baseline (B1). An equivalent decrease in R (DR) in both patients results in a small 
increase in compliance (DC) for patient B (B2) but a large increase in compliance for patient A (A2). 
Patient A will have a substantial improvement in C (pulsatile afterload) and R (steady afterload) 
whereas patient B will only have a substantial improvement in R. This relationship is similar in 
reverse for an increase in R. Image form Lankhaar et al. 147 
The relationship between an increase in “steady afterload” (PVR, R) and the 
change in “pulsatile afterload” (compliance, C) for patients with mild and severe 
PAH are demonstrated in Figure 1-27. As the RC relationship is constant, the 
changes demonstrated with a therapeutic decrease in R therefore are also true in 
reverse, i.e. in an increase in afterload. If the patient starts at A2 with low 
pulsatile (C) and steady (R) afterload then PVR increases by DR to A1 there is a 
large increase in pulsatile afterload (DCA) relative to DR. If the patient starts at a 
point of high pulsatile and steady afterload (B2) then the resultant increase in 
pulsatile afterload is relatively small (DCB) from an identical increase in steady 
afterload by DR to point B1. As such the increase in pulsatile afterload in the 
setting of normal PVR, may be a more sensitive marker of RV afterload than PVR. 
This relationship has been demonstrated in patients with mild PAH, a small 
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increase in PVR is associated with a far greater relative decrease in compliance 
and the change in compliance is a better predictor of survival than PVR147, 210.  
1.2.6.4.2 Resistance – compliance time constant in individual lungs 
The RC time constant can be applied to each individual lung. Saouti et al. 
performed an informative study in 23 patients, 19 with CTEPH and 4 with chronic 
pulmonary embolisms, but without pulmonary hypertension146. They combined 
CMR flow and area measurements (MPA, RPA and LPA) with PAC pressure 
measurements in the MPA to form a 2-element Windkessel model. Of note, PA 
pressure was assumed equal in the MPA, RPA and LPA. From this they calculated 
PVR and compliance ((systolic–diastolic area)/pulse pressure) for each vessel, 
Figure 1-28. The distribution of cardiac output (CO) was influenced by the 
distribution of clots (and therefore afterload) between the RPA and LPA, they 
were termed low flow (higher afterload) or high flow (lower afterload) dependent 
on percentage of total CO. The low flow lung had higher PVR and lower compliance 
compared to the high flow lung. To combine the parameters from each lung, they 
added the compliances while the resistances were combined as resistors in parallel 
(1/Rtotal= 1/Rlow.flow + 1/Rhigh.flow). The finding that the combined values for R and C 
in the high and low flow PAs were equal to the calculated values in the MPA and 
the RC time constant was similar in all vessels suggests that the RC time constant 
is universal in the pulmonary vasculature.  
The authors interpret the finding of a similar RC time constant as evidence that 
the relationship between resistance and compliance is an “intrinsic property of 
each lung”, irrespective of the magnitude of flow or resistance. This means that 
unilateral resistance and compliance are independent of the other lung although 
the governing relationship (RC time constant) is similar in both lungs. They 
speculate that both resistance and compliance therefore originate from the same 
area of the pulmonary vasculature, namely the distal circulation. Through 
reinterpretation of CMR studies that have previously investigated PA 
compliance211-213, Saouti et al. demonstrated that the proximal PAs account for 
only a fifth of overall compliance with the remainder originating in the distal 
vasculature146. Vessel occlusion (or lung resection) may lead to an increase in 
resistance and a decrease in compliance secondary to reduction in the distal 
vasculature leading to a reduced blood flow in that lung (akin to the low flow lung 
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in Figure 1-28) whereas the contralateral lung is unable to compensate for the 
increase in flow as its relationship between resistance and compliance is constant. 
 
Figure 1-28 Resistance-compliance relationship in the main, right and left pulmonary 
arteries 
A and B, resistance (R) and compliance (C) in the main pulmonary artery (PA) (Total) and the right 
or left PA termed low or high flow lung. R calculated as mean PA pressure (measured in main PA, 
assumed constant between vessels) divided by mean flow in that vessel. Compliance calculated as 
systolic–diastolic area (in that vessel) divided by pulse pressure (in the main PA).  
C, RC time constant is equal in each individual lung and is equal to the total value. 
Images from Saouti et al.146. 
1.2.6.4.3 Resistance – compliance time constant in pulmonary artery 
occlusion 
The constant RC relationship may not apply in the case of proximal pulmonary 
artery occlusion (similar to following lung resection). Pagnamenta et al.207 
calculated RC relationship in dogs with two levels of simulated proximal PA 
occlusion (by ensnarement) compared to distal PA occlusion (glass microbeads 
injected into the right atrium). They demonstrated a reduction of the RC time 
constant in the proximal occlusion group, Figure 1-29, signified by a left shift of 
RC curve. This reduction results in reduced compliance for the same PVR following 
occlusion, the alteration of the proximal pulmonary vasculature (occlusion) 
therefore fundamentally changed the relationship between steady and pulsatile 
afterload whereas distal alteration (PE) did not. Of note, they caution against the 
use of Doppler derived echocardiographic estimation of MPAP in the setting of 
proximal PA occlusion as the normal correlation between SPAP and MPAP is altered 
by the reduction in compliance and RC time constant and therefore the derived 




Figure 1-29 Resistance-compliance relationship in disease 
Compliance (Ca, stroke volume/pulse pressure) against total pulmonary vascular resistance 
(TPVR, mean pulmonary pressure/cardiac output) following PA occlusion (ensnarement, black 
squares) and emoblisation (white triangles). Black line represent resistance compliance (RC) 
relationship for each group. PA occlusion leads to a left shift in the RC relationship from the 
embolism group. Note reduction in Ca for given TPRV in ensnarement group. Image from 
Pagnamenta et al. 207. 
Pagnamenta et al. also performed impedance analysis in this study, Figure 1-30. 
At a low level of proximal occlusion Z0 was unchanged (no change in PVR, 
representative of afterload contributed by distal vasculature) whilst Z1 and Zc 
increased (increased pulsatile and steady afterload contribution from proximal 
vasculature). Greater proximal PA occlusion subsequently led to an increase in Z0 
and further increase in Z1 and Zc. Embolization showed the opposite pattern, no 




Figure 1-30 Impedance analysis in proximal and distal pulmonary artery occlusion 
Impedance (Z) against frequency for healthy (baseline, solid line), pulmonary artery (PA) embolism 
(distal occlusion, dotted line) and proximal PA occlusion (ensnarement, dashed line). Note increase 
in steady afterload (Z0) only in embolism group whereas Z0, wave reflection (Z1) and proximal 
vessel resistance to steady flow (ZC) are all increased in PA occlusion/ensnarement group. Image 
from Pagnamenta et al.207. 
The results of Pagnamenta et al are similar to an impedance swine study of 
pneumonectomy by Heerdt et al.214. In 4 pigs, they demonstrated that, following 
pneumonectomy, there was a modest increase in MPAP and PVR, indicating 
minimal change in impedance from the distal vasculature. There was however a 
marked increase in Zc suggesting an increase in impedance from the proximal 
vasculature214. This supports the suggestion that PVR and MPAP may be unable to 
detect changes in afterload following lung resection. 
Table 1-6 Changes in right ventricular function and afterload following pneumonectomy 
Impedance analysis before (control) and on post-operative day 3 (POD3) following 
pneumonectomy in pigs. Note reduction in right ventricular ejection fraction (RVEF). There is only a 
small increase in distal vessel impedance, pulmonary vascular resistance (PVR) and mean 
pulmonary artery pressure (MPAP), but a marked increase proximal vessel impedance highlighted 
by the 56% increase in characteristic impedance (Zc). CO= cardiac output. Data from Heerdt et 
al.214.  












3.5 (0.2) 49 (2) 26 (2) 254 (16) 41 (4) 
POD3  
(n=4) 
3.4 (0.3) 41 (3) 30 (2) 295 (22) 64 (6) 
Percentage  
change (%) 
↓3% ↓16% ↑15% ↑16% ↑56% 
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1.2.6.5 Assessment of right ventricular afterload following lung resection  
Whilst PVR and MPAP are most commonly used to assess changes in afterload they 
only assess changes in steady afterload. The studies by Pagnamenta et al.207 and 
Heerdt et al.214 demonstrate that a proximal PA occlusion may lead to a marked 
increase in pulsatile afterload, not detected by isolated assessment of PVR and 
MPAP. If the RC time constant is unchanged and the baseline PVR is low then a 
marked increase in pulsatile afterload may result in only a modest increase in PVR 
(Figure 1-27) although if the RC time constant is altered by the proximal occlusion 
(as in Pagnamenta et al.207, Figure 1-29) then the increase in pulsatile afterload 
may occur without any change in PVR. 
Assessment of pulsatile afterload can be performed invasively by specialised PACS 
and impedance analysis or by CMR and assessment of measures of pulsatile 
afterload (discussed later in Chapter 6) or WIA (discussed later in Chapter 7). 
Similar to the assessment of RV function following lung resection, 1.2.5.4, CMR 
has the advantage of being non-invasive and can perform assessment of both RV 
function and RV afterload although it cannot measure PAP. Whilst a conductance 
catheter would allow simultaneous assessment of RV function and afterload peri-
operatively it would require repeated invasive catheter placement to assess post-
operative changes adding a significant burden to any participant involved in the 
study and an, albeit slight, risk of morbidity and mortality. 
1.3 Conclusion 
Lung cancer is the leading cause of cancer death and although lung resection 
offers the best chance of cure, it is associated with significant post-operative 
morbidity. RV dysfunction, secondary to an increase in RV afterload, has been 
widely hypothesised as a potential contributory factor to this morbidity. As 
detailed above, assessment of RV function and afterload are challenging due to 
the irregular RV shape, load dependency, difficulty in imaging and complexity of 
RV afterload. Whilst each modality of assessment has limitations, CMR is the 




Chapter 2 Right ventricular response to lung 
resection - literature review 
2.1 Introduction 
This thesis builds upon a study undertaken by its supervisors investigating “The 
Right Ventricular Response to Lung Resection”. The aim of the study was to 
investigate the established hypothesis that RV function deteriorates following lung 
resection. This was the first study of lung resection patients to utilise CMR, the 
gold standard method of investigating RV volumes168, 215, to analyse cardiac 
function pre- and post-operatively. The study was required due to the lack of 
consistent evidence for the hypothesis. In a 2009 review of RV function following 
lung resection, Pedoto and Amar stated: 
“Currently, it remains controversial whether routine lung resection leads 
to clinically significant changes in right heart function.” 
Pedoto 200978 
The evidence base on which this conclusion was made is flawed due to the 
potentially inaccurate methods in which RV function was assessed, namely 
volumetric pulmonary artery catheters (VPACs) or echocardiography. This chapter 
will discuss the major studies, highlighting their insights and limitations. It will 
summarise the evidence to date for the existence of RV dysfunction following lung 
resection, whilst focusing on specific papers that investigate its potential 
mechanisms, the remit of this thesis.  
2.2 Method 
A database search of the Ovid Medline (R) Database, 1946 until search date, was 
performed in September 2017 and updated in November 2020o. The following 
search terms and results were generated; 
 
 
o Publications arising from “The Right Ventricular Response to Lung Resection” are excluded from 
discussion in this section.  
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1. exp Ventricular Function, right/ (6575)  
2. exp Ventricular Function/ (65272) 
3. exp ventricular dysfunction, right/ (5970) 
4. exp ventricular dysfunction/ (37908) 
5. cardiac function.mp. (29110) 
6. heart function.mp. (17425) 
7. ejection fraction.mp. (58176) 
8. ('pulmonary artery' adj2 pressure).mp. (11896) 
9. afterload.mp. (6633) 
10. pulmonary vascular resistance.mp. (8765) 
11. (lobectomy adj4 lung).mp. (1665) 
12. (lung adj2 resection).mp. (5412) 
13. exp Pneumonectomy/ (26594) 
14. 11 or 12 or 13 (29733) 
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 (179107) 
16. 14 and 15 (331) 
17. limit 16 to English language (215) 
18. limit 17 to human (179) 
The results were screened for studies investigating RV function and/or pulmonary 
afterload following lung resection, with investigations performed pre-operatively 
and post-operatively. Studies were only included if the extent of surgery was 
lobectomy or greaterp. Review articles and case reports were excluded, although 
their references were screened for additional studies. In total, 179 studies were 
screened with 42 selected for full text analysis and 21 of these studies were 
included in the review below. Five further studies identified from a review of 
references were included.  
The methods used in the studies vary, although they can be broadly grouped by 
the modality of assessment namely; volumetric pulmonary artery catheters48, 49, 
58-66, non-volumetric pulmonary artery catheters 67-69 and echocardiography70-77. 
These studies are summarised in Table 2-1, Table 2-2 and Table 2-3. Of note, 2 
 
p Sublobar resections may result in minimal change cardiopulmonary function. AS such they were 
not included in the literature review of the overall study, see section 4.3.5.1 page 117. 
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studies investigated RV function utilising echocardiographic strain analysis, they 
are discussed separately in Chapter 5. 
2.3 Pulmonary artery catheter studies 
2.3.1 Volumetric pulmonary artery catheter studies 
In the 1990’s two main groups, those of Reed et al. and Okada et al., investigated 
RV dysfunction following lung resection48, 49, 58-60. In combination, they 
investigated not only changes in RV function at rest and on exercise but also RV 
preload, afterload and contractility. Whilst the studies were innovative and gave 
a thorough investigation of RV function following lung resection, they are 
undermined by use of the VPAC178. Although the derived values (RVEF and RVEDV) 
are potentially unreliable, the studies remain informative, particularly in terms 
of possible mechanisms of RV dysfunction. The directly measured pulmonary 
artery pressures (PAP), along with the derived measures of cardiac output and 
therefore PVRq are more readily accepted and remain in clinical use.  
2.3.1.1 Investigations by Reed et al. 
In the USA during the early 1990’s Carolyn Reed and colleagues undertook three 
studies assessing RV function60 and the mechanisms of RV dysfunction following 
pulmonary resection including the role of contractility58, 59. Their hypothesis and 
study of RV dysfunction following lung resection is based on observational 
experience with translation of RV assessment methods from sepsis, shock and 
cardiac surgery populations.  
2.3.1.1.1 Effect of Pulmonary Vascular Resection on Right Ventricular 
Function, 1992. 
A VPAC was placed prior to induction of anaesthesia in 15 patients undergoing 
open lung resection (13 lobectomies, 2 pneumonectomies)60. Direct measurement 
of PA pressures and derived measurements of cardiac output, PVR, RVEF and 
RVEDV were preformed pre-induction, on opening of the chest, on partial and on 
 
qThe VPAC studies measure afterload by PVR. As detailed in the introduction and later in the 
afterload chapters, PVR is an incomplete measure of afterload. For ease of interpretation and 
consistency with the authors interpretation of the following papers, PVR will be discussed as 
afterload in this section. 
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complete PA branch clamping, at the end of resection and on closure of the chest. 
Repeated measurements were performed 4-6 hours, 1 and 2 days post-operatively.  
Intra-operatively RVEF and RVEDV were unchanged. Post-operatively RVEF was 
decreased from baseline (4-6 hours and lowest at POD2) and RVEDV was increased 
(POD 1 and 2). PVR and SPAP increased on occlusion of the branch of the PA 
(dependent on side and extent of surgery) although PVR was lower than baseline 
in the initial post-operative period. 
The authors’ conclusions are not a true representation of their results and 
potentially highlight the persistent hypothesis of RV dysfunction due to increased 
afterload. They conclude that RV dysfunction was present post-operatively and 
that afterload was not the “sole determinant,” in spite of only detecting a 
transient intra-operative increase in afterload temporally unrelated to the main 
POD2 drop in RVEF. They focus on the increase in RVEDV as “significant RV 
dilatation” although it is similar to the preoperative fasted state, a low RVEDV can 
be used as a marker of hypovolaemia216. Impaired contractility is suggested as an 
additional potential mechanism and their subsequent study is designed to 
investigate this. 
2.3.1.1.2 Assessment of right ventricular contractile performance after 
pulmonary resection, 1993 
In an attempt to remove the influence of RV loading conditions on contractility 
measurement, Reed et al. tested a mechanism of assessing the preload recruitable 
stroke work (PRSW)59. PRSW is proposed as a load independent measure of RV 
contractility generated when RV stroke work (RVSW, ((MPAP - CVP) x RVSV)) is 
plotted against RVEDV over varying load conditions. Given that the value for stroke 
volume is this calculation is derived from the VPAC, PRSW is subject to the same 
inaccuracies as VPAC RVEF calculation. Pre-operatively patients are given rapid 
fluid boluses in increments up to a total 1000ml with RVSW and RVEDV calculated. 
This is essentially a pilot study trialling the technique in a lung resection 
population of 10 patients.  
In this small study, they again find a reduced PVR and increased RVEDV following 
lung resection. Of note, SPAP was increased post-operatively, this may be 
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secondary to increased cardiac filling caused by a 1000ml preload challenge given 
pre-operatively as part of the study.  
2.3.1.1.3 Mechanisms of right ventricular dysfunction after pulmonary 
resection, 1996 
This two-part study was designed to investigate changes in RVEF after lung 
resection and the effect of pulmonary vasodilation on any such changes in a 
subgroup of patients58. 
Part one, 35 patients undergoing open lung resection (lobectomy and 
pneumonectomy) repeat the 1993 study protocol. RVEF reduced on POD2 with 
increased RVEDV but without any change in MPAP, SPAP or PVR. A subset of 6 
patients repeated the PRSW fluid loading on POD2. Post-operative RV PRSW (a 
surrogate marker of contractility) was unchanged, although post-operative fluid 
loading resulted in a marked increase in RVEDV. Unfortunately, the authors do not 
provide matched analysis of the difference in response to fluid challenge in the 6 
patients pre- and post-operatively. 
Part two, in 6 additional patients a prostaglandin E1 (PGE1) infusion was 
commenced intra-operatively and continued until POD2. PGE1 was given to reduce 
afterload with the hypothesis that this would prevent the reduction in RVEF. A 
reduction in PVR was maintained until POD2, although the reduction in RVEF was 
again present. Interestingly there was no difference in post-operative RVEF when 
the PGE1 group was compared to the control, i.e. reducing peri-operative 
afterload did not have an effect on RVEF. 
2.3.1.1.4 Summary of Reed at al studies 
This trio of studies demonstrates, with caution given VPAC controversies, a 
decrease in RVEF and increase in RVEDV without an increase in afterload or 
decrease in contractility.  
As the VPACs are kept in situ from insertion, the duration of the studies is limited. 
Therefore, they are peri-operative studies focusing on mechanisms of RV 
dysfunction with the latest assessments occurring on POD2 and no longer-term 
investigation of RV function. In the discussions, the drop in RVEF at POD2 is 
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repeatedly claimed by the authors to be a “peak”, without any measurements 
after this time point. We can see the pathophysiological argument, that RV 
dysfunction must be caused by an increase in afterload, is well established even 
in these early studies. In spite of the first two studies demonstrating reduced post-
operative PVR, the design of the third study investigates if RV dysfunction is 
prevented by reducing afterload. 
In conclusion to the third study the author states: 
“. . . RV dysfunction after pulmonary resection is not caused by primary 
alterations in contractility or immediate changes in afterload.” 
Reed 199658 
There are subtle signs of RV and pulmonary circulation dysfunction in the post-
operative response to fluid loading in the 1996 study. Direct comparison is not 
provided between pre- and post-operative response to fluid; yet there is a 
reduction in RVEF and an increase in RVEDV, RVSWI, SPAP and heart rate compared 
to the pre-operative response to fluid loading. This suggests that when the RV and 
pulmonary vasculature are challenged post-operatively there is an increase in 
afterload (increased PAP), RV dilatation (increased RVEDV) and an increase in 
contractility to maintain output (decreased RVEF and increased HR, increased 
RVSWI). 
2.3.1.2 Investigations by Okada et al. 
In Japan, Okada et al. contemporaneously investigated RV function following lung 
resection in a similar approach to Reed et al., although they also stressed the RV. 
They assessed RV function on exercise pre-operatively potentially as method of 
identifying patients at risk of RV dysfunction48 and post-operatively as a method 
of detecting RV dysfunction49. Additionally, both studies had a longer post-
operative follow-up period of 3 weeks. 
2.3.1.2.1 Right ventricular dysfunction after major pulmonary resection, 1994 
The aim of the study was to “confirm the existence of RV dysfunction” and to 
determine its causes49. VPACs were inserted into 20 patients undergoing open lung 
resection, 3 pneumonectomies and 17 lobectomies, with assessment of RV 
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function pre-operatively then 1 hour, 6 hours, 1 day, 2 days and 3 weeks post-
operatively. The final 10 patients underwent assessment of RV function during a 
single stage submaximal exercise protocol pre-operatively and 3 weeks post-
operatively. 
The resting results are similar to Reed et al.; decreased RVEF at all post-operative 
time points, with the nadir at day 2. There was no change in PVR or PAP. 
Interestingly the results show increased RVEDV on day 2, also observed by Reed et 
al., but the longer follow-up period shows that it returns to pre-operative levels 
by three weeks.  
Exercise results, for the first time, convincingly demonstrate the hypothesised 
post-operative RV dysfunction with increased afterload. Pre-operative exercise 
does not result in changed RVEF or PVR whereas on post-operative exercise RVEF 
decreased whilst MPAP, SPAP, PVR and HR all had a greater relative increase from 
rest than pre-operatively. Absolute values of RVEDVI and RVESVI were increased 
but there was no relative increase from rest.  
2.3.1.2.2 Right ventricular ejection fraction in the preoperative risk 
evaluation of candidates for pulmonary resection, 1996 
This study investigated potential predictors of post-operative morbidity, 
measured by complications and hospital length of stay48. Pre-operative and 
predicted post-operative lung function values were able to predict post-operative 
complications but failed to discriminate between patients who had increased 
length of stay and those that did not. Baseline RVEF did not predict complications 
or length of stay. When patients were divided into groups based on whether their 
RVEF increased or decreased on pre-operative exercise, the decreased RVEF group 
had increased complications and nearly double the hospital length of stay. At 3 
weeks post-operatively, both groups had unchanged PAP, CO and HR but the 
decreased RVEF group had a lower RVEF than pre-operative testing. 
2.3.1.2.3 Summary of Okada et al. studies 
Okada et al. (and their patients) performed a challenging protocol including 
exercise testing at 3 weeks post-operatively. The 3-week follow-up testing added 
additional patient burden and risk given the (presumed) second central venous 
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access and catheter placement, this is not detailed in the paper. Their second 
study is not designed or powered as a true pre-operative screening tool but does 
highlight a potential method of identifying “at risk” patients. 
The design of the studies allows retrospective determination of the reserve of the 
pulmonary vasculature and RV, i.e. their ability to cope with increased demand 
on exercise (increased cardiac output). The gradient of the linear relationship 
between MPAP and cardiac index/output is a measure of pulmonary vascular 
reserve (PVreserve)120. An increase in the gradient, a greater increase in MPAP per 
unit increase cardiac index, is a sign of reduced PVreserve. Okada et al.s’ studies 
can be reinterpreted to assess PVreserve from the results presented in their 
studies. An example is shown in Figure 2-1, the light grey lines depict each 
individual patients PVreserve before (dashed line) and after (solid line) lung 
resection. The longer darker lines depict the averaged results for the study and 
show an increased gradient (decreased PVreserve) following lung resection. This 
may be due to an inability of the reduced volume of pulmonary vasculature to 
accommodate the increased CO, meaning afterload rapidly increases.  
 
Figure 2-1 Pulmonary vascular reserve following lung resection, Okada et al. 
Relationship between mean pulmonary artery pressure and cardiac index before (dotted lines) and 
after (solid lines) lung resection. Light grey lines are individual patients from original Okada et al. 
paper. The long black lines are the mean values for each group. Note the steep gradient after 
resection in all of the subjects (lightly shaded solid lines). Image from Okada et al. 199449 with 
superimposed PVreserve before and after lung resection (long black lines). 
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In their second study, the difference in PVreserve between the increased RVEF 
and decreased RVEF groups can be determined on initial exercise testing. The 
decreased RVEF group have a greater increase in mPAP on exercise than the 
increased RVEF group suggesting reduced PVreserve48. This may indicate that 
patients with reduced PVreserve are at increased risk of post-operative 
complications. 
Right ventricular reserve (RVCreserve) is measured by the gradient of RVEF plotted 
against cardiac index. In health, RVEF increases on exercise, whilst in patients 
with pulmonary vascular disease (demonstrated in patients with chronic 
thromboembolic pulmonary hypertension), RVEF decreases (reduced 
RVCreserve)120. In the 1996 study by Okada et al. the patients with normal 
RVCreserve (increase RVEF on exercise group) had fewer complications, a shorter 
length of stay and no post-operative RVEF decrease48. In the 1994 study there is 
evidence of reduced RVCreserve following resection, pre-operatively RVEF is 
unchanged on exercise however at three weeks post-op RVEF decreases on 
exercise49. 
This approach of challenging the RV (with exercise) demonstrated, for the first 
time, increased afterload with a decrease in RVEF following lung resection. It is 
arguably more important to understand what happens to the RV when it is 
challenged in order to explain and potentially limit morbidity following lung 
resection.  
2.3.1.3 Investigation by Elrakhawy et al.  
The largest patient population investigation RV dysfunction is the recently 
published retrospective study of 178 patients (142 lobectomies and 36 
pneumonectomies) by Elrakhawy et al.62. Of note, a VATS approach was an 
exclusion criteria for inclusion in the study. Standard practice for lung resections 
(lobectomy and pneumonectomy) in their Egyptian institution included insertion 
of a VPAC post-induction, remaining in situ until at least 48 hours post-operatively. 
Any patient with pre-operative evidence of RV dysfunction or pulmonary 
hypertension was excluded from the study, the number excluded is not stated in 
the paper.  
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Pneumonectomy and lobectomy groups had reduced RVEF with increased RVEDVI, 
MPAP and PVR at all post-operative time points (3 to 48 hours). These changes 
were greater in the pneumonectomy group compared with the lobectomy group, 
Figure 2-2. 
 
Figure 2-2 Post-operative haemodynamic changes to lung resection 
Changes in right ventricular (RV) and pulmonary function following lobectomy (open circles) and 
pneumonectomy (closed stars), all values mean and 95% confidence intervals. Note the similar 
trends but differing degree of the reduction in RV ejection fraction (RVEF) and increase in RV end-
diastolic volume index (EDVI), mean pulmonary artery pressure (MPAP) and pulmonary vascular 
resistance (PVR) between pneumonectomy and lobectomy. Images from Elrakhawy et al.62. 
The results of this study vary significantly from the prospective studies in terms 
of PVR. This is the only study to find a persistent and meaningful post-operative 
rise in PVR in the immediate post-operative period whereas all others showed 
either no difference48, 49, 65 or a decrease58-60. The practice of VPAC insertion for 
all patients until 48 hours post-operatively is out of keeping with current 
practice217 and raises the question of what other aspects of care are different. 
Due to the retrospective nature of Elrakhawy et al.s’ study, there was no control 
over fluid management and no standardised approach to VPAC measurements.  
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2.3.1.4 Additional studies 
Lewis et al. investigated intra-operative changes in a high-risk population of 20 
patients undergoing pneumonectomy with moderately severe COPD with 77% of 
patients having pulmonary arterial hypertension (PAH) secondary to COPD at 
baseline63. Intra-operatively, RVEF decreased and PVR increased on PA clamping. 
RVP/RVESVI (described as a “reflector of contractility”) was unchanged suggesting 
that the increase in afterload was responsible for the RVEF deterioration however 
there was no association between RVEF and PVR. Of note, the response to PA 
clamping in the patients with PAH showed two distinct responses. Seven patients 
had a drop in PAP (8mmHg) whilst the other 6 patients had a rise in PAP (12mmHg). 
This may represent differing disease processes in the pulmonary vasculature and 
may explain why there was no overall change in PAP or PVR on clamping. 
Boldt et al. randomised patients into two different anaesthetic and extubation 
strategy groups without determining any post-operative difference between the 
groups61. Remarkably, this is one of the few remaining unretracted papers from 
the discredited German researcher218. Its results are mentioned for completeness, 
they are in line with the previous studies and will not be included in any further 
discussion. The ten pneumonectomy patients had RV dysfunction (reduced RVEF 
and increased RVEDV) and increased SPAP intra- and post-operatively. 
Bäcklund et al. performed a randomised controlled trial investigating the impact 
of the duration (1-day vs 3 days) of supplemental oxygen (O2) therapy on RV 
function and afterload in the post-operative period65. There were no consistent 
differences in RVEF, PVR or atrial fibrillation (AF) occurrence between the two O2 
therapy groups although raised PVR was associated with development of post-
operative AF. Interestingly, in the 1-day group RVEF decreased and PVR increased 
following cessation of O2 therapy. The authors argue that the cessation of O2 led 
to hypoxic pulmonary vasoconstriction resulting in an increase in afterload, PVR 
and reduced RVEF. They also attempted echocardiographic assessment of RVEF in 
all patients but, “reliable measurements of RVEF could not be obtained”. 
Mikami et al. compared post-operative changes between open lobectomy (10 
patients) and VATS lobectomy (13 patients) groups66. Neither group showed a 
change in RVEF from pre-operative values although the authors, somewhat 
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tenuously, comment that there was a trend to reduction in RVEF in the open group 
at six hours post-op (p=0.08). At this point RVEF was lower (relative to pre-op) in 
the open group compared to the VATS group. Similar to Reed at al58-60, total PVR 
actually decreased post-operatively in both groups.  
Mageed et al. investigated peri-operative changes in RV function, loading and gas 
exchange in 30 patients undergoing open/VATS lobectomy64. Measurements were 
taken pre-induction, 15 minutes post-induction and 2 hours post-operatively. 
Given that the patients had VPAC monitoring in situ for the duration of surgery, 
they unfortunately did not assess changes in RV function and loading before during 
and after institution of one lung ventilation (OLV) or PA clamping. They do not 
explicitly state whether the “15 minutes post-induction” time point is on OLV or 
not. There was no change in any parameter post-induction although RVEF and 
stroke volume index were reduced at 2 hours post-op. As the latest point of 
investigation was at 2 hours post-op, they do not investigate any potential 
recovery in RVEF following this time point.  
2.3.2 Non-volumetric pulmonary artery catheter studies 
Three further studies have investigated changes in afterload before and after lung 
resection using a conventional (non-volumetric) pulmonary artery catheter (PAC), 
Table 2-2, page 102. These studies investigate afterload changes peri-
operatively69, at 6 months67 and at 4 years68 following lung resection. The two 
studies with post-operative follow-up also assess the response to exercise 
(Nishimura et al.67 and Miyazawa et al.68) and support the reduced pulmonary 




The two exercise studies assess the change in the haemodynamic response to 
supine bicycle exercise. They were performed in the same Japanese centre67, 68. 
Nishimura et al. (1993) assessed 9 patients pre-operatively and 6 months post-
operatively and Miyazawa et al. (1999) assessed 8 patients using the same protocol 
as Nishimura et al. with an additional follow-up at 4 yearsr. Both were in mixed 
lobectomy and bilobectomy patients, the results are similar between the studies 
and are presented together.  
Compared to pre-op testing, resting MPAP was unchanged at 6 months but there 
was a modest increase at 4 years (17.8±3.9 vs 14.4±1.7mmHg pre-op, p<0.05, 
paired t-test). As there were no control subjects in this study the increase may 
result from other factors, such as aging219. On exercise, MPAP was increased at 
both post-op time points compared to the pre-op exercise values. Of note not all 
patients were able to complete the 50W exercise post-operatively. Similar to the 
reinterpretation of the work by Okada et al. presented in section 2.3.1.2.3 page 
88, PVreserve can be plotted for both Nishimura et al. and Miyazawa et al., Figure 
2-3. When the gradient (PVreserve) is plotted for each complete time-point there 
is a clear progressive increase in the gradient, i.e. there is a progressive reduction 
in PVreserve at 6 months post-operatively and a further reduction by 4 year post-
operatively.  
 
r It is difficult to determine whether Miyazawa et al.s’ study include any of the patients from 
Nishimura et al.s’ study. The pre-op and 6 months results are very similar but not identical 
although the loss of one patient may explain. Contrary to this both authors provide baseline 
details(age, surgery and pack years) about the patients in each study. Only 5 of the 8 patients in 
Miyazawa et al. correspond to Nishimura et al. assuming that the ages provided are age at 




Figure 2-3 Pulmonary vascular reserve following lung resection, Nishimura et al. and 
Miyazawa et al. 
Relationship between mean pulmonary artery pressure and cardiac index pre-operatively (circles 
and solid lines), 6 months (triangles and dashed lines) and 4 years (squares and dotted line) 
following lung resection. Closed shapes are Nishimura et al.67 open shapes are Miyazawa et al.68 
Values are taken at rest, 25W and 50W pre-operatively. As not all subjects were able to complete 
50W exercise post-operatively values presented are rest and 25W exercise. Note, the 
progressively increasing gradient after resection. Note very similar results at pre-op and 6 months 
between studies as there is likely at least some shared patients between the trials.  
Pulmonary vascular resistance, indexed to body surface area (PVRI), was 
increased, compared to pre-op, at 6 months67 and 4 years68. Similar to MPAP, PVRI 
increased on exercise compared to corresponding pre-operative exercise values. 
Of note, pulmonary capillary wedge pressure, representative of left atrial pressure 
and therefore LV filling, was unchanged at all time-points suggesting that the 
increase in afterload was not secondary to back pressure from the LV. Whilst RV 
function was not assessed in these studies, there is a clear increase in afterload 




Finally, Waller et al. investigated the peri-operative changes in PVR and MPAP in 
patients undergoing open lobectomy (11 patients) or open pneumonectomy (10 
patients)69. There was only a modest increase in MPAP (26.5mmHg [18-45] from 
19.5mmHg [16-27]) on PA clamping and an increase in PVR at the end of the 
surgery and 2 hours post-op. At 18 hours post-op there was no change in either 
parameter. Interestingly, they demonstrated an inverse relationship (r=-0.68, 
p=0.02) between the pre-operative MPAP and the peri-operative increase in MPAP, 
i.e. the patients with higher MPAP had a lesser peri-operative increase in MPAP. 
They suggest that this may be explained as the patients with pre-existing 
pulmonary ‘reactive vasoconstriction’ in the lung containing the cancer may have 
little subsequent change in blood flow and therefore pressure.  
2.3.3 Summary of pulmonary artery catheter studies  
It is unfortunate that a large proportion of this series of studies (those utilising 
the VPAC) is based on a flawed method of assessment. The main findings 
(decreased RVEF, increased RVEDV and unchanged RV contractility (RVSWI)) 
cannot be accepted given the lack of association between VPACs and the gold 
standards of RV assessment168, 173. These findings are however remarkably 
consistent between the studies with a relative decrease in RVEF at POD1/2 of 10-
20% (22% in pneumonectomy alone62), as seen in Table 2-1. 
The risk of complication of PACs limits the duration of the majority of these 
studies220, with only Okada et al. assessing RV function after 48 hours. Whilst they 
did not show any improvement in RVEF at 3 weeks, this is insufficient to 
definitively state that there is persistent RV dysfunction following lung resection. 
These studies may only demonstrate a transient peri-operative insult that may 
have limited clinical significance, as concluded from the echocardiography 
evidence, detailed below, by Pedoto and Amar78. 
VPACs tend to overestimate RVEDV and underestimate RVEF, the same changes 
seen following lung resection, but the design of all the studies ensures any 
comparison is between the same patient pre-, intra- and post-operatively. This 
within-subject analysis may mitigate for any bias in the measurement, as long as 
it is consistent and in the same direction. It is not possible to conclude that RV 
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dysfunction occurs following lung resection based on this evidence but clearly it 
warrants further investigation.  
There are, however, inferences that can be taken from the VPAC (and PAC) work 
if we look at the data which they can reliably measure, i.e. PAP, CO and (by 
calculation) PVR, Table 2-1 and Table 2-2. Intra-operatively, Reed et al. found 
that PVR and MPAP increased on PA clamping60. Post-operatively, PVR was shown 
to increase in the immediate post-operative period in two prospective studies65, 69 
and reduce in three other studies59, 60, 66. In the longer post-operative follow-up of 
Nishimura et al.67 and Miyazawa et al.68 increased PVR developed by 6 months and 
a modest increase in MPAP was only present at 4 years months post-operatively. 
Nishimura et al.67, Miyazawa et al. 68 and Okada et al.49 demonstrated that MPAP 
and PVR increase on exercise post-operatively. In Okada’s words: 
“exercise-loading pushes the RV to its limitations, unmasking a clear 
elevation in afterload.” 








 Comparisons	 RVEF  
(%change) 




15 (2)  Pre- vs intra-
op  
(PA occlusion) 
↔   ↔ - ­  ­  ↔ RV dysfunction only present post-op. 
Afterload increased intra-op but 
decreased post-op 








10 (0)  Pre- vs post-
op  
(1, 4-6, 24hrs) 
↔  ­  ↔ ¯  ­  ↔ No post-op difference in RVEF and 









¯  (14) ­  ↔ ↔	 ↔ ↔ RV dysfunction with no post-op 
difference in afterload. RV 
dysfunction similar in prostaglandin 
E1 group and control despite 
reduction in afterload 
10 (0) Part 
2 
Pre- vs post-
op (POD2)  
¯  (19) ­  - ¯  - - 
 POD2 pPGE1 vs 
control 





 Comparisons	 RVEF  
(% change) 









¯  (20) ­ (only 
POD2) 
- ↔ ↔ ↔ RV dysfunction with no 
difference in afterload 
Decrease of RVEF on 
exercise with marked 
increase in afterload on 
exercise 
10 (?) Exercise Exercise, pre-
op vs 3weeks 
post-op 








¯ in decrease - - - - ↔ Decrease in RVEF on 
exercise pre-op developed 





20 (20)  Pre vs intra-op  
(PA clamping)  
¯  (16) ↔ - ↔ ↔ ↔ Deterioration of RV function 
and coupling on PA clamping 






40 Lobectomy Pre vs intra-op  
(30min OLV) 
A/B 
↔/¯ (2) ↔/↔ - - ­/­ - Lobectomy were split into 
two groups based on 
anaesthesia and post-op 
ventilation. Only post-op 
ventilation group had RV 
dysfunction intra-op 
Pneumonectomy group had 
RV dysfunction and increase 
SPAP intra- and post-op 




↔/↔  ↔/↔	 - - ↔/↔ - 
10 Pneumo- Pre vs intra-op  
(30min OLV) 
¯ (22) ­ - - ­ - 









 Comparisons RVEF  
(%change) 




24 (2) Oxygen 
therapy 
Prolonged (P) 
vs short (S) O2 
group 
↔  ↔ ↔ ↔ - ↔ No difference between groups 
in O2 therapy. Decreased RVEF 
and increased PVR from 
baseline in S group 
 
10 (?)  Pre vs post-op 
(P/S) 
↔/¯ (16) ↔/↔ ↔/↔ ↔/­ - ↔/↔ 
Mikami et 
al. 2001 66 
23 (0)  Pre- vs post-op 
(6, 12, 24, 48 
hours) 
↔ - ↔ ¯ - - Comparisons of haemodynamic 
effects of VATS vs open 
surgery. RVEF lower in open 
that VATS at 24hours only. No 
change from baseline. 
Open (10) vs 
VATS (13) 
¯ (in open 
at 24 hrs) 
- ↔ ↔ - - 
Mageed et 
al. 2005 64 
30 (0)  Pre- vs intra-
op 
↔  ↔ ↔ ↔ - ↔ Peri-operative study 
demonstrating reduced RVEF 
at 2 hours post-op only. Intra-
op time point not defined if 
OLV or not. No follow-up after 
2 hours.  
Pre- vs post-op 
(2 hours) 







 Comparisons RVEF  
(% 
change) 




178 (36) Pneumo- Pre- vs post-
op (3, 6, 12, 
24, 48 hours) 
¯ (24) ¯ - ­ - ­ Largest retrospective review of 
patients undergoing lung 
resection. Only study to show 
increase in PVR and MPAP in 
lobectomy group. As 
retrospective the study 
highlights the markedly 
different routine management 
of lung resection in Egypt 
compared to UK.  
Lobectomy Prost-op (3, 
6, 12, 24, 48 
hours) 




Post-op (3, 6, 




¯ - ­ - ­ 
Pneumo= pneumonectomy. RV= right ventricle. RVEF= RV ejection fraction. RVEDV= RV end-diastolic volume. RVSWI= RV stroke work index. PVR= pulmonary 
vascular resistance. SPAP= systolic pulmonary artery pressure. MPAP= mean pulmonary artery pressure. VATS= video assisted thoracoscopic surgery. POD= post-




Table 2-2 Summary of changes in afterload following lung resection assessed by pulmonary artery catheter  
Study Patients 
(pneumo) 
 Comparisons PVR  SPAP MPAP Comment 
Nishimura 
et al. 199367 
9 (0) At rest Pre- vs post-op 
(4-6 months) 
­ ↔ ↔ Increased MPAP at rest post-operatively with increased 
MPAP and SPAP on exercise post-op. Also reduced 
stroke volume index on post-operative exercise. On 
exercise 
Pre- vs post-op 
(4-6 months) 
­  ↔ ­ 
Waller et 
al., 199669 
21 (10) Pneumo Pre- vs intra-op  ↔ - ­ Transient increases in PVR and MPAP in 
pneumonectomy group only. No changes in lobectomy 
group. Longest follow-up 18 hours with no changes at 
this time point. 
Pre- vs post-op  
(end + 2hrs) 
­ - ↔ 
Lobectomy Pre- vs intra-op  ↔ - ↔ 
 Pre- vs post-op  
(end + 2hr) 




8 (0) At rest Pre- vs post-op 
(4-6 months) 
­ ↔ ↔ Repeat of Nishimura et al. study with longer follow-up 
in same centre. PVR increased at rest by 42-48 months. 
Similar increase in MPAP on exercise post-operatively. 
Likely includes patients from Nishimura et al.67. 
Pre- vs post-op 
(42-48 months) 
­­ ↔ ­ 
On 
exercise 
Pre- vs post-op 
(4-6 months) 
­ ↔ ­ 
Pre- vs post-op 
(42-48 months) 
­ ↔ ­ 
Pneumo= pneumonectomy. RV= right ventricle PVR= pulmonary vascular resistance. SPAP= systolic pulmonary artery pressure. MPAP= mean pulmonary artery 
pressure. Echo= echocardiography. PAC= pulmonary artery catheter.  
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2.4 Echocardiography studies 
The echocardiographic studies can be broadly grouped into studies that focused 
on assessing RV loading conditions or assessing RV contractile function. Loading 
conditions were assessed my surrogate markers of RV dilation (RV volume or RV 
diameter) and estimated SPAP or RV systolic pressures (RVSP) whilst a variety of 
methods to assess contractile function were used. As previously described, the 
hypothesis was that increased afterload and impaired contractility resulted in RV 
dysfunction. 
2.4.1 Studies investigating right ventricular loading conditions 
Amar et al. performed a series of studies utilising TTE to investigating RV function 
and its relationship with dysrhythmias in patients undergoing lung resection, 
published between 1995-770, 71, 221. They investigated RVSP by measuring the 
tricuspid regurgitant jet (TRJ) velocity and calculation by a modified Bernoulli 
formula, Equation 2-1.  
Right	ventricular	systolic	pressure	(mmHg) = 4(9:;<	=>?	@:ABCDEF)! + >H 
Equation 2-1 Pulmonary artery systolic pressure 
TRJ= tricuspid regurgitant jet. RAP= right atrial pressure. 
The first paper, 1994, showed that patients who developed dysrhythmias had a 
higher TRJ velocity (a surrogate of SPAP interpreted as increased afterload)71. 
Only peri-operative blood loss of >1000ml and a TRJ velocity of ≥2.7 m/s were 
identified as independent predictors of dysrhythmia in a stepwise logistic 
regression. There was no evidence of RV enlargement in the group with 
dysrhythmia. 
The second paper, 1996, in the series specifically investigated changes in RV 
loading conditions70. In the 86 patients (47 lobectomy and 39 pneumonectomy) 
TTE examination was performed pre-operatively, on POD1 and once between 
POD2 to POD6 (usually POD3). Technically adequate studies of the lobectomy 
group were achieved in 79% pre-operatively, 87% on POD1 and 77% on POD2-6. 
 
s RVSP is assumed equal to SPAP unless RV outflow obstruction is present73. 
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Similar percentages of studies were adequate following pneumonectomy except 
on POD1 when only 59% were adequate. Neither group showed a change in RVSP 
or TRJ velocity at any time point, the POD2-6 RVSP and TRJ velocity were greater 
in the pneumonectomy group. RV enlargement was said to have occurred in 5 
pneumonectomy and 2 lobectomy patients although there was no definition, 
timing or degree of enlargement documented in the text. The 1997 paper 
investigated the use of prophylactic administration of diltiazem or digoxin to 
prevent dysrhythmias, there was no significant changes in RV function or RVSP in 
either group221. 
The authors argue that their results show increased afterload (RVSP) in 
pneumonectomy compared to lobectomy in the post-operative period following 
resection, but that there is no difference from baseline or impact on RV function. 
They however claim that this is in line with the results of Reed at als’ 1992 and 
1993 studies that show “mild elevations in pulmonary vascular resistance”. As 
detailed above, this is the opposite of their actual results and PAP/RVSP are not 
equitable with PVR or afterload. Additionally, they claim to demonstrate a lack of 
a “significant incidence of right ventricular systolic dysfunction” despite not 
discussing their methods of echocardiographically assessing RV function.  
Foroulis et al., 2004, performed a similar study to Amar et al.s’ 1996 TTE paper 
but extended the post-operative follow-up until 6 months73. By 6 months, SPAP 
had increased following pneumonectomy and, to a lesser extent, lobectomy. 
Interestingly there was a stepwise reduction in SPAP from right pneumonectomy 
to left pneumonectomy and then (bi)lobectomy suggesting SPAP change is related 
to volume of lung resectiont. A similar pattern is observed with a progressive 
increase in SPAP with increasing dyspnoea, significant for pneumonectomy 
(ANOVA, p=0.016, 35 patients) but non-significant for lobectomy. Post-operative 
RV dilation occurred in 60% of pneumonectomies and 23% of lobectomies, with the 
degree of RV dilatation associated with increasing SPAP. 
 
t In the relevant part of the table within the paper, right and left pneumonectomy are incorrectly 
labelled but the result is detailed in the text. As such the results detailed here are different to 
those stated in paper. 
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Venuta et al., 2007, further extended follow-up echocardiography until 4 years 
post-operatively74. In the pneumonectomy group, RV diameter and SPAP 
progressively increased with time, but there were no changes seen in the 
lobectomy group. There was a smaller increase in SPAP than Foroulis et al. 
(31.8mmHg vs 40.5mmHg) although this may be explained by the higher proportion 
of right sided pneumonectomy and larger resected lung volume in Foroulis et al.  
2.4.2 Studies investigating contractile function 
Kowalewski et al., 1999, performed detailed TTE assessment of the RV pre-
operatively and on POD2 in 31 patients undergoing open resection (22 
pneumonectomies, 9 lobectomies) 72. The aim of the study was to confirm the 
presence of RV dysfunction and investigate its relationship with dysrhythmia but 
contrary to Amar et al. their focus of investigation was RV function and not 
pulmonary vascular pressures. RV volume were calculated by subtraction of LV 
volume from the volume of both ventricles in systole and diastole with RVEF then 
calculated. 
The results are similar to VPAC studies; post-operatively the pneumonectomy 
group had decreased RVEF (19% relative reduction) and increased RV volume 
(RVEDV and RVESV), with no significant changes in the lobectomy group. Within 
the pneumonectomy group, the patients who developed post-operative 
arrhythmias had lower RVEF and higher RVEDVI than those who did not develop 
arrhythmia, however, the rate of arrhythmias was far greater in this study than 
previously reported; 64% of pneumonectomy patients in this cohort developed 
arrhythmia (10/14 atrial fibrillation, 4/14 supraventricular tachycardia) compared 
to 10-22% in previous studies60, 71, 222. All cases of arrhythmia occurred after the 
POD2 TTE imaging and they concluded that RV dysfunction leads to the 
arrhythmia.  
An explanation for the high rate of arrhythmias is not given in the paper although 
they discuss a subsequent change in practice to give prophylactic digoxin in the 
presence of post-operative RV dilatation. They report this results in reduced 
arrhythmias although this work has not been published. Separately, Amar et al. 
have demonstrated that diltiazem reduces the incidence of arrhythmias in high-
risk groups following lung resection221, 223. 
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Andaluz-Ojeda et al., 2011, attempted to overcome the limitations of 2D TTE 
estimation of RVEF by measuring tricuspid annular systolic plane excursion 
(TAPSE), a measure of the longitudinal contraction of the RV75. TAPSE (mm) was 
only slightly reduced (22.98±3.71 to 21.18±3.27) on POD3 in the 38-patient mixed 
pneumonectomy/lobectomy population. There was no change in LV function. 
Potaris et al., 2014, assessed 69 patients who underwent pneumonectomy with 
echocardiographic and functional assessment by New York Heart Association 
(NYHA) classification77. Patients were followed up for 12-months. During this time 
there was a progressive increase in SPAP and decrease in functional status. 
Increased SPAP at any time point was predictive of ‘suboptimal clinical outcome’, 
defined as reduction in functional status or death.  
Mandal et al., 2017, performed the most extensive TTE investigations to date in 
this population76. Twenty-six patients (5 pneumonectomies and 21 lobectomies) 
had detailed TTE examinations pre-operatively, POD2, POD3, POD7 and POD30. 
Unfortunately, this work has been negated by the statistical analysis of the results. 
A repeated measures analysis of variance has been performed only determining if 
there was a change over all time points. No subsequent analysis between pre-
operative and any post-operative time-points was performed. It is impossible to 
determine if the POD30 values are significantly different to pre-operative values. 
There however appears to be a trend of reduced RV function (TAPSE, RV strain 
and RV fractional area change) and increased RVSP at POD2 with recovery by 
POD7. 
2.4.3 Summary of echocardiographic studies  
TTE cannot directly assess pressure and so they have estimated RSVP/SPAP from 
the tricuspid regurgitant jet70, 73, 74, 76, 224. This technique has been demonstrated 
to have an accuracy of only 56% in a lung transplant population85, have a sensitivity 
of 60% and specificity of 74% for diagnosing PAH in an emphysematous 
population225 and so may be inaccurate in a lung resection population78. 
Additionally, as described in 1.2.6.4.3 page 78, proximal PA occlusion may alter 
the RC time constant of the pulmonary vasculature therefore the derived 
estimations of SPAP and MPAP from the TRJ may be inaccurate following lung 
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resection207. VPACs are superior in assessing pressure and therefore the afterload 
data from the VPACs studies are more reliable than the TTE studies.  
Measurement of RV volume is complicated by its shape and so accurately 
measuring RV volume by TTE is difficult85. RV diameter and volume are 
consistently shown to increase in the echocardiography studies however their 
measurement by TTE only show, at best, moderate association with CMR 
assessment156, 226. Only Kowalewski et al. estimate RVEF although their approach 
of subtracting LV volume from total ventricular volume has been shown to 
underestimate RVEF78.  
The reliability of the echocardiography studies must be questioned given the 
difficulties in obtaining echographic images following lung resection and the 
difference to the PAC results. The increase in SPAP demonstrated by 
echocardiography is directly contradicted by the PAC studies. The majority of 
studies suggest an increase in RVEDV which neither echocardiography nor VPAC 




Table 2-3 Summary of right ventricular changes following lung resection assessed by echocardiography  
 







47 Lobectomy Pre- vs post-op 
(POD1-6) 
- - ↔ 
 
No evidence of RV dysfunction except 
for higher RVSP in pneumonectomy 
39 Pneumo Pre- vs post-op 
(POD1-6) 
- - ↔ 
 
 Lobectomy  
vs Pneumo 
Post-op lobectomy vs 
pneumonectomy 




9 Lobectomy Pre- vs post-op 
(POD2) 
 ↔ - RV dysfunction following 
pneumonectomy with increased 
incidence of arrhythmia. 22 Pneumo Pre- vs post-op 
(POD2) 
¯ ­ - 
Foroulis 
’0473 
17 Lobectomy Pre- vs post-op  
(6 months) 
- ­ ­ Increased SPAP and RV dilatation, 
lobectomy > pneumonectomy. 
35 Pneumo Pre- vs post-op  
(6 months) 
- ­­ ­­ 
 Lobectomy  
vs Pneumo 
Post-op lobectomy vs 
pneumonectomy 




Venuta ‘0774 36 Lobectomy Pre- vs post-op  
(1 week, 3, 6, 12-
months) 
- ↔ ↔ Increase in SPAP and RVEDD in 
pneumonectomy only progressively 
over 4 years of follow-up.  
15 Pneumo Pre- vs post-op  
(1 week, 3, 6, 12-
months) 
- ­  ­ 
109 
 








Ojeda et al., 
201175 
47 Lobectomy Pre- vs post-op 
(POD1-6) 
- - ↔ 
 
No evidence of RV dysfunction except 
for higher RVSP in pneumonectomy 
39 Pneumo Pre- vs post-op 
(POD1-6) 




Post-op lobectomy vs 
pneumonectomy 
- - ­ in 
pneumo 
Potaris et al. 
201477 
69 (69) Pneumo Pre- vs post-op  
(1, 6, 12-months) 
- - ­  Progressive increase in SPAP. Increased 
SPAP predictive of “suboptimal clinical 




17 Lobectomy Pre- vs post-op  
(6 months) 
- ­ ­ Increased SPAP and RV dilatation, 
lobectomy > pneumonectomy. 
35 Pneumo Pre- vs post-op  
(6 months) 
- ­­ ­­ 
 Lobectomy 
vs Pneumo 
Post-op lobectomy vs 
pneumonectomy 




Pneumo= pneumonectomy. RV= right ventricle. RVEF= RV ejection fraction. RVFAC= RV fractional area change. RVEDV= RV end-diastolic volume. RVEDD= RV 
end-diastolic diameter. RVSP= RV systolic pressure. SPAP= systolic pulmonary artery pressure. POD= post-operative day.
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2.5 Cardiac magnetic resonance study 
Smulders et al. performed the only CMR study in this population prior to the RV 
Response to Lung Resection Study227. They imaged 15 pneumonectomy patients 
over 5 years after their surgery and compared the results to population reference 
values. Patients had a higher HR and lower SV than healthy controls, with a lower 
LVEF and LV mass. RVEDV was reduced, the only study to show this, whilst there 
was no evidence of RV hypertrophy and RV mass was within normal limits. 
Unfortunately, RVEF was not calculated and the authors do not comment on it. 
There was marked rotation of the heart following left sided pneumonectomy, 
Figure 2-4.  
 
Figure 2-4 Four chamber view of heart following left sided pneumonectomy  
Heart shifted from normal mediastinal position towards left. Note clear outline of right ventricle 
(diamond) wrapped around left ventricle (star). Image from Smulders et al.227 
Although this study is the first use of CMR in this population, it is limited by the 
design. The patient population imaged likely do not represent an average lung 
resection population; they did not have pulmonary or cardiac disease pre-
operatively and they were selected from a group of survivors. This is not the 
normal lung cancer population who frequently have COPD16 and have a 5 year 
survival following pneumonectomy of 30%228, 229. As patients were only scanned 
post-operatively a healthy control group from another study were used a 
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comparator. Little information is given regarding the group other than a 
substantial difference in age between the participants (64±10 years) and controls 
(43±14 years). Such a marked difference limits the conclusions that can be drawn 
from this study.  
2.5.1 Conclusion 
In conclusion the PA catheters and echocardiographic studies contradict each 
other. They each show a change in the measure that they are inaccurate in, i.e. 
VPAC shows a reduction in RVEF whereas echocardiography shows an increase in 
PA pressure. The converse is also true, (V)PAC show no change in PA pressure 
whereas echocardiography shows no change in RV function. Given the 
methodological concerns with all of the above studies, the hypothesised reduction 
in RV function following lung resection is unproven.
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Chapter 3 Thesis aims and hypotheses 
As detailed in Chapter 2, there is insufficient prior evidence to confirm the widely 
hypothesised presence of RV dysfunction secondary to an increase in afterload 
following lung resection. To investigate this the “RV Response to Lung Resection 
Study” (RV study) was designed and undertaken by this research groupu230. The 
study, detailed in Chapter 4, demonstrates the presence of RV dysfunction 
following lung resection and was designed to investigate the potential mechanisms 
that contribute to this dysfunction. This thesis will detail and perform the 
investigations into the hypothesised mechanisms of RV dysfunction following lung 
resection, as described below. 
3.1 Chapter 4, Generic methods and results 
This section will detail the design of the “RV study” and present the results that 
have been described elsewhere by McCall et al.156, 231-234. All the investigations in 
this thesis are performed on the cardiac magnetic resonance images from this 
study, as such this chapter describes the patient population for these 
investigations. 
3.2 Chapter 5, Right ventricular strain analysis 
Hypothesis 1: RV contractility decreases following lung resection. 
McCall et al. have shown that RVEF decreases following lung resection230, however 
RVEF is significantly impacted by loading conditions. Strain and strain rate analysis 
are considered to be less load dependent than RVEF and therefore may offer a 
more complete assessment of RV contractility and allow assessment of regional 
changes in RV function. Although speckle tracked echocardiography strain analysis 
did not demonstrate RV dysfunction233 in this study group, CMR strain analysis is 
the gold standard and can be performed post-hoc on the CMR images. Chapter 5 
details CMR strain analysis methodology and investigation. 
 
u The investigations are performed on CMR scans of the patients from the “Right ventricular 
response to lung resection” study230 
113 
 
3.3 Right ventricular afterload analysis 
Hypothesis 2: RV afterload increases following lung resection. 
As detailed in the Chapter 2, the hypothesis that afterload increases following 
lung resection is well established. The previous studies have however focused on 
incomplete measures of afterload and so they have been unable to demonstrate 
this. Chapter 1 justifies that the measures used in these studies (PVR and PA 
pressure) are insufficient to assess changes in afterload, particularly following 
lung resection. Such measures predominately assess the resistance to the steady 
flow of blood and therefore overlook the pulsatile components of afterload.  
Two separate methods of assessing pulsatile afterload will be presented. Both 
methods are derived from flow and cross-sectional area plots of the pulmonary 
arteries. The data which investigation Chapter 6 and Chapter 7 utilise are the pre-
operative, POD2 and 2-months post-operative CMR scans of the 27 patients 
described in Chapter 4. At each time-point velocity encoded flow sequences of 
the PAs (main, left and right) were performed. This allows both comparison over 
time within each vessel and comparison between left and right PA dependent on 
which side the resection was performed.  
3.3.1 Chapter 6, Pulmonary artery blood flow, acceleration time 
and distensibility 
Chapter 6 will assess conventional CMR measures of afterload taken directly from 
area and flow plots to test hypothesis 2. Additionally, it will describe changes in 
the distribution of blood flow in the pulmonary vasculature following lung 
resection. 
3.3.2 Chapter 7, Pulmonary artery wave intensity analysis  
Chapter 7 will combine the area and flow profiles to generate wave intensity and 
allow assessment of afterload in a time-domain based approach. This is the first 
use of wave intensity analysis in this population. 
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3.4 Chapter 8, Mechanisms of right ventricular 
dysfunction following lung resection 
Chapter 8 will combine the changes in afterload, and RV function (assessed by 




Chapter 4 Generic methods and results 
4.1 Introduction 
This chapter details the design, methods and initial results of the “RV Response 
to Lung Resection” study. As described in Chapter 2, a cardiac magnetic resonance 
study was required to investigate the hypothesised RV dysfunction following lung 
resection. Whilst the primary outcome of the study, post-operative change in 
RVEF, has been reported by McCall et al.230, the study was designed to perform an 
extensive investigation of the mechanisms of RV dysfunction following lung 
resection. All investigations undertaken within this thesis are performed on the 
data collected from this study. As such, this chapter will summarise the design, 
methods and patient characteristics of the study and briefly summarise the 
relevantv results reported separately to the analysis performed within this 
thesis156, 230, 233-236.  
4.2 Study design 
Prospective observational cohort study of patients presenting for lung resection 
of primary lung cancer.  
4.2.1 Primary outcome 
4.2.1.1 Primary outcome measure 
Change in CMR determined RVEF, at 2 days following lung resection compared to 
pre-operative values.  
4.2.1.2 Rationale for primary outcome 
To overcome the methodological issues of the previous studies, see Chapter 2, 
this study was designed to be the first sequential study of RV dysfunction utilising 
cardiac magnetic resonance (CMR) imaging, the gold standard in assessing RV 
function 80, 168. The hypothesis that RV dysfunction occurs following lung resection 
 
v There are other investigations performed as part of this study and they have been detailed 
elsewhere. Only the general study population and the aspects of the study that are relevant to 
the investigations within this thesis are described.  
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is well established but poorly investigated. As previously discussed, multiple 
previous studies have investigated both the presence and the mechanism of RV 
dysfunction following lung resection but there remains uncertainty over the true 
RV response to lung resection. These studies utilised echocardiography and 
volumetric pulmonary artery catheters (VPAC), both of which are potentially 
flawed in this population48, 49, 58-77. Although the accuracy of VPAC ability to 
measure RVEF is questioned237 these studies consistently demonstrated a post-
operative (absolute) reduction in RVEF of 6-9% on POD2 49, 58, 60.  
Pre-operative, POD2 and 2-month imaging allowed assessment of the acute and 
longer-term RV response to lung resection. Whilst RVEF is load dependent and is 
influenced by changes in contractility and afterload, Table 1-3 page 58, it is the 
most commonly used measure of RV function83.  
4.2.2 Secondary outcomes 
4.2.2.1 Secondary outcomes measures 
• Association of changes in RVEF with CMR and echocardiographically derived 
indices of contractility and loading 
• Change in RVEF (∆RVEF) compared to changes in left ventricular ejection 
fraction (DLVEF) over the same period 
• Association between biomarkers of myocardial and endothelial dysfunction 
and ∆RVEF  
4.2.2.2 Rationale for secondary outcomes 
• Association of DRVEF with CMR and echocardiographically derived indices 
of contractility and loadingw. 
Complete interpretation of RV function following lung resection requires 
assessment of RV function within its loading conditions. CMR allows assessment of 
RV preload (initial volume), contractility (strain), coupling and afterload 
 
w Echocardiographic assessment of RV function and indices of contraction and loading were 
investigated by Dr Philip McCall. Changes in CMR derived loading conditions and contractility 




(pulmonary artery diameter and flow analysis). The measures of CMR loading 
conditions defined a-priori within the study protocol are detailed below. All 
echocardiographic investigations, CMR coupling and preload investigations were 
performed Dr Philip McCall, results detailed below, whilst the CMR investigations 
of contractility and afterload are the basis of the investigations in this thesis and 
are explored in greater detail in the corresponding investigations. 
Preload, RV end-diastolic volume determined by manual planimetry of a “stack” 
of short axis images of the RV. 
Afterload, measured by pulmonary artery distensibility and flow analysis212. 
Afterload was also assessed by echocardiographic estimation of systolic pulmonary 
artery pressure (SPAP) (derived from the tricuspid regurgitant jet via the Bernoulli 
equation70) and measuring pulmonary artery acceleration time (PAAT) form pulsed 
wave Doppler interrogation of the RV outflow tract80. CMR based afterload 
assessment is performed in Chapter 6 and Chapter 7. 
Ventriculo-arterial coupling, matching between contractility and afterload 
(Emax/Ea)110.  
Diastolic dysfunction, E/A ratio determines the ratio of ventricular filling from 
passive early diastolic filling rate (E) and peak filling rate due to atrial contraction 
(A), discussed further in 5.2.3.2 page 151. 
Contractility, strain analysis was performed by echocardiography and CMR. 
Echocardiographic strain assessment was performed by speckle tracking 
echocardiography (STE). Strain is a dimensionless number that measures 
myocardial shortening, the ratio between the length of a myocardial segment 
after contraction to its initial length238. Speckle tracking utilises artefacts from 
echocardiographic images to track the shortening of myocardial segments 
throughout the cardiac cycle239, results below. CMR strain investigation performed 
in Chapter 5.  
• ∆RVEF compared to changes in left ventricular ejection fraction (DLVEF) 
over the same period.  
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Right ventricular function must be assessed with LV function. A decrease in RV 
function could be due to impaired global cardiac function or lead to a decrease in 
LV function due to ventricular interdependence89.  
• Association between biomarkers of myocardial and endothelial dysfunction 
and ∆RVEF.  
RV myocardial dysfunction, brain natriuretic peptide (BNP) and high sensitivity 
Troponin-T (hsTnT) were used as markers of myocardial stress and dysfunction 240.  
4.3 Generic methods  
4.3.1 Ethical approval 
Ethical approval was gained from the West of Scotland Research Ethics Committee 
(REC Ref: 134/WS/0055, Approval Date 16th April 2013). 
4.3.2 Study setting 
The study was performed at the Golden Jubilee National Hospital (GJNH), West of 
Scotland heart and Lung Centre, Clydebank. 
4.3.3 Patient population 
Patients scheduled for the Wednesday elective lung resection list were screened 
by the lead surgeon (Mr Kirk). Patients meeting the inclusion criteria were 
approached at pre-operative assessment the Friday prior to surgery. Providing no 
exclusion criteria were met, they were issued with information leaflets about the 
study. The patients had the opportunity to read the information prior to admission 
the day before surgery (Tuesday). If willing to participate in the study, informed 
consent was obtained by a member of the study team. 
4.3.4 Power analysis 
The study was powered to investigate the primary outcome detailed in 4.2.1.1. 
The VPAC studies by Reed et al.60 58 and Okada et al.49 demonstrated an absolute 
reduction in RVEF of 6-9% with a standard deviation of up to 7%, therefore an 
absolute reduction in RVEF of at least 6% on POD2 was used for power calculation. 
119 
 
This was carried out in consultation with the Robertson Centre for Biostatistics 
(University of Glasgow). A study of 19 patients would have 80% power to detect a 
deterioration in RVEF of 6%, based on a 2-sided, paired t-test with a significance 
level of 5%. Allowing a margin of 30% for withdrawals, 28 patients were planned 
to be recruited. 
4.3.5 Inclusion and exclusion criteria 
Inclusion criteria defined as; 
• provision of informed consent 
• age >16 years 
• planned elective lobectomy by thoracotomy 
Exclusion criteria were;  
• pregnancy 
• on-going participation in any investigational research which could 
undermine the scientific basis of the study 
• contraindications to magnetic resonance imaging  
a. cardiac pacemaker, artificial heart valve, neurostimulator, cochlear 
implant  
b. aneurysm clips 
c. metal injuries to the eye 
d. loose metal in any part of the body  
• wedge/segmental/sub-lobar lung resection 
• pneumonectomy 
• isolated middle lobectomy  
• video assisted thoracoscopic surgery (VATS)/minimal access lung resection. 
4.3.5.1 Justification of inclusion/exclusion criteria 
The rate of pneumonectomy has fallen over recent years representing only 5% of 
total resections9, although pneumonectomy has a greater physiological disruption, 
the reduced numbers of resections performed would limit the generalisability of 
any results. Selection of solely pneumonectomy patients would also greatly reduce 
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the population of patients to recruit from. Conversely, wedge/segmental/sub-
lobar resections may lead to less physiological disruption, thus potentially 
increasing the sample size required for detection of RV dysfunction.  
VATS resections were excluded as, at time of study design, they accounted for 
only 30% of lung resections in our institution241. Additionally, VATS are associated 
with reduced inflammatory response compared to an open approach242. As such 
the decision was taken to exclude any patients undergoing VATS resection from 
this study. Pregnancy and contraindications to CMR were excluded on the basis of 
patient safety. 
4.3.6 Peri-operative management 
The peri-operative management protocols of the study were designed with the 
intention to support standardised patient care. 
4.3.6.1 Surgical management 
Surgical management reflected the standard practice of the operating surgeon; 
postero-lateral muscle sparing thoracotomy with anatomically appropriate lymph 
node clearance.  
4.3.6.2 Anaesthetic protocol 
In order to prevent variation in patient care during the study period, an 
anaesthetic protocol based on the practice of the lead anaesthetist (Dr Mark 
Steven) was developed.  
Thoracic epidural was placed prior to induction of anaesthesia, was “loaded” 
intra-operatively and maintained post-operatively with continuous infusion. If 
insertion failed, paravertebral catheters were placed intra-operatively by the 
surgeon and a patient controlled analgesic morphine pump used post-operatively. 
Anaesthesia was commenced by intra-venous (IV) induction and maintained with 
volatile anaesthetic. Lung isolation was performed with double lumen endo-
tracheal tube. A lung protective ventilation strategy of tidal volume <8ml/kg, 
positive end-expiratory pressure of 0-5cmH20, maximal airway pressure <30cmH20, 
inspired oxygen to maintain saturations maintained at 92-98% and a permissive 
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approach to hypercapnia was used. All patients had arterial and central lines 
placed. Fluid administration was by a generally restrictive approach with a target 
of <1000ml unless exceptional losses.  
4.3.7 Data collection 
During the hospital stay and at the 2-month follow-up appointment data collection 
was perform by Dr McCall and research nursing staff. Postal questionnaires were 
distributed one year following surgery and data input was performed by the author 
and Dr McCall. Data was anonymised and stored on a password protected database 
(Microsoft Access® 2007, Microsoft, Washington, USA). Data collection timetable 
demonstrated in Table 4-1. 
Table 4-1 Timetable for data collection 
Data collection timetable. CRF – case report form. CMR= cardiac magnetic resonance imaging. 
ECHO= echocardiography. POD= post-operative day. Amended table from study protocol. 
4.3.7.1 Baseline demographic data 
Routine patient demographics were collected once the patient consented to 
participate in the study. Data collected included baseline demographics, smoking 
status, past medical history and medications. The results of routinely performed 
pulmonary function tests and pre-operative bloods were also collected.  
4.3.7.2 Imaging 
Cardiac magnetic resonance imaging and trans-thoracic echocardiography (TTE) 
were performed pre-operatively, on POD2 and at 2-months post op. Further details 
of the CMR and TTE protocols are described in 4.4. 
 Pre-op Post-op/ recovery POD1 POD2 
2-
months 








Baseline demographics       
CMR      
ECHO      
Biomarkers 
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4.3.7.3 Laboratory sampling 
Markers of cardiac dysfunction, BNP and hsTnT were testing pre-operatively, 
immediately post-operatively (in recovery), on POD1 and POD2, and 2-months 
post-op.  
Where possible all blood samples (including pre-operative) were taken from an 
arterial cannula that is routinely placed prior to induction of anaesthesia for lung 
resection. If the arterial cannula had been removed as it was no longer required 
for clinical reasons venepuncture was performed. At each time point 20 millilitres 
of blood was taken, BNP and hsTnT were tested as described below. 
4.3.7.3.1 Brain Natriuretic Peptide  
Brain Natriuretic Peptide was measured by a point-of-care fluorescence-based 
immunoassay, Alere Triage® system (Alere, Stockport, UK). All research team 
members received device training prior to use.  
4.3.7.3.2 High sensitivity Troponin-T 
High sensitivity Troponin-T was processed in the biochemistry laboratory in GJNH 
by enhanced immunoturbidimetric assay run on a Roche Cobas 6000e analyser 
(Roche, Basel, Switzerland) under the supervision of Dr Frank Findlay (consultant 
clinical scientist, biochemistry). 
4.3.7.4 Clinical data 
4.3.7.4.1 Intra-operative 
The duration of one lung ventilation (OLV) and duration of surgery were calculated 
from the electronic anaesthetic record, 'RECALL Anaesthetic Intra-operative 
Management System' (Informatics Clinical Information Systems Limited, Glasgow). 
OLV was either recorded by the anaesthetist in charge of the case or calculated 
from the anaesthetic record. When not recorded, the change in airway pressure 
and tidal volume observed when switching between ventilating two lungs to one 
lung and vice versa was used as a marker for the start and end of OLV. The duration 
of surgery was calculated as the duration of an end-tidal carbon dioxide trace 
(only recorded in an intubated patient). 
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4.3.7.4.2 Post-operative  
At the time the study was conducted, patients in the GJNH were routinely cared 
for in the high dependency unit (HDU) following lung resection. An electronic 
record of patient observations was generated throughout the HDU stay by the 
electronic clinical information system (Centricity CIS; GE Healthcare©, 
Buckinghamshire, UK). Haemodynamic and respiratory parameters were recorded 
at two-minute intervals. Fluid administration and urine output were recorded in 
the system by nursing staff and overall fluid balance is calculated from 08:00am 
to 07:59am the following morning. Additionally, the requirement for vasopressors 
and the presence of arrhythmia were recorded. 
Duration of HDU stay was determined as the duration of continual oxygen 
saturation monitoring. Frequently patients are deemed ‘ward ready’ but remain 
in HDU awaiting transfer to the ward for a variety of reasons, e.g. lack of available 
ward bed, time of day, etc. Transition from continual to intermittent monitoring 
was taken as a pragmatic definition of the end of HDU (level 2) care. Similarly, 
hospital length of stay was defined as the post-operative length of stay due to the 
variation in time admitted prior to surgery. Numerous factors can increase the 
pre-operative length of stay and so this time was excluded from the hospital length 
of stay. For instance, patients at the GJNH travel from a wide geographical area, 
often necessitating arrival to hospital early on the day before surgery.  
4.3.8 Data synthesis and statisticsx 
Parametric data are presented as mean (standard deviation) if normally 
distributed/parametric, or median (inter-quartile range) if non-parametric. 
Normality was assessed using visual inspection and with use of the Shapiro-Wilk 
test (normal distribution confirmed if p>0.05).  
Testing for changes over time in parametric data were performed by one-way 
repeated measures analysis of variance (ANOVA) or Friedman’s test for non-
parametric data, significance accepted if p<0.05. Sphericity (a condition where 
 
x Statistical advice was sought throughout the thesis from supervisors Ben Shelley and Phil McCall. 
Further advice and technical support were provided by Dr Martin Shaw for performing the 
statistical analysis in R.  
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the variance of the differences between all related groups are equal) was tested 
with Mauchly’s test and assumed if p>0.05, if sphericity is not met the results are 
interpreted with Greenhouse-Geisser correction. Post-hoc comparisons were 
performed with paired t-test (parametric) or Wilcoxon rank sum test (non-
parametric). Comparisons between results for unpaired comparisons was 
performed by unpaired t-test (parametric) or Wilcoxon signed rank test (non-
parametric). 
Association testing between two continuous variables was performed by visual 
inspection of a plot and with either Pearson’s or Spearman’s correlation 
coefficient testing performed and interpreted as per Landis and Koch243, Table 
4-2. 
Correlation coefficient Interpretation  




0.80-1 Very strong 
Table 4-2 Interpretation of correlation coefficient 
Strength of association interpretation as per Landis and Koch243 
Given the design of the study, patients were tested at multiple time points. Pooled 
analysis of such studies is widely reported although, as Bland and Altman describe, 
this “could be highly misleading”244. Regression analysis assumes independence of 
observations, repeated measures violates this assumption245. An alternative to this 
is offered by Bland and Altman by performing analysis of covariance (ANCVOA) 
with the patient as the factor with the two variables of which the association is 
being tested used as the dependent and covariate variables (interchangeably)244. 
This assesses the association between the two continual variables controlling for 
the categorical variable, i.e. the patient.  
Analysis at individual time points assess between-subject associations whereas 
ANCOVA analysis measures within-subject association245. An ‘R’ package “Rmcorr” 
(repeated measures correlation) was used to perform the analysis described above 





Figure 4-1 Example of analysis of covariance controlling for repeated measures 
Measures of cerebellar hemisphere volume at two points analysed separately (plots in A), by 
combining both time points (plot C) and by analysis of covariance (plot B). In plot B the paired 
coloured dots and line represent the 2 time points and a regression line for that patient, the 
regression line is parallel to the overall line of fit and is plotted between the two values on the x-axis 
and at the mid-point between the two measures in the y-axis. Note that there is a strong correlation 
within-subject association although only weak/moderate associations at individual time points and 
pooled analysis. Example from Bakdash et al.245. 
4.3.8.1 Reliability testing 
Reliability is defined as  
 “the extent to which measurements can be replicated” 
Koo et al.246 
A test of reliability must assess both agreement and correlation between 
measurements. Intraclass correlation coefficient (ICC) is an index that can assess 
both components or reliability246. Agreement between separate observers 
(interobserver) and repeated assessment by the same observer (intraobserver) 
were performed to determine variability. Two-way mixed effect models testing 
for absolute agreement were performed and interpreted as per Koo et al.244, Table 
4-3.  
Coefficient of variation (CV) was calculated, Equation 4-1, to assess the degree 
of variability within measurements. CV is a standardisation of the standard 
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deviation, it removes the influence of the magnitude of the value being 




Equation 4-1 Coefficient of variation 
 
Coefficient of variation (%) Intraclass correlation 
coefficient (ICC) 
Interpretation of reliability 
>15 <0.5 Poor 
10-15 0.5-0.75 Moderate/acceptable 
<10 0.75-0.9 Good 
>0.9 Excellent 
Table 4-3 Definitions of reliability and variability 
Interpretation from Koo et al. and Holm et al.246, 248. 
Data handling, interpretation and statistical analysis of the results presented in 
this thesis was performed in R Studio (Version 1.1.463 – © 2009-2018). A p-value 
<0.05 was considered statistically significant. Exact p values are reported to 3 
decimal places down to <0.001. 
4.4 Imaging 
4.4.1 Cardiac magnetic resonance 
Patients underwent CMR pre-operatively, on POD2 and at 2-month follow up. Pre-
operative scanning was performed either the day before surgery or, if this was not 
possible, on the morning of surgery. POD2 scanning was performed in the 
afternoon of the second day following surgery and 2-month scanning arranged to 
coincide with their routine follow-up clinic appointment.  
CMR imaging was performed using a 1.5 Tesla Siemens Avanto (Siemens, Germany) 
whole body scanner. A standardised protocol was completed by band 7 Health and 




4.4.1.1 Safety checks 
Patients were asked to complete a CMR safety questionnaire prior to recruitment 
and consent, to ensure that there were no contra-indications to CMR. A 
departmental safety questionnaire was completed prior to entering the CMR 
scanning room. Patients were dressed in either pyjamas or a hospital gown. 
Continuous 3-lead echocardiographic and oxygen saturation monitoring were 
applied with the patient lying on the examination table but outside the bore to 
the scanner. Ear defenders and an emergency buzzer were provided for patient 
safety. The ability to communicate with the patient was maintained throughout 
the scan with a microphone and headphones.  
Additional precautions were required for POD2 scanning. All patients were 
escorted throughout the scan by a member of the research team and a consultant 
thoracic surgeon was available for management of potential complications.  
Thoracotomy and lung resection introduce surgical clips and staples to the thorax. 
A detailed record of all implanted medical equipment was reviewed by a 
consultant radiologist (Dr Alcorn) prior to scanning. CMR safety of all equipment 
was confirmed with the manufacturer generating a list of “confirmed MR safe” 
equipment. 2-month scanning did not require any additional checks unless the 
patient had undergone subsequent procedures following the POD2 scan.  
At POD2 patients may have chest drains in situ and medication infusions ongoing. 
Chest drains are routinely sited following lung resection to drain air and fluid from 
the thoracic cavity. In the GJNH chest drains are routinely attached to an 
electronic system, Thopaz (Mendela, Switzerland), which is not MR safe thus the 
chest drain was switched to an MR safe underwater seal system for the duration 
of the scan. Where feasible, infusions were disconnected for the duration of the 
scan or transferred to MR safe infusion pumps. Epidural infusions were 
disconnected for the duration of the scan and re-established following completion.  
4.4.1.2 Image acquisition 
ECG-gated fast imaging steady state free precision cines (TrueFISP, Siemens) were 
utilised throughout. For functional assessment slices of 6mm thickness with a 4mm 
gap between and voxel size 1.5 x 1.3 x 6mm were measured. Following localisation 
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scans, short axis stacks of the ventricles were performed from the atrioventricular 
valve plane to the cardiac apex, this was perfumed during breath holds.  
Flow analysis was performed in the aorta and pulmonary arteries (main, left and 
right). The parameters for flow imaging were: field of view 320-360mm, slice 
thickness 5mm, base resolution 256, phase resolution 100%, echo time 2.7ms, 
repetition time 29.2ms, velocity encoding as appropriate (150cm.s-1 for normal 
flow). Effective temporal resolution was one thirtieth of the duration of the 
cardiac cycle. Reporting of the flow analysis is described in Chapter 6. 
Completed scans were stored locally on the hard drive of the scanner with copies 
on the hospital imaging network. On completion of the study the scans were 
randomised and anonymised by a member of the radiography staff (Miss Vanessa 
Orchard) with a random number sequence generated by the ‘RAND’ function in 
Microsoft Excel® 2007 (Microsoft, Washington, USA).Two copies of the allocation 
were stored at the GNJH, one in the radiography office and one in a locked drawer 
in the research office. The completed images were stored on CDs (10 studies per 
disc) and analysed as detailed below. 
4.4.1.3 Analysis 
Safety reporting of all anonymised scans was performed by Dr John Payne 
(consultant cardiologist and lead for cardiac imaging at GJNH) with a report 
generated that entered the patients’ clinical notes.  
All analysis was performed in proprietary software (Argus, Siemens, Erlangen, 
Germany). Randomised images were dual reported. Functional images were 
reported by Dr Philip McCall (PM) and Dr Alex Arthur (AA) (both clinical research 
fellows in cardiothoracic anaesthesia at time of reporting). Dr David Corcoran 
(Clinical Research Fellow in CMR imaging with level 3 European Association of 
Cardiovascular Imaging certification in CMR imaging) provided initial training in 
assessment and assisted with scan analysis. He gave an expert deciding opinion in 
cases of disagreement in reporting between Drs Arthur and McCall. Interpretation 
was performed as per guidelines produced by the Society for Cardiovascular 




4.4.1.3.1 CMR reporting 
For functional assessment the ‘short axis stacks’ for each individual anonymised 
scan was loaded into Argus from the CD file. The images were reviewed for 
duplication of slices, this can occur if there was concern over image quality or 
artefact at time of scanning. For any duplicated slices the poorer image was 
removed.  
 
Figure 4-2 Short axis stack interpretation  
Bottom section, each row represents a cine loop of short axis stack of the heart. One loop 
represents an entire cardiac cycle start from end-diastole (ED). Top row represents the base of the 
heart with consecutive slices represented by each row until the apex of the heart, not demonstrated 
in image.  
Top panels display image selected from bottom row and column. Manual planimetry preformed on 
the top panels. Image from analysis of study patient. 
The cardiac cycle is represented by a cine loop of the heart with the cardiac cycle 
divided into 35 frames (irrespective of duration of cardiac cycle) starting at end-
diastole (matched to the R wave of the ECG). End-systole was manually 
determined by visual assessment of the frame with the smallest LV blood volume. 
The same frame was used for RV and LV end-systole. The endocardial borders of 
the ventricles were traced at end-diastole and end-systole, Figure 4-3. The 
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selection of the basal RV slice was initially performed on the short axis stack and 
then cross referenced with the long axis view to ensure that the right atrium had 
not been mistakenly included. Incorrect selection of the basal slice can lead to 
large errors in ventricular volumes by inappropriately including/excluding a large 
volume. The RV outflow tract (up to the pulmonary valve) was included in the RV 
volumes where visualised. A smooth RV border was drawn and trabeculations of 
the RV were ignored, this standard technique increases reproducibility249. 
Left ventricular (LV) volumes were determined by a similar approach to the RV. 
The basal slice was determined as the most basal slice surrounded by greater than 
50% of ventricular myocardium. Papillary muscles were included in the blood pool. 
 
Figure 4-3 Defining ventricular borders 
The endocardial border of the ventricle is manually traced (red line) and Argus calculates the 
ventricular volume. Volumes determined at end-diastole (left) and end-systole (right). Image from 
study patient. 
Argus automatically calculates the volume of each mapped slice of the ventricle 
and therefore the total volume of the ventricle giving end-diastolic volume (EDV) 
and end-systolic volume (ESV). The difference between EDV and ESV is the stroke 
volume (SV) of the ventricle, Equation 4-2. Ejection fraction (EF) is calculated as 
the SV divided by the EDV, Equation 4-3. 
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Equation 4-3 Ejection fraction 
 
A CMR derived surrogate of RV-PA coupling was calculated from the RV volumes 







Equation 4-4 Right ventricular coupling 
Emax= maximal elastance. Ea= arterial elastance. 
4.4.2 Echocardiography 
Whilst CMR is the gold standard of RV assessment, echocardiography is the most 
commonly utilised assessment in clinical practice. As described in 1.2.5.1 page 63, 
echocardiography is particularly challenging following lung resection. 
Comprehensive echocardiographic analysis of RV function was performed and 
published by PM156, only the afterload and strain echocardiographic analysis is 
discussed in this thesis.  
4.4.2.1 Image acquisition 
Contemporaneous trans-thoracic echocardiography (TTE) was performed with CMR 
imaging (pre-op, POD2 and 2-months). Where possible, TTE was performed on the 
same transfer to/from the CMR scanner. All imaging was performed according to 
a standardised protocol by band 7 British Society of Echocardiography (BSE) 
accredited cardiac physiologists on the Vivid E9 cardiovascular ultrasound system 
(GE Healthcare, Chicago, Illinois, USA) using a M5Sc-D transducer with a frequency 
of 1.5 to 4.6 MHz. Imaging was performed in the lateral decubitus position, except 
on POD2 in patients who were unable to tolerate this position due to surgical 
wounds and chest drains. The standardised protocol utilised parasternal, apical 4-
chamber (A4C) and subcostal views.  
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4.4.2.2 Afterload assessment 
Pulmonary artery systolic pressure (SPAP) was calculated from the pressure 
gradient across the tricuspid valve was estimated from the tricuspid regurgitant 
jet (TRJ) velocity with the simplified Bernoulli equation. The TRJ was imaged with 
continuous wave Doppler in each view of the RV and the measurement with the 
greatest velocity was used. RV systolic pressure (RVSP) was then estimated with 
the addition of right atrial pressure (estimated by inferior vena cava diameter), 
Equation 2-1 page 103. RVSP is assumed equal to pulmonary artery systolic 
pressure (SPAP) if there is no RV outflow tract or pulmonary valve obstruction. 
Pulmonary artery acceleration time (PAAT), was measured as the time to peak 
flow from a pulsed wave Doppler analysis of flow in the main pulmonary artery250. 
4.4.2.3 Two-dimensional speckle tracked echocardiography  
Speckle tracked echocardiography (STE) is angle independent measure of 
contractility. Contrary to tissue doppler imaging, STE is not dependent on the 
angle of incidence of ultrasound and has the ability to obtain an image along the 
true axis of RV wall movement 251. It tracks artefacts on 2D echo images of the 
myocardium (speckles; generated from reflections, refractions and scattering of 
echo beams) during the cardiac cycle. The position of these speckles and their 
movement relative to each other allows calculation of strain parameters252.  
4.4.2.3.1 Image analysis 
Apical four chamber views at a frame rate of 60-80 frames per second were 
obtained for four consecutive cardiac cycles during the echocardiography 
protocol. Anonymised and randomised A4C views were uploaded into proprietary 
analysis software (EchoPAC, GE Healthcare, Chicago, United States). Analysis was 
performed by PM with support from Dr Piotr Sonecki (Consultant cardiologist with 
a special interest in imaging). Semi-automated tracking of the RV endocardial 
border was performed of the RV free wall and septum. The software divides the 
RV into six segments and calculates RV global peak longitudinal strain (RV-GPLS) 
by averaging strain in each segment and RV free wall peak longitudinal strain (RV-




Figure 4-4 Speckle tracked echocardiography strain calculation  
Contouring of the right ventricular endocardial border at end diastole (A) and end systole (B). Strain 
calculated by tracking each segment of the RV (C) generating right ventricular global peak 




4.5 Results  
This section will detail the patient cohort used in the investigations Chapters 5, 
6, 7 and 8, with an overview of the results of the study as described by previous 
authors. 
4.5.1 Generic results 
4.5.1.1 Patient recruitment and imaging 
Recruitment took place from September 2013 to September 2014. In total, 28 
patients were recruited from 44 patients that were approached, Figure 4-5. 
Patient recruitment was performed by PM and AA. Twelve patients approached 
refused to participate in the study. Of the 28 recruited, one patient was excluded 
due to discovery of a contra-indication to CMR on pre-operative scanning. During 
scanning it was discovered that there was a ferromagnetic object in the patient’s 
chest wall. Whilst there were no clinical sequelae from this it prevented imaging 
of the heart and so this patient was removed from the study and had no further 
follow-up. 
 
Figure 4-5 Consort diagram of study recruitment 
RV1-RV28 notation used as anonymised patient study numbers. CMR= cardiac magnetic 
resonance. MRI= magnetic resonance imaging.  
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Pre-operative CMR imaging was performed in 27 patients, however one patient 
had incomplete imaging performed due to an administrative error that omitted 
the short axis stack of the heart. As such, pre-operative ventricular volumes and 
function could be calculated for 26 patients. Twenty-two patients (81.5%) 
completed POD2 imaging: three patients declined imaging, one had a persistent 
air leak preventing CMR transfer and one had an epidural catheter that was 
deemed incompatible with CMR254. Twenty-four patients (88.9%) completed 2-
month imaging; one patient declined, one had undergone cataract surgery since 
their lung resection (CMR contraindicated within 6 weeks of cataract surgery) and 
one was an inpatient in another hospital with a broncho-pleural fistula. 
Ultimately, complete pre-operative, POD2 and 2-month scans were available for 
20 patients. Patient demographics and results are presented for the 27 patients 
form the study and the 20 patients with complete imaging. CMR strain analysis, 
described in investigation Chapter 5, was performed on the patients with 
complete imaging (Strain cohort) and thus their characteristics are described 
separately belowy. 
4.5.1.2 Patient demographics and operative characteristics  
Baseline, intra-operative and post-operative details are described for the patients 
in Table 4-4, Table 4-5 and Table 4-6 respectively. The strain cohort were similar 
to the overall cohort in all parameters.  
  
 
y As described in Chapter 5, strain analysis was performed on patients with complete sets. 
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Table 4-4 Baseline demographic data 
Thoracoscore is a validated multivariate model that predicts in-hospital mortality (as a percentage) 
in patients undergoing general thoracic surgery 255. Values are number (%), mean (SD) or median 
(IQR). n=number of patients for each parameter. BMI= body mass index. SaO2= oxygen 
saturations. FEV1= forced expiratory volume in 1 second. FVC= forced vital capacity. TLCO= 
transfer factor for carbon monoxide. COPD= chronic obstructive pulmonary disease. IHD= 
ischaemic heart disease. PVD= peripheral vascular disease. ASA= American Society of 
Anaesthesiologists.   
Patient Demographics All patients Strain patients 
 n Descriptive statistics n Descriptive statistics 
Age (years) 27 67.0 (59.0, 74.0)  20 65 (58.8, 74.5) 
Female sex  27 17 (62.9%)  20 12 (60%) 
Height (cm) 27 163.3 (9.0)  20 163 (9.1) 
Weight (kg) 27 69.9 (13.4) 20 69 (13.9) 
BMI (kgm-2) 27 26.1 (3.9)  20 26 (3.9) 
Smoking status 27  20  
Current smoker 
 










 2 (7.1%)  
 
2 (10%) 
Pack years 25 38.2 (21.7)  18 34 (22.3) 
Pre-operative pulmonary function 
SaO2 on air (%) 27 96.4 (1.7) 20 97 (1.7) 
FEV1 (L) 27 1.9 (1.6, 2.4)  20 2.0 (1.6, 2.5) 
% Predicted FEV1 (FEV1%)  26 87.5 (25.1)  19 89 (28.4) 
FEV1/FVC (%) 27 64.1 (14.8) 20 63 (15.1) 
TLCO (ml/kPa/min)  27 5.2 (1.7)  20 5.0 (1.9) 
% Predicted TLCO (TLCO%)  27 66.6 (15.2)  20 65 (16.7) 
Co-morbidities and risk score 
History of Cancer 27  7 (25.9%)  20 7 (35%) 
COPD  27 6 (22.2%)  20 4 (20%) 
Hypertension  27 9 (33.3%) 20 4 (20%) 
IHD 27 6 (22.2%) 20 4 (20%) 
Diabetes Mellitus  27 0 20 0 
PVD 27 5 (18.5%)  20 2 (10%) 
Obesity  27 2 (7.4%) 20 1 (5%) 
Alcoholism 27 0 20 0 
Thoracoscore (%)  27 0.7 (0.5, 0.8)  20 1 (0.6, 0.8) 





















5   0   0 
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Table 4-5 Operative data 
Values are number (%), mean (SD) or median (IQR). n=number of patients for each parameter. 
ppoFEV1= predicted post-operative forced expiratory volume in 1 second. ppoTLCO= predicted 
post-operative transfer factor for carbon monoxide.   
 
z The planned surgery for all recruited patients was a lobectomy or bilobectomy (incorporating the 
right middle lobe). One patient had an intra-operative conversion to pneumonectomy. They are 
included in all results and sensitivity analysis was performed in this section. They are discussed 
further in the afterload analysis, Chapter 6, as this requires comparison of post-operative blood 
flow in the right and left pulmonary arteries pulmonary which is impossible following 
pneumonectomy.  
Patient Demographics  All patients Strain patients 
 n Descriptive statistics n Descriptive statistics 
Resection type 27  20  
Pneumonectomyz 
 










4 (14.8%)  
 
2 (10%) 







5 (3, 5) 
 
5 (3, 5) 
Predicted post-operative lung function 
ppoFEV1 %  26 67.66 (20.8) 20 68.85 (23.4) 
ppoTLCO%  27 51.2 (11.6) 20 49.54 (12.7) 









Other Malignant  1 (3.7%)  1 (5%) 





Lung Cancer Staging  
    




















2A T2b N0  2 (7.4%)  2 (10%) 















































    
Surgery (mins) 27 146 (116, 169) 20 128 (114, 154) 




Table 4-6 Fluid administration and post-operative clinical data 
Values are number (%), mean (SD) or median (IQR). n=number of patients for each parameter. 
Op= operation. POD= post-operative day. HDU= high dependency unit. 
4.5.2 Imaging results 
4.5.2.1 Cardiac magnetic resonance 
In total 72 CMR scans were completed and interpreted (26 pre-operatively, 22 on 
POD2 and 24 at 2-months). Inter-observer variation was good/excellent for RVEDV, 
RVESV, LVEDV and LVESV (ICC >0.84) whilst RVEF and LVEF were acceptable (ICC 
0.53 and 0.71 respectively). Intra-observer variation was good/excellent for all RV 
and LV volume and ejection fractions (ICC >0.85).  
Haemodynamic and ventricular results are detailed in Table 4-6. Heart rate and 
cardiac output were increased from baseline at POD2 but by 2-months had 
returned to baseline.  
Patient Demographics  All patients Strain patients 
 n Descriptive statistics n Descriptive statistics 
Fluid administration (L)      
Intra-op 27 0.9 (0.4)  20 0.94 (0.43) 
Op day to 07:59 POD1 27 1.7 (1.4, 2.2)  20 1.6 (1.3, 2.2) 
to 07:59 POD2 17 2.3 (2.0, 2.5)  12 2.3 (2.1, 2.5) 
to 07:59 POD3 6 1.9 (1.4, 2.7)  2 2.9 (2.7, 3.2) 
     
HDU Fluid Balance (L)  
    
Op day to 07:59 POD1 27 1.0 (0.6, 1.4)  20 1.1 (0.8, 1.4) 
to 07:59 POD2 17 0.1 (-0.5, 0.7)  12 0.1 (-0.4, 0.6) 
to 07:59 POD 3 6 -0.6 (-1.2, 0.3) 2 -1.3 (-1.3, -1.4) 
     











     
Arrhythmia  
    





     
Length of stay      
HDU (Hours)  27 47.2 (29.2, 53.5) 20 47 (29.2, 51.3) 
Hospital (Days)  27 8 (7, 11) 20 8 (7, 10.5) 
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Table 4-7 Right and left ventricular changes following lung resection 
Results displayed for the complete cohort. Data are mean (SD). *= One-way repeated measures 
ANOVA. #= Significant difference from Pre-op. ¥= Significant difference from POD2. POD= post-
operative day. HR= heart rate. Bpm= beats per minute. CO= cardiac output. RV= right ventricle. 
LV= left ventricle. EF= ejection fraction. EDV= end diastolic volume. ESV= end systolic volume. 
SV= stroke volume. Data from McCall231. 
RVEF was decreased at POD2 and 2-months from pre-operative (p<0.001 and 
p=0.002, paired t-tests), Figure 4-6. The mean POD2 drop was 4.84%. There was a 
clear outlier for RVEF at 2-months (16.9%), sensitivity analysis revealed that there 
was no difference in the result when this patient was excludedaa. RVESV was higher 
on POD2 (p=0.003, paired t-test) and RVEDV was lower than pre-op and POD2 at 
2-months (p>0.017, paired t-test). RVSV was reduced at 2-months (p=0.0005, 
paired t-test). There was no change in LVEF throughout the study. At 2-months 
LVEDV, LVESV and LVSV were all lower than pre-operative. 
 
aa This patient was an outlier in numerous measures at 2-months post-op in the study. On 
cardiology follow-up it was deemed that they had suffered a myocardial infarction between 
POD2 and 2-month follow-up. 
 Pre-op POD2  2-months p value 
 n=26 n=22 n=24  
HR (bpm) 64.4 (13.0) 77.0 (11.0) # 69.4 (10.3)¥ 0.002 * 
CO (l/min) 6.6 (1.7) 8.0 (1.6) # 6.5 (1.7)¥ 0.004 * 
     
Right ventricle 
RVEF (%) 50.5 (6.9) 45.6 (4.5) # 44.9 (7.7) # 0.003 * 
RVEDV (ml) 119.1 (25.4) 125.9 (22.5) 109.4 (31.6) #¥ 0.019 * 
RVESV (ml) 59.8 (17.1) 68.6 (14.5) # 59.8 (17.6)¥ 0.040 * 
RVSV (ml) 59.3 (12.0) 57.3 (10.7) 49.6 (16.5) # 0.002 * 
     
Left ventricle 
LVEF (%) 58.4 (7.1) 57.4 (7.3) 59.7 (9.3) 0.621 * 
LVEDV (ml) 109.2 (19.5) 106.3 (19.2) 93.6 (28.2) #¥ 0.001 * 
LVESV (ml) 46.0 (13.2) 46.0 (14.2) 37.7 (13.1) #¥ 0.019 * 




Figure 4-6 Right ventricular ejection fraction following lung resection 
Box plots representing median and interquartile ranges of right ventricular ejection fraction. Note 
reduction at post-operative day 2 (POD2) and 2-months. Image from McCall et al.231  
Right ventricular coupling was reduced at POD2 and at 2-months, Table 4-8 and 
Figure 4-7.  
 
Figure 4-7 Right ventricular coupling following lung resection 
Box plots representing median and interquartile ranges of right ventricular (RV) “coupling” 
calculated by RV stroke volume (RVSV) divided by RV end systolic volume (RVESV). Note 





Table 4-8 Right ventricular coupling following lung resection 
Right ventricular (RV) coupling calculated by RV stroke volume (RVSV) divided by RV end systolic 
volume (RVESV). Data are median (IQR). §= Friedman's test. #= Significant difference from Pre-
op. POD= post-operative day. Data from McCall et al. 230 
4.5.2.2 Echocardiographic results 
In total 77 transthoracic echocardiography scans were completed, 27 patents pre-
operatively, 26 patients on POD2 and 24 patients at 2-months. All scans were dual 
reported by PM and echocardiography technicians (ET).  
4.5.2.2.1 Afterload  
Pulmonary artery systolic pressure was only obtained by PM and ET in 12 patients 
pre-operatively (44.5), 14 patients on POD2 (53.8%) and 6 patients at 2-months 
(25.0%). PAAT was obtained in 26 patients pre-operatively (96.3), 23 patients on 
POD2 (88.5%) and 23 patients at 2-months (95.8%). There were acceptable limits 
of agreement and minimal bias between observers. There was a trend to change 
in SPAP (p=0.074, Friedman’s) but no change in PAAT (p=0.350, ANOVA), Table 
4-9. 
Table 4-9 Echocardiographic measures of afterload following lung resection 
Values are median (IQR) or mean (SD) . §= Friedman's test. *= One-way repeated measures 
ANOVA. POD= post-operative day. SPAP= systolic pulmonary artery pressure. PAAT= pulmonary 
artery acceleration time.  
4.5.2.2.2 Speckle tracked echocardiography 
Strain calculation was available in 27 patients pre-operatively (100% of completed 
scans), 22 patients on POD2 (84.6%) and 24 patients at 2-months (100%). Inter- 
and intra-observer variability was excellent (ICC >0.91). There were no changes 
 Pre-op POD2  2-months p value 
 n=26 n=22 n=24  
RVSV/RVESV 1.0 (0.9, 1.2) 0.8 (0.7, 1.0) # 0.8 (0.8, 1.0) # 0.011 § 










 n=12 n=10 n=5  
PAAT (ms) 86.4 (24.9) 72.0 (16.9) 81.0 (22.8) 0.350 * 
 n=26 n=23 n=23  
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in RV-GLPS or FWPLS over time (p>0.229, Friedman’s test), Table 4-10. Pooled 
analysis demonstrated moderate association between RV-GLPS or FWPLS and RVEF 
(r=-0.412, p=0.001 and r=-0.477, p<0.001, both Pearson’s). At each individual 
time-points there was moderate association between RV-GLPS or FWPLS and RVEF 
(r>-0.409, p<0.038, all Pearson’s), Figure 4-8. 
Table 4-10 Speckle tracked strain changes following lung resection 
Values are median (IQR). Both Friedman’s test. POD= post-operative day. RV-GLPS= right 
ventricular global peak longitudinal strain. RV-FWPLS= right ventricular free wall peak longitudinal 
strain. 
 
Figure 4-8 Association between right ventricular speckle tracked strain and ejection fraction 
Note moderate association between right ventricular global longitudinal peak strain (RV-GLPS) and 
free wall peak longitudinal strain (RV-FWPLS) with right ventricular ejection fraction (RVEF) 
measured by cardiac magnetic resonance at all time points. All Pearson’s correlation coefficient. 
Pre-op= pre-operative. POD= post-operative day. Image from McCall 253. 
 Pre-op POD2  2-months p value 
 n=27 n=22 n=24  
RV-GPLS (%) -17.7  
(-20.1, -13.6) 
-17.5  




RV-FWPLS (%) -22.1  
(-27.2, -16.0)  
-20.4  
(-26.5, -13.3)  
-22.7  




4.5.3 Plasma biomarkers of myocardial dysfunction  
Brain natriuretic peptide and hsTnT both changed over the duration of the study, 
Table 4-11. BNP raised post-operatively and, within the time points tested, peaked 
at POD2. At this point, increased BNP was associated with the fall in RVEF from 
pre-op (r=0.490, p=0.021, Spearman’s), there were no other significant 
associations. hsTnT increased post-operatively and peaked at POD1 although it 
was not associated with any change in RVEF. At 2-months a small, not clinically 
significant, hsTnT increase remained whilst BNP had returned to baseline. 
Table 4-11 Plasma biomarkers of myocardial dysfunction following lung resection 
Data are presented as median (IQR). Both Friedman's test. BNP= Brain Natriuretic Peptide. 
hsTnT= Highly sensitive Troponin-T. POD= post-operative day. #= Significant difference from Pre-
op. ¥= Significant difference from Immediate Post-op. §= Significant difference from POD1. ll= 
Significant difference from POD2. Data from McCall et al.230 
4.6 Discussion 
In total, 27 patients were recruited into the study. In spite of the significant extra 
investigations required to participate in the study patients tolerated the study 
well with only three patients refusing scanning at POD2 and only one patient 
refusing at 2-months. All other scans that were not completed were due to medical 
contraindications. The recruited patients were similar to the overall cohort at 
GJNH and in published literature; an older population with multiple co-morbidities 
and the vast majority either current or ex-smokers16-18, 256. There were no 
significant differences between the cohort analysed as part of the “strain group” 
and the overall group. 
The primary outcome of the study was confirmed, RVEF is reduced on POD2 
following lung resection. Interestingly this reduction remained at 2-months and 
occurred without any reduction in LVEF. The mean absolute reduction of RVEF at 
POD2 of 4.9% is comparable to the 6-9% reduction seen in VPAC studies49, 58-60.  
 Pre-op Post-op POD1 POD2 2-months p-value 
BNP 
(pg/ml) 


































As discussed in Chapter 1 and 2, the cause of impaired RV function following lung 
resection is widely hypothesised to be an increase in afterload. The impaired 
coupling, determined by CMR, on POD2 and 2-months suggest either an increase 
in afterload, a decrease in contractility or a combination of both. Contractility 
and afterload were only assessed by TTE in this part of the analysis. Accurate 
interpretation of the changes in coupling and RVEF requires assessment of RV 
loading conditions and contractility. 
The ability of echocardiography to determine changes in contractility and 
afterload was poor. It was not possible to obtain the required apical four chamber 
view required for STE strain in four patients (15.4%) on POD2, a further 22.1% of 
all scans required “expert review” due to discrepancies between reporters. 
Although RV-GPLS and RV-FWPLS were consistently associated with RVEF at each 
time point they were unable to demonstrate the post-operative reduction in RVEF. 
There was however some evidence of a relationship between RV-FWPLS and RVEF. 
Trend analysis showed that the change in RV-FWPLS and the change in RVEF had 
a moderate association on POD2 (r=-0.317, p=0.019) and a RV-FWPLS of <-18.0% 
on POD2 was predictive of RVEF <45% (AUROCC= 0.76, [95% CI 0.65, 0.88]).  
Systolic pulmonary artery pressure could only be estimated in 32 out of 77 
attempted scans although there was a trend to increased SPAP at POD2 (p=0.09, 
Wilcoxon Signed Rank Test). PAAT could be measured in 72 out of 77 scans. It was 
associated with RVEF in pooled and within-subject analysis but it did not change 
over the study period. There was however a moderate association between the 
change in PAAT and the change in RVEF from pre-op to POD2 (r=0.596, p=0.009, 
Pearson’s correlation coefficient) suggesting that afterload increase is associated 
with RV dysfunction in the early post-operative period.  
4.6.1 Strengths and limitations 
The main strength of the study is in the design. This is the first sequential use of 
the gold standard method of assessing the RV (CMR) in a lung resection population. 
This overcomes the methodological concerns expressed in Chapters 1 and 2. As 
patients were imaged pre-op, on POD2 and at 2-months the acute post-operative 
and longer term post-operative function of each patient can be tracked. The post-
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operative completion rate of CMR and TTE are encouraging given the labour-
intensive investigations required from each patient.  
The main limitation of the design of the study is that RV loading conditions are 
not directly measured. As CMR and echocardiography are non-invasive, direct 
pressure measurements cannot be performed. Although echocardiography analysis 
showed some associations of increased afterload and decreased contractility on 
POD2 with RVEF this interpretation is undermined by the lack of consistency and 
the lack of a change in contractility or afterload over time. Whilst there were 
difficulties in obtaining echocardiographic estimation of strain and afterload 
measures there is a growing evidence base of validated methods of assessing 
contractility and afterload from CMR. Flow analysis of the pulmonary arteries and 
RV strain imaging could overcome these issues. 
4.7 Conclusion 
The main finding of the investigation is that RVEF is decreased following lung 
resection with a decrease in RV coupling. TTE was unable to detect the reduced 
RVEF demonstrated by CMR. Although impaired contractility and/or increased 
afterload are suggested by decreased coupling, TTE did not demonstrate 
consistent post-operative changes in measures of contractility or afterload. 
Further investigation of RV loading conditions and contractility are required to 




Chapter 5 Cardiac magnetic resonance strain 
measurement  
5.1 Introduction 
This investigation will examine changes in myocardial strain following lung 
resection. It is the first use of cardiac magnetic resonance (CMR) strain analysis in 
a lung resection population. 
5.2 Right ventricular strain 
A general overview of RV function is in provided in Chapter 1. Compared to 
conventional measures of RV function, strain analysis has a number of potential 
benefits. It allows regional assessment of the RV257-260, assessment of diastolic 
function and ventricular relaxation257, 259-262, it may detect early RV dysfunction263, 
264 and it is predictive of morbidity and mortality in numerous conditions265-269. 
Analysis of changes in regional RV strain from pre-operatively to the acute post-
operative and longer-term follow-up has the potential to help understand the 
mechanisms of RV dysfunction following lung resection. 
5.2.1 Strain definitions 
Strain is a measure of myocardial shortening238. It is calculated as the difference 
between length of a defined section of the myocardium after contraction (L) and 
the initial length (Lo) relative to its initial length (Lagrangian strain)238, Equation 
5-1 and Figure 5-1A. 
1(,+%'	(%) =
(H − H")
H" × 	100 
Equation 5-1 Strain calculation 
Lo= initial length. L= contracted length. 
Strain rate is the rate of myocardial shortening. It can be calculated as the 
temporal derivative of strain or by the difference in velocity measured at two 










Equation 5-2 Strain rate calculation  
V1= velocity at point 1. V2= velocity at point 2. d= distance between points. ∂(Strain)= derivative of 
strain. ∂t= temporal derivative. 
 
Figure 5-1 Strain and strain rate derivation 
A, Strain derived by difference in length (DL) divided by initial length (Lo).  
B, Strain rate is the difference in relative velocity at two points (V1 and V2) divided by the distance 
(d) between them. Images from Blessberger and Binder270. 
The distinction between displacement and deformation is important in the 
understanding and calculation of strain. Displacement is the change in position of 
an object, whereas deformation is the change in shape of an object due to regional 
differences in velocities. Displacement of the RV may occur without contraction 
and therefore without deformation, i.e. passive movement of an akinetic RV 
secondary to contraction of the LV. Deformation (measured by strain) will measure 
the relative movement of a specific region of the ventricle257. Strain therefore is 
able to differentiate between active and passive movement of the RV and 
determine regional variations in the extent and rate of deformation238, 257. 
Maximal RV volume and therefore maximal RV myocyte length occurs at end-
diastole, this is the initial length for strain calculation. Contraction causes 
shortening of the RV and therefore a negative strain value, Figure 5-2. Peak 
systolic strain occurs at maximal shortening of the RV. Strain rate is negative 
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during shortening of the RV (contraction/emptying) but positive during 
lengthening (relaxation/filling). During diastole there are two strain rate peaks; 
the early (E) diastolic peak is caused by passive relaxation and filling of the RV 
and the late diastolic peak is caused by atrial contraction (A) leading to RV 
filling261.  
 
Figure 5-2 Right ventricular strain and strain rate curves 
Right ventricular (RV) longitudinal free wall strain (left panel) and strain rate (right panel) over two 
cardiac cycles. Note strain rate is temporal derivative of strain, i.e. at turning points of strain, strain 
rate is 0. Strain is always negative and strain rate is negative until peak contraction then it is 
positive during relaxation of the RV. Peak systolic strain highlighted by dashed red line in left panel. 
Diastolic strain rate peaks highlighted in right panel, early (E) diastolic and atrial (A) peaks. Images 
from Orde et al.262. 
5.2.2 Strain classifications 
The majority of research into myocardial strain has focused on LV strain. The LV 
contracts in 3 planes (longitudinal, circumferential and radial)270, Figure 5-3. In 
contrast to the LV, RV muscle fibres are predominately arranged in superficial and 
deep muscle layers that will cause longitudinal and circumferential contraction 
without significant radial contraction271, it is estimated that 80% of RV contraction 




Figure 5-3 Diagrammatic representation of left ventricular strain analysis 
Strain can be measured in three vectors; radial, circumferential and longitudinal. Image from 
Blessberger and Binder270. 
Regional division of the RV is demonstrated in Figure 5-4. RV strain measures 
global longitudinal strain (RVGLS) in a long axis view along the free wall 
(RVGLS.FW) and septum (RVGLS.S), this can further be divided into apical, mid-
ventricular and basal segmentsbb. RV global circumferential strain (RVGCS) can be 
measured in a short axis view at basal, mid-ventricular and apical274. The majority 
of studies that perform RV strain measure RVGLS and, to a lesser extent, RVGCS160, 
224. Whist global radial strain (GRS) measurement is utilised in LV assessment it is 
not commonly measured in the RV due to its limited contribution to RV function 
and difficulty in measurement in the thin-walled RV271, 275. 
 
bb The notation RVGLS.FW and RVGLS.S are used as per Lee et al.271. This is primarily used for 
the CMR results presented below as, for example, RVGLS.FW are free wall segments of the 




Figure 5-4 Long axis view of right ventricular regional strain 
Left panel demonstrates the echocardiographic plane and image of an apical four-chamber view of 
the heart with right (R) and left (L) ventricles (V) and atria (A) all visible. Right panel depicts the 
regional definitions of RV strain from a corresponding echocardiographic image. Solid white line 
divides long axis into free wall and septum. Dashed white line, division of the RV into basal mid and 
apical regions. Images annotated from Ho et al.85 and Chang et al.274. 
5.2.3 Strain interpretation 
5.2.3.1 Load dependence 
Strain and strain rate have been described as “load-independent” measures of RV 
function, i.e. they are not dependent on preload and/or afterload276. In a 2010 
review of RV strain, La Gerche et al. detail the changes in myocyte contraction 
with increased afterload, demonstrating that they are in fact load dependent277, 
Figure 5-5. As detailed in 1.2.2.4 page 44, myocyte function can be described by 
the force generated, the degree of shortening (strain) and the velocity of 
myocardial fibre shortening (strain rate). Each strain parameter is affected by the 
loading conditions of the myocyte. Increased afterload will require a greater force 
(and pressure) to generate the forward flow of blood, there will also be a 
reduction in the shortening of the myocyte (strain) and the velocity at which this 
occurs (strain rate). Increased preload (starting length of myocyte) will result in 




Figure 5-5 Change in myocyte contraction with loading 
Myocyte contraction against a given load (a) will determine the force generated (b, top plot), the 
degree of shortening and the velocity of myocyte shortening (b, bottom plot). When loading 
(afterload) is increased (dashed line) a greater force (pressure) is required and there is a reduction 
in the degree (strain) and the velocity (strain rate) of myocardial shortening. Image from la Gerche 
et al.277 
Further experimental data supports the argument that strain analysis is load 
dependent. In sheep, Missant et al. demonstrated that strain rate increases with 
contractility in states of increased inotropy, however in the setting of increased 
afterload, strain rate inappropriately decreased when contractility was 
unchanged278. Jamal et al. similarly demonstrated with sonomicrometry strain 
analysis that strain rate was less sensitive at detecting changes in contractility 
during altered loading conditions144. In patients with atrial septal defects 
(increased preload due to left to right shunt) Jategaonkar et al. demonstrated 
that RVGLS decreased with closure of the defect, i.e., the value of RVGLS was 
influenced by change in preload without any change in RV contractility142. Human 
and animal studies have consistently shown that strain is related to PA pressure 
and therefore loading279-282.  
5.2.3.2 Diastolic strain assessment 
Over recent years there has been growing interest in the utility of strain analysis 
to evaluate diastolic relaxation of the RVcc. Hachulla et al. investigated the 
pattern of diastolic RV strain rate during passive RV filling (E) and filling secondary 
to atrial contraction (A), analogous to the echocardiographic labels given to 
Doppler assessment of flow across the atrioventricular valves284. They 
 
cc Assessment of RV diastolic strain has been performed by Dr Emma Murphy283 based on the 
work presented in this chapter. 
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demonstrated that in pulmonary hypertension there is a reduction in early 
diastolic strain rate, (E) with a secondary increase in late diastolic strain rate 
caused by atrial contraction (A), Figure 5-6. The authors theorised that this is a 
sign of RV hypertrophy with impaired lusitropy, therefore it has reduced passive 
early diastolic filling (E) and is more reliant on atrial filling (A)261.  
 
Figure 5-6 Right ventricular diastolic strain and strain rate 
Strain and strain rate in control (top row) and a patient with pulmonary hypertension (bottom row). 
Note reduction in right ventricular (RV) early diastolic strain rate (E) with increased main pulmonary 
artery pressure (MPAP), red lines in top right highlight the systolic and diastolic strain rates. In 
pulmonary hypertension the RV is more dependent on atrial filling (A). Image from Hachulla et 
al.261. 
5.2.4 Modalities of strain measurement 
The main methods of strain analysis are by echocardiography and CMR imaging, 
although it can also be assessed with computed tomographydd 270, 285, 286. Within 
echocardiography and CMR there are differing methods of strain analysis, the main 
distinction between methods is if it requires additional images/techniques during 
the scans or if it can be performed post-processing with the routinely collected 
images. The advantages and disadvantages of each method will be discussed 
below. As with the majority of RV literature, the techniques discussed were first 
 
dd The discussion of RV strain will focus on echocardiographic and CMR measurement of strain. 
The previous evidence in lung resection is exclusively of echocardiographic strain and this 
chapter describes the first analysis of RV strain with CMR in a lung resection cohort.  
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devised, performed and validated on the LV although there is growing interest in 
the assessment of RV strain287. 
5.2.4.1 Echocardiographic strain measurement 
Introduced in 1997, tissue Doppler imaging (TDI) was the first echocardiographic 
method of calculating strain288. TDI relies on real time Doppler imaging along the 
ventricular wall to assess the velocity of the myocardium. It can only assess the 
velocity towards or away from the transducer252, Figure 5-7. This results in angle 
dependency, i.e. as the angle between the true vector of contraction and the 
ultrasound beam increases the angular error of strain measured also increases251. 
The technique has been validated against direct sonomicrometry strain 
assessment in animal models (r=0.92)289 and CMR strain analysis (r>0.89)290 and its 
use is well established in clinical practice291. 
Strain calculation can be performed from the velocity measurement. Whilst TDI 
measures the velocity of the myocardium relative to the stationary transducer, 
the velocity of myocardium can be calculated relative to adjacent myocardium 
and therefore strain rate can be determined. This can then be integrated to 
calculate strain292. This technique can lead to error with excessive signal noise252, 
292.  
 
Figure 5-7 Echocardiographic strain assessment 
Tissue velocity (Doppler) imaging (TVI). Velocity of myocardium measured in parallel to the 
ultrasound beam. Movement only measured in one dimension. Image from Sareen et al.252. 
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Speckle tracked echocardiography (STE) was introduced in 2004 by Reisner et al.239 
and Leitman et al.293. This technique utilises artefacts within the echo image 
created by reflection, refraction and scattering of the ultrasound beams. These 
“speckles” will move relative to each other through the cardiac cycle and thus 
allow the calculation of the change in distance between these points throughout 
the cardiac cycle, i.e. two-dimensional Langrangian strain (2D-STE)270, Figure 5-8. 
Interpretation requires tracking of the myocardium to define regions of interest 
(ROI), this can be performed post-processing on appropriate echocardiography 
images. Three-dimensional STE (3D-STE) can be performed on 3D 
echocardiographic images and is increasingly performed in research studies to 
assess the RV. It has been shown to provide accurate and reproducible assessment 
of RV volume, RVEF and strain294, 295.  
 
Figure 5-8 Speckle tracked echocardiography  
Green dots represent initial position of speckle, red dots final position. Tracking of individual 
speckles allow measurement of deformation of the ventricle in two dimensions. Image from 
Blessberger and Binder 270. 
In comparison to TDI, STE has potential advantages. It is angle independent, less 
sensitive to noise, has better reproducibility and can be performed post-
processing, thus reducing scan duration. Additional, as demonstrated in Figure 5-7 
and Figure 5-8, STE measures strain in two-dimensions whereas TDI measures 
strain in only one dimension (towards or away from transducer). TDI has greater 
temporal resolution (greater ability to detect short lived cardiac events and 
increased accuracy of temporal parameters) whereas STE has greater spatial 




5.2.4.2 Cardiac magnetic resonance strain measurement 
Cardiac magnetic resonance strain measurement can be performed with tissue 
tagging (CMR-Tag) or post-processing feature tracking (CMR-FT)286.  
The first description of CMR-Tag, 1988, predates echocardiographic TDI strain 
analysis296. Through pulsation of selective radiofrequency saturation planes a 
magnetised grid is imprinted onto the myocardium at the onset of systole, Figure 
5-9D. As the heart contracts the grid is deformed thus allowing deformation 
calculation. The tags fade throughout the cardiac cycle resulting in poor 
assessment of regional relaxation and diastolic function286, 297. Additionally, the 
tagging at the onset of systole results in a temporal delay in strain assessment 
potentially underestimating strain, especially at higher heart rates as the true 
end-diastolic length is not imaged. Whilst CMR tagging is the most widely validated 
method of strain assessment, it remains predominately a research tool due to the 
additional time taken for imaging, specialist software required for analysis and 
numerous variations of the tissue tagging process297. CMR-Tag is more established 
in the thicker LV although authors have performed it in the RV where the thin RV 
wall further increases the technical difficulties298. 
Feature tracking software can be applied to standard cine sequences of the heart 
to calculate myocardial deformation post-processing, Figure 5-9C. The advantage 
of this technique is that it can be performed without dedicated additional imaging. 
As CMR images of the myocardium are relatively homogenous, CMR-FT is unable 
to determine strain by detection of intramyocardial features (as performed in 
speckle tracking). Strain calculation is instead performed by a “block matching” 
approach, i.e. it tracks anatomical features on regions of the myocardial 
boundaries297. 
5.2.4.3 Comparison between modalities of strain measurement 
There are common causes of variations in strain measurement between modalities 
(inter-modality) and within modalities (intra-modality).  
The images generated by echocardiography and CMR differ in terms of spatial 
and temporal resolution, Figure 5-9. High spatial and temporal resolution are 
required to ensure accurate strain analysis. Low spatial resolution will require 
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tracking of a larger area of the myocardium thus limiting the analysis of 
subsegments of the ventricular wall297, 299. Low temporal resolution can 
underestimate strain and prevent detection of short-lived events such as 
isovolumetric contraction (especially in the RV)297, 299. Speckle tracked 
echocardiography has excellent spatial resolution (2D-STE 0.2-0.3mm and 3D -
STE 0.4-0.5mm) although it has low temporal resolution (2D-STE 40-60 frame.s-1 
and 3D-STE 20-50 frame.s-1) whereas TDI determined strain has excellent 
temporal resolution (>100 frame.s-1) although this results in a lower spatial 
resolution than STE257, 292, 297. Comparatively, CMR techniques (tagging and FT) 
have lower spatial resolution (1-2mm) and temporal resolution (20-30 frames per 
heartbeat for tagging techniques and 25-35 frames per heartbeat for feature 
tracking)297. 
 
Figure 5-9 Modalities of tissue tracking strain analysis 
Tissue tracking in two-dimensional echocardiography (A), three-dimensional echocardiography (B), 
feature tracking cardiac magnetic resonance (C) and tissue tagging cardiac magnetic resonance 
(D). Images from Amzulescu et al. 297. 
The acquisition of the images will also affect the strain analysis. Echocardiography 
relies on acoustic windows and probe positioning to obtain true long and short axis 
images of the RV. 2D imaging planes that are not correctly orientated can result 
in foreshortening and the ROI determined at end-diastole may move out of the 
plane during systole297. This may be especially challenging for the imaging of the 
RV following lung resection85, 156. The mapping process of CMR should limit this 
variation, although this depends on the position of the heart remaining constant 
in the chest and therefore depends on the patient’s ability to perform breath 
holds, again potentially limiting its utility following lung resection300.  
Speckle tracking echocardiography software requires smoothing of the temporal 
and spatial data collected to reduce noise. This can lead to loss of short-lived 
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events and localised motion abnormalities301. Differing smoothing parameters of 
localised areas of myocardium can result in variation between segments causing 
the reliability of regional strain to be lower than global strain297.  
The experience of the operator will also influence results. Manual tracing of the 
myocardium and determination of the level of the heart can result in marked 
differences between observers297, 302. Although both have excellent reliability, STE 
has better intra- and inter-observer variability than CMR-FT for LVGLS (intra-
observer 0.94 vs 0.89 and inter-observer 0.91 vs 0.86)303. Automated detection of 
the myocardium, in STE, has been shown to have lower inter-observer variability 
although the majority of packages still rely on manual tracing304.  
Strain values are not directly comparable between differing modalities due to the 
subtle differences in how it is calculated297, 305. As demonstrated in Figure 5-10, 
there is marked variation in the value for LVGLS in healthy subjects between 
modalities297.  
 
Figure 5-10 Reported normal left ventricular global longitudinal strain values 
Mean and 95% confidence intervals for left ventricular global longitudinal strain (GLS) in healthy 
subjects. Note variation in mean value dependent on modality and low numbers in cardiac 
magnetic resonance tagging techniques (cMR-Tag) compared to two- and three- dimensional (2D 
and 3D) speckle tracking echocardiography (STE). cMR -FT, feature tracking cMR. Image from 
Amzulescu et al.297 
Taha et al. performed the first direct comparison of STE and CMR-FT strain analysis 
in the RV306. They imaged 110 subjects; 34 with arrhythmogenic RV 
cardiomyopathy (ARVC, a condition of progressive loss of cardiac myocytes), 30 
relatives (at-risk of ARVC or pre-clinical ARVC) and 46 controls. CMR-FT was 
successfully performed in 99% of RV segments versus 95% in STE. Whilst STE and 
CMR-FT were both able to detect reduced RVGLS in the ARVC patients, CMR-FT 
strain values were consistently greater than STE and there was “suboptimal” inter-
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modality agreement. RVGLS had strong correlation (r=0.578) between STE and 
CMR-FT, whilst the agreement was poor in the apical region (r=-0.261), discussed 
later in 5.2.6.2. 
5.2.5 Strain measurement in the right ventricle 
As detailed above, each method of strain analysis has its advantages and 
disadvantages. The modalities were predominately developed, validated and 
subsequently compared in analysis of LV strain, there are additional challenges of 
assessment of RV strain, particularly in a lung resection population. CMR strain 
had not been performed in this population prior to this investigation. The work by 
McCall et highlight the difficulty in echocardiographic assessment following lung 
resection156, 233.  
5.2.5.1 Reliability of strain assessment in the right ventricle 
Mirea et al. demonstrated, in 200 patients, that the reproducibility of 2D-STE 
measurement of RV strain is comparable to LV strain measurement. Intra- and 
inter-observer variabilities were excellent/good for RVGLS (ICC= 0.90 and 0.83 
respectively) and moderate/good for RVGLS.FW of basal, mid-ventricular and 
apical subsegments (ICC 0.61 – 0.81). The images were interpreted for intra-
observer variability by a single experienced observer with >2000 prior analyses 
and for inter-observer variability by a second observer of “average” experience, 
100 analyses prior to study307. Chamberlain et al. have demonstrated a marked 
improvement in intra-observer variability with experience in 2D-STE, eventually 
reaching a plateau after 100 patients302, Figure 5-11. In order to achieve their 
sample size of 200, Mirea et al. scanned 221 patients with 21 patients (9.5%) 
patients excluded due to poor image quality307. Whilst reliability of image 
interpretation is excellent, the issues of image acquisition quality may limit the 




Figure 5-11 Right ventricular speckle tracked echocardiography learning curve 
Right ventricular (RV) free wall global longitudinal strain (GLS) intra-class co-efficient (ICC) against 
groups of 25 scans reported. Note the rapid improvement in Intra-class coefficient after reporting of 
first 25 scans and plateau after 100 scans. Dashed horizontal line represents an ICC of >0.9 
required for “expert level of competency”. Image from Chamberlain et al.302. 
Cardiac magnetic resonance RVGLS is susceptible to inaccuracies in tracking and 
may also have a learning curve similar to STE300. Liu et al. performed an 
informative CMR-FT analysis of RV strain in 100 healthy individuals, 10 females 
and 10 males from each decade of life from 20-70 years who were in “optimal 
health”. Intra- and inter-observer variability showed excellent/good reliability for 
RVGLS (ICC 0.92 and 0.80)259. 
5.2.5.2 Regional strain patterns 
There are normal regional variations in strain; in healthy patients, RVGLS.FW is 
greater than RVGLS.S259 although all regions contract together with the time to 
peak strain similar between all regions264. RVGLS (RVGLS.FW and RVGLS.S 
combined) and RVGLS.FW are both commonly reported in literature. RVGLS.S is 
influenced by LV function due to the shared interventricular septum. Impaired 
RVGLS.S may purely be secondary to LV dysfunction, however, this will still 
influence RV function271, 308. 
As detailed below, the regional response of the RV to increased afterload is 
dependent on the nature of the insult. Region specific reduction in strain has been 
shown to be diagnostic and predictive of mortality; reduced RVGLS.FW is 
predictive of mortality in sepsis309, heart failure310, 311, PE265-268 and pulmonary 
hypertension145, 269, 312, 313. Regional impairment in RV strain also lead to RV 
dyssynchrony with a delay in time to peak strain between the RV regions264; in 
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PAH, RV dyssynchrony is increased in RV dysfunction160, 314 and is predictive of 
reduced exercise capacity315.  
5.2.6 Right ventricular strain in disease 
In a review of RV strain, La Gerche et al. detail the potential changes in strain 
related to changes in afterload and myocardial function 277. In response to changes 
in RV afterload and/or contractility RV deformation (measured by strain) may be 
normal or reduced; 
• normal deformation  
normal afterload and contractility  
or  
increased afterload with increased contractility 
• reduced deformation  
increased afterload with normal/reduced contractility 
or 
normal afterload and reduced contractility 
Reduced deformation (less negative strain) may therefore occur if RV contractility 
is reduced or if RV contractility does not increase to compensate for an increase 
in afterload. Differentiation between the groups may be based on the degree of 
impairment in strain316, the response of the RV to exercise317 (RV contractile 
reserve, discussed in 1.2.6.1 page 70) or evidence of myocardial injury133, 135.  
As discussed in 1.2.3 page 50, the RV has subtly different responses to acute and 
chronic increases in afterload. The global measure of RVEF is unable to determine 
the regions that contribute to any deterioration. Although there is significant 
overlap in the regions affected by acute and chronic insults, it may be possible to 
demonstrate a temporal difference between RV regions and insults. With an 
understanding of the temporal and regional responses to chronic pressure overload 
(PAH) and acute pressure overload (PE) it may be possible to determine whether 
the mechanism of RV dysfunction following lung resection results from an acute 
intra-operative insult, chronic increase in afterload or both. 
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5.2.6.1 Right ventricular strain in pulmonary hypertension 
One of the largest studies investigating RVGLS in pulmonary hypertension (PH) is 
the work of Fine et al.269. RVGLS.FW was measured with 2D-STE in 575 patients 
referred for investigation of known or suspected PH along with extensive 
echocardiographic, clinical, functional and biochemical testing. The PH group (406 
patients) had impaired (less negative) RVGLS.FW than the non-PH group, 
(−19.6±6.6% vs −25.0±5.2%), Figure 5-12 A. The greatest difference was in basal 
and mid free wall segments, there was no assessment of septal strain. Dividing 
the PAH patients into quartiles based on RVGLS.FW showed a progressive 
deterioration in all measured echocardiographic, functional and biochemical 
parameters in each quartile (p<0.04 for all). Patients were followed up until 18 
months post-investigations and RVGLS.FW of >-15%ee had a sensitivity of 89% for 
predicting cardiopulmonary death269, Figure 5-12B.  
 
ee Cut-off values are only generalisable if the method of strain analysis is the same, i.e. the value of 




Figure 5-12 Right ventricular free wall strain in pulmonary hypertension 
A. Right ventricular (RV) longitudinal strain (speckle tracking echocardiographic) distribution in 
patients with and without pulmonary hypertension (PH). Note significant overlap between 
populations. 
B. Reduced strain predictive of all-cause mortality (406 patients). Note progressive increase in 
cardiopulmonary death with progressive reduction in strain. Images from Fine et al.269. 
Hardegree et al. investigated the effect of initiation of medical therapies 
(treatment determined by routine clinician preference) on RVGLS in patients with 
PAH. Prior to commencing medical therapy, 80 patients underwent 2D-STE with 
50 patients undergoing repeat imaging 6 months following treatment with survival 
follow-up for 4 years. The remaining 30 patients were excluded due to no further 
imaging (12 patients), death prior to follow-up (10 patients) and inadequate 
imaging for strain analysis (8 patients, 10%). Therapeutic interventions did not 
reduce PAP or PVR, but RVGLS improved from -15±5% to -20±7% (p=0.0001). Failure 
to improve RVGLS by >5% (22/50 patients) and a follow-up RVGLS.FW of >-12.5% 
were both predictive of increased mortality313. 
In a combined conductance catheter and CMR strain study, Tello et al. confirmed 
that, RVGLS reduction is associated with RV-PA uncoupling in PAH. In chronic 
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pressure overload the initial adaptive increase in contractility with increased 
afterload/preload (maintaining coupling) becomes exhausted. Ultimately the RV 
uncouples with RV strain markedly reduced282.  
5.2.6.2 Right ventricular strain in pulmonary embolism 
Regional reduction in RVGLS has also been demonstrated in patients with PE by 
Platz et al.258, Figure 5-13. All echocardiography was performed within 72 hours 
of diagnosis of PE; when comparing patients with PE to healthy controls, the 
greatest reduction in RVGLS was seen in the basal and mid ventricular regions of 
the RV free wall with lesser reduction in the free wall apex, mid septum and basal 
septum. This pattern is similar to the free wall findings of Fine et al.269. Platz et 
al. also demonstrated a weak association between brain natriuretic peptide (BNP) 
and RVGLS (r=0.39, p<0.05)258.  
 
Figure 5-13 Regional right ventricular longitudinal strain in pulmonary embolism vs control  
Regional right ventricular global longitudinal strain is reduced in patients with pulmonary embolism 
(n=75) compared to controls (n=30). Note greatest reduction is in the free wall. Image from Platz et 
al.258. 
Comparison of strain analysis with the classical echocardiography sign of PE 
(McConnell’s sign, McCS) highlights the utility of regional strain analysis in 
distinguishing between displacement and deformation. The original description of 
McCS is an echocardiographic picture of “akinesia of the mid-free wall ... but 
normal motion at the apex”318. In Platz et al.s’ study in patients with PE; 
comparison of patients with McCS (36/72 patients, 50%) to those without McCS 
demonstrated no difference in RVGLS.FW in the basal or mid segments, but a 
reduction in RVGLS.FW at the apex in those with McCS258. Similarly, Mediratta et 
al. investigated RV strain by STE in patients with McCS319, they also demonstrated 
reduced apical strain in patients with McCS. This seemingly paradoxical reduced 
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strain but apparent normal motion of the apical RV free wall may be caused by 
the apical attachment of the RV to a hyperdynamic LV. Strain analysis reveals that 
the apparently “normal motion” of the RV free wall apex in McCS is actually 
passive, i.e. it is displacement not deformation. 
Echocardiography within 72 hours of PE diagnosis has consistently demonstrated 
that acute reduction in RVGLS.FW is predictive of morbidiy and mortality265-268. 
Vitarelli et al. investigated wether there is resolution of RV dysfunction following 
PE. In 66 patients with confirmed PE, they repeated echocardiography at 30 days 
and 6 months following initial diagnosis and imaging. They showed that the acute 
reduction in RVGLS.FW seen following PE is transient and recovers by 30 days post-
event, whilst RVEF and RV systolic pressure (RVSP) only partially recover by 6 
months, Figure 5-14. The authors state that the acute pressure overload distorts 
the RV free wall reducing RVGLS.FW and that a rapid reduction of this pressure 
overload, by treatment of the PE, rapidly resolves this distortion and therefore 
resolves RVGLS.FW. The delayed and incomplete recovery in RVEF is secondary to 




Figure 5-14 Resolution of right ventricular function following pulmonary embolism 
Mid free wall right ventricular longitudinal strain (MFW-RVLS) (top pane), right ventricular ejection 
fraction (3D-RVEF) (middle pane) and right ventricular systolic pressure (RVSP) (bottom pane) 
following pulmonary embolism (PE) over time and against controls (C). Note RVLS and RVEF are 
acutely reduced against controls following PE, RVLS recovers by 30 days whilst RVEF remains 
reduced until 6 months. *= p<0.001 vs PE. † and ‡= p<0.005 vs PE. Image from Vitarelli et al.320. 
As discussed in 1.2.3.4 page 55, a rat model of PE reveals a similar pattern of RV 
damage as above. Watts et al. introduced microspheres into the pulmonary 
circulations of rats to simulate a PE. They demonstrated an inflammatory response 
within the RV free wall without any RV apical or LV changes. Longitudinal strips 
of the RV free wall were isolated and paced showing a reduction in contractile 
force, at 24 hours and at 6 weeks following PE, compared to rats that did not 
received the microspheres. Histological examination revealed an acute post-
operative neutrophil and macrophage infiltration of the RV free wall, which results 
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in collagen deposition and scarring by 6 weeksff. This process may contribute to 
prolonged reduction in RV free wall contractility134, 135, 321.  
5.2.6.3 Summary of right ventricular strain in disease 
It is established that reduced RVGLS occurs with increased afterload. This 
predominately affects the RV free wall in both acute increases258, 265-268 (PE) and 
chronic increases145, 269, 313 (PAH). 2D-STE consistently demonstrates reduced 
RVGLS.FW within 72 hours following a PE258, 265-268 although Vitarelli et al. showed 
that this recovers by 30 days320. In PAH, RVGLS.FW is a sensitive marker of disease 
serverity, marker of repsonse to treatment, and is predictive of morbidity and 
mortality145, 269, 313.  
5.2.7 Studies investigating right ventricular strain following lung 
resection 
Three investigations of RV strain following lung resection have been performed to 
date76, 224, 233. All of the studies have been performed with 2D-STE and the results 
are inconsistent.  
5.2.7.1 Study by Wang et al.  
Thirty patients (10 pneumonectomies and 20 lobectomies) had pre-operative and 
one-week post-operative echocardiography studies224. They demonstrated marked 
reduction in all measures of RV and LV strain. Pneumonectomy patients had a 
greater post-operative reduction in RVGLS.FW than lobectomy (-30.86±5.88% to -
11.77±4.14%, p<0.05 and -29.7±6.23% to -18.03±8.06%, p<0.05) and RVGLS.S (-
17.51±7.11% to -10.1±5.92%, p<0.05 and -19.88±5.92% to -15.6±6.40%, p<0.05). 
Additionally, LV longitudinal strain reduced in both groups.  
Comparison of their results to PH cohorts raises potential concerns regarding the 
levels of post-operative strain in the results. Vitarelli et al. demonstrated that a 
2D-STE RVGLS.FW strain of <-18% had an 89% sensitivity and a 74% specificity for 
detection of RV failure322. Smith et al. demonstrated that 2D-STE values for RVGCS 
 
ff The inflammatory response and scarring of the RV demonstrated in the Watts et al. rat studies is 
discussed further in the future work section, section 9.3.2 page 337, and is the physiological 
basis of one of the two future studies, detailed in Appendix 3.  
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<-9.9% and RVGLS <-16.1% had hazard ratios for mortality of 4.17 (1.93-12.97) and 
7.63 (1.76-10.27) respectively323. Whilst the results of Wang et al. are in a post-
operative setting, the reduction in RV strain values demonstrated are in keeping 
with a severe reduction in RV function269. 
The authors argue that speckle tracked echocardiography has been validated in 
other diseases, but that the changes in heart position may influence the image 
acquisition. Overall inter- and intra-observer variability were good (ICC >0.84) but 
they do not differentiate this between pre-operative and post-operative scans. 
Heart rate was elevated in both groups post-operatively which may influence 
strain results when measured by 2D-STE317, 324 although this was included as a co-
variate in the analysis.  
5.2.7.2 Study by Bhat et al.  
Twenty-six patients (5 pneumonectomies and 21 lobectomies) underwent 
echocardiographic assessment pre-operatively and on POD 2, 7 and 3076. RVGLS 
changed over the course of the study (p=0.045), whilst the lowest value was at 
POD2 (-15.1±3.7%) there was no post-hoc testing to determine if this was a 
significant difference from pre-operative (-19.2±4.5%).  
5.2.7.3 Study by McCall et al.  
Twenty-seven patients from the RV Response to Lung Resection study underwent 
speckled tracked echocardiography pre-operatively, POD2 and 2-months post-
op156, 233. In pooled analysis RVGLS and RVGLS.FW were associated with CMR RVEF 
(r=-0.412 and r=-0.477) and were able to identify RV dysfunction (RVEF <45%), 
Figure 5-15. A RVGLS value of −17.7% had 76.0% sensitivity and 66.7% specificity 
for identifying RV dysfunction and a RVGLS.FW value of −20.0% had 62.5% 
sensitivity and 79.5% specificity for identifying RV dysfunction156. There was no 




Figure 5-15 Receiver-operator curves for identification of right ventricular dysfunction 
Area under receiver operator curve (AUROCC) for tricuspid annular plane systolic excursion 
(TAPSE, dashed-dotted line), right ventricular global longitudinal peak strain (RV-GPLS in image, 
dashed line) and right ventricular free wall longitudinal peak strain (RV-FWPLS in image, solid line). 
Diagonal dashed line is the line of no effect. Image from McCall et al.156. 
5.2.7.4 Summary of right ventricular strain following lung resection 
There are differing results between the three studies; Wang et al. show a marked 
reduction in RVGLS and RVGCS224 whilst Bhat et al. show only a transient small 
reduction76 and McCall et al. show no change233. All three studies have similar 
patient numbers although differing numbers of pneumonectomy patients (ten in 
Wang et al., five in Bhat et al. and one in McCall et al.). This may explain the 
difference in RV strain results, the greater physiological insult may cause a greater 
reduction in strain. Contrary to this is the fact that the lobectomy patients in 
Wang et al. have reduced strain and there is no difference between the lobectomy 
and pneumonectomy strain results in Bhat et al.  
5.3 Hypotheses  
Hypotheses:  
• RV contractility, measured by CMR-FT RVGLS and RVGLSrate,  
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a. decreases following lung resection 
b. predominately affects the RV free wall. 
• The magnitude of a reduction in RVGLS/RVGLSrate will be associated with  
a. reduction in RVEF 
b. increase in BNP  
c. increase in afterloadgg 
5.4 Methods  
Patients from the RV Response to Lung Resection Study with complete CMR scans 
at each time point were selected for strain analysis using commercially available 
software (QStrain, Version 2.1.12.2, Medis Medical Imaging, Leiden, The 
Netherlands). In total, pre-operative, POD2 and 2-months post-operative scans for 
20 patients, 60 in total, were analysed. 
The description of the generic methods, statistical analysis plan, patient 
population and previously described results are discussed in Chapter 4. 
5.4.1 Strain analysis 
5.4.1.1 Image interpretation 
Anonymised and randomised cardiac magnetic resonance scans were uploaded into 
QStrain and interpreted as per Padervinskienė et al.325. Visual inspection of the 
four-chamber “cine” was performed to assess for artefact in both; RV and LV long 
axis motion.  
LVGLS and LVGCS were calculated from two, three and four chamber views of the 
LV. QStrain constructs a 3D model of the LV from these views and calculates GLS, 
GCS and GRS. RVGLS, RVGLS.S and RVGLS.FW were calculated form the four 
chamber long axis views of the RVhh, Figure 5-16. For both ventricles, the 
endocardial border was traced at end-diastole and then automatically 
interpolated across the cardiac cycle. Visual inspection of each of the 35 
 
gg This will be explored in chapter 8. 
hh QStrain does not calculate subsegmental strain regions of the RV free wall or septum. This 
prevents calculation of strain in the basal, mid-ventricular and apical segments of the RV free 
wall and septum. 
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sequential frames of the cardiac cycles was then performed with correction of the 
automated endocardial border where required. This was repeated for each of the 
views detailed above.  
  
Figure 5-16 Generation of global longitudinal strain for left and right ventricles 
Mapping of endocardial border of left ventricle (A) and right ventricle (B). QStrain, Medis, calculates 
regional and global longitudinal strain. Note free wall in green and septal strain in pink in image B. 
Indicative image from interpretation of scan MRIRAN 15 from this study. 
All scans were reported by the author, with 15 scans randomly selected for repeat 
interpretation by the author to allow calculation of intra-observer variability, this 
was performed one week after completion of the original 60 scans. A further 
selection of 9 randomly selected scans were interpreted for inter-observer 
variability by Kenneth Mangion (KM), Cardiology Research Fellow, University of 




5.4.1.2 Data processing 
QStrain calculates strain and time to peak strain (TTPS) for each defined cardiac 
region. This output is in the form of single data results displayed on the console, 
bottom left in Figure 5-16. Additionally, a “.txt” file including values for strain, 
area/volume and time points for each of the images of the cine is generated. The 
data in the .txt file is required for calculation of strain rate and for more detailed 
assessment of the strain plots generatedii. Using R Studio (Microsoft, 
Version 1.1.463) an automated programme was written by the author to convert 
the “.txt” files to an excel “.csv” file. Once in “.csv” format the data was 
uploaded to R Studio for processing and analysis as detailed below. The process 
detailed below was completed for calculation of strain and strain rate from plots 
of RVGLS, RVGLS.FW, RVGLS.S, LVGLS, LVGCS and LVGRS. 
In order to calculate strain rate, the strain data generated in the “.txt” must be 
filtered and the temporal differential calculated. QStrain uses a filter to smooth 
the measured strain values to predict peak strain and TTPS. Medis does not publish 
the filtering method used in QStrain. In order to replicate this, the data was 
smoothed with a second order, seven point Savitzky Golay filter 326 and then 
interpolated to 1 millisecond, this technique is discussed in greater detail in 
section 7.2.6.2 page 261. Visual inspection was performed to compare smoothed 
and original data for all plots generated, an example is demonstrated in Figure 
5-17. Agreement was then tested between the smoothed strain results and the 
result generated by QStrain for RVGLS, RVGLS.FW, RVGLS.S, LVGLS, LVGCS and 
LVGRS.  
An original R Studio programme was written to measure TTPS and strain values. 
These were automatically detected as the time to and value of the most negative 
strain value from the smoothed data. Plots for each scan were automatically 
generated, with the point at which these values were measured indicated upon 
it. Visual inspection of the generated plot profile was performed to assess for 
physiological plausibility. The points at which the automated programme 
 
ii The results generated by QStrain for the RV limit analysis to the timing and magnitude of strain. 
Filtering and smoothing of the data not only allowed strain rate calculation, but also investigation 
of diastolic function, performed separately by Dr Emma Murphy.  
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measured values for TTPS and strain were assessed to ensure accuracy of the 
programme, an example is given in Figure 5-18. 
Strain rate is not calculated for each region in QStrain and so the temporal 
differential of strain was calculated in R. Calculation of the derivative from the 
35 time points of the original data exaggerates any small sudden change in the 
strain value measured whereas using the smoothed data minimises this effect, see 
Figure 5-17 (bottom panel). The differential of this smoothed data was interpreted 
with the same programme as strain, i.e. time to and value of most negative strain 
with visual inspection of plots again performed. 
  
 
Figure 5-17 Strain and strain rate plots demonstrating effect of data filter 
Strain (%) (left panel) and strain rate (s-1) (right panel) plots from scan MRIRAN 32 in this study. 
Black circles represent measured data points of strain. Dashed black line (strain rate) represents 
differential of these points. Solid red line demonstrates these results following fitting of a smoothing 
filter (Savitzky Golay filter applied to measured vales of strain) and 1ms temporal interpolation. 
Note minimal divergence from measured value in strain plot but significant smoothing of differential 
in strain rate plot. The temporal relationship and the magnitude of peaks in strain and strain rate 
are maintained between measured and smoothed data. 
5.5 Results 
Strain analysis was completed at all time points for the 20 patients. Visual 
inspection was performed on the plots of all strain analysis parameters, an 
example of normal plots for strain and strain rate are given in Figure 5-18. There 
were no abnormal patterns found for any LV strain, RVGLS or RVGLS.S although 
RVGLS.FW had two abnormal plots at POD2, scans MRIRAN 29 and MRIRAN 44. 
MRIRAN 29 had a positive strain inflection in early systole and MRIRAN 44 had 
positive strain in early and late systole, neither of which were present in the RVSA 
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views or RVLA septum. Both scans were excluded from RVGLS.FW and 
RVGLSrate.FW analysis and subsequent association testing.  
  
Figure 5-18 Normal strain and strain rate plot interpretation 
Automated R programme detects the value at and timing of the point of lowest strain (left panel) 
and strain rate (right panel) then generates plots demonstrating these results for visual inspection 
and plausibility checking. TTPS=time to peak strain. RVGLS=right ventricular global longitudinal 
strain. ms=millisecond. Image of a right ventricular longitudinal strain interpretation of scan 
MRIRAN 32 from this study. 
 
5.5.1 Reliability and variability of CMR measurements 
A random selection of the 60 scans were selected for repeat reporting by the 
author (15 scans) and for reporting by KM. 
5.5.1.1 Interobserver reliability and variability 
Interobserver testing showed moderate agreement and low variability for RVGLS 
(ICC 0.50, CV 8.68%), Table 5-1 and Figure 5-19. Interpretation of LVLA scans 
showed moderate/good reliability and good variability (ICC >0.57, CV <9.81%). All 




Table 5-1 Interobserver variability for right and left ventricular strain 
Intraclass correlation coefficient (ICC) calculated as interobserver two-way mixed method absolute 
agreement. RV= right ventricle. LV= left ventricle. GLS= global longitudinal strain. GCS= global 
circumferential strain. GRS= global radial strain. CV= coefficient of variation. CI= confidence 
interval. Nine repeated scans.  
  
Figure 5-19 Interobserver reliability in strain measurement 
Association between observer 1 and 2 in right ventricular long axis (RVLA) measurement of global 
longitudinal strain (GLS). Solid line is the line of association, i.e. no difference between 
measurements. Nine repeated scans. ICC= intra-class correlation co-efficient. 
5.5.1.2 Intraobserver reliability and variability 
Intraobserver testing showed moderate reliability and low variability in RVGLS (ICC 
0.73, CV 8.48%), Table 5-2 and Figure 5-20. LVLA had good/excellent reliability 
and low variability (ICC >0.88, CV <4.55%) with narrower confidence intervals than 
the RV. 
Ventricle Measure CV (%) ICC (95% CI) p value  
RV GLS(%) 8.68 0.50 (-0.12, 0.86) 0.077 
LV GLS (%) 7.36 0.85 (0.15, 0.97) 0.011 
GCS (%) 7.57 0.57 (-0.01, 0.88) 0.027 
GRS (%) 9.81 0.71 (-0.04, 0.94) 0.034 
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Ventricle Measure CV (%) ICC (95% CI) p value  
RV GLS(%) 8.48 0.73 (0.37, 0.90)  <0.001 
LV GLS (%) 4.55 0.88 (0.68, 0.96) <0.001 
GCS (%) 4.21 0.94 (0.83, 0.98) <0.001 
GRS (%) 3.44 0.96 (0.89, 0.98) <0.001 
Table 5-2 Intraobserver variability for right and left ventricular and strain 
Intraclass correlation coefficient (ICC) calculated as intraobserver two-way mixed method absolute 
agreement. RV= right ventricle. LV= left ventricle. GLS= global longitudinal strain. GCS= global 
circumferential strain. GRS= global radial strain. CV= coefficient of variation. CI= confidence 
interval.  
 
Figure 5-20 Intraobserver reliability in strain measurement 
Association between observation 1 and 2 by author in right ventricular long axis (RVLA) 
measurement of global longitudinal strain (GLS). Solid line is the line of association, i.e. no 
difference between measurements. Fifteen repeated scans. ICC= intra-class correlation co-
efficient. 
5.5.1.3 Agreement between smoothed and original data 
Visual inspection of the smoothed plots against the original data did not highlight 
any discrepancies between them. There was excellent agreement between the 
peak strain values calculated after smoothing of the data and the results 
generated in QStrain (ICC>0.98, two-way mixed method absolute agreement). 
Smoothed data was consistently more negative (greater strain) than the QStrain 
generated results although relative magnitude of the mean difference was not 
clinically significant, Table 5-3.  
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Ventricle Measure Mean difference SD CV (%) ICC (95% CI) p value  
RV GLS(%) 0.84 1.35 2.55 0.98 (0.93, 0.99)  <0.001 
GLS.FW (%) 0.06 0.08 0.15 1.00 (1.00,1.00) <0.001 
GLS.S(%) 0.07 0.08 0.19 1.00 (1.00,1.00) <0.001 
LV GLS (%) 0.44 0.80 1.41 0.98 (0.95, 0.99) <0.001 
GCS (%) 0.53 1.01 1.78 0.99 (0.97, 0.99) <0.001 
GRS (%) -1.23 2.69 1.51 0.99 (0.97, 0.99) <0.001 
Table 5-3 Agreement between smoothed data and QStrain results 
Mean difference (QStrain – smoothed) and standard deviation (SD) of smoothed data compared 
with QStrain generated results. Intraclass correlation coefficient (ICC) calculated as intraobserver 
two-way mixed method absolute agreement. RV= right ventricle. LV= left ventricle. GLS= global 
longitudinal strain. GCS= global circumferential strain. GRS= global radial strain. CV= coefficient of 
variation. CI= confidence interval.  
5.5.2 Changes in strain and strain rate over time 
5.5.2.1 Right ventricular strain and strain rate over time 
The results for RVGLS, RVGLSrate, RVGLS.FW, RVGLSrate.FW, RVGLS.S and 
RVGLSrate.S are shown in Table 5-4, Figure 5-21 and Figure 5-22. Data were a 
mixture of parametric and non-parametric, with ANOVA or Friedman’s test used 
as indicated.  
Table 5-4 Right ventricular global longitudinal strain and strain rate results 
Values are mean (SD) or median (IQR). RVGLS= right ventricular global longitudinal strain. 
RVGLS.FW= free wall RVGLS. RVGLS.S= septal RVGLS. *= one-way repeated measures 
ANOVA. §= Friedman’s test. #= significant difference from pre-op. n=20 for each time-point. 
Significant results (p<0.05) highlighted bold italics. 
RVGLS showed a significant difference over time (p=0.049, ANOVA). Paired t-test 
showed that RVGLS was reduced at 2-months from pre-operatively (p=0.022) and 
at POD2 the reduction in RVGLS from pre-op approached significance (p=0.082, 
paired t-test), Figure 5-21. There was no change in RVGLSrate over this period. 
Region Parameter Pre-op POD2 2-months p-value 
Global RVGLS  
(%)  










Free wall RVGLS.FW  
(%) 








(-2.24, -1.49) # 
0.016 § 
Septum RVGLS.S  
(%) 













Figure 5-21 Right ventricular global longitudinal strain over time 
Reduction in strain by 2-months post-op. Non-significant reduction at post-operative day 2 POD2 
(p=0.082). Paired t-test for both comparisons. Bar plot represents mean and 95% CI. 
There was a difference in RVGLS.S over the study period, with a significant 
reduction at POD2 from pre-operative (p=0.018, paired t-test) and trend to 
reduction at 2-months (p=0.061, paired t-test). RVGLS.FW showed a reduction 
from pre-operative levels to 2-months post-operative (p=0.023, paired t-test), 
Figure 5-22. Of the strain rate results, only RVGLSrate.FW was reduced from 





Figure 5-22 Right ventricular free wall and septal global longitudinal strain over time 
Bar plot represents mean and 95% CI. Free wall right ventricular global longitudinal strain 
(RVGLS.FW) in dark grey and septal right ventricular global longitudinal strain (RVGLS.S) in striped 
light grey. RVGLS.S reduced at post-operative day 2 (POD2), RVGLS.FW reduced at 2-months. 
Both tests Paired t-test. Note stepwise reduction in RVGLS.S at POD2 followed by a reduction in 
RVGLS.FW at 2-months.  
5.5.2.2 Left ventricular strain and strain rate over time 
There were no changes in LVGLS, LVGCS or LVGRS over the duration of the study, 
Table 5-5. ANOVA demonstrated a change in both LVGLSrate, LVGCSrate and 
LVGRSrate over the study period. On comparison between time points there was 
only POD2 (against pre-op) increases in LVGLSrate (p=0.007), LVGCSrate (p=0.005) 
and LVGRSrate (p=0.013), all paired t-tests.  
Table 5-5 Left ventricular global longitudinal and circumferential strain and strain rate 
results 
Strain and strain rate changes in left ventricular global longitudinal strain (LVGLS), global 
circumferential strain (LVGCS) and global radial strain (LVGRS) changes over time. Values are 
mean (SD) or median (IQR). *= one-way repeated measures ANOVA. §= Friedman test. #= 
significant difference from pre-op. Significant results (p<0.05) highlighted bold italics. 
Region Parameter Pre-op POD2 2-months p -value 
Longitudinal LVGLS (%) -25.42 (5.02) -26.18 (3.38) -25.34 (4.39) 0.739 * 
LVGLSrate (s-1) -1.12 (0.32) -1.39 (0.32) # -1.26 (0.27) 0.013 * 
Circumferential LVGCS (%) -33.33 (6.54) -34.70 (6.56) -32.97 (7.66) 0.500 * 
LVGCSrate (s-1) -1.62 (0.30) -1.89 (0.35) # -1.85 (0.41) 0.021 * 
Radial LVGRS (%)  70.65 (18.48) 73.97 (17.68) 69.17 (19.73) 0.524 * 
LVGRSrate (s-1) 3.11 (0.79) 3.89 (1.12) # 3.59 (1.21) 0.049 * 
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5.5.3 Association between right ventricular ejection fraction and 
longitudinal strain and strain rate 
5.5.3.1 Right ventricular longitudinal strain 
There were moderate negative within-subject associations between the change in 
RVGLS.S and the change in RVEF between pre-op and POD2 and between pre-op 
and 2-months, Table 5-6 and Figure 5-23, impaired RVGLS.S was associated with 
reduced RVEF. Individual time point associations reveal moderate negative 
associations between RVGLS.FW and RVEF on POD2 and at 2-months, Figure 5-24, 
impaired RVGLS.FW was associated with reduced RVEF. 
Table 5-6 Within-subject association between RVGLS and RVEF  
RVGLS= right ventricular global longitudinal strain. RVGLS.FW= free wall RVGLS. RVGLS.S= 
septal RVGLS. RVEF= right ventricular ejection fraction. Analysis of covariance with patient as 
factor. *= Pearson’s correlation co-efficient. §= Spearman’s correlation co-efficient. Significant 
results (p<0.05) highlighted bold italics. 
Analysis of covariance, within-subject  
Change between pre-op and POD2 
   RVGLS RVGLS.FW RVGLS.S 
RVEF r -0.365 -0.066 -0.446 
p 0.103 0.788 0.043 
 
Change between pre-op and 2-months 
   RVGLS RVGLS.FW RVGLS.S 
RVEF r -0.423 -0.282 -0.463 
p 0.062 0.229 0.040 
 
Time point analysis 
 
  
RVGLS RVGLS.FW RVGLS.S 
RVEF Pre-op r -0.393 -0.171 -0.279 
p 0.086 * 0.471 * 0.234 * 
POD2 r -0.238 -0.510 0.104 
p 0.313 * 0.031 * 0.660 * 
2-months r -0.341 -0.528 0.398 




Figure 5-23 Within-subject association between RVGLS and RVEF  
Within-subject associations between septal right ventricular global longitudinal strain (RVGLS.S) 
and right ventricular ejection fraction (RVEF) between pre-op and post-operative day 2 (left) and 2-
months (right). Note reduction in RVGLS.S associated with reduction in RVEF. Analysis of 
covariance with patient as factor. Coloured dots represent each patient and lines depict parallel 
lines of association for each patient. 
  
Figure 5-24 Association between RVGLS.FW and RVEF at post-operative day two and 2-
months 
Moderate negative associations between free wall right ventricular global longitudinal strain 
(RVGLS.FW) and right ventricular ejection fraction (RVEF) at post-operative day 2 (POD2) and two 
months, both Pearson’s. 
5.5.3.2 Right ventricular longitudinal strain rate 
There were no associations on within-subject ANCOVA or individual time-points 
association testing between RVGLSrate, RVGLSrate.FW or RVGLSrate.S and RVEF, 




Table 5-7 Association between RVGLSrate and RVEF  
RVGLSrate= right ventricular global longitudinal strain rate. RVGLSrate.FW= free wall RVGLSrate. 
RVGLSrate.S= septal RVGLSrate. RVEF= right ventricular ejection fraction. Analysis of covariance 
with patient as factor. *= Pearson’s correlation co-efficient. §= Spearman’s correlation co-efficient. 
5.5.4 Association between BNP and right ventricular strain and 
strain rate  
5.5.4.1 Right ventricular longitudinal strain/strain rate 
There were no within-subject associations between RVGLS/RVGLSrate, 
RVGLS.FW/RVGLSrate.FW or RVGLS.S/RVGLSrate.S and BNP, (p>0.292). Association 
testing at each individual time-point is shown in Table 5-8. There were moderate 
and strong positive associations between BNP and RVGLS.S pre-operatively and 2-
months post-operatively (r=0.506 and 0.666). RVGLSrate.S had a strong positive 
association with BNP at 2-months. At POD2 RVGLS and RVGLSrate were moderately 
associated with BNP and RVGLS.FW approached significance (p=0.052). In each 
association increased BNP was associated with impaired (less negative) strain.  
Analysis of covariance, within-subject 
Change between pre-op and POD2 
   RVGLSrate RVGLSrate.FW RVGLSrate.S 
RVEF  r -0.014 -0.092 -0064 
  p 0.951 0.709 0.783 
      
Change between pre-op and 2-months 
   RVGLSrate RVGLSrate.FW RVGLSrate.S 
RVEF  r -0.335 -0.317 -0.309 
  p 0.124 0.174 0.184 
      
Time point analysis 
 
  
RVGLSrate RVGLSrate.FW RVGLSrate.S 
RVEF Pre-op r -0.260 -0.361 -0.279 
p 0.268 § 0.118 § 0.234 * 
POD2 r -0.184 -0.225 0.114 
p 0.437 * 0.370 * 0.633 * 
2-months  r -0.105 -0.264 0.326 
p 0.669 * 0.275 * 0.173 * 
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Individual time point analysis 
 
  
RVGLS RVGLS.FW RVGLS.S 
BNP Pre-op r 0.028 -0.062 0.506 
p 0.905§ 0.796§ 0.023§ 
POD2 r 0.497 0.465 0.223 
p 0.026* 0.052* 0.345* 
2-months r 0.070 -0.125 0.666 
p 0.769§ 0.600§ 0.001§ 
     
  RVGLSrate RVGLSrate.FW RVGLSrate.S 
Pre-op r -0.129 -0.312 0.344 
p 0.588§ 0.181§ 0.138§ 
POD2 r 0.490 0.387 0.163 
p 0.028* 0.113* 0.492* 
2-months r 0.019 -0.218 0.722 
p 0.937§ 0.357§ <0.001§ 
Table 5-8 Association between RVGLS/ RVGLSrate and BNP at individual time-points 
RVGLS/ RVGLSrate= right ventricular global longitudinal strain/ strain rate. RVGLS.FW/ 
RVGLSrate.FW= free wall RVGLS/ RVGLSrate. RVGLS.S/ RVGLSrate.S= septal RVGLS/ 
RVGLSrate.S. BNP= brain natriuretic peptide. *= Pearson’s correlation co-efficient.  
§= Spearman’s correlation co-efficient. Significant results (p<0.05) highlighted bold italics. 
5.5.5 Association between left ventricular strain with BNP 
There were no within-subject associations between the change in LVGLS, LVGCS 
or LVGRS and the change in BNP between any time points (p>0.178). There were 
moderate within-subject associations between the change in LVGLSrate (r=-0.595, 
p=0.006) and LVGRSrate (r=0.41, p=0.046) and the change in BNP between pre-op 
to POD2. On individual time-point analysis only 2-month post-op LVGCSrate was 
associated with BNP (r=0.590, p=0.006, Spearman’s). There were no other 
significant associations between LVGLS, LVGLSrate, LVGCS or LVGCSrate and BNP on 
individual time-point analysis.  
5.5.6 Summary of main results 
Hypotheses: 
• RV contractility, measured by CMR-FT RVGLS and RVGLSrate,  
a. decreases following lung resection 
b. preferentially affects the RV free wall. 
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The main finding is that RVGLS changes over time, with reduction at 2-months 
following lung resection. The RV septum and the free wall that contribute to this 
reduction have differing temporal responses. RVGLS.S is reduced from baseline at 
POD2 with a trend to reduction at 2-months (p=0.061) whereas RVGLS.FW is 
unchanged at POD2 but reduced at 2-months, with a concurrent reduction in strain 
rate. 
• The magnitude of reduction in RV strain/strain rate will be associated with  
a. reduction in RVEF 
b. increased BNP  
c. increased afterloadjj  
Within-subject analysis demonstrated a moderate association between the change 
in RVGLS.S and the post-operative change in RVEF. Post-operative (POD2 and 2-
month) RVGLS.FW was moderately associated with RVEF. Whilst there were 
numerous individual time-point associations between strain and BNP, there were 
no within-subject associations between the change in RV strain and the change in 
BNP. 
5.6 Discussion 
5.6.1 Strengths and limitations 
The main strength of this study is that it is the first utilisation of CMR strain in a 
lung resection population, allowing temporal tracking of the changes in RV strain 
following lobectomy. Whilst all patients (of the 27 patients in the study) 
completed the CMR protocol pre-operatively, five patients did not complete the 
POD2 scan. Three patients refused, one patient had a persistent air leak requiring 
intercostal drainage that could not safely be transferred and one patient had an 
epidural catheter in-situ that was not CMR compatible254. Patient refusal to return 
to the MRI scanner on POD2 (3/27, 11%) results in a similar non-completion rate 
to RV 2D-STE. 2D-STE RV analysis was not possible in 9.5% of patients in a 
comparable studies307 and in 15.6% in patients from this study254. 
Echocardiography and CMR are both challenging for patients following lung 
 
jj Investigation performed in Chapter 8. 
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resection. CMR can be a lengthy process for patients to undertake; it requires 
transfer to the scanner, lying flat for up to an hour, frequent breath holds and can 
be claustrophobic. Given this, it is perhaps encouraging that so many patients 
were willing to perform the follow-up scans. 
The main limitation in the data collected is the reliability of the strain 
measurement. The intra- and inter-observer ICC were lower than published 
literature143, 259, 303, 307, 327 and there is evidence of a systematic inter-observer 
bias. 
Backhaus et al. argue that QStrain, Medis (the software used in this analysis) may 
have lower reproducibility with inexperienced operators, but greater 
reproducibility when used by an experienced operator, due to a large degree of 
manipulation required in tracing the RV border. Additionally, the four-chamber 
views required for RVGLS interpretation are greatly affected by the motion of 
breathing300. This may cause the greatest impact in the immediate post-operative 
period (POD2); secondary to altered breathing mechanics, acutely reduced lung 
volume, increased respiratory rate and pain. The two RVGLS.FW scans removed in 
the current analysis were both on POD2 and the causes of the factors limiting 
analysis, are potentially due to motion artefact secondary to breathing and/or 
incorrect tracing of the myocardium due to operator inexperience. Neither of the 
excluded scans were dual reported in the randomly selected intra- or inter-
observer reliability tests. Given that RVGLS is calculated from RVGLS.FW and 
RVGLS.S, the abnormalities in the RVGLS.FW analysis may influence RVGLS. 
Sensitivity analysis with removal of the corresponding RVGLS scans on POD2 
showed that the change in RVGLS over time retained significance (p=0.006 vs 
p=0.049 prior to removal, ANOVA) and the result of the comparison between pre-
op and POD2 was also unaffected (p=0.096 vs p=0.082 prior to removal, paired t-
test). 
Schmidt et al. have performed an extensive reliability assessment of RV and LV 
CMR-FT strain analysis327. It includes 40 patient scans dual reported by 4 observers 
(320 interpretations) allowing interobserver and intraobserver ICC and CV 
calculation, comparison with the results of this study are shown in Table 5-9. When 
compared to Schmidt et al., there was lower interobserver and intraobserver 
185 
 
reliability throughout. Two potential explanations for this difference are; 
experience of observer and difference in the population investigated.  
 Ventricle Measure Current study Schmidt et al. 
   CV (%) ICC   CV (%) ICC  
Inter-
observer 
RV GLS (%) 8.68 0.50 18.7 0.75 
LV GLS (%) 7.36 0.85 15.4 0.78 
GCS (%) 7.57 0.57 5.1 0.96 
GRS (%) 9.81 0.71 19.2 0.62 
Intra-
observer 
RV GLS (%) 8.48 0.73 7.1 0.96 
LV GLS (%) 4.55 0.88 5.2 0.94 
GCS (%) 4.21 0.94 2.1 0.97 
GRS (%) 3.44 0.96 6.4 0.90 
Table 5-9 Comparison of reliability and variability data with Schmidt et al. 
Note lower Intraclass correlation coefficient (ICC) in majority of interobserver and intraobserver 
variability but lower CV data between the results of the current study and Schmidt et al.327. RV= 
right ventricle. LV= left ventricle. GLS= global longitudinal strain. GCS= global circumferential 
strain. GRS= global radial strain. CV= coefficient of variation.  
As demonstrated by Chamberlain et al., there is learning curve for 2D-STE RVGLS 
analysis; this may also be present in CMR-FT302, contrary to this, a study by 
Backhaus et al. suggest that training does not improve reliably with QStrain. In an 
investigation of the effect of training on the reproducibility of CMR-FT analysis 
they did not find any difference in RVGLS values before and after training. In 
QStrain they actually demonstrated a reduction in ICC (intra-observer ICC 0.89 to 
0.76 and inter-observer ICC 0.70 to 0.58) and CV following training. Their ICCs 
after training are similar to the results presented here300. 
Inter-observer testing, detailed in 5.5.1.2, demonstrated that Observer 2 (KM) 
consistently reported a less negative RVGLS than Observer 1 (author) with a mean 
difference of 3.5±2.8%, Figure 5-25. There was a similar inter-observer bias 
between observers of equal experience in the QStrain results from the study of 
Backhaus et al. with a mean difference between RVGLS of 3.06±3.54% before 
training and 3.33±4.72% after training although this was not replicated in a similar 
study by Gertz et al.328. The bias was not present with either of the other two 
CMR-FT software investigated by Backhaus et al.300 or in separate studies327, 329. 
To the best of our knowledge a comparison between experienced and 
inexperienced observer has not been performed in QStrain for RV strain although 
Feisst et al. have demonstrated that inexperienced observers tend to report lower 




Figure 5-25 Bland-Altman plot for inter-observer strain analysis 
Absolute difference in right ventricular global longitudinal strain (RVGLS, %) between Observer 1 
and Observer 2 against mean RVGLS. Note consistent bias with Observer 1 reporting more 
negative RVGLS than Observer 2.  
In order to minimise any potential inaccuracies in this investigation I undertook 
extensive training in CMR reporting. I completed Level 1 Society for Cardiac 
Magnetic Resonance training, Kings College London, prior to commencing the CMR 
analysis detailed in this thesis. Subsequently, I performed CMR analysis of patients 
from this study in Argus with supervision of CMR experienced anaesthetic research 
fellows (AA and PM) who have dual reported the RV volume analysis, discussed in 
Chapter 4, and the cardiology research fellow David Corcoran. Prior to undertaking 
the interpretation detailed above in QStrain, I had further training by the 
cardiology research fellow (KM) who performed the interobserver scans. This 
included direct supervision of reporting of training scans from this study, these 
reports were discarded prior to commencing the interpretation detailed above. 
There are marked differences in the study populations in the study by Schmidt et 
al. and this study. The patients in the Schmidt et al study were either healthy 
controls or patients with myocarditis with a mean age of 36 and 37 respectively. 
This is very different to the older (mean age 64) and co-morbid population of our 
study who subsequently underwent lung resection, which has been shown to 
reduce CMR image quality. In reporting RVEF in the patients from this study, 
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McCall et al. demonstrated CV for RVEF increased post-operatively (12.9% pre-op 
to 16.8% on POD2 and 15.9% at 2-months)231.  
The inter-observer reliability is limited by the small number of repeated measures 
and therefore the wide 95% confidence intervals. Although all ICC lie between 
moderate to excellent reliability it is impossible to conclude where the true ICC 
absolute agreement lies within the confidence intervals. Additionally, it was not 
possible to investigate the impact of lung resection on reliability due to low 
numbers dual reported at each time point. Further investigation of inter-observer 
differences in RV strain analysis following lung resection should be incorporated 
into future work in this setting. 
5.6.2 Strain results 
5.6.2.1 Magnitude of changes in strain 
The numerical value of strain measurement is determined by not only the method 
of analysis (TDI, STE, CMT-Tag or CMR-FT, section 5.2.4.3) but also the software 
used within each method. Bourfiss et al. demonstrated that repeated CMR-FT 
analysis of the same CMR images with different software results in a poor inter-
vendor agreement, ICC= 0.373331, with Gertz et al. showing RVGLS has the lowest 
inter-vendor agreement of any strain measurement328. To quantify the changes in 
strain reported in this study, a comparison must be made to CMR-FT studies that 
used QStrain for RV strain analysis. There are a limited number of such studies 
and they all focus on RVGLS, the results of these studies are detailed below.  
In pulmonary hypertension Leng et al. demonstrated that RVGLS is reduced;  
-21±7% vs -29±4% in controls and progressively lower in patients at low risk  
(-25.4%), intermediate risk (-19.2%) and high risk (-13.0%) of clinical deterioration. 
It was also lower in patients who developed adverse events (-14.8% vs -22.5% no 
adverse event)332. In a study investigating patients with heart failure, RVGLS was 
-14.9% versus -26.2% in controls328. In patients with ARVC, Taha et al. 
demonstrated RVGLS of -27.9% in ARVC patients, -33.6% in ARVC relatives (an at 
risk or pre-clinical population) and -36.4% in controls306. Not only is there variation 
in RVGLS between diseases, but there is also marked variation in apparently 
similar control groups with RVGLS reported from -24.1% to -36.4%. The control 
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groups are younger and healthier than the pre-op patients in this current study, 
although the pre-op RVGLS of -32.73% seen in this study is in the middle of this 
range. Of note, volunteer STE studies have shown that RVGLS decreases with age 
and authors advise adjustment for age when comparing different groups333, 334. 
The post-operative reduction in RVGLS, -28.06% from -32.73% pre-op, is a modest 
reduction compared to patients with established PAH. Compared to the RVGLS 
values of Leng et al., 2-months post-operative RVGLS remains greater than RVGLS 
values seen in patients with PAH332. The patients in the study of Leng et al. had 
established PAH, therefore potentially have greater RV afterload than in this 
current study. As discussed in 5.2.3.1 and contrary to some author’s 
interpretation, strain is a load dependent variable and in states of increased 
afterload, strain measurements can be reduced whilst contractility is actually 
unchanged278. To fully assess contractility, strain must be interpreted with the RV 
loading conditions. Leng et al. also found that reduced RVGLS (-25% cut-off) was 
had 69.9.% sensitivity and 86.3% specificity for detection of pulmonary 
hypertension (AUROC 0.838)332. At 2-months, six patients in the current study had 
RVGLS <-25% although there was no difference in either RVEF or the change in 
RVEF between those above or below this cut-off. The post-op RVGLS decrease is 
however similar to the difference between “at-risk” ARVC relatives and 
established ARVC patients demonstrated by Taha et al.306.  
Strain values for the LV seen in the current cohort are similar to the healthy 
patients in the studies by Gertz et al.328, Backhaus et al.300 and in a pulmonary 
hypertension study by collaborators from this current study335. The increase in LV 
strain rate and within-subject associations between the change in LV strain rate 
and the change in BNP between pre-op and POD2 may be explained by an increase 
in heart rate to meet increased cardiac output, although there is not a change in 
RV strain. Within-subject association testing revealed consistent associations 
between the change in heart rate and the change in LV strain rate, whereas there 
was no such association for RV strain rate, Table 5-10. The increase may be 
influenced by reduced filling (preload) secondary to RV dysfunction; although LV 
ejection fraction, stroke volume, end-diastolic and end-systolic volumes were all 
unchanged at this time point. 
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Analysis of covariance, within-subject   
  
RVGLSrate  LVGLSrate  LVGCSrate  LVGRSrate  
Heart 
rate 
r -0.062 -0.497 -0.318 0.455 
p 0.709 0.001 0.049 0.004 
Table 5-10 Within-subject association between left ventricular strain rate and heart rate  
RVGLSrate= right ventricular global longitudinal strain rate. LVGLSrate= left ventricular global 
longitudinal strain rate. LVGCSrate= left ventricular global circumferential strain rate. LVGRSrate= left 
ventricular radial strain rate. Analysis of covariance with patient as factor for all time points. 
Significant results (p<0.05) highlighted bold italics. 
5.6.2.2 Temporal and regional pattern of strain changes 
As described in 5.2.6 page 160, a reduction in RV strain may be caused by an 
increase in afterload and/or a reduction in contractility (from myocardial injury 
and/or dysfunction). Furthermore, a reduction in strain with increased afterload 
may occur with or without a reduction in RV contractility277. The early post-
operative reduction in RVGLS.S and late reduction in RVGLS.FW are therefore 
either secondary to afterload increase and/or myocardial injury, the reduced 
strain alone does not confirm the hypothesised reduced contractility following 
lung resection. Additionally, the reduction in RVGLS.S may be influenced by LV 
dysfunction, there were however no associations between the reduction in 
RVGLS.S and the change in LVGLS or LVGCS between any timepoints (ANCOVA, 
p>0.184).  
As the mechanism of RV dysfunction following lung resection is widely 
hypothesised to result from increased afterload, RV strain analysis may be able to 
determine the temporal nature of an afterload increase, i.e. an acute increase, a 
chronic increase or both. Both predominately affect the RV free wall but with 
differing temporal responses. As demonstrated in Chapter 4, RVEF decreased at 
POD2 and remained decreased at 2-months in the study population. If the nature 
of the insult is truly analogous to a PE this would be expected to result in 
decreased RVGLS.FW in the immediate peri-operative period (imaging at POD2) 
that recovers by 2-months whilst RVEF may remain decreased, similar to the PE 
results by Vitarelli et al.320, 5.2.6.2 and Figure 5-14 page 165. If solely due to a 
chronic increase in afterload, secondary to reduction in lung volume and 
pulmonary vasculature circulation, RVGLS.FW reductions would be expected to 




The strain results observed, demonstrate no immediate post-operative change in 
RVGLS.FW, but a delayed reduction at 2-months. The development of impaired 
RVGLS.FW over the 2-month period is suggestive of a chronic increase in 
afterload. Previous studies, however, have failed to demonstrate increased 
afterload following lung resection. Pulmonary artery catheterisation studies 
demonstrate that PVR is either unchanged48, 49, 63 or actually reduced in days to 
weeks following lung resection58-60. Through exercise testing post-operatively by 
Okada et al. 49, Nishimura et al.67 and Miyazawa et al.68 provided evidence of 
reduced pulmonary vascular reserve following lung resection, i.e. an increase in 
afterload due to an inability of the pulmonary vasculature to accommodate 
increased cardiac output. The sequalae of an afterload increase may not develop 
in the immediate post-operative period but develop gradually in the weeks to 
months after surgery, but this requires concurrent analysis of strain with 
afterload to confirm. 
There is a consistent post-operative relationship between RVGLS.FW and RVEF, 
with reduced RVGLS.FW consistently occurring with reduced RVEF. There are 
moderate associations between these parameters both on POD2 (r=-0.510, 
p=0.031) and at 2-months (r=-0.528, p=0.020). Reduced RVGLS.FW appears to be 
at least contributory to the reduction in RVEF demonstrated. 
5.6.2.3 Strain associations with BNP 
An alternative mechanism of the reduction in strain is that it occurs secondary to 
an intrinsic reduction in contractility caused by myocardial dysfunction. Local 
inflammation and scarring secondary to the significant peri-operative stresses 
placed on the RV during lung resection (acute afterload increase with one lung 
ventilation and stress response to major surgery) could result in myocardial 
dysfunction and impaired contractility336. BNP is released secondary to myocardial 
stretch and is a non-specific marker of RV dysfunction337, its release is associated 
with impaired RVGLS.FW following PE258. In this study group, the change in RVEF 
from pre-op to POD2 was associated with POD2 BNP, i.e. the patients with greatest 
drop in RVEF had the highest BNP230. Although there are positive associations 
between strain and BNP at individual time points (increased BNP associated with 
impaired strain), there are no consistent within-subject associations between the 
change in RV strain or strain rate and the change in BNP.  
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5.6.2.4 Comparison with previous studies 
There are important distinctions between these results and the three previous 
studieskk that have investigated RV strain following lung resection156, 224. All three 
studies have investigated strain with 2D-STE, with similar patient numbers and 
study design, but all giving conflicting results, discussed in 5.2.7.  
Wang et al.224 demonstrated a marked universal reduction in all RV strain 
parameters (and LVGLS) following lobectomy (20 patients) and pneumonectomy 
(10 patients) at one week post-operatively. Comparison of RVGLS between the 
lobectomy group and the patients in this investigation (19 lobectomies and 1 
pneumonectomy) reveals that whilst both show a reduction in RVGLS, the results 
of Wang et al. are strikingly different. It is not reliable to directly compare 
numerical strain values between different modalities, but the relative decrease 
in RVGLS seen by Wang et al. is far greater than in this investigation, Table 5-11. 
Additionally, we did not find any signal of the marked reduction in LV strain shown 
by Wang et al. No other studies investigating ventricular function following lung 
resection has shown any change in LV function, Chapter 2. In contrast Bhat et al. 
demonstrated results similar to this investigation although as they have not 
performed post-hoc testing to compare post-operative strain against pre-
operative for each time point, the temporal nature of this decrease is unclear.  
 
kk Study by McCall et al. is performed in the same patients as this study. 
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RVGLS  Pre-op -25.69 (4.71)  -32.73 (6.18)  
POD2   -29.66 (6.85) -9.4 
1 week -17.07 (5.26) -33.6    
2-months   -28.06 (7.34) -14.3 
RVGLS.FW  Pre-op -29.7 (6.23)  -37.31 (10.21)  
POD2   -36.48 (9.13) -2.2 
1 week -18.03 (8.06) -39.3    
2-months   -32.47 (10.62) -13.0 
RVGLS.S  Pre-op -19.88 (5.92)  -31.56 (9.10)  
POD2   -26.00 (9.85) -17.6 
1 week -15.65 (6.40) -21.3   
2-months   27.27 (7.97) -13.6 
Table 5-11 Comparison of changes in RV strain with study by Wang et al. 
Note difference between percentage change in Wang et al.224 and results of this investigation. 2D-
STE= two-dimensional speckle tacked echocardiography. CMR= cardiac magnetic resonance. 
RVGLS= right ventricular global longitudinal strain. RVGLS.FW= free wall RVGLS. RVGLS.S= 
septal RVGLS. POD2= post-operative day 2.  
A potential explanation for a degree of the difference is that Wang et al. had 
healthier pre-operative patients; they were younger (57.0±11.4 years vs 65.2±10.8 
years), had less comorbidities, lower BMI and significantly lower pre-op SPAP 
(20.3mmHg vs 30.8mmHg, estimated on echocardiography) than the patients 
included in this current study. Additionally, the 2D-STE strain results in this 
investigation’s patient group (detailed in 4.5.2.2.2 page 141) had lower pre-
operative RVGLS than in Wang et al.156. There is evidence that healthier patients 
have greater post-operative impairment following lung resection63, 231, 338. 
Any reduction in strain may also be influenced by heart rate. In healthy 
participants, an increased heart rate during exercise has been shown to increase 
RVGLS.FW when measured by TDI but decrease when measured by 2D-STE317, 324. 
In the study by Wang et al., one-week post-operative heart rate was 87.8±18.5 
beats/min (lobectomy group) whilst POD2 heart rate was 77.0±11.0 beats/min in 
the current study. This may cause underestimation of strain with 2D-STE or it may 
be due to impaired myocardial function necessitating an increased heart rate to 
maintain cardiac output224. The timing of post-operative scanning is also different 
between the studies, although it is difficult to explain such a marked reduction in 




Strain analysis demonstrated that RVGLS is reduced at 2-months following lung 
resection. In the initial post-operative period, there is a reduction in RVGLS.S but 
by 2-months there is a reduction in RVGLS.FW and ultimately RVGLS. On individual 
time point analysis, reduced RVGLS.FW is associated with the previously 
demonstrated post-operative reduction in RVEF. The delayed reduction in 
RVGLS.FW is hypothesised by the author to be caused by a chronic increase in 
afterload. Further correlation between RV function, strain values and afterload 




Chapter 6 Pulmonary artery blood flow, 
acceleration time and distensibility 
This chapter will describe the first of two investigations of pulsatile afterload 
following lung resection. Previous investigations of afterload following lung 
resection are discussed in Chapter 2. These investigations assessed pulmonary 
artery pressure (PAP) and pulmonary vascular resistance (PVR) however, as 
detailed in Chapter 1, these are incomplete measures of afterload and overlook 
potential changes in pulsatile afterload.  
6.1 Cardiac magnetic resonance indices of afterload 
The use of CMR in pulmonary arterial hypertension (PAH) is predominantly to 
assess RV function, however there is growing interest in CMR derived indices of 
afterload149, 211-213, 339-344. Its use in research is rapidly expanding and has numerous 
potential benefits, in summarising a review on this topic Bradlow et al. conclude 
that CMR, 
“is a flexible research tool which has opened new avenues for 
understanding treatment effects, outcomes and pathogenesis.” 
Bradlow et al.162 
6.1.1 Pulmonary artery distensibility 
Multiple definitions are used in literature for the term distensibilityll, see below. 
Within this thesis, distensibility will describe the percentage area change from 
minimum to maximum cross-sectional area of a vessel149, 159, 345, 346, Equation 6-1. 
Other definitions for distensibility include; relative area change from maximal 
area343, 347 and relative area change for change in pressure211, 212 whilst others have 
used alternative terms to describe the area change; pulsatility212, PA strain342, 
relative area change211 and elasticity348. 
 
ll The lack of agreed terminology in CMR research highlights the lack of an agreed approach that 
would be required for use in clinical practice. Of note, in papers just two years apart, Sanz et al. 







Equation 6-1 Distensibility 
PA= pulmonary artery 
Distensibility and compliance are mathematically linked212, Equation 6-1 and 
Equation 6-2. Whilst compliance requires measurement of PA pressure, 
distensibility does not, therefore it can be measured non-invasively. Swift et al. 
demonstrated a similar inverse relationship between distensibility and PVR, Figure 
6-1, as demonstrated between compliance and PVR340, Figure 1-27 page 76.  
!":E8%+'&#	(::&/::PF) = 100	4	
3+4%:9: −:%'%:9:	MN	+,#+
1@=("8%& − 2%+=("8%&	MNM  
Equation 6-2 Compliance 
PA= pulmonary artery. PAP= PA pressure 
 
Figure 6-1 Relationship between distensibility and pulmonary vascular resistance 
Distensibility (RAC in image) has an inverse relationship with pulmonary vascular resistance 
(PVR). Image from Swift et al.340. 
Numerous studies have demonstrated that distensibility (or any other term used 
to describe the product of Equation 6-1) is reduced in PAH212, 213, 340-342, 349. Ray et 
al. demonstrated that MPA distensibility is markedly reduced, even in mild PAH 
and therefore may be able to detect early PAH350. In this setting, it is also 
predictive of; poor outcome340, reduced functional capacity149, response to 
treatment343 and survival211, 340, 344. Distensibility has also been shown to be a 
better predictor of survival than other methods of assessing afterload. Gan et al. 




than PVR (AUROC=0.67) 211, Figure 6-2. Similarly, Swift et al. demonstrated that 
MPA distensibility <16% was predictive of reduced survival, whereas compliance 
and PVR were not340.  
  
Figure 6-2 Distensibility Kaplan-Meier survival curve 
Kaplan-Meier survival curve for distensibility above and below 16% in a pulmonary hypertension 
cohort. Image from Gan et al. 211. 
The differences in vessel area and distensibility between main and left/right 
pulmonary arteries has been investigated sparingly. Some studies have negated 
this by using the left/right pulmonary artery for assessment, with the assumption 
of uniform disease between each lung211, 351. Given the predominately unilateral 
insult in lung resection it is clearly important to assess potential differences in the 
MPA and PA branches (LPA and RPA).  
6.1.2 Flow measurements 
An example of a flow profile generated from CMR and its interpretation is shown 
in Figure 6-3. Measurements of peak flow, time to peak flow (pulmonary artery 
acceleration time (PAAT)), ejection time (ET) and flow rate can all be made from 
simple interpretation of the flow profile346. Total blood flow can also be calculated 
as the area under the curve for the entire cardiac cycle. PAAT may be influenced 
by heart rate although PAAT/ET normalises the PAAT to the duration of cardiac 
ejection (systole)342. PAAT and PAAT/ET have been shown to be reduced in PAH 





Figure 6-3 Assessment of pulmonary artery flow profile 
Representative plot of flow against time in the pulmonary artery. Parameters derived from plot 
include max/peak flow, acceleration time (AT), ejection time (ET) and acceleration flow rate (Dƒ/Dt). 
Image from Ibrahim et al.354 
In CTEPH, there is a characteristic ‘notched’ appearance to the flow profile345, 346, 
351, 353, Figure 6-4. This has been shown to be secondary to a proximal site of wave 
reflection, i.e. a proximal clot in CTEPH351. Wave reflection is the reflection of 
forward travelling blood flow from a change in vessel calibre or compliance, this 
is discussed in detail in 7.2.4.4 page 242. The notch disappears following removal 
of the clot by pulmonary endarterectomy (PEA), whilst elevated PAPs may persist 
due to distal changes in the pulmonary vasculature346, Figure 6-4. 
 
Figure 6-4 Flow profile with and without proximal clot 
Plots of flow against time in patient with chronic thromboembolic pulmonary hypertension before 
pulmonary artery endarterectomy (PEA) (left) and after PEA (right). Note notching of flow profile 




6.2 Hypotheses  
As detailed in Chapter 3 and throughout this thesis the hypothesised change in 
pulsatile afterload following lung resection are:  
• Pulsatile afterload, measured by PAAT, PAAT/ET and distensibility,  
a. increases following lung resection 
b. predominately affects operative PA. 
• The magnitude of increase in pulsatile afterload rate will be associated with  
a. reduction in RVEF 
b. increased BNP  
c. impaired strainmm 
6.3 Methods  
The description of the generic methods, statistical analysis plan, patient 
population and previously described results are discussed in Chapter 4. 
Methodology specific to this investigation is explained below. 
6.3.1 Analysis 
6.3.1.1 Image interpretation 
Anonymised and randomised cardiac magnetic resonance scans were uploaded into 
the proprietary CMR analysis software (Argus, Siemens, Erlangen, Germany) as per 
4.4.1.3 page 128. Flow and area assessment was performed for the MPA, RPA and 
LPA as per Schulz-Menger et al.249, detailed below. 
Argus displayed a single perpendicular slice of the artery in phasenn and magnitude 
images of the 30 frames comprising a cine loop of the cardiac cycle, Figure 6-5. 
The border of the vessel was manually traced in the frame with the greatest 
intensity of flow then Argus extrapolated the border to each frame of the cardiac 
 
mm This will be explored in Chapter 8. 
nn Phase-contrast CMR quantifies blood velocity by measuring the change in phase (proportional to 
blood velocity) compared to stationary tissue. The brightness of the blood increases with 
increasing of blood velocity in the phase images, this results in greatest demarcation of the 




cycle. Visual inspection and augmentation of the extrapolated border was 
performed for each frame. Flow, velocity and vessel area were plotted by Argus 
for each frame and displayed as plots against time. Visual inspection of the plots 
was performed prior to generating the final results. Results were generated as a 
“.txt” file. Similar to Chapter 5, an automated programme was written by the 
author to convert the “.txt” files to an excel “.csv” file in R Studio (Microsoft, 
Version 1.1.463). Once in “.csv” format the data was uploaded to R Studio for 
processing and analysis as detailed below. 
 
Figure 6-5 Main pulmonary artery interpretation 
Top left panel of top row display the magnitude images of the main pulmonary artery. Top right 
panel and bottom row display the phase images of the same artery. Each column of the bottom 
panel represents a frame of the cine loop of the cardiac cycle. Endocardial border mapping 
displayed by red line in both magnitude and phase images and in each pane of the cardiac cycle in 
the corresponding rows. Image from study patient MRIRAN40. 
All images and vessels were dual reported by Alex Arthur (clinical research fellow) 
and the author. Six weeks after initial reporting, a further 9 patients (27 vessels) 
were randomly selected for repeat interpretation by the author to calculated 




6.3.1.2 Data processing 
Data processing was performed in R Studio with an original R programme written 
by the author. The process described below was repeated for each individual 
vessel in each scan. In order to differentiate the changes in pulsatile afterload 
between the PA (RPA or LPA) supplying the operated lung and the PA supplying 
the non-operated they was termed “operative” or “non-operative” dependent on 
the side of lung resection. For example, in a patient who had a right sided 
lobectomy the RPA would be termed the operative PA for each time point whilst 
the LPA would be the non-operative PA.  
The two “.csv” files for the interpreter’s report of an individual vessel were 
uploaded into R Studio. The averages were calculated for the measurements of 
flow, area and velocity at each individual time point between the two reports. 
Averaging of the measured data prior to interpretation was performed to reduce 
inaccuracies at individual time points in an attempt to minimise the artifactual 
changes in area and flow prior to interpretation. This is particularly important in 
the subsequent wave intensity analysis investigation, Chapter 7. The data was 
then interpolated to 1 millisecond temporal resolution by performing a spline fit 
without smoothing of the data, Figure 6-6. 
  
Figure 6-6 Flow and area plots demonstrating interpolation 
Flow (left plot) and area (right plot) vs time plots from the main pulmonary artery of scan MRIRAN 
40oo in this study. Black circles represent measured data points whilst the red line demonstrates 
these results following temporal interpolation. Note no divergence from measured values.  
 




Peak flow was measured as the value of maximal flow and PAAT was measured as 
the time to peak flow. As PAAT is influenced by heart rate, PAAT was normalised 
to heart rate by calculating PAAT as a percentage of ejection time (ET). ET is 
defined as the time from onset of flow to the “horizontalization of flow”, i.e. end 
systole136, Figure 6-3. 
Total flow was measured as the total blood flow per minute in that vessel. This 
was calculated by the area under the curve for the entire cardiac cycle multiplied 
by heart rate. For the MPA and the sum of the operative and non-operative PA, 
this equates to cardiac output. The percentage of the cardiac output (CO) in the 
operative PA and non-operative PA was calculated as the total flow in that vessel 
divided by the sum of the flow in the operative PA and non-operative PA combined, 
Equation 6-3. Of note the percentage.CO was only calculated if both vessels were 
imaged at that time point, the patient that had a pneumonectomy is therefore 
not included in this analysis. 
Q"'. "E	MN	E#,&#'(+F#. CO	(%) = 100	4	
("(+8	'"'. "E	MN	$8"U
("(+8	"E	MN	$8"U + ("(+8	'"'. "E	MN	$8"U 
Equation 6-3 Percentage of non-operative cardiac output 
Non-op= non-operative. PA= pulmonary artery. Op= operative.  
Pulmonary artery distensibility was calculated from the maximum and minimum 
area, as per Equation 6-1 page 195. In order to check accurate detection of PAAT 
and distensibility, minimum and maximum areas “.pdf” files were generated for 
the flow and area against time plots for each vessel with the point of measurement 
indicated. Visual inspection of all plots was performed to ensure accurate 
detection of results, Figure 6-7. This process was repeated for the 3 vessels in 
each of the scans.  
To calculate inter- and intra-observer variability, the process detailed above was 
performed for the results generated by each interpreter’s original analysis without 
averaging of values. Comparison was made on the results generated for peak flow, 
PAAT, total flow, maximum and minimum areas. The methodology and 
interpretation of reliability and variability assessment is discussed previously in 





As described in Chapter 4, CMR scans were completed in 27 patients pre-
operativelypp, 22 on POD2 and 24 at 2-months. In three of these scans imaging was 
not completed in all three PAs. In the two post-operative scans of RV6 (the patient 
that had an on-table conversion to pneumonectomy) the LPA had been resected 
and so was not imaged. Due to a scanning oversight, neither the LPA nor RPA was 
visualised in the POD2 scan of RV14. All imaged vessels were included in the 
analysis. In total, 73 scans are included in the analysis with results available for 
215 vessels (73 MPAs, 70 LPAs and 72 RPAs). 
 
  
Figure 6-7 Normal flow and area plot interpretation 
Example of interpretation of flow and area plots against time. For the flow plot (left panel) R was 
programmed to detect the peak flow, the time at which it occurs (pulmonary artery acceleration 
time (PAAT)) and the time to end of ejection (ET). For the area plot (right panel) R was 
programmed to detect the minimum and maximum area for distensibility calculation. The results 
generated were programmed to be displayed on the plots of flow and area for visual inspection. 
Images of the MPA of MRIRAN 40 from this study. 
Visual inspection was performed for the plots of area and flow against time for all 
vessels, examples shown in, Figure 6-7. The were no abnormalities detected in 
flow profiles for any vessel. Whilst there were no obvious area plot abnormalities 
detected in the RPA or LPA, there were numerous abnormalities revealed in MPA 
scans. Non-physiological diastolic peaks in area were visualised in 14 MPA scans (8 
pre-op, 2 POD2 and 4 at 2-months), an example is shown in Figure 6-8. Area and 
distensibility analyses are therefore only performed on the MPA scans without the 
 
pp Of note the one patient that did not have a short axis stack of the ventricles performed at pre-




diastolic movement artefact, discussed further in 6.6.1. The flow profile was not 
affected by the artefact therefore all of the MPA flow results were included in 
analysis. 
,  
Figure 6-8 Example of main pulmonary artery plot with artifact 
Area against time plot for main pulmonary artery (PA), red lines highlight minimum and maximum 
area. Note the minimum area occurs towards end-systole with a marked increase in area following 
this. There was no reciprocal change in flow to correspond to the increase in area or corresponding 
diastolic area changes in the operative or non-operative PAs (not shown). Image MPA of 
MRIRAN69 from study.  
6.4.1 Reliability and variability of measurements 
6.4.1.1 Interobserver reliability and variability 
Interobserver testing showed good to excellent agreement and variance for all 
flow measurements, Table 6-1. Maximal and minimal areas showed good/excellent 
agreement for all vessels (ICC > 0.919 CV < 5.24% and ICC > 0.847 CV < 10.37%) 





Measure Vessels Result CV (%) ICC (95% CI) p value  
Flow All 
n=215 
Peak flow (ml.s-1) 4.10 0.983 (0.977, 0.987) <0.001 
PAAT (ms) 5.96 0.876 (0.839, 0.905) <0.001 
Total flow (ml) 4.10 0.987 (0.983, 0.990) <0.001 
LPA + RPA 
n=142 
Peak flow (ml.s-1) 4.55 0.959 (0.942, 0.971) <0.001 
PAAT (ms) 5.90 0.872 (0.824, 0.908) <0.001 
Total flow (ml) 4.57 0.964 (0.949, 0.974) <0.001 
MPA 
n=59 
Peak flow (ml.s-1) 4.11 0.984 (0.979, 0.988) <0.001 
PAAT (ms) 5.94 0.880 (0.842, 0.909) <0.001 





Maximum area (cm2) 5.17 0.955 (0.941, 0.966) <0.001 
Minimum area (cm2) 9.16 0.935 (0.914, 0.950) <0.001 
LPA + RPA 
n=142 
Maximum area (cm2) 5.24 0.917 (0.885, 0.940) <0.001 
Minimum area (cm2) 10.37 0.847 (0.778, 0.893) <0.001 
MPA 
n=59 
Maximum area (cm2) 5.03 0.957 (0.943, 0.968) <0.001 
Minimum area (cm2) 9.20 0.937 (0.916, 0.953) <0.001 
Table 6-1 Interobserver variability for flow and area results 
Intraclass correlation coefficient (ICC) calculated as interobserver two-way mixed method absolute 
agreement. PA= pulmonary artery. LPA= left PA. RPA= right PA. MPA= main PA. PAAT= 
pulmonary artery acceleration time. CV= coefficient of variation. CI= confidence interval. 73 dual 
reported scans.  
6.4.1.2 Intraobserver reliability and variability 
Intraobserver testing showed excellent reliability and variability for flow 
measurements (ICC>0.94, CV<4.94%), Table 5-2. Area plots had good reliability 





Table 6-2 Intraobserver variability for flow and area results 
Intraclass correlation coefficient (ICC) calculated as intraobserver two-way mixed method absolute 
agreement. PA= pulmonary artery. LPA= left PA. RPA= right PA. MPA= main PA. PAAT= 
pulmonary artery acceleration time. CV= coefficient of variation. CI= confidence interval. 9 repeated 
scans. 
6.4.2 Flow results 
6.4.2.1 Changes in blood flow and distribution over time 
Total blood flow, measured in the MPA, increased at POD2 before returning to 
pre-operative level of flow by 2-months, Table 6-3. Compared to pre-op, at POD2 
and 2-months, both the value of total flow and the percentage of CO were reduced 
in the operative PA and increased in the non-operative PA (p<0.001, paired t-test 
for all). Pre-operatively, there was no difference between the percentage of CO 
travelling in the (what would be) operative PA and in the non-operative PA 
(p=0.486, unpaired t-test) although non-operative PA percentage of CO was 
greater than in the operative PA at POD2 and at 2-months (both p<0.001, unpaired 
t-test), Figure 6-9.  
Measure Vessels Result CV (%) ICC (95% CI) p value  
Flow All 
n=27 
Peak flow (ml.s-1) 2.24 0.998 (0.996, 0.999) <0.001 
PAAT (ms) 3.90 0.960 (0.913, 0.982) <0.001 




Peak flow (ml.s-1) 2.83 0.997 (0.991, 0.999) <0.001 
PAAT (ms) 3.35 0.970 (0.919, 0.989) <0.001 
Total flow (ml) 2.31 0.991 (0.952, 0.997) <0.001 
MPA 
n=9 
Peak flow (ml.s-1) 1.12 0.997 (0.988, 0.999) <0.001 
PAAT (ms) 4.94 0.941 (0.770, 0.986) <0.001 





Maximum area (cm2) 3.44 0.982 (0.961, 0.992) <0.001 




Maximum area (cm2) 3.54 0.981 (0.946, 0.993) <0.001 
Minimum area (cm2) 7.71 0.910 (0.773, 0.966) <0.001 
MPA 
n=9 
Maximum area (cm2) 3.23 0.971 (0.882, 0.993) <0.001 




Table 6-3 Changes in flow in pulmonary arteries over time 
Values are mean (SD) or median (IQR). PA=pulmonary artery. MPA=main PA. *= one-way 
repeated measures ANOVA. §= Friedman’s test. #= significant difference from pre-op. ¥= 
significant difference from post-operative day 2 (POD2). Percentage of flow is calculated from sum 
of operative and non-operative vessel flow. Significant results (p<0.05) highlighted bold italics. 
 
Figure 6-9 Changes in distribution of pulmonary artery blood flow over time 
Percentage of blood flow through the operative pulmonary artery (PA) (dark grey boxes) and non-
operative ( light grey boxes). Note reduction in percentage of total blood flow on operative PA at 
post-operative day 2 (POD2) and 2-months compared to pre-operative, (p<0.001, paired t-test for 
both). Operative PA flow percentage lower than non-operative at POD2 and 2-months (unpaired t-
test for both). Bar plot represents mean and 95% CI.  
Compared to pre-operatively, on POD2 and at 2-months, peak flow was increased 
in the non-operative PA (both p<0.001, paired Wilcoxon signed rank test) and 
decreased in operative PA (both p<0.001, paired t-test). Operative PA and non-
operative PA peak flow was similar pre.op (p=0.256, Wilcoxon rank sum test) 
Vessel Parameter Pre-op POD2 2-months p-value 
MPA Total flow  
(l.min-1)  
6.57 (1.68) 8.00 (1.57) # 6.52 (1.65) ¥ <0.001 * 
Peak flow  
(ml.s-1) 
351.5  
(332.8, 388.6)  
389.8  
(347.0, 434.4) # 
339.2  
(293.6, 388.2) #¥ 
0.026 § 





2.99 (0.82) 2.31 (0.74) # 2.33 (0.75) # <0.001 * 
Percentage  
of CO (%) 
51.92 (6.23) 33.69 (9.52) # 39.06 (11.41) #¥ <0.001 * 
Peak flow  
(ml.s-1) 
181.9 (52.4) 123.6 (42.1) # 117.8 (44.3) #¥ <0.001 * 





2.82 (0.96) 4.72 (1.43) # 3.84 (1.45) #¥ <0.001 * 
Percentage  
of CO (%) 
48.08 (6.23) 66.31 (9.52) # 60.94 (11.41) #¥ <0.001 * 
Peak flow  
(ml.s-1) 
156.6 
(136.7, 179.8)  
247.8  
(195.5, 284.8) # 
197.5  
(164.2, 260.0) #¥ 
<0.001 § 




whereas operative PA peak flow was lower than non-operative PA at POD2 and 2-
months (p<0.001, Wilcoxon rank sum test).  
6.4.2.2 Pulmonary artery acceleration time 
Pulmonary artery acceleration time was shorter at POD2 and 2-months in the MPA, 
Table 6-4 and Figure 6-10. PAAT was also shorter in the operative PA and non-
operative PA at POD2, although by 2-months only operative PA remained shorter 
than pre-op, Figure 6-11. There was no difference between operative PAAT and 
non-operative PAAT pre-operatively (p=0.588, unpaired t-test) although operative 
PAAT was shorter than non-operative PAAT on POD2 and at 2-months (p=0.008 and 
p=0.022 respectively, both unpaired t-test). When corrected for heart rate, 
PAAT/ET, the POD2 reduction remained significant in all vessels whereas at 2-
months only operative PAAT/ET was shorter than pre-operatively. Compared to 
the non-operative PA, operative PAAT/ET was shorter on POD2 and at 2-months 
(p=0.007 and p=0.046, unpaired t-tests).  
Vessel Parameter Pre-op POD2 2-months p-value 
MPA PAAT (ms) 115.9 (20.7) 82.7 (18.9) # 104.0 (19.5) #¥ <0.001 * 
PAAT/ET (%) 30.0 (3.8) 24.0 (5.4) # 29.0 (5.9) ¥ <0.001 * 
n 27 22 24  
Operative  
PA 
PAAT (ms) 124.7 (19.3) 82.1 (23.0) # 106.0 (23.9) #¥ <0.001 * 
PAAT/ET (%) 31.3 (4.5) 23.1 (5.3) # 28.2 (6.4) #¥ <0.001 * 




PAAT (ms) 128.0 (24.8) 100.5 (18.8) # 121.4 (20.4) ¥ <0.001 * 
PAAT/ET (%) 31.9 (5.3) 27.1 (4.3) # 32.0 (4.7) ¥ 0.003 * 
n 27 21 24  
Table 6-4 Pulmonary artery acceleration time results 
Values are mean (SD). PA= pulmonary artery. MPA= main PA. PAAT= PA acceleration time. ET= 
ejection time. *= one-way repeated measures ANOVA. §= Friedman’s test. #= significant difference 
from pre-op. ¥= significant difference from post-operative day 2 (POD2). Significant results 





Figure 6-10 Main pulmonary artery acceleration time 
Main pulmonary artery acceleration time (PAAT) was shorter at post-operative day 2 (POD2) and 
2-months. All paired t-tests. 
 
Figure 6-11 Operative and non-operative pulmonary artery acceleration time 
Pulmonary artery acceleration time (PAAT) was shorter at post-operative day 2 (POD2) in 
operative pulmonary artery (PA) (dark grey boxes) and non-operative PA ( light grey boxes) whilst 
only operative PA remains shortened at 2-months. All paired t-tests. Note operative PA PAAT lower 
than non-operative PA at POD2 and 2-months (p=0.008 and p=0.022 respectively, unpaired t-
tests). 
6.4.3 Pulmonary artery distensibility 
There was no change in MPA distensibility over time, Table 6-5. Operative PA 
distensibility was decreased from pre.op on POD2 and at 2-months (p=0.020 and 
p=0.043, both paired t-test) and non-operative PA distensibility was increased at 




distensibility were similar pre.op (p=0.644, unpaired t-test) and on POD2 
(p=0.494, unpaired t-test) although operative PA distensibility was lower at 2-
months (p=0.027, unpaired t-test), Figure 6-12. 
Vessel Parameter Pre-op POD2 2-months p-value 
MPA Distensibility 
(%) 
30.9 (23.6, 42.1) 31.3 (23.3, 38.6) 27.8 (25.0, 45.7) 1.000 § 





65.2 (25.5) 50.7 (16.9) # 51.8 (16.2) # 0.037 * 






62.6 (23.2)  54.4 (17.7) 67.4 (28.7) ¥ 0.029 * 
n 27 21 24  
Table 6-5 Distensibility changes over time 
Values are mean (SD) or median (IQR). OP= operative. NONOP= non-operative. PA= pulmonary 
artery. MPA= main PA. *= one-way repeated measures ANOVA. §= Friedman’s test. #= significant 
difference from pre-op. ¥= significant difference from post-operative day 2 (POD2). Significant 
results (p<0.05) highlighted bold italics. 
 
Figure 6-12 Operative and non-operative distensibility 
Distensibility was reduced on post-operative day 2 (POD2) in the operative pulmonary artery (PA) 
(dark grey boxes) and at 2-months. Non-operative PA distensibility (light grey boxes) was 
increased at 2-months compared to POD2. All paired t-tests. Note operative PA distensibility lower 
than non-operative PA at 2-months, unpaired t-test.  
6.4.4 Association between pulmonary artery acceleration time 
and distensibility 
Within-subject association testing showed that there were weak to moderate 
positive associations between PAAT and PA distensibility in the operative PAs and 




Table 6-6 Associations between pulmonary artery acceleration time and distensibility 
PAAT= pulmonary artery acceleration time. PAAT/ET= PAAT/ejection time, normalised for heart 
rate. PA= pulmonary artery. Analysis of covariance with patient as factor. Significant results 
(p<0.05) highlighted bold italics. 
6.4.5 Association between right ventricular ejection fraction and 
afterload results 
6.4.5.1 Pulmonary artery acceleration time 
Within-subject association testing between pre-op and POD2 revealed that there 
were moderate to strong positive within-subject associations between the change 
in RVEF and the change in PAAT in all vessels, Table 6-7, although when corrected 
for heart rate (PAAT/ET) only the association in the non-operative PA retained 
significance, Figure 6-13. The shortening in non-operative PAAT/ET (increase in 
pulsatile afterload) was associated with a decrease in RVEF. Looking at individual 
time points, PAAT and PAAT/ET had moderate positive associations with RVEF on 
POD2. Again, a shorter PAAT or PAAT/ET (increased afterload) was associated with 
reduced RVEF, Figure 6-14.  
Analysis of covariance, within-subject 
Distensibility (%) 
  MPA Operative PA  Non-operative PA 
PAAT (ms) r -0.108 0.377 0.571 
p 0.551 0.013 <0.001 
PAAT/ET (%) r -0.142 0.245 0.410 




Analysis of covariance, within-subject 
Change between pre-op and POD2 
  PAAT (ms) PAAT/ET (%) 










RVEF r 0.571 0.519 0.613 0.400 0.329 0.482 
p 0.004 0.016 0.002 0.059 0.146 0.023 
        
Change between pre-op and 2-months 
  PAAT (ms) PAAT/ET (%) 










RVEF r -0.046 0.099 -0.042 -0.086 0.094 0.118 
p 0.836 0.662 0.848 0.697 0.676 0.592 
    
Individual time point analysis    
   PAAT (ms) PAAT/ET (%) 
 
  










RVEF Pre-op r -0.075 -0.210 -0.003 -0.076 -0.301 0.034 
p 0.716 0.304 0.989 0.712 0.135 0.870 
POD2 r 0.323 0.125 0.464 0.322 0.001 0.459 
p 0.143 0.598 0.034 0.144 0.995 0.036 
2-
months 
r -0.307 -0.011 -0.173 -0.318 -0.184 -0.301 
p 0.155 0.962 0.429 0.0139 0.412 0.163 
Table 6-7 Association between pulmonary artery acceleration time and RVEF  
PA= pulmonary artery. MPA= main PA. RVEF= right ventricular ejection fraction. POD2= post-
operative day 2. Analysis of covariance with patient as factor. All individual time point analysis 





Figure 6-13 Within-subject association between non-operative pulmonary artery 
acceleration time and right ventricular ejection fraction 
Pre-operative to post-operative day 2 within-subject analysis of covariance between non-operative 
pulmonary artery acceleration time (PAAT, left plot), PAAT/ejection time (PAAT/ET, right plot) and 
right ventricular ejection fraction (RVEF). Coloured dots represent each patient and lines depict 
parallel line of association for each patient. Note that a reduction in non-operative PAAT and 
PAAT/ET were associated with a decrease in RVEF.  
 
Figure 6-14 Association between PAAT and RVEF on POD2 
Note association between non-operative (NONOP) pulmonary artery acceleration time (PAAT, left 
plot), PAAT/ejection time (PAAT/ET, right plot) and right ventricular ejection fraction (RVEF) at 
post-operative day 2 (POD2). Both Pearson’s correlation co-efficient. ms= millisecond. 
6.4.5.2 Distensibility 
There were moderate positive within-subject associations in the operative and 
non-operative PAs between the change in RVEF and the change in PA distensibility 




afterload was associated with reduced RVEF. There were no associations between 
RVEF and distensibility on individual time point analysis in any vessel.  
Analysis of covariance, within-subject 
Distensibility (%) 
Change between pre-op and POD2 
  MPA  Operative PA  Non-operative PA 
RVEF r 0.010 0.488 0.547 
p 0.970 0.025 0.037 
     
Change between pre-op and 2-months 
  MPA  Operative PA  Non-operative PA 
RVEF r 0.371 0.407 -0.181 
p 0.157 0.060 0.407 
      




MPA  Operative PA  Non-operative PA 
RVEF Pre-op r 0.038 0.088 0.142 
p 0.880 § 0.667 * 0.488 * 
POD2 r 0.079 -0.131 0.322 
p 0.742 * 0.582 * 0.154 * 
2-months r 0.209 -0.247 -0.181 
p 0.404 § 0.267 * 0.408 * 
Table 6-8 Association between distensibility and RVEF 
PA= pulmonary artery. MPA= main PA. RVEF= right ventricular ejection fraction. Analysis of 
covariance with patient as factor. *= Pearson’s correlation co-efficient. §= Spearman’s correlation 





Figure 6-15 Within-subject association between operative pulmonary artery distensibility 
and right ventricular ejection fraction 
Pre-operative to post-operative day 2 within-subject analysis of covariance between operative 
pulmonary artery (PA) distensibility (left), non-operative PA distensibility (right) and right ventricular 
ejection fraction (RVEF). Coloured dots represent each patient and lines depict parallel line of 
association for each patient. Note that a lower operative PA distensibility (increased afterload) was 
associated with lower RVEF. 
6.4.6 Association between brain natriuretic peptide and afterload 
results 
6.4.6.1 Pulmonary artery acceleration time 
There were negative within-subject associations between the change in BNP and 
the change in PAAT in all vessels between pre-op and POD2 analysis, Table 6-9. 
The MPA and non-operative PA had moderate to strong within-subject associations 
between the change in PAAT/ET and the change in BNP between pre-op and POD2, 
Figure 6-16. The negative associations showed that an increase in afterload 
(shortened PAAT and PAAT/ET) at POD2 was associated with increased BNP 
release. There were no associations between PAAT or PAAT/ET and BNP at 




Analysis of covariance, within-subject 
Change between pre-op and POD2 
  PAAT (ms) PAAT/ET (%) 










BNP r -0.584 -0.392 -0.799 -0.555 -0.246 -0.796 
p 0.003 0.079 <0.001 0.006 0.283 <0.001 
        
Change between pre-op and 2-months 
  PAAT (ms) PAAT/ET (%) 










BNP r 0.270 0.240 -0.288 0.300 0.326 -0.250 
p 0.212 0.283 0.183 0.164 0.139 0.249 
    
Individual time point analysis    
   PAAT (ms) PAAT/ET (%) 
 
  










BNP Pre-op r -0.055 -0.056 -0.116 -0.268 -0.067 -0.232 
p 0.786 § 0.779 § 0.566 § 0.176 § 0.740 § 0.245 § 
POD2 r -0.248 -0.104 -0.178 -0.359 0.107 -0.389 
p 0.266 * 0.664 * 0.305 * 0.101 * 0.654 * 0.082 * 
2-
months 
r 0.276 0.202 0.044 0.009 -0.093 -0.245 
p 0.213 § 0.380 § 0.848 § 0.968 § 0.689 § 0.271 § 
Table 6-9 Association between pulmonary artery acceleration time and BNP  
PA= pulmonary artery. MPA= main PA. BNP= brain natriuretic peptide. POD2= post-operative day 
2. Analysis of covariance with patient as factor. All individual time point comparisons Pearson’s 





Figure 6-16 Within-subject association between PAAT/ET and brain natriuretic peptide 
Pre-operative to post-operative day 2 within-subject analysis of covariance between pulmonary 
artery acceleration time normalised for heart rate (ejection time, PAAT/ET) in main (left) and non-
operative pulmonary artery (right) against brain natriuretic peptide (BNP). Coloured dots represent 
each patient and lines depict parallel line of association for each patient. Note that shortened 
PAAT/ET (increased afterload) was associated with an increase in BNP at post-operative day 2.  
6.4.6.2 Distensibility 
There was a moderate negative within-subject association between the change in 
BNP and the change in non-operative PA distensibility between pre-op and POD2, 
Table 6-10. On individual time point analysis, operative PA distensibility had a 
weak association with BNP pre-operatively whilst MPA and non-operative PA 
distensibility had a moderate negative association with BNP at POD2, Figure 6-18. 




Table 6-10 Association between distensibility and BNP at individual time points 
PA= pulmonary artery. MPA= main PA. BNP= brain natriuretic peptide. Analysis of covariance with 
patient as factor. *= Pearson’s correlation co-efficient. §= Spearman’s correlation co-efficient. 
Significant results (p<0.05) highlighted bold italics. 
 
Figure 6-17 Within-subject association between non-operative pulmonary artery 
distensibility and brain natriuretic peptide 
Pre-operative to post-operative day 2 within-subject analysis of covariance between pulmonary 
artery (PA) distensibility and brain natriuretic peptide (BNP). Coloured dots represent each patient 
and lines depict parallel line of association for each patient. Note that reduced non-operative 
distensibility (increased afterload) was associated with an increase in BNP at POD2.  
Analysis of covariance, within-subject 
Distensibility (%) 
Change between pre-op and POD2 
  MPA  Operative PA  Non-operative PA 
BNP r -0.419 -0.143 -0.535 
p 0.106 0.535 0.010 
     
Change between pre-op and 2-months 
  MPA  Operative PA  Non-operative PA 
BNP r -0.388 0.004 -0.327 
p 0.137 0.985 0.128 
      




MPA  Operative PA  Non-operative PA 
BNP Pre-op r 0.206 -0.382 -0.139 
p 0.398 § 0.049 § 0.490 § 
POD2 r -0.484 -0.177 -0.545 
p 0.031 * 0.456 * 0.011 * 
2-months r -0.195 -0.316 -0.018 





Figure 6-18 Association between main and non-operative pulmonary artery distensibility 
and BNP on POD2 
Main pulmonary artery (MPA) and non-operative pulmonary artery (NONOP) distensibility is 
moderately associated with brain natriuretic peptide (BNP) at post-operative day 2 (POD2). The 
patients with the lower distensibility have higher BNP. 
6.5 Summary of main results 
The main findings of this investigation are summarised in Table 6-11 and Table 
6-12. Following lung resection, the distribution of blood flow is uneven between 
the operative and non-operative PAs, the percentage of flow travelling in the non-
operative PA is increased on POD2 (66%) and 2-months (61%). Indices of pulsatile 
afterload increased following lung resection, predominately in the operative PA. 
On POD2, PAAT was shortened in all vessels and remained shortened in the MPA 
and operative PA at 2-months. Distensibility was reduced at both post-operative 





Parameter Pulmonary artery Pre-op POD2 2-months 
Percentage of  
total flow  
Operative   ¯¯ ¯ 
Non-operative   ­­ ­ 
Operative vs non-operative = ¯ ¯ 
PAAT  Main  ¯¯ ¯ 
Operative   ¯¯ ¯ 
Non-operative   ¯ - 
Operative vs non-operative = ¯ ¯ 
PAAT/ET Main  ¯ - 
Operative   ¯¯ ¯ 
Non-operative   ¯ - 
Operative vs non-operative = ¯ ¯ 
Distensibility  Main  - - 
Operative   ¯ ¯ 
Non-operative   - - 
Operative vs non-operative = = ¯ 
Table 6-11 Summary of changes in pulmonary artery blood flow, acceleration time and 
distensibility 
PAAT= pulmonary artery acceleration time. PAAT/ET= PAAT normalised for ejection time (heart 
rate). POD2= post-operative day 2.  
Comparisons are POD2 vs pre-op and 2-months vs pre-op. - = no change. ¯= less than pre-
operatively. ¯¯= less than pre-op and 2-months. ­= greater than pre-operatively. ­­= greater than 
pre-op and 2-months.  
Operative vs non-operative, no difference between measures (=). ¯= operative less than non-
operative. ­= operative greater than non-operative. 
Whilst the increases in indices of pulsatile afterload were predominately in the 
operative PA the strongest associations with impaired RV function (RVEF and BNP) 
were in the non-operative PA. A shortening of PAAT and PAAT/ET (increased 
afterload) in the non-operative PA had a strong negative association with an 
increase in BNP between pre-op and POD2, i.e. patients with the largest increase 
in non-operative pulsatile afterload on POD2 had the largest increase in BNP. 
Similarly, on POD2 a reduction in non-operative PA distensibility had a moderate 
negative association with BNP and a moderate positive association with RVEF 
(increased afterload was associated with decreased RVEF). The only consistent 
within-subject association in the operative PA was that reduced PA distensibility 
(increased afterload) was associated with a reduction in RVEF between pre-op and 




Comparison Parameter Pulmonary artery RVEF BNP 
Pre-op to  
POD2 
PAAT Main  + + - - 
Operative  + + - 
Non-operative  + + + - - - 
PAAT/ET Main   - - 
Operative    
Non-operative  + - - - 
Distensibility Main    
Operative  + +  
Non-operative  + + - - 
Table 6-12 Summary of association between indices of afterload, RVEF and BNP 
+/+ +/+ + += weak/moderate/strong positive association. -/- -/- - - = weak/moderate/strong negative 
association. Blank= no association. RVEF= right ventricular ejection fraction. BNP= brain natriuretic 
peptide. POD2= post-operative day 2. PAAT= pulmonary artery acceleration time. PAAT/ET= 
PAAT normalised for ejection time (heart rate). Note associations predominately between pre-op 
and POD2 in the non-operative PA. NB there were no associations between any index of afterload 
and RVEF or BNP between pre-op and 2-months, not displayed.  
6.6 Discussion 
This is the first study to investigate the change in pulsatile afterload following 
lung resection, as such it is the first to describe a predominately unilateral 
increase in pulsatile afterload. The distribution of cardiac output is potentially 
altered by this unilateral increase in afterload. Interestingly, the associations with 
the measures of pulsatile afterload and RV function are strongest in the non-
operative PA, suggesting an inability to accommodate the increased blood flow 
may result in impaired RV function. 
6.6.1 Strengths and limitations 
The main strength of this study is the detailed analysis of afterload pre- and post-
operatively. Additionally, imaging of the MPA, LPA and RPA provide an overall 
measure of afterload for both lungs combined and comparison of afterload in the 
operative and non-operative. CMR provides detailed and reproducible data with 
inter- and intra-observer testing revealing good to excellent agreement for all 
measures of flow and area which is comparable to published CMR results352, 357. 
A limitation of the study is the diastolic area increases seen in some of the MPA 
scans. It is possible that this reflects a true increase in vessel area, however there 
was no reciprocal change in flow in that vessel and the corresponding operative 




that would be expected if this was a true reading. Additionally, PA area can be 
used as a surrogate for PA pressure and as such a diastolic increase to the extent 
seen in these images is not in keeping with normal physiology.  
A potential explanation for the MPA diastolic increase in area is the motion of the 
PA during CMR imaging. Quail et al. described that when the RV contracts it pulls 
the PA inferiorly, bringing the narrower distal MPA into the imaging plane351. This 
motion could lead to an artificially early time to minimum area occurring during 
or just after peak RV contraction. This may explain why, for the MPA only, there 
is a diastolic increase in area as the larger proximal MPA moves back into the 
imaging plane. Additionally, the MPA is known to be affected by a “rocking” 
motion secondary to contraction of the RV which moves the MPA in and out of the 
defined imaging plane of the perpendicular cross section of the vessel358. This also 
could erroneously lead to measuring increased cross-sectional area in diastole. An 
alternative explanation is reporting error, on mapping the PA endocardial border 
the brightness of the enclosed blood is proportional to the rate of flow in that 
frame. During diastole there is minimal blood flow and vessel mapping is therefore 
more challenging. 
Post hoc analysis demonstrated the time to minimum area was lower in the MPA 
scans with diastolic artefact compared to those without (442±81.8ms vs 
612.4±169.2ms, p<0.001 unpaired t-test). The relationship between the time to 
minimum area and RV contraction can be demonstrated by the time difference 
between peak RV longitudinal contraction, measured by the time to peak RV 
global longitudinal strain (RVGLS), see Chapter 6, and the time to minimum area. 
In the MPA scans with diastolic artefact, the time difference between peak RVGLS 
and minimum area is lower than the time difference in MPA scans without diastolic 
artefact (115.7±109.3ms vs 300.7±140.1ms, p<0.001, unpaired t-test). As such, 
the diastolic artefacts are temporally related to MPA motion secondary to RV 
contraction. There is, however, likely a continuum between the MPA scans with 
marked motion artifact and the scans without any motion artifact, as such the 
accuracy of MPA area measurement must be considered.  
The flow results are minimally affected by diastolic motion artefact as PAAT and 
PAAT/ET are measured during systole. Whilst cardiac output measurement may 




significant as diastolic blood flow is minimal and its measurement may not be 
significantly affected by either a change in the site of measurement within the 
MPA or a rotation from the true vessel cross-section. 
6.6.2 Afterload results  
Previous studies have repeatedly shown that afterload (measured by PA pressure 
and/or PVR) does not increase in the days to months following lung resection49, 58-
60, 63-68. Whilst there are no directly comparable studies of PAAT and distensibility 
following lung resection the results can be interpreted in the context of published 
control groups and studies that investigated changes seen in PAH and CTEPH. Of 
note, such comparisons must account for the vessel imaged and the age of the 
subject. Distensibility decreases with age and tends to be higher in RPA than the 
LPA potentially secondary to the larger blood volume travelling in the RPA. 
Burman et al. demonstrated that in healthy volunteers aged 60-69 (similar to the 
patients in the study presented here) RPA distensibility is 7-11% greater than LPA 
distensibility359.  
In this study, MPA distensibility is similar to healthy age-matched controls347, 359, 
360 and greater than in patients with PAH149, 212, 348 from other studies. In 
comparison to the RPA distensibility analysis performed by Gan et al., pre-
operative RPA distensibility in the study presented here is greater than the control 
group of Gan et al. (72±23% versus 58±21%) and the post-operative reduction in 
operative PA distensibility on POD2 (50.7±16.9%) and at 2-months (51.8±16.2%) 
are modest compared to the marked reduction in patients with PAH in the study 
by Gan et al. and (20±10%)211.  
In the current study pre-operative and 2-month main PAAT and PAAT/ET are 
shorter than those described in patients with established PAH (PAAT; pre-op 
115.9±20.7ms and 2-months 104 ±19.5ms vs 127.8±26ms in Sanz et al., PAAT/ET; 
pre-op 30.0±3.8% and 2-months 29.0±5.9% vs 34±8 % in Sanz et al.)342. Of note, 
Ertan et al. have demonstrated that PAAT is reduced in patients with mild COPD 
(98.1±32.3ms vs 139.7±24.4ms in healthy controls)361, therefore the shortened 




et al.qq assessed PAAT in the RPA and LPA in controls and in patients with PAH. In 
the current study, pre-op operative PAAT and non-operative PAAT (124.7±19.3ms 
and 128.0±24.8ms) are similar to the PAAT in control group of Quail et al. 
(121±11ms). The reduction in operative PAAT on POD2 and at 2-months 
(82.1±23.0ms and 106.0±23.9ms) were modest compared to marked reductionrr 
seen in patients with PAH in Quail et al. (67±4ms). They also showed that in 
patients with CTEPH, PAAT <57.6ms was predictive of the presence of a proximal 
PA clot (area under the curve 0.84 (95% CI 0.70-0.90)), in no patient from the 
current study is operative PAAT below this value at 2-months351. 
6.6.2.1 Cardiac output distribution  
Any change in afterload should be interpreted with the conditions in the 
pulmonary vasculature at that time, i.e. the cardiac output (CO). On POD2 CO is 
increased compared to pre-op and 2-months post-operatively. At this point, PAAT 
and PAAT/ET are shortened in all vessels and distensibility is reduced in the 
operative PA. The increased CO predominately travels down the non-operative PA 
(66.3%) and at 2-months although the CO has returned to baseline the distribution 
between the operative PA (39.1%) and NONPO.PA (60.9%) remains uneven. 
Operative PAAT, PAAT/ET and distensibility all remain shortened/reduced at 2-
months when the total flow down the operative PA is essentially unchanged (2.31 
l.min-1 on POD2 and 2.33 l.min-1 at 2-months). To our knowledge, this is the first 
description of the post-operative change in the distribution of blood flow between 
the operative PA and non-operative PA.  
Pulmonary vascular reserve (PVreserve), classically measured by the gradient of 
the positive linear association between PAP and cardiac output, measures the 
ability of the pulmonary vasculature to accommodate an increase in cardiac 
output120, 362, discussed further in 1.2.6.1 page 70. Pulmonary artery catheter 
studies have shown that there is not a significant increase in MPAP at rest following 
 
qq This study was primarily designed to assess wave intensity analysis changes in PAH and is 
discussed further in Chapter 7. 
rr PAAT in the study of Quail et al. is lower than other published studies whilst PAAT in the 
investigation presented in this chapter is lower than in patient with established PAH in the study 
by Sanz et al. This may be explained by an increased accuracy secondary to an increase in the 
temporal resolution of the CMR imaging between Quail et al. (10.5ms), this investigation 




lung resection48, 49, 58-61, 63, 65, 67-69, although PVreserve decreases as demonstrated 
by reinterpretation of the studies by Okada et al., Nishimura et al. and Miyazawa 
et al.49, 67, 68, 2.3 page 84. A reduction in blood flow through the operative PA may 
be expected given the reduced quantity of lung that remains, although it may 
highlight a potential mechanism of the reduction in PVreserve following lung 
resection. Even with a reduced blood volume travelling through the operative PA 
on POD2 and at 2-months, there are signs of increased afterload compared to pre-
op. This may be interpreted as reduced PVreserve in the operative PA. Whilst the 
non-operative PA anatomical architecture may be unchanged, it is required to 
accommodate a higher total blood flow for the same level of cardiac output 
therefore the ‘starting point’ on the PVreserve gradient is increased. A subsequent 
increase in cardiac output would results in a greater increase in MPAP than pre-
operatively. 
An illustrative example of this scenario using the operative and non-operative 
cardiac output at pre-operative and 2-months seen in the current study is 
presented in Figure 6-19. This illustration describes the theorised physiological 
basis of the reduction in the PVreserve seen following lung resection and trend in 
changes of MPAP/afterload. MPAP is assumed to be equal in both PAs and the non-
operative lung is assumed not to compensate for changes in the operative lung, as 
per Saouti et al.146, discussed in 1.2.6.4 page 75, and that there is a constant split 





In the top- plot, the “normal” PVreserve MPAP-CO relationship (solid line) from 
the pre-operative results from Nishimura et al.67 and Miyazawa et al.68 is plotted 
and the pre-operative values of the operative and non-operative PA CO from this 
current investigation are plotted. If the cardiac output doubles, as may be seen 
with exercise, flow in both the operative and non-operative PAs is assumed to 
increase by the same amount (50:50 split in CO) and MPAP increases by DMPAP.  
In the bottom plot, the CO from the non-operative PA at 2-months post-op (in this 
current study) is plotted on the normal PVreserve MPAP-CO relationship although 
at a higher ‘starting position’ with a modest increase in MPAP. The non-operative 
PVreserve is assumed to be unchanged as the non-operative pulmonary 
vasculature is anatomically unchanged. As the operative PA CO is reduced at 2-
months, when it is plotted it must have a separate steeper PVreserve MPAP-CO 
relationship than the non-operative PA as MPAP is assumed to be equal in each 
PA. If CO doubles, flow in both vessels doubles, assuming the 60:40 split in CO 
demonstrated at 2-months in the current study is maintained. This results in a 
larger absolute increase in non-operative CO and a smaller absolute increase in 
operative CO than pre-operatively resulting in a greater overall increase in MPAP 
(DMPAP increases by a factor of 1.2 in this example). This may be an 
underestimation if the CO percentage in the non-operative PA further increases 
with cardiac output. In the current study, when CO was increased on POD2 the 
ratio of CO in the non-operative increased to 66:34 as the absolute value of CO in 
the operative PA is unchanged. 
The above processes may explain the changes observed following lung resection 
demonstrated in previous studies. Differing PVreserve between the operative and 
non-operative PAs may account for the lack of significant increase in MPAP at reset 
and the rapid increase on exercise. Additionally, it highlights the requirement for 
the non-operative PA to accommodate increased blood flow, this may lead to an 





Figure 6-19 Pulmonary vasculature reserve before and after lung resection 
Illustrative representation of theoretical change in pulmonary vascular reserve (PVreserve) 
following lung resection. Red lines depicts doubling of cardiac output on exercise. PA= pulmonary 
artery. Image constructed by author. NB mean pulmonary artery pressure units are removed as this 
is not intended as a literal interpretation of values but to illustrate a potential mechanism of a 




Evidence that the increased blood flow in the non-operative PA results in 
increased pulsatile afterload and may lead to RV impairment can be seen in the 
within-subject associations between RVEF, BNP and indices of afterload between 
pre-op and POD2. The POD2 shortening in non-operative PAAT/ET and reduction 
in distensibility have moderate to strong associations with the reduction in RVEF 
and increase in BNP, Figure 6-13 and Figure 6-16. This suggests that an inability 
of the non-operative PA to accommodate the increased flow may be a significant 
factor in the development of impaired RV function. This may be a purely peri-
operative effect (as it resolves by 2-months) or it may be revealed by the increased 
cardiac output on POD2 and this relationship may persist post-operatively were 
the patient challenged by an increased CO.  
6.6.3 Conclusion 
This study demonstrates, for the first time, that there is an increase in the indices 
of pulsatile afterload in the operative PA following lung resection. As the changes 
are unilateral, they may be the cause of the increase in the percentage of cardiac 
output travelling in the non-operative PA. The combination of increased pulsatile 
afterload in the operative PA and increased blood flow in the non-operative PA is 
a potential mechanism of a reduction in PVreserve following lung resection. On 
POD2 it is the increase in pulsatile afterload in non-operative PA that is associated 
with impaired RV function and not the operative PA. 
 
 
Chapter 7 Pulmonary artery wave intensity 
analysis  
This chapter details the background to and the first use of wave intensity analysis 
(WIA) in a lung resection population. WIA combines the changes in flow and 
pressure (or area) throughout the cardiac cycle to model wave travel and assess 
pulsatile afterload. Similar to impedance analysis, 1.2.6.3 page 72, and the 
surrogate indices of pulsatile afterload investigated in Chapter 6, it may 
demonstrate increases in afterload following lung resection that previous studies 
may have missed. 
7.1 Arterial wave mechanics 
The main distinction between impedance and WIA is based on the mathematical 
approach of decomposition of the arterial waveformss 363. Impedance analysis is 
performed in the frequency domain whilst WIA is performed in the time domain. 
Each method has its own strengths and limitations. It is important to note that the 
method of interpretation does not imply any underlying characteristics of the 
waveform, as Parker states,  
“No particular decomposition is inherently better than any other; their 
value depends solely on their utility.” 
Kim Parker (2009)364 
7.1.1 Wave definition and decomposition 
The term “wave” has a general broad usage in medicine and can be interpreted 
as the arterial waveform or as a sinusoidal “wavetrain”364. Hughes et al. define a 
wave as, 
 
ss References in this section are predominately from a special issue of Medical & Biological 
Engineering & Computing, volume 47, Issue 2, February 2009. It is a complete and thorough 
review of the scientific background of wave intensity analysis and impedance. Detailed 





 “a disturbance that is propagated through a medium with an exchange 
between kinetic and potential energy”  
Hughes et al. 365.  
In the arterial system, a wave causes a transmission of energy with a simultaneous 
change in pressure and flow. It is important to note that a wave can travel at a 
velocity greater than and separate to the bulk flow velocity of blood365.  
The two main methods by which arterial waveform can be interpreted, Fourier 
analysis and successive wavefronts, demonstrated in Figure 7-1. Impedance 
analysis by Fourier decomposition breaks the waveform into constituent sinusoidal 
waves (wavetrains) that sum to give the original waveform, impedance is 
therefore measured in the frequency domain. Successive wavefronts are formed 
by the decomposition of the waveform into successive wavelets. This equates to 
successive incremental changes in pressure over time and therefore wavefronts 
are assessed in the time domain. Each wavelet can be calculated as the change in 
pressure during the sampling period (∆t), Equation 7-1, and is demonstrated as 16 
successive wavefronts in Figure 7-1. The accuracy of the wavefront model can be 
improved by reducing the sampling period364. 
!" = "(%+ ∆%) − "(%) 
Equation 7-1 Wavelet decomposition 





Figure 7-1 Decomposition of arterial waveform 
The arterial waveform (top line) can be decomposed into sinusoidal wavetrain (left panel, Fourier 
decomposition) or successive wavefronts (right panel, wave intensity analysis). P= pressure. t= 
time. Image from Parker364. 
The fundamental difference between the two methods is whether an arterial pulse 
is an isolated event or part of a long series of pulses366. Fourier analysis presumes 
that the overall waveform is comprised of underlying sinusoidal waves and a 
heartbeat is not an isolated event. The cardiac system must therefore be deemed 
to be in steady-state oscillation. This view is established in literature and 
reinforced by observation; under normal physiology the heart has a regular “near-
periodic” rhythm. Evidence against this can be seen following ectopic or missed 
heart beats, Figure 7-2. The rapid exponential decline in pressure without any 
further upward inflection following the missed beat demonstrates that the arterial 
system is over-damped, i.e. oscillations stop immediately following cessation of 
stimulus. Over-damped systems cannot oscillate by definition as there is no 
continuum between one heartbeat and the next, therefore it can be argued that 
the arterial system is not in steady-state oscillation and heart beats should be 





Figure 7-2 Pressure response following missed beat in coronary artery 
Arterial pressure (P) waveform (top panel) shows rhythmic pulsation until missed beat, 
demonstrated on ECG (bottom panel). Following a missed beat the pressure trace rapidly 
decreases until the following beat occurs. The lack of any oscillation demonstrates that the 
cardiovascular system is over-damped. ECG= electrocardiogram. LMS= left main stem. t= time. 
Image from Parker364. 
Whilst the interpretation that a heartbeat is an isolated event is logical, it is based 
on a literal interpretation of Fourier analysis. When describing this interpretation 
Remington commented that, ‘‘The most major assumption is that the harmonics 
obtained by a Fourier curve fitting actually exist as separate waves, traveling 
independently…’’367. It also assumes that, for each harmonic, there is a linear 
relationship between pressure and flow rate368. The most accurate interpretation 
of Fourier analysis is that it, as described by Avolio et al., “predicts, based on 
assumed linearity, what single, separate harmonics would do” and it does not 
imply that the sinusoidal wavetrains calculated at each harmonic exist in the 
artery366. As commented by Parker, both methods of wave decomposition are valid 
although wave intensity analysis does not require the assumption of steady state 
oscillation364, 368. 
7.2 Wave intensity analysis  
Parker et al. published the basis of wave intensity analysis (WIA) in two papers in 
1988369 and 1990368. These papers detail the complex mathematical derivation on 
which the technique is based. In his 2009 review Kim Parker, who holds a PhD in 
aerospace and mechanical engineering, states that, “the mathematics are not 
always accessible to those whose mathematical training does not extend to 
partial differential equations, eigenvalues and eigenvectors”. In the review, he 




A balanced description will be provided in this thesis as a non-mathematical 
description alone is sufficient to interpret the results generated364. 
7.2.1 Wave intensity definition 
Hughes et al. defines wave energy as, “the part of a fluid’s total energy, that is 
associated with a wave” and wave intensitytt (dI) as, “the rate of transport of 
wave energy”365. Wave energy and intensity therefore are only part of the total 
energy within the arterial tree. dI is calculated as the product of the change in 
pressure and the change in velocity during a small interval (sampling period)151, 
Equation 7-2, and measures the instantaneous power per unit cross sectional area 
(Wm-2) that is carried by the wavefront151 370. 
2W = 2M	. 2X 
Equation 7-2 Wave intensity 
dI= wave intensity. dP= change in pressure. dU= change in flow velocity 
7.2.2 Wave classifications 
7.2.2.1 Forward and backward waves 
Waves can be classified by their direction of travel and the rate of change of 
pressure (dP/dt) that they cause. As WIA is performed from pressure and velocity 
measurement at one particular point in the artery, the interpretations are relative 
to this point. Waves that travel forward (away from the heart)uu across the point 
of measurement have a positive dI whereas waves that travel backwards (towards 
the heart) have a negative dI. As these waves coexist, the net dI will only 
determine if forwards or backwards waves dominate at any given time and will 
not fully describe the individual component waves. To do so net dI must be 
separated into the forward (dI+) and backward (dI-) components370, Equation 7-3. 
 
tt Wave intensity is calculated from the temporal derivatives of pressure and velocity (or surrogate 
markers), as such the notation dI is used. 
uu Wave intensity analysis has been utilised in arterial, coronary and venous circulations. The 
classifications of waves, unless otherwise stated, will be as described in the arterial (systemic 
and pulmonary) circulations where forwards waves travel away from the heart and backward 




2W = 2W' + 2W$ 
Equation 7-3 Wave intensity addition 
dI= wave intensity. dI+= forward wave intensity. dI- = backward wave intensity. 
7.2.2.2 Compression and expansion waves 
Waves that increase the rate of change in pressure (dP/dt>0) are called 
compression waves. Expansion waves (also termed decompression waves by some 
authors) cause a decrease in the rate of change in pressure (dP/dt<0). Of note, 
compression waves are caused by compression of fluid but lead to an expansion of 
the arterial vessel whereas expansion/decompression waves are caused by 
expansion of fluid volume but lead to a reduction in vessel cross-section364, 365. 
The generation of these waves from contraction and relaxation of the ventricle 
can be visualised as the pushing of a piston on a fluid filled tube. The relative 
compression and expansion of the fluid secondary to the piston action generates 
forward travelling waves, Figure 7-3A. The initial forward compression wave 
(FCW) travels down the tube increasing pressure and therefore vessel diameter, 
Figure 7-3B. At the end of compression there is a relative decrease in the pressure 
and vessel diameter when the piston recoils that generates a forward 
expansion/decompression wave (FEW). This pair of compression and expansion 
waves propagate down the tube at a specific wave speed (c) and the wave 






Figure 7-3 Generation and propagation of compression and expansion waves 
Generation of compression/expansion waves (A) and propagation of waves down fluid filled column 
(B). Bottom graph demonstrates the wave intensity (dI) for compression (unshaded) and 
expansions (shaded) waves over time (t), both are positive as the waves are travelling forward. 
Image from Hughes et al.365. 
As Hughes states in the definition of a wave there must be, “an exchange between 
kinetic and potential energy”365, in an artery, kinetic energy (blood flow velocity, 
U) and potential energy (pressure, P) are therefore linked. The dP that the wave 
causes must be accompanied by a dU, which is assumed to occur with negligible 
loss of energy. This can be expressed by the water hammer (Joukowsky) equation, 
Equation 7-4, where dP is calculated from dU, wave speed (c) and the density of 
the blood (p)369. Similar to dI, there are forward and backward wavefronts for 




to be constant (as can blood density) for that particular wave, this assumption and 
the calculation of wave speed is discussed in detail in 7.2.6.3 page 262. 
2M± =	±E&2X± 
Equation 7-4 Water hammer equation 
dP= change in pressure. p= density of blood. c= wave speed. dU= change in flow velocity. 
7.2.2.3 Origin of backward waves 
In general, a backward wave originates from reflection of a forward travelling 
wave. Parker describes how this can occur at a “discontinuity of characteristics”, 
i.e. a change in the cross-sectional area of the vessel, a vessel bifurcation or a 
change in local wave speed. At a bifurcation, the nature of the resultant backward 
wave is determined by the vasculature distal to this point364. The two extremes 
can be imagined as “open-ended” and “close-ended”. In a close-ended system the 
distal vasculature is completely obstructed and therefore reflects the forward 
wave as a backward compression wave (BCW) which causes an increase in pressure 
but a decrease in the forward velocity of blood. An open-ended system, such as a 
bifurcation to markedly larger daughter vessels, reflects a backward 
expansion/decompression wave (BEW) which causes a decrease in pressure and an 
increase in the forward flow of blood151, Figure 7-4.  
Interestingly, the coronary circulation has been shown to generate an early 
systolic BCW and an early diastolic BEW from the compression and expansions of 
the distal coronary microvasculature by myocardial contraction371. The novel BEW 
travels towards the aortic origin of the coronary artery and increases the forward 
velocity of blood flow down the coronary artery372. This is an additional component 
of coronary filling to the pressure gradient driven diastolic filling discussed in 





Figure 7-4 Wave classification 
Piston analogy of wave generation with corresponding value of and change in pressure (P and dP), 
velocity (U and dU) and wave intensity (dI). Note forward waves have positive dI and backward 
waves negative dI. Compression waves always cause an increase in pressure (dP) but the change 
in flow velocity (dU) in determined by the direction of travel. As dI is the product of dP and dU 
forward waves (positive dI) therefore cause an increase or decrease in both dP and dU whereas 
backward waves cause either an increase in dP and a decrease in dU or vice-versa. Images from 
Su et al.151. 
7.2.3 Wave separation 
If wave speed and blood density are known, the changes in pressure and velocity 
can be decomposed into the forward and backward components (with the water 
hammer equation, Equation 7-4) and the components of dP± and dU± 
calculated373, Equation 7-5. dI+ and dI- can then be calculated by multiplying the 
dP+ with dU+ and dP- with dU- respectively373, Equation 7-6. This method of 
separation is based on Parker’s original work. Derivations of this have utilised 
cross-sectional area instead of pressure, allowing non-invasive WIA374, 375, further 
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Equation 7-5 Separation of change in pressure and velocity 
dP= change in pressure. p= density of blood. c= wave speed. dU= change in flow velocity.  
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Equation 7-6 Separation of wave intensity  
dI= wave intensity. dP= change in pressure. dU= change in flow velocity. p= density of blood. c= 
wave speed. 
7.2.4 Interpretation of wave intensity analysis 
Parker’s initial description and the majority of subsequent investigations relating 
WIA to pathophysiologic mechanisms have been performed relative to the left 
ventricle in the systemic circulation and to a lesser extent the coronary arteries369-
371. As detailed in 7.2.2.3, the coronary circulation is unique for WIA as backward 
waves are generated de novo. Whilst there are few studies of WIA in the pulmonary 
circulation, the principles of interpretation are transferable between the 
circulation and so the evidence in the left ventricle/systemic circulation will also 
be discussed. The handful of WIAs performed in the pulmonary circulation of 
human subjects are discussed in detail in 7.2.5. Of note, the studies detailing the 




7.2.4.1 Wave intensity throughout the cardiac cycle 
The temporal relationship of wave intensity to the cardiac cycle is demonstrated 
in Figure 7-5. It should be noted that, as WIA is performed on a vessel distal to 
the heart, there will always be a delay between the peak of the R wave on the 
ECG, ventricular ejection of blood and the onset of increases in pressure, velocity 
and therefore wave intensity (R – W1, Figure 7-5) at the site of measurement. The 
duration of this delay is dependent on the wave speed and the distance between 
the heart and the point of measurement. In both the pulmonary and systemic 
circulations, the main waves detected are two positive (forward) waves and an 
early systolic negative (backward) wave376. Separation of the forward and 
backward pressure components allows identification of the nature of these waves. 
 
Figure 7-5 Wave intensity throughout cardiac cycle 
Wave intensity measured in the carotid artery. Combination of pressure (BP) and velocity (U) 
profiles to give net wave intensity (WI). Peaks in wave intensity of W1 and W2 and time difference 
between these peaks (W1 – W2). Note negative WI (NA) immediately following W1. Also, the onset 
of pressure, velocity and WI are delayed from the peak of R wave on ECG (R-W1). Image from 
Sugawara et al.376. 
7.2.4.2 Separation of waves 
An example of WIA in the systemic circulation (carotid artery) is given in Figure 
7-6. Of note, vessel diameter is used as a surrogate for pressure. Diameter and 
area are commonly used in non-invasive assessment of WIA as they have a linear 
relationship with pressure351, 377. In 2002, Vulliémoz et al. detailed the 
mathematical derivation of the relationship for calculation of wave speed from 
flow and area (QA method)378, this method has gained widespread use for wave 
speed calculation, discussed further in 7.2.6.3, and has been used for non-invasive 
WIA in the pulmonary circulation351, 377. Figure 7-6a and Figure 7-6b demonstrate 




separated in a similar method as Equation 7-5 with the calculated forward 
components (dD+ and dU+) and backward components (dD- and dU-) then 
integrated and displayed as D+/P+ (green, dashed line) and D-/P- (red, dotted 
line). 
 
Figure 7-6 Wave separation into positive and negative components 
Profiles for carotid artery diameter (D) (a) and velocity (U) (b). Measured values in blue (solid line), 
separation into forward (+, green, dashed line) and backward (-, red, dotted line) components. 
Wave intensity (dI) profiles (c) shows forward (blue) and backward (red) waves. Arrows indicate 
time of onset of backward wave. Note overlap of forward and backward waves that would mask 
smaller waves without separation. t= time. FCW= forward compression wave. BCW= backward 
compression wave. FEW= forward expansion wave. Image from Feng et al.379.  
Forward compression wave (FCW). Ventricular contraction causes an initial rapid 
increase in diameter and velocity, represented by the increases in D+ and U+, 




(dI>0) compression (dP/dt > 0) wave which is responsible for the forward flow of 
blood in systole. Note that the FCW is short lived and terminates prior to the peak 
in diameter (pressure), although the forward flow of blood continues until it is 
decelerated by a BCW and/or a FEW.  
Backward compression wave (BCW). The onset of the backward (reflected) wave 
is indicated by the arrow. Whilst dI is negative, the direction of D- is positive, i.e. 
it results in an increase in diameter (dP/dt > 0). As such this is a backward (dI-) 
compression (dP/dt > 0) wave. As U- is negative, it causes a decrease in forward 
velocity of blood (dU/dt < 0). Ultimately, a BCW causes an increase in the 
pressure/ diameter and a decrease in the forward velocity/flow of blood within a 
vessel. It a sign of increased wave reflection and increased pulsatile afterload, 
explained further in 7.2.4.4.  
Forward expansion wave (FEW). Following peak ventricular contraction there is 
a rapid decline in D and U, note the changes occur in D+ and U+, therefore it is 
caused by a forward wave (dI>0). As it causes a decrease in vessel diameter (dP/dt 
< 0) and velocity (dU/dt <0) it is a forward expansion wave (FEW). This wave 
travels away from the heart, causes a decrease in blood pressure and a decrease 
in the forward flow of blood. It offloads the ventricle thus easing ventricular filling 
and also aids coronary blood flow in the systemic circulation. 
7.2.4.3 Interpretation of forward waves 
7.2.4.3.1 Forward compression waves 
The generation of an FCW is related to the contractile force of the ventriclevv. 
Ohte et al. demonstrated that peak FCW is strongly associated with the maximal 
rate of LV pressure rise (r=0.74, p<0.001)380. Peak FCW decreases with age and is 
also independently associated with gender, systolic BP, HR and stroke volume 
(normalised for body surface area)381. Peak FCW is also affected by inotropy; 
 
vv The different waves generated by WIA can be quantified by either their maximal value, peak 
wave intensity (WI), or the total wave energy, calculated by the area under the curve. Both 
measures are used in literature. Additionally, the timing of the waves can be related to both 




dobutamine (increased inotropy) increases FCW, whilst propanolol (decreased 
inotropy) reduces it382.  
7.2.4.3.2 Forward expansion waves 
The description of the FEW, in Parker et al.s’ first publication of WIA, challenged 
the established theory that reflection of arterial blood flow was responsible for 
the rapid decrease in forward flow of blood in the aorta369. Instead, WIA explained 
that the LV (in this description) generates a forward travelling wave that 
decreases pressure and forward flow of blood in the aorta, the FEW. The impact 
of this is that the heart actively stops the forward flow of blood383.  
The rapid decrease in aortic blood flow/pressure cannot be explained purely from 
the decrease in LV tension. At closure of the aortic valve (AV) the pressure in the 
LV is always lower than aortic pressure376. At this point there remains a forward 
flow of blood through the aortic valve against a pressure gradient, similar to the 
“hangout interval” of RV ejection described by Dell’italia and Walsh98, 1.2.2.1 
page 40. This continued forward flow of blood and the generation of the FEW are 
caused by a rapid fall in LV pressure and is influenced by two main factors, the 
forward momentum of blood leaving the LV (inertia force) and the decrease in LV 
wall tension376.  
The inertia force of blood is generated by ventricular contraction. As contraction 
and therefore myocyte shortening stops, the momentum of the blood exiting the 
ventricle (inertia force) maintains forward flow of blood thus rapidly emptying the 
ventricle. This leads to a smaller end-systolic volume, greater elastic recoil of the 
myocytes and a more rapid pressure decline376, 383. Ohte et al. have highlighted 
the active process of the relaxation of the ventricle. High frame rate doppler 
echocardiography revealed apically directed intra-ventricular blood flow prior to 
aortic valve closure. This originated at the apex with subsequent flow throughout 
the entire LV directed towards the apex, except for just below the mitral valve, 
pulling blood from the aorta towards causing closure of the aortic valve and 
offloading the ventricle384.  
The generation of a FEW is a product of both mechanisms and as such, reflects 




been demonstrated by both Ohte et al. and Sugawara et al. in follow-up studies; 
FEWs have a strong association to LV pressure decay (r=-0.61, p<0.001) and the 
time constant of LV relaxation (r=-0.77, p<0.001)376, 380.  
7.2.4.3.3 Forward waves in disease 
The FCWs and FEWs generated by the LV differ depending on the pathophysiologic 
process affecting it. In dilated cardiomyopathy, the contractile function of the LV 
is impaired without change in relaxation, therefore there is reduction in the FCW 
but no change in the FEW376. Hypertrophic cardiomyopathy has impaired 
ventricular relaxation and so has a lower FEW but unchanged FCW376. In mitral 
regurgitation, the LV is distended with impaired relaxation, therefore there is an 
absence of a FEW. This, however, returns following surgical correction of the 
valve, whereas FCW is unchanged throughout385. 
7.2.4.4 Backward waves 
Backward waves are caused by reflection and so demonstrate the condition of the 
distal vasculature in the systemic and pulmonary circulationsww. As discussed 
previously in 7.2.2.3, the distal vasculature will determine if the reflected wave 
is a compression (closed-ended system) or expansion wave (open-ended system). 
In the pulmonary circulation, BCWs tend to occur in disease as they are a sign 
increased pulsatile afterload (wave reflection). They cause an increase in pressure 
and a decrease in the forward flow of blood and therefore add to RV workload. 
Conversely, BEWs cause a decrease in pressure and an increase in forward flow of 
blood. They are seen in normal pulmonary vasculature and are beneficial to RV 
workload351. 
7.2.4.4.1 Wave reflection  
Wave reflections occur at a bifurcation, a change in vessel calibre or a change in 
local wave speed. Between the parent (proximal) and daughter vessel(s) (distal) 
of an arterial bifurcation there must be constant pressure (conversation of energy) 
and an equal net volume into and out of the bifurcation (conservation of mass). If 
 
ww In the coronary circulation backward waves are generative from the distal end of the coronary 





the cross-sectional area of the parent (A0) and daughter vessels (A1 and A2) are 
not matched, there will be a reflection of the incident forward wave. This can be 
described by the reflection coefficient (Γ), the ratio of pressure changes caused 




Equation 7-7 Reflection coefficient 
 Γ= reflection coefficient. δP= magnitude of pressure change due to reflected wave. ΔP= pressure 
change due to incident wave. 
The reflection coefficient is determined by the ratio of the parent vessel to 
daughter vessel(s) (a)364, Equation 7-8, and the asymmetryxx of the diameter of 





Equation 7-8 Daughter-parent vessel ratio 
a= daughter-parent ratio. A1 and A2= cross-sectional area of daughter vessels. A0= cross-sectional 





Equation 7-9 Vessel asymmetry ratio 
a= daughter-parent ratio. A1 and A2= cross-sectional area of daughter vessels. A0= cross-sectional 
area of parent vessel.  
Asymmetry (g) has minimal effect on Γ in fully open or fully closed systems 
however it influences the a value at which there is no reflection (Γ=0), Figure 7-7. 
g can range from 0 (only one daughter vessel, i.e. a dilation or constriction) to 1 
(A1=A2). In a point in a straight tube a=1 (A0=A1) and g=0 therefore Γ=0 (no wave 
reflection). In an ideal system with a bifurcation when Γ=0 (no wave reflection) 
and g=1 (the daughter vessels are symmetrical) then a≈1.15 (A0=(A1+A2)/1.15). In 
 
xx In this context, assymetry refers to the ratio of vessel area between daughter vessels. The angle 
between the partner and daughter vessels will however alter the distribution of total flow in that 




human arterial systems a≈1.14±0.03, evidence that in normal circumstances the 
arteries are a well-matched system with minimal reflections364.  
 
Figure 7-7 Reflection coefficient at a bifurcation  
The reflection coefficient (R) is a function of the ratio of daughter to parent vessels (a). g represent 
the effect of vessel symmetry of the daughter vessels, g=0 depicts a straight tube with no 
bifurcation (purely a dilation of the vessel), g=1 represents symmetrical bifurcation (daughter 
vessels equal in size). Image from Parker364. 
The following examples are depicted in Figure 7-8. In a close-ended tube a=0 (A1 
and A2=0) therefore Γ=1 as the entire incident wave is reflected. In an open-ended 
tube a®¥ and Γ®-1, where the δP approaches the magnitude of the ΔP but as a 





Figure 7-8 Factors influencing reflection coefficient  
Three examples of reflection sites and the generation of wave reflection. A0= cross-sectional area 
of parent vessel. A1 and A2=cross-sectional area of daughter vessels. 
Top row, a close-ended parent vessel (A0) that has no daughter vessels (A1 and A2) therefore the 
ratio of vessel areas (a) is 0. The entire incident forward compression wave (FCW) is reflected and 
a backward compression wave (BCW). 
Middle row, a relatively open-ended vessel. a=2 as the daughter vessels are equal in size to the 
parent vessel. A1 and A2 are symmetrical (g) as A1=A2. Reflection coefficient (Γ)=-0.35. The 
reflected wave is a backward expansion wave (BEW). 
Bottom row, dilation of parent vessel. a=2 as the daughter vessel (A2 is twice the size of parent 
vessel. As A1 does not exist g =0. Reflection coefficient (Γ) is increased at -0.41. Again, the 
reflected wave is a BEW. 
Image made by author.  
The arterial tree contains multiple bifurcations down to the small arteries and 
arterioles where there is significant wave reflection. These reflections will then 
be returned through the same vessels they travelled, however at each bifurcation 
the parent-daughter ratio is altered. Assuming a well-matched forward system (no 
reflection (Γ=0), a=1.15 and the daughter vessels are equal in size (g=1)) the 




as (A2+A0)/A1 and therefore an a>1.15 with Γ<0. As such any wave reflections in 
the pulmonary vasculature will be reflected for a second time and sent back 
towards the peripheries364.  
7.2.4.4.2 Wave reflection index 
Wave intensity analysis offers an alternative method to calculate wave reflection. 
Wave reflection index (WRI) is the ratio of the integral of the BCW over the FCW386, 
Equation 7-10. Analogous to Γ, WRI calculates the total reflected energy (∑BCW) 
over the total incident energy (∑FCW). This has two potential benefits over 
calculation of BCW alone; it removes any numerical differences between methods 





Equation 7-10 Wave reflection index 
WRI= wave reflection index. BCW= backward compression wave. FCW= forward compression 
wave. 
As discussed later in 7.2.6, there are a variety of methods to calculate WIA, this 
results in values for FCW and BCW that are only directly comparable to studies of 
the same methodology151. WRI describes the ratio of ∑BCW to ∑FCW and therefore 
removes any numerical differences between methods. Additionally, it can easily 
be calculated in studies that only report BCW and FCW areas.  
Forward compression wave area is influenced by inotropy, heart rate and loading 
conditions381. As the size of the BCW is dependent on the incident FCW, it will be 
affected by any factor that changes the FCW and any change in the pulmonary 
vasculature, WRI minimises the effects of changes in FCW size.  
7.2.4.4.3 Distance to site of reflection 
Intuitively the distance to the site of wave reflection can be calculated from the 
wave speed (c) and the time difference between the peaks of the forward and 
corresponding backward waves351. This is an over simplification as it assumes a 
constant wave speed throughout the vasculature, whereas wave speed actually 
increases towards the peripheries387. It also assumes that there is a single 




Davies et al. investigated the relationship between the point of measurement and 
the distance to reflection site by measuring WIA at progressively distal points in 
the aorta. They demonstrated that the distance to the reflection site remained 
constant, irrespective of the point of examination, i.e. as the point of examination 
moved distally so did the calculated site of reflection. They concluded that there 
is not a distinct site of reflection and the site of reflection is an amalgamation of 
all subsequent wave reflection dominated by the proximal reflections, described 
as the “horizon-effect”388.  
Quail et al. calculated the distance to the site of wave reflection in patients with 
PAH and healthy controls. In patients with PAH, the distance to wave reflection 
was markedly reduced at 2-3cm from the point of imaging (midpoint of RPA or 
LPA), equivalent to the next bifurcation to the lobar PAs. They reference the study 
by Davies et al. and describe this as evidence of the horizon effect as PAH affects 
the distal vasculature351. It is interesting to note that following lung resection, the 
point of reflection may actually be the now ligated subsequent bifurcation to the 
RPA or LPA. As such, a similar finding to Quail et al. following lung resection may 
represent the true reflection site and not the horizon effect. 
7.2.4.5 Reservoir wave hypothesis 
Separation of pressure and flow into forward and backward components gives 
distinct forward and backward components in systole. In order to explain the 
gradual decline in pressure with no flow during diastole, WIA calculates large 
simultaneous forward and backward components that cancel each other out364, 
left side of Figure 7-9. The pressure decline is caused by a reservoir of pressure in 
the form of the elastic recoil of the arterial wall, termed the Windkessel effect389, 
see 1.2.6.4. Incorporation of a Windkessel reservoir pressure into wave separation 
removes the diastolic separation between forward and backward waves364, right 





Figure 7-9 Wave intensity analysis with and without pressure reservoir 
Separation of pressure (P, top row) and velocity (U, bottom row) into its forward (blue) and 
backward (red) components. Left column is separation without a pressure reservoir, right column is 
incorporating a pressure reservoir (green line). Plots are against time (t). Note the cancelling 
diastolic forward and backwards wave in the plots in the left column are removed by adding the 
pressure reservoir. Image from Parker et al.364. 
The reservoir wave hypothesis has faced criticism and its use is not universal. 
Arguments against the mathematical assumptions required for the hypothesis have 
been made by Westerhof et al. who describe the concept as “inconsistent”390. 
Modelling by Alastruey391 and experimental data by Hametner et al.392 found that 
the pressure reservoir calculated is equal to double the backward pressure. 
Mynard et al. found that the addition of a pressure reservoir to an experimental 
model of WIA “markedly underestimates or eliminates” BCWs, overestimates FEW 
and BEWs and displayed “non-physical” interactions 393, 394. 
In summarising the evidence for a pressure reservoir, Parker stated “preliminary 
results do not provide conclusive evidence of the utility of reservoir and excess 




7.2.4.6 Blood flow distribution across a bifurcation 
Whilst cross-sectional area ratios between the parent and daughter vessels 
influence wave reflection, there are other factors that influence the distribution 
of the incident blood flow between the daughter vessels396-398. This has been 
elegantly demonstrated in a computer model of variations of PA anatomy in 
patients with repaired tetralogy of Fallot by Boumpouli et al.398, Figure 7-10. 
Whilst the study uses a two-dimensional model of the pulmonary tree, assumes 
steady flow and non-compliant vessel walls, it highlights the contribution of each 
factor to the splitting of flow. As detailed in Figure 7-10, the percentage 
distribution of blood flow in a daughter vessel is reduced when, compared to the 
other daughter vessel, it has a; 
• Smaller vessel diameter 
• Longer length 
• Increased pressure at its output (afterload) 
• Increased angle of vessel at bifurcation (not in figure). 
Any decrease in operative vessel diameter may either be secondary to or 
contributory to a reduction in vessel blood flow. The assumptions described above 
do not account for the compliance of the PAs and so it cannot be assumed that 
any change in area alone will determine blood flow distribution without also 





Figure 7-10 Factors affecting blood flow distribution between right and left pulmonary 
arteries 
Computational presentations of blood flow distribution following repair of tetralogy of Fallot. Velocity 
(U) of blood flow represented by colour, red= high velocity, blue= low velocity. Corresponding 
velocity plots displayed for the right pulmonary artery (RPA) and left PA (LPA) beneath each 
representation of the artery. |D P|/0.5ρU2= pressure difference normalised for blood density (ρ) and 
velocity. P= pressure. Table summarises changes flow (Q) split between LPA and RPA for each 
example of a bifurcation. Adapted from Boumpouli et al.398 
i) Symmetrical bifurcation with no pressure difference. Equal split of flow 50:50. 
ii) Hypoplastic LPA with decreased branch diameter. Decreased LPA flow.  
iii) Extended RPA but equal diameters. Decreased RPA flow. 
iv) Markedly increased pressure at the LPA output. Markedly reduced LPA flow. 
v) Slight increase in LPA output pressure. 40:60 split, similar to normal blood flow distribution. 
NB RPA and LPA plots for iii) are swapped from published paper as they are different to results 
explained in table and text of the paper.  
7.2.5 Wave intensity analysis in the pulmonary circulation 
There are few studies investigating WIA in the pulmonary circulation in man and 
no previous studies specifically investigating it following lung resection. Initial 




similar wave intensity profile to the systemic circulation. In health, the pulmonary 
vasculature is relatively open-ended generating an early-mid systolic BEW which 
encourages the forward flow of blood399-401.  
When making comparisons across studies it is important to note that the value of 
dI is dependent on the sampling time of the data. If the sampling rate is doubled 
(the time differential is halved) then dP and dU double whilst dI will increase by 
fourfold (22). Direct comparison between studies therefore is only possible when 
the sampling time is the same151. Alternatively, calculation of the time normalised 
wave intensity (WI) from the time derivatives of pressure (dP/dt) and velocity 
(dU/dt) can be performed380. Calculation of WRI also allows direct comparisons 
between studies by describing the BCW relative to the FCW.  
7.2.5.1 Animal studies 
The changes in WIA describing the response of the RV and pulmonary circulation 
to increased afterload has been neatly demonstrated by Nie et al.402. In their 
concise study, WIA was performed by pulmonary catheter in eight ventilated dogs. 
Baseline WIA was measured in conditions of normoxia, hypoxia (fraction of 
inspired O2 0.08-0.11) and hypoxia with vasodilation (nitric oxide, NO), Figure 
7-11. The hypoxic mixtures were both performed in nitrogen and helium to assess 
if helium increases the diffusion velocity and therefore the effect of NO. FCW and 
FEW were present at baseline, as described in the systemic circulation. In response 
to hypoxia the FCW increased as the RV increased contraction to increase cardiac 
output. The hypoxic vasoconstriction converted the pulmonary vasculature to a 
relatively closed-ended system, demonstrated by the development of a BCW. This 
change was partially reversed by pulmonary vasodilation from adding NO to the 
inspired gas mixture. This reduced the FCW and almost removed the BCW. Helium 





Figure 7-11 Pulmonary wave intensity analysis in hypoxia and vasodilation 
Pressure (P), flow velocity (U) and wave intensity (WI) profiles of normoxia, hypoxia and 
vasodilation. Inhalation of hypoxic gas mixture in nitrogen (N2) and helium (He) initial increased 
forward compression wave (FCW, marked on plot) and caused a backward compression wave 
(BCW). Additional of nitric oxide (NO) to the gas mixtures reduced forward compression wave and 
backward compression waves. Image from Nie et al.402 
Further animal models have demonstrated a similar response to hypoxia and have 
attempted to determine the apparent site of reflection, the results vary between 
the studies399-401. Hollander et al. calculated that in normal conditions BEWs 
appear to originate from a “proximal site” 3cm from the main PA whereas, in 
hypoxia, BCWs appear to originate from the pulmonary microcirculation 9cm from 
the MPA399. A similar pattern was demonstrated in sheep by Dwyer et al.400. 
Bouwmeester et al. found the reflection to occur at a constant site for both BEW 
and BCW, the site corresponds to the junction between the RPA or LPA and the 
lobar pulmonary arteries401. As discussed in 7.2.4.4, the site of wave reflection is 
unlikely to relate to a single distinct site of reflection in global changes in the 
pulmonary vasculature and is instead representative of wave reflection distal to 




“This so-called “horizon effect” is due to re-reflection and entrapment of 
reflected waves and may be even more important in the highly fractal pulmonary 
circulation.” 
Quail et al.351 
7.2.5.2 Human studies 
The first study of human pulmonary artery WIA was performed in a 2014 ‘‘proof 
of principle’’ study by Lau et al403. WIA measurements were performed invasively 
by a specialised pulmonary artery catheter (PAC) with a dual-tipped pressure and 
doppler flow wire in 6 patients with PAH and 7 healthy controls. Patients with 
established PAH had larger FCW, FEW and BCW compared to controls. The wave 
reflection index was also increased (0.35±0.05 versus 0.11±0.06; p=0.01) with an 
apparent reflection site 15±5cm downstream. Wave speed was also increased in 
PAH (6.9±1.3 m.s-1 versus 3.8±1.0 m.s-1, p=0.01). These results suggest PAH results 
in a relatively close-ended pulmonary vasculature with increased wave reflection 
from the terminal branches and increased RV workload. Although reflection occurs 
at a more distal site, the increased wave speed resulted in the BCW returning to 
the RV earlier than in controls403. 
7.2.5.2.1 Pulmonary artery catheter studies 
In work from research group of Parker and Hughes, Su et al. have published 3 
papers investigating WIA by pulmonary artery catheter in patients referred for 
cardiac investigations of PAH or CTEPH and controls404-406. The three investigations 
are performed on patients from the same study and assess WIA variation with 
loading (PAH vs control)404 and in patients with PAH or chronic thromboembolic 
pulmonary hypertension (CTEPH) versus controls405. Additionally, repeat 
measurements were performed 3 months following pulmonary endarterectomy for 
the patients with CTEPH406. These studies also offer insight into the potential 
mechanisms by which the RV responds to PAH and CTEPH, therefore they may help 
predict and interpret any potential changes following lung resection. An example 
of the velocity, pressures and WIA profiles generated in the pulmonary circulation 





Figure 7-12 Wave intensity analysis in the pulmonary artery 
Pressure (P), velocity (U) (top row) and wave intensity (dI) (bottom row) profiles of healthy patient 
(a) and a patient with pulmonary arterial hypertension (b). Note steeper pressure profile with higher 
peak and a lower ‘notched’ velocity profile in b. This is demonstrated as a larger forward 
compression wave (FCW) and forward expansion (decompression in example) wave (FDW) 
indicating increased work of the right ventricle. The increased backward compression wave (BCW) 
indicates increased wave reflection (afterload). Image from Su et al.151. 
The workload of the RV was assessed by calculation of RV energy and power 
density, defined as the energy and power delivered by the RV to generate the 
stroke volume per unit cross-sectional area405, see Equation 7-11, energy density 
is power density multiplied by the duration of the cardiac cycle. These measures 
account for the “steady-flow” (hydraulic) portion of RV work as they are averaged 
over the entire cardiac cycle, similar to PVR. The ratio of oscillatory power/energy 
to hydraulic power/energy can be estimated by dividing the FCW by the RV 
power/energy densities405. An animal model of PAH demonstrated a slight increase 
in the hydraulic power of the RV with a decrease in the oscillatory to hydraulic 
power ratio407. This can be interpreted as a change in the nature of energy transfer 
from the RV to the pulmonary circulation with a greater reliance on hydraulic 
load, similar to the systemic circulation. 
h%Fℎ(	*#'(,%&98+,	E"U#,	2#'=%(@ = 	 (MNM: − hNM). X!*"+ 
Equation 7-11 Right ventricular power density  




As described by Lau et al.403, Su et al. also demonstrated greater FCW, FEW, BCW 
and WRI in patients with PAH and CTEPH compared to control, there were no 
differences between PAH and CTEPH. Wave speed was 3m.s-1 in controls, 12m.s-1 
in PAH and 15m.s-1 in CTEPH (p<0.001 for both comparisons vs control). Wave 
speed was associated with MPAP (r=0.62, p<0.01), PA pulse pressure (r=0.78, 
p<0.01) and TAPSE (r=-0.58, p=0.01). Peak FCW and FCW area were not associated 
with any measures of RV function (RV fractional area change and TAPSE). BCW and 
WRI were not associated with MPAP, PVR or any other parameter. Wave speed 
increased with severity of pulmonary hypertension whilst WRI was similar at all 
stages of disease, Figure 7-13. Su et al. interpret this as a sign that an increase in 
WRI occur early in the development of pulmonary hypertension (increased in all 
cases irrespective of disease severity) whereas wave speed increases with 
increasing clinical severity405. 
 
Figure 7-13 Wave speed and reflection index against pulmonary hypertension severity 
Note the progressive increase in wave speed with increased pulmonary hypertension (PH) severity 
whereas wave reflection index (WRI) is greater than normal in PH but it is similar between all 
stages of PH. Image from Su et al.405. 
RV power and energy density were both increased from control in PAH and CTEPH 
with no difference between PAH and CTEPH. FCW/RV power density ratio and 
FCW/RV energy density ratio were similar to control in CTEPH but reduced in PAH, 
Figure 7-14. Su et al. argue that this may represent differing response of the RV 
and pulmonary vasculature to afterload between the two disease processes. As 
discussed in 1.2.3 page 50, the RV has differing responses to gradual and sudden 
increases in afterload133. In PAH there is a gradual change in the PA vasculature 
increasing afterload whilst in CTEPH the RV is subjected to an episodic stepwise 





Figure 7-14 Oscillatory to hydraulic power ratios in pulmonary hypertension 
Ratio of right ventricular (RV) oscillatory power to hydraulic power calculated by forward 
compression wave (FCW) divided by RV power density ratio (A) and RV energy density ratio (B). 
Ratios reduced in pulmonary arterial hypertension (PAH) against control and chronic 
thromboembolic pulmonary hypertension (CTEPH). Image from Su et al.405. 
Su et al. argue that the reduced oscillatory/hydraulic power ratios in PAH are 
more likely secondary to differences in pulmonary vasculature adaption than 
differences in RV adaption. They base this on a higher wave speed, lower PVR and 
lower MPAP in CTEPH than PAH, although none of these differences is statistically 
significant. Also, they argue that whilst RV adaption is generally better in diseases 
such as Eisenmenger syndrome (a chronic increase) the differences may represent 
a “more rapid (in most cases) RV adaption to sudden change in pressure load, as 
it is in CTEPH, versus gradual alteration over time in PAH.” An alternative 
interpretation of their results is that in PAH there is more marked RV hypertrophy 
and therefore a greater hydraulic component. RV energy power and density 
tended to be higher in PAH, although again neither of these differences were 
statistically significant. Patients with CTEPH may therefore have maintained 
oscillatory power compared to the stiffer hypertrophied RV adaption of chronic 
afterload increase. Given that there are only 10 controls, 11 PAH patients and 10 
CTEPH patients to compare, the study is likely underpowered to determine such 
differences. 
Su et al. also demonstrated in patients with CTEPH that, although pulmonary 
artery endarterectomy (PEA) reduced PA pressure, PVR and wave speed; there 
were no changes in WRI, wave energies or RV energy density. Additionally, the 
ratio of FCW to RV stroke work was unchanged. This implies that even when PAPs 
and PVR are reduced, the adapted RV maintains the same oscillatory to hydraulic 
energy ratio. The preserved WRI demonstrates residual wave reflection and 




This residual afterload may be caused by pulmonary vascular remodelling distal to 
the sites of the large emboli that are removed and/or secondary to established 
micro-emboli in other vessels406. Again, this highlights the complexities of 
afterload that PVR and PA pressures overlook. 
7.2.5.2.2 Cardiac magnetic resonance studies 
Wave intensity analysis can be performed non-invasively by CMR. It allows 
accurate flow measurement in the MPA, RPA and LPA although as it cannot directly 
measure pressure, WIA can be calculated with vessel area. Area has been used 
instead of pressure in ultrasound studies of WIA in the systemic circulation351, 375. 
MPA imaging is subject to through plane motion from contraction of the RV which 
pulls the MPA inferiorly, shifting the narrower distal MPA into the imaging plane 
during systole and artificially reducing the increase in area seen in systole351. 
Additionally, the motion of the MPA may bring it in and out of the true cross 
section of the imaging plane358, as discussed in 6.6.1 page 220. In comparison, 
whilst Su et al. were able to perform MPA and RPA WIA, they were unable to 
perform WIA in the LPA with PACs405. 
Quail et al. utilised CMR to compare WIA in 20 patients (13 PAH and 7 CTEPH) and 
10 healthy controls of a similar age351. Their methods (discussed below) and results 
are the most applicable to the investigation performed in this chapter. Similar to 
Su et al. they demonstrated increased wave speed in disease, although the 
calculated speeds were much lower in Quail et al. (1.36m.s-1 vs 12m.s-1 in PAH and 
0.72m.s-1 vs 3m.s-1 in controls). Contrary to Su et al., they demonstrated reduced 
FCW energy in patients with PAH compared to controls. The main differences 
between the patients with PAH versus controls can be demonstrated in the 
backward waves, Figure 7-15. There were BEW in controls (relatively open-ended 
pulmonary circulation) but BCW (relatively closed-ended pulmonary circulation) 
in PAH. In this cohort, a BCW area of >0.0006cm5 had a 100% sensitivity and 91% 
specificity for detection of a proximal clot (AUROC 0.97). Quail et al. also sought 
association between haemodynamic variables and WIA parameters. Only FCW was 





Figure 7-15 Wave intensity analysis in pulmonary hypertension versus control 
Acceleration time (AT) (A) and forward compression wave (FCW) (B) were reduced in pulmonary 
hypertension (PH) against controls. The main difference between the groups was the nature of the 
wave reflection and therefore the degree of pulsatile afterload. In patients with PH the reflected 
waves were backward compression waves (BCW) (C) whilst in controls the reflected wave was a 
backward expansion wave (BEW) (D). Image from Quail et al.351. 
Quail et al. also investigated the relationship between PAAT and WIA. PAAT has 
been demonstrated to be decreased in PAH with a “notched” flow pattern, 
demonstrated in panel A of Figure 7-16 and previously342, 353, 408, Figure 6-4 page 
197. The notched flow pattern is a widely recognised indication of PAH409 and it 
has been recognised that the notching of the PA flow profile is caused by wave 
reflection 410, see 6.1.2. This is the first study to demonstrate that the onset of 
the notching and therefore PAAT occurs when a BCW exceeds the initial FCW. As 
demonstrated in Figure 7-16 net dI rapidly declines following the initial FCW peak. 
When dI crosses the x-axis the negative BCW exceeds the remaining positive dI 
from the FCW, i.e. the BCW is the dominant wave. At this point the effect of the 
BCW is to reduce forward flow of blood causing the rapid decline in blood flow 
and the characteristic “notched” flow pattern. In Quail et al.s’ study, PAAT was 
reduced in PAH versus controls and a PAAT of <57.6ms was predictive of the 





Figure 7-16 Acceleration time and wave intensity analysis 
Area and flow plots against time (A) show a “notched” flow profile with a reduced acceleration time 
(AT) that is temporally related to the onset of negative net wave intensity (B) and the peak of a 
backward compression wave (†) (C). AT occurs when the negative wave intensity (dI-) is greater 
than the positive wave intensity (dI+) *= forward compression wave. Image from Quail et al.351. 
Schäfer et al. have performed a retrospective study of children who had required 
both CMR and right heart catheterisation (RHC) for investigation of PH377. Their 
WIA methodology was based on that of Quail et al.351, although flow analysis was 
only performed in the MPA in their departmental protocol. Similar to Quail et al. 
and Sue et al., they demonstrated increased BCWs and wave speed in PH versus 
control, although they found no difference in FCW or FEW. Of the WIA parameters 
they demonstrated; increased wave speed (HR 3.67, [95% CI=1.47-10.20]), 
increased BCW (HR 2.91, [95% CI=1.18-7.55]) and reduced FEW (HR 0.34, [95% 
CI=0.11-0.90]) were all prognostic of “clinical functional worsening”. 
Additionally, they showed that increased MPAP, PVR index, end-diastolic pressure 
and reduced RVEF were also prognostic of clinical deterioration. PA distensibility 





7.2.6 Methods of calculating wave intensity 
7.2.6.1 Modality of assessment 
Pulmonary WIA was originally performed with PAC in animal models399-402 and 
subsequently in man by Lau et al.403 and Su et al.404-406. To date only Quail et al.351 
and Schafer et al.377 have reported CMR pulmonary WIA in man although feasibility 
of the technique was originally demonstrated in an abstract by Leimbigler et al. 
in 2012411.  
As previously discussed, 1.2.5 page 61, analysis of blood flow in the pulmonary 
arteries can be performed invasively by pulmonary artery catheters or non-
invasively by CMR and echocardiography. The main distinction in WIA methodology 
between techniques, is the measurement of pressure. PAC studies allow direct 
measurement of pressure and as such calculate WIA as per Equation 7-2, Equation 
7-5 and Equation 7-6. Non-invasive techniques measure changes in cross-sectional 
area instead of changes in pressure. Whilst echocardiography has been used to 
calculated carotid WIA379, 383 it has not yet been used to measure pulmonary WIA. 
An additional benefit of PAC is greater temporal resolution of measurement, 200-
1000Hz403, 405 versus 30-100 Hz with CMR351, 377. 
The other main distinction between PAC and CMR techniques is the ability to 
perform WIA in the main, left and right PAs. Whilst PAC allows measurement of 
WIA in the MPA, this is difficult in CMR techniques. The MPA is pulled inferiorly 
with contraction of the RV causing a distortion the angle of cross section of the 
curved MPA358, 412 and pulls the narrower distal MPA into the imaging plane in 
systole351. As cross-sectional area is used as a pressure surrogate, any deviation 
from the true cross-sectional axis leads to an artefactual increase in area/pressure 
and therefore WIA. Conversely, compared to CMR, measurement of WIA the RPA 
or LPA with PAC is challenging. Directing the PAC into the desired artery is difficult 
and requires live angiographic or x-ray guidance. Su et al. were only included 
measurements from the RPA as they were unable to obtain satisfactory velocity 




7.2.6.2 Data filters 
As WIA is calculated as the product of the differences in measured pressure/area 
and flow/velocity it is very sensitive to noise in these measurements. To minimise 
this potential source of error, it is necessary to apply a filter to the data. Parker 
advises use of a Savitzky-Golay filter364; this was first described in 1964 and has 
been described as the “dawn of the computer-controlled analytical 
instrument”326, 413. It calculates the central point of a given window size to a 
polynomial fit of a chosen order to the least sum of square. The window size (n) 
is the number of data points included in the smoothing calculation (+$%&  points 
either side of the central point, therefore n is always an odd number), see Figure 
7-17. In WIA a second order polynomial is generally used with a symmetrical 
window size, i.e. a graph of a second order polynomial is given by the equation 
ƒ(x)=a0 + a1x + a2x2 where a2≠0326. The benefit of this filter is that is maintains the 
peaks and troughs of the original data that are required for detection of the rapid 
changes in pressure/area and flow/velocity that are essential in WIA.  
 
Figure 7-17 Seven-point Savitzky-Golay smoothing filter 
Example of a smoothing filter from the original Savitzky and Golay paper. The brackets represent 
the window size (7) in which the data central data point is replaced by the value in the open circle. 
Image from Savitzky and Golay326. 
Su et al. (including Parker as an author) used a second order polynomial fit with 
an 11-point window size in their analysis of data collected with a PAC with a 
sampling frequency of 200Hz405. The width of the window size determines the 




and may risk removal of the underlying signal. The most appropriate window size 
needs to be optimised for the data collected405. Quail et al. used a Butterworth 
filter in their investigation351; this removes noise above a set frequency414 and has 
been used to a lesser extent in WIA studies402, 415.  
7.2.6.3 Wave speed  
There are three broad mechanisms of calculating wave speed (c) in the time 
domainyy 416, 417. The most logical method of wave speed calculation is the time 
delay (transit time) between the onset of flow/pressure increase between two 
points a known distance apart. This is called the foot-to-foot method417, see Figure 
7-18(b).  
 
Figure 7-18 Methods of calculation of wave speed 
a) Pressure (P) velocity (U) loop over cardiac cycle, arrows demonstrate direction of the loop. 
Wave speed can be calculated from the gradient of the early systolic linear prior to wave reflection 
(dashed line in plot). 
b) Foot-to-foot method of wave speed calculation. Time difference (Dt) between onset of increase 
in pressure at two sites of known distance apart. Wave speed calculated as distance/Dt.  
Image from Khir and Parker417 
Rearrangement of the water hammer equation, Equation 7-4, allows calculation 
of wave speed from the change in pressure and the change in velocity (PU-loop)418, 
Equation 7-12. This assumes that in early systole there are no reflected waves and 
that there is a linear section of the PU-loop, wave speed can therefore be 
 
yy Characteristic impedance (Zc) can also be used to calculate wave speed but as detailed above 
this approach is distinctly separate to the time-domain methods of WIA. 
bifurcation has a mother tube of 1 in diameter and the
two daughter tubes of 0.5 in diameter each. One of the
daughter tubes is clamped 70 cm away from the centre of
the bifurcation and the other daughter is connected to
open to the air reservoir at a distance of 105 cm from the
centre of the bifurcation. The wave intensity is
calculated and the reflected waves are shown as
individual peaks in Fig. 5. Each individual peak
represents one or more reflected waves, depending on
their arrival time to the measurement site. Table 3
contains a description of the possible waves with their
paths and a comparison between the theoretical and the
calculated arrival times of reflected waves to the
measurement site at the inlet of the mother tube.
The measured reflection coefficient in this experiment
calculated as the ratio of the magnitude of the second
pressure peak minus the pressure at the onset of the
second peak to the magnitude of the first pressure peak,
is R ! 0:48: From Eq. (10) the bifurcation of this
experiment is expected to produce a reflection coefficient
of R ! 0:45: Experimental result is in good agreement
with theoretical results and the difference is on the order
of 7%.
5. Discussion and conclusions
As seen in Fig. 1, the path of the waves included more
than the latex tube; portex connectors were used to give
access to the mea ur ment catheter and polyur thane
tubing to connect the pump and the downstream
reservoir. However, since they were made of a much
more rigid material than the latex tubing, their wave
speeds are much larger and the time taken to traverse
these parts of the wave path will be an order of
magnitude smaller. For example, the wave speed in the
20 cm long polyurethane tube connecting the latex tube
to the downstream reservoir, using Eq. (2), is approxi-
mately 43m/s (E ! 10Mpa, h ! 0:3 cm, d ! 1:5 cm and
r ! 1080 kg/m3). The wave travel time in that tube is
o5ms, which is less than one sampling period. We have
therefore neglected those rigid parts of the path of the
wave travel in our wave timing calculations, since they
would affect the results negligibly.
We assumed that reflections caused at an open-ended
tubes have no time lag. The reservoir is more rigid than
the polyurethane connecting tubes and the latex tubes,
hence the wave speed in the reservoir will be so high that
it will affect the results negligibly. Also, the amount of
saline injected by the pump is approximately 28ml,






























Fig. 2. Wave speed measured in a 1 in diameter latex tube by (a) PU-loop method. The slope of the initial part of the PU-loop indicates wave speed
of 3.47m/s and the arrows indicate the direction of the loop. (b) foot-to-foot method. The time that takes the wave to run from one site to the other,
Dt; is 62ms as indicated by the arrows which point at the foot of the wave at each site. The distance between the two sites is 220 cm and the calculated
wave speed is 3.55m/s.
Table 1
Average wave speed calculated by the PU-loop and foot-to-foot
methods in latex tubes
Tube size PU-loop (m/s) Foot-to-foot (m/s) Difference %
1 in 3.470.8 3.570.8 2.2
0.5 in 4.571.2 4.671.1 2.9
0.5 in ‘‘hard wall’’ 5.371.1 5.571.2 3.7
Average difference 2.970.8




calculated as the gradient of this section, Figure 7-18(a). This method requires a 
high sampling frequency to have at least three data points (in order to plot an 
accurate straight line) prior to the influence of wave reflection351. Variations of 
this technique calculate wave speed without direct pressure measurement, 
instead wave speed is calculated from either the changes in flow (dQ) and change 
in cross sectional area (dA) (QA-loop)419 or the change in the natural log of vessel 
diameter and velocity ((lnD)U-loop)379. These methods again rely on detection of 




Equation 7-12 PU-loop wave speed calculation 
c= wave speed. dP= change in pressure. ρ= density of blood. dU= change in velocity. 
Calculation of wave speed in the coronary arteries is not possible with the above 
methods as there is no stage when wave travel is unidirectional. Davies et al. 
devised the sum of squares (SOS) method where wave speed is calculated from 










Equation 7-13 Sum of squares wave speed calculation 
c= wave speed. ρ= density of blood. dP= change in pressure. dU= change in velocity. dA= change 
in cross sectional area. dQ= change in flow.  
The influence of wave reflection on calculation of wave speed has been 
investigated in bench top tube models. All methods show increasing inaccuracy as 
the site of measurement approaches the site of wave reflection416, 417, 423. 
Compared to the foot-to-foot method (the gold standard), SOS underestimates 
wave speed whereas loop methods over-estimate wave speed416. Interpretation of 
 
zz In Quail et al.s’ original description of this method the paper states that wave speed was 
calculated as *∑"#!∑"$!. This was highlighted in a letter
421 and Quail replied that the equation in the 
original paper was a typographical error. They state that the equation displayed Equation 7-13 




wave speed is therefore dependent on both the method used to calculate it and 
the proximity of measurement site to a site of wave reflection.  
In the pulmonary circulation, Su et al. found that in “many” of their participants 
the PU-loops did not have a linear section from which to calculate wave speed404-
406. Instead, they use SOS (PU method as they used PACs and therefore measured 
pressure) to forgo the assumption that there is a reflection free period in systole 
given that they were investigating hypothesised increased wave reflection in PAH. 
Quail et al. used the QA-loop for their analysis but also calculated wave speed by 
the SOS method for comparison (QA method as they used CMR). They show good 
agreement with minimal bias between the methods but they do not specifically 
investigate agreement in arteries with and without significant wave reflection351.  
7.2.7 Wave intensity analysis conclusion 
Complete assessment of RV afterload is challenging, particularly following lung 
resection. Cardiac magnetic resonance WIA offers a model to investigate wave 
reflection and simultaneously measure afterload and assess RV function. Such 
analysis has not been performed in this population and this investigation allows 
the first opportunity to track changes in WIA following a defined unilateral 
anatomical change in the pulmonary vasculature. 
7.3 Hypotheses  
As detailed in this Chapter, Chapter 3 and throughout this thesis, RV pulsatile 
afterload is hypothesised to following lung resection. The following are 
investigated in this chapter (and Chapter 8),   
• Pulsatile afterload, measured by WRI,  
a. increases following lung resection 
b. predominately affects operative PA 





• The magnitude of increase in pulsatile afterload rate will be associated 
withaaa  
a. The altered post-operative distribution of CO between the PAs 
b. reduction in RVEF 
c. impaired strain 
7.4 Methods 
This investigation was performed on the RPA and LPA flow and area plots described 
in Chapter 4, where the methodology for the image acquisition, interpretation, 
initial data processing and reproducibility analysis are explained. The further 
steps required to perform wave intensity analysis (WIA) are detailed below. Of 
note, WIA was not performed in the MPA given the potential errors in cross-
sectional area measurement demonstrated in the area measurements in this thesis 
and previously by other authors351, 358. 
7.4.1 Data processing 
All data processing was performed in R Studio with original R programmes written 
by the authorbbb. The cardiac cycle was divided into 30 frames during CMR scanning 
and therefore the initial temporal resolution of the data was one thirtieth of the 
cardiac period. The processes described below were repeated for each individual 
vessel (RPA or LPA) at each time point for each participant. Statistical analysis 
was also performed in R Studio.  
7.4.1.1 Savitzky-Golay filter 
The averaged individual time points of PA flow and area of the dual reported 
results, detailed in 6.3.1.2 page 200, were uploaded into R. As described by Parker 
et al.364 and Su et al.405, a second order polynomial fit Savitzky-Golay filter was 
applied to the original data points for flow and area. In order to ensure an accurate 
fit at the beginning and end of the cardiac cycle the measured data points were 
repeated three times, giving three cardiac cycles, Figure 7-19. Window sizes (n) 
 
aaa This will be explored in Chapter 8. 
bbb The initial code and training for R was provided by Dr Martin Shaw. Additionally, he was kindly 




of 5, 7, 9 and 11 points were tested for maintenance of signal against removal of 
noiseccc. Visual inspection of the plots generated for filtered data against original 
data were performed for the entire dataset to select the most appropriate balance 
between loss of noise and maintenance of signal. The single selected filter width 
was applied to all vessels for flow and area. The filtered data was then 
interpolated to a 1ms temporal resolution without further smoothing.  
 
Figure 7-19 Example of Savitzky-Golay filter applied to flow profile 
Original data points (red circles) repeated for three cardiac cycles. Black line represents the 
Savitzky-Golay (second order 7-point window), results interpreted to 1ms temporal resolution. Note 
the effect of the filter on the first cardiac cycle. The 7-point window only includes the centre (first) 
data point and the 3 points following (grey shaded area), as such the filtered value is plotted as part 
of the steep slope of flow increase. In this example the flow calculated is therefore negative. In the 
second repeated cardiac cycle, when the filter is applied to the “first” data point of the cardiac cycle 
the 7-point window (second wider grey shaded box) now includes the preceding diastolic plateau in 
flow. As such the calculated point is more accurately filtered. The same effect occurs, to a lesser 
extent, at the last point of the cardiac cycle. The filtered data is then extracted for selection of 
starting point. Flow profile is from patient in this study. Of note, the CMR reported flow profile is an 
amalgamation of separate cardiac cycles and is only representative a single heartbeat.  
 
ccc A window size of 5 will have a closer fit to the original data than a higher size although it will 





7.4.2 Wave intensity calculation 
The distance between the heart and the site of flow and area measurement may 
differ not only between LPA and RPA but also differ in the same vessel between 
different visits. This may be secondary to selection of a more proximal or distal 
site of analysis or changes in the position of the heart, lungs and pulmonary 
arteries in the chest following lung resection227. In order to minimise the effect of 
this on comparison between vessels, temporal interpretation of WIA was 
normalised to the onset of wave intensity in that vessel.  
Net wave intensity (dI) was calculated as the product of the change in area (dA) 
by the change in flow (dQ) as per Quail et al.351, Equation 7-14. To determine the 
starting point dI was initially calculated with the filtered and interpolated data of 
the repeated cardiac cycles, Figure 7-20. The starting point of the flow profile 
was determined by the time of initiation of the main peak in dI from the central 
cardiac cycle. This wave was detected by selection of the maximal dI in the central 
portion of the plot and then the start point was determined as either the preceding 
time when dI=0 or the preceding turning point when d2I=0 (second temporal 
derivative). An entire cardiac cycle was extracted from the filtered and smoothed 
flow and area data from this point. dI was calculated again from this starting 
point. 
2W = 2N. 2p 
Equation 7-14 Net wave intensity calculation 





Figure 7-20 Example of net wave intensity calculation and detection of starting point  
Top plot, flow (blue solid line) and area (red dashed line) against time from the repeated sample. 
Starting time point of the plot is after 70% of the preceding cardiac cycle. Bottom plot, net wave 
intensity (dI) against time. Note rapid increase in dI coincides with the increase in flow and area of 
top plot. Peak wave intensity measured as the maximal value of dI. The starting point is the latest 
time preceding this peak at which dI=0 or there is a turning point in dI (measured by the time at 




7.4.2.1 Wave speed calculation 
Wave speed (c) was calculated from the sum of squares method (SOS) described 
by Quail et al.351, Equation 7-13 page 263. Additionally, wave speed was calculated 
from the QA-loop method from the filtered and interpolated data, Equation 7-15. 
A best fit linear regression line was applied to the filtered and smoothed data 
points corresponding from t=0 until the time of third 3 phaseddd of the original CMR 
imaging (assumed prior to reflection), as per Schafer et al.377 and Quail et al.351. 
Visual inspection of the QA-loops and gradient (wave speed) generated was 
performed to determine the presence of a linear period in early systole. SOS and 
QA-loop results were assessed for agreement and bias with Bland-Altman plots424. 
Following these comparisons, a single method of wave speed calculation was 





Equation 7-15 Flow-area loop wave speed calculation 
c= wave speed. dA= change in area. dQ= change in flow 
7.4.2.2 Wave separation 
Separation of the flow, areaeee and wave intensity plots was performed as per 
Equation 7-16, Equation 7-17 and Equation 7-18. Plots for each separation were 
generated and visually inspected for anomalies.  
2p± =	
1
2 (2p	 ± &2N) 
Equation 7-16 Flow wave separation 
dQ= change in flow. c= wave speed. dA= change in area.  
  
 
ddd The third phase is a balance between ensuring accuracy of a best fit line (increased data points 
increase the accuracy) and measuring prior to wave reflection (increased data points increase 
risk of influence by wave reflection). 
eee In Quail et al.s’ 2015 paper there is an error in the equation for calculation of dA±, it states A 










Equation 7-17 Area wave separation 








Equation 7-18 Wave intensity separation 
dI= net wave intensity. c= wave speed. dA= change in area. dQ= change in flow. 
7.4.2.3 Wave detection 
Complete interpretation of the wave intensity plots was performed for all vessels 
prior to unblinding. The process below describes the initial approach for analysis 
of all vessels which was successful in the majority of vessels.  
An original R programme was written to automatically detect individual forward 
(dI+) and backward (dI-) waves from the corresponding wave intensity plots and 
their secondary temporal derivatives (d2I, d2I+ and d2I-). The programme measured 
the magnitude (value at peak) and the time to the peak (from the start of dI) for 
each wave. Additionally, it detected the beginning and end of each wave (detailed 
below) and determined the nature of each wave (expansion or compression). The 
area under the curve for each wave was calculated using the R package auc::MESS, 
this calculated the area under the curve between two points defined as the start 
and end of the wave, see below. Plots for dI+ and dI- were generated as ‘.pdf’ 
files with the area under each curve marked and shaded accordingly depending on 
the nature of the wave, example shown in Figure 7-21. Visual inspection of each 
plot was performed to confirm correct wave identification. Where this approach 
did not correctly identify the wave forms (usually the beginning or end points of 
the FEW and BCW) an alternative programme was written for analysis of that wave 





Figure 7-21 Wave intensity plot example 
Representative example of wave intensity (WI) plot from patient in this study (MRIRAN31). Black 
line represents overall WI. Initial peak in WI caused by a forward compression wave (FCW, blue). 
Secondary positive peak is a forward expansion wave (FEW, green). Most negative point between 
these peaks in the backward wave which can be a compression wave (BCW, red) or an expansion 
wave (BEW, orange, not shown in example). Note the areas of the waves were separate to the 
overall WI measured as they are determined from the forward and backward components of the 
overall WI.  
Forward compression waves and FEWs were detected from the dI+ plots. The 
magnitude and timing of the FCW was measured from the maximal value for dI+ 
and the time to this point. The starting point was the beginning of the cardiac 
cycle and the end of the wave was defined when dI+=0 or d2I+=0 following that 
peak dI+. The FEW was detected as the peak in dI+ following the FCW wave. The 
beginning and end of the wave were detected by the turning point (point at which 
temporal derivative of dI+= 0) of dI+ immediately preceding or following the FEW 
peak at which dI+<(0.05 x the magnitude of FEW). This differentiated between 
small notches in the dI+ plot that create turning points but were not caused by a 
distinct wave and the boundaries between separate waves.  
Backward waves (BW) were detected from the dI- plots. The most negative dI- 
occurring between the times of the peaks in FCW and FEW was detected as the 
peak of the backward wave, this approach was taken to ensure the backward wave 





































































measured was a reflection of the FCW and not an earlier artefact, discussed 
further in 7.6.3. Given that this was either a BCW or BEW, the nature of the wave 
was determined by analysis of the corresponding contemporaneous dQ and dA. If 
dA was positive and dQ was negative (measured as dA>dQ) then the wave was 
classified as a BCW, if dQ>dA then the wave was classified as a BEW. The beginning 
and end points of this wave were detected as for the FEW although, as dI- was 
negative it was the turning point at which dI->(0.05 x the magnitude of backward 
wave). Timing of the backward wave and distance to the reflection site was 
interpreted together for the backward irrespective if it was a BEW or BCW. Peak 
WI and area of the BW were expressed as the value of BCW detected. If the wave 
was a BEW the value was recorded as 0.  
Wave reflection index (WRI) was expressed and the sum area of the BCW over the 
sum of the area of the FCW expressed as a percentage, Equation 7-10 page 246.  
7.4.2.4 Distance to reflection site 





Equation 7-19 Distance to reflection site 
BW= backward wave. FCW= forward compression wave.  
7.5 Results 
As described in Chapter 4, CMR scans were completed in 27 patients pre-
operatively, 22 on POD2 and 24 at 2-months. In total flow/area plots were 
available for WIA in 142 vessels (70 LPAs and 72 RPAs).  
7.5.1 Data filtration and inspection  
Visual inspection of filtration of the original data by a Savitzky-Golay filter with 
window widths of 5, 7, 9 and 11 points revealed an optimum window of 7 points 
for area and flow plots, Figure 7-22. This was deemed the optimum balance 





Figure 7-22 Examples of Savitzky-Golay filters of increasing size 
Plots of unfiltered measured area (left column) and flow (right column) (black circles and line) with 
overlapped transformed data from Savitzky-Golay filter of 5 points to 11 points (red line, window 
size indicted on each plot). Note the effect of increasing window size with progressive loss of the 
underlying signal, particularly in the area plots. Increasing window size in flow plots results in a 
delayed representation of the rapid systolic increase in flow. A width of 7 points was selected as 
the best balance between reduction in noise and maintenance of underlying signal. Images from 




Visual inspection of WIA plots revealed abnormalities in 6 scans. All 6 scans had 
marked late diastolic increases in area without corresponding changes in flow, an 
example is shown in Figure 7-23. Whilst this was not significant enough to be 
detected in the distensibility results, Chapter 6, the impact on WIA was more 
pronounced resulting in the calculation of a large wave in late diastole that was 
non-physiological and would make wave speed calculation by SOS or QA loop 
inaccurate. Two scans were pre-op, one was on POD2 and three scans were at 2-
months post-op. The abnormalities are potentially caused by motion artefact, 
similar to the MPA scans, discussed further in 6.6.1 page 220. These 6 scans were 
removed from analysis leaving 68 operative and 68 non-operative PAs (71 RPA and 
65 LPAs) for analysis.  
 
Figure 7-23 Example of abnormal wave intensity plot 
Top plot, flow (blue solid line) and area (red dashed line) against time, note the late diastolic 
increase in area (marked by arrow). Bottom plot, net wave intensity (dI) against time. Note late 




7.5.2 Wave speed 
7.5.2.1 Calculation of wave speed by sum of squares method 
Operative PA wave speed decreased post-operatively on POD2 and 2-months 
(p<0.001, paired Wilcoxon for both) whilst non-operative PA wave speed was 
increased on POD2 before returning to baseline by 2-month, Table 7-1. Operative 
PA wave speed was similar to non-operative PA pre-operatively (p=0.856) but 
lower on POD2 and at 2-months (p<0.001, Wilcoxon rank sum test for both). 
Table 7-1 Changes in wave speed over time 
Values are median (IQR). SOS= wave speed calculated by the sum of square method. Both 
Friedman’s test. Comparison between time-points Wilcoxon signed rank test. #= significant 
difference from pre-op. ¥= significant difference from post-operative day 2 (POD2). Significant 
results (p<0.05) highlighted bold italics. 
 
Figure 7-24 Operative and non-operative wave speed  
Wave speed calculated from sum of squares technique. Wave speed was reduced post-operatively 
in the operative pulmonary artery (PA) (dark grey boxes) whilst in the non-operative PA (light grey 
boxes) wave speed was increased at post-operative day 2 (POD2) compared to pre-op and 2-
months, paired Wilcoxon signed rank test for comparisons. Non-operative wave speed was greater 
than operative at both post-operative time points, Wilcoxon rank sum test. 
Pulmonary  
artery 
 Pre-op POD2 2-months p-value 
Operative SOS  
(m.s-1) 
1.38 (1.28, 1.53) 0.92 (0.73, 1.20) # 0.90 (0.75, 1.06) # <0.001 





1.29 (1.06, 1.76) 1.60 (1.33, 1.97) # 1.27 (1.10, 1.78) ¥ 0.019 




7.5.2.2 Calculation of wave speed by flow-area loop method 
Visual inspection of QA loops for all vessels revealed that 32/136 (23.5%) had 
marked curvature in early systole, example shown in Figure 7-25. As wave speed 
was calculated from the best fit line to the linear segment in early systole this 
prevented wave speed calculation in these scans. The percentage of the vessels 
scanned that had the curvature (non-linear) did not significantly increase post-
operatively; 8/52 (15.3%) pre-operative vessels, 11/41 (26.8%) on POD2 and 13/43 
(30.2%) at 2-months (p=0.198, Chi-squared test). There was a similar rate between 
the right (19/71 (26.7%)) and left PAs (13/65 (20%)) (p=0.353, Chi-squared test) 
and between operative (19/68 (27.9%)) and non-operative PAs (13/68 (19.2%)) 
(p=0.225, Chi-squared test). There was a trend to an increase in non-linear scans 
in the vessels that had undergone resection (POD2 and 2-months operative PA 
(14/41 (34.1%)) compared to those that had not undergone resection (non-
operative PA and pre-op operative PA, (18/95, (18.9%)), (p=0.055, Chi-squared 
test). 
 
Figure 7-25 Flow-area loop example 
Example of flow–area (QA) loop method of wave speed calculation in left and right pulmonary 
arteries of same scan (MRIRAN 37, patient from study). Flow was plotted against area for the 
entire cardiac cycle. Wave speed was calculated from the gradient of the plot in early systole. Red 
circles represent starting time (time= 0ms) and finishing time (time corresponding with third phase 
of original imaging) from which wave speed was calculated (red gradient line). Note linear segment 
in early systole in left panel but curved (non-linear) in right. 
Table 7-2 depicts the results for wave speed calculated by SOS and QA loop 
methods. QA loop all (including non-linear scans) and QA loop linear (excluding 




although the direction of change in wave speed by the QA loop was similar to the 
significant changes in the SOS method, i.e. increased non-operative PA wave 
speed on POD2 only and reduced post-operative wave speed in the operative.PA. 
Table 7-2 Comparison of wave speed by flow-area loop and sum of squares techniques 
Values are median (IQR). SOS= sum of square method. QA loop= flow area loop method. §= 
Friedman’s test. Comparison between time-points Wilcoxon signed rank test. #= significant 
difference from pre-op. ¥= significant difference from post-operative day 2 (POD2). Significant 
results (p<0.05) highlighted bold italics. 
7.5.2.3 Agreement between methods of calculating wave speed 
The agreement between the SOS and the linear QA loop scans showed a median 
bias of -0.12m.s-1 [95% CI -0.38, 0.07m.s-1] for all scans, (SOS-QA). When separated 
into the resected vessels (operative PA on POD2 and at 2-months) and the non-
resected vessels (non-operative PA and pre-op operative PA) there was superior 
agreement between the SOS and QA in the non-resected vessels. The bias was 
minimal for the non-resected vessels with good agreement (-0.06m.s-1 [95% CI -
0.30,0.10m.s-1] compared to the agreement in the resected vessels (-0.32m.s-1 
[95% CI -0.78,0.10 m.s-1], (p=0.002, Wilcoxon rank sum test).  
Pulmonary  
artery 
Method Pre-op POD2 2-months p-value 
Operative  SOS  
(m.s-1) 
1.38 (1.28, 1.53) 0.92 (0.73, 1.20) # 0.90 (0.75, 1.06) # <0.001 § 




1.63 (1.29, 1.89) 1.14 (0.85, 1.73) 1.09 (0.93, 1.73) 0.056 § 
n 27 20 21  
QA Linear 
(m.s-1) 
1.64 (1.34, 1.90) 1.34 (0.87, 1.78) 1.36 (1.03, 1.78) 0.165 § 
n 22 13 14  
Non- 
operative   
SOS  
(m.s-1) 
1.29 (1.06, 1.76) 1.60 (1.33, 1.97) # 1.26 (1.11, 1.74) ¥ 0.019 § 




1.45 (1.18, 1.88) 1.74 (1.41, 2.15) 1.47 (1.07, 1.85) 0.101 § 
n 25 21 22  
QA Linear 
(m.s-1) 
1.40 (1.13, 1.80) 1.66 (1.35, 2.00) 1.38 (0.97, 1.76) 0.067 § 





Figure 7-26 Bland-Altmann plots for agreement between methods of wave speed calculations 
Top row, percentage difference between wave speed calculation by sum of squares (SOS) and 
flow – area loop (QA) calculated as (100*(SOS-QA)/SOS) in the PA that had not undergone 
resection (non-resected, left plot) and that had undergone resection (resected, right plot) against 
the mean wave speed (c) of the two measures.  
Bottom row, absolute difference between SOS and QA in the non-resected (left plot) and resected 
(right) against the mean wave speed of the two measures.  
Note greater bias in the resected PAs and that the absolute and percentage differences are related 
to mean wave speed.  
Given the ability of the SOS method to determine wave speed in every vessel 
imaged and the overall agreement between methods, the wave speed results from 





7.5.3 Wave intensity results 
Wave intensity analysis calculation and wave detection was possible in all but the 
six vessels excluded in 7.5.1. In total WIA was performed in 68 operative PAs (27 
pre-op, 20 on POD2 and 21 at 2-months) and 68 non-operative PAs (25 pre-op, 21 
on POD2 and 22 at 2-months).  
7.5.3.1 Forward compression wave 
The time to peak FCW was reduced in both vessels on POD2 only (p<0.008, paired 
t-tests), Table 7-3. Non-operative PA FCW peak WI and area were increased on 
POD2 and 2-months (p<0.003, Wilcoxon signed rank) whilst operative PA FCW area 
was reduced on POD2 and 2-months (p<0.008, Wilcoxon signed rank). Operative 
PA FCW peak WI and FCW area were similar to non-operative PA pre-op (p>0.583, 
Wilcoxon signed rank) but lower on POD2 and at 2months (p<0.002, Wilcoxon 
signed rank) suggesting a differing post-operative distribution between the 
vessels, Figure 7-27.  
Parameter Pulmonary 
artery 
Pre-op POD2 2-months p-value 
Time to peak  
FCW WI (ms) 
Non-
operative  
86.3 (23.7) 72.7 (17.2)# 76.5 (16.9) 0.017 * 
Operative  77.6 (19.1) 63.4 (17.4)# 69.7(21.8)¥ 0.022 * 




































Table 7-3 Forward compression wave results 
Values are mean (SD) or median (IQR). FCW= forward compression wave. WI= wave intensity. *= 
one-way repeated measures ANOVA. §= Friedman’s test. Comparison between time-points paired 
t-test or Wilcoxon signed rank test. #= significant difference from pre-op. ¥= significant difference 





Figure 7-27 Operative and non-operative forward compression wave area  
Forward compression wave (FCW) area of the operative pulmonary artery (PA) (dark grey boxes) 
and non-operative PA (light grey boxes). Operative PA FCW area was decreased on post-
operative day 2 (POD2) and at 2-months whereas non-operative PA FCW area was increased at 
both time points, Wilcoxon signed rank test. Non-operative PA FCW area was not different to 
operative PA pre-operatively (p=0.583) but was greater at both post-operative time points, 
Wilcoxon rank sum test. 
7.5.3.2 Forward expansion wave 
There was no change in the time to peak FEW in the operative PA or non-operative 
PA, Table 7-4. FEW peak WI and area were increased in the non-operative PA on 
POD2 and 2-months (p<0.017, Wilcoxon signed rank test) whereas operative PA 
FEW area was reduced from pre-operatively at 2-months only (p=0.018, Wilcoxon 
signed rank). Similar to the FCW results, there was no difference between 
operative and non-operative PA FEW peak WI and area pre-operatively (p>0.206, 
Wilcoxon) although operative PA WI and area were lower on POD2 and at 2-months 







Pre-op POD2 2-months p-value 
Time to peak  










Operative  282.4 (58.6) 296.6 (70.8) 286.2 (74.8) 0.566 * 




































Table 7-4 Forward expansion wave results 
Values are mean (SD) or median (IQR). FEW= forward expansion wave. WI= wave intensity. *= 
one-way repeated measures ANOVA. §= Friedman’s test. Comparison between time-points paired 
t-test or Wilcoxon signed rank test. #= significant difference from pre-op. ¥= significant difference 
from post-operative day 2 (POD2). Significant results (p<0.05) highlighted bold italics. 
 
Figure 7-28 Operative and non-operative forward expansion wave area  
Forward expansion wave (FEW) area of the operative pulmonary artery (PA) (dark grey boxes) 
than non-operative (light grey boxes). Operative PA FEW area was decreased at 2-months only 
whereas non-operative PA FEW area was increased on post-operative day 2 (POD2) and at 2-
months, Wilcoxon signed rank test. Non-operative PA FEW area was not different to operative PA 
pre-operatively (p=0.206) but was greater at both post-operative time points, Wilcoxon rank sum 
test. 
7.5.3.3 Backward waves 
The backward waves were predominately compression waves in nature at all time 
points except for three BEW pre-operatively, one on POD2, and three at 2-months, 
Table 7-5. There was no difference in the rate of BEW between operative and non-




squared tests). Also, there was no difference over time in the number of BEWs in 
the operative PA or non-operative PA (p>0.223, Cochran test).  
The time to peak BCW was reduced in operative PA post-operatively on POD2 and 
2-months (p<0.005, Wilcoxon signed rank) and was less than the non-operative PA 
at both post-operative time points (p=0.040 and p=0.003 respectively, both 
Wilcoxon rank sum). Unlike the opposing change in FCW and FEW between the 
PAs, non-operative and operative PA BCW peak WI and area were increased on 
POD2 (p<0.033, all Wilcoxon). Only non-operative PA BCW peak WI and area 
remained increased at 2-months (p<0.002, both Wilcoxon), Figure 7-29. BCW area 
in the operative PA was similar in the non-operative PA pre-operatively and on 
POD2 (p=0.558 and p=0.767 respectively, Wilcoxon rank sum) but operative PA 
BCW area appeared reduced at 2-months though this did not reach statistical 
significance (p=0.063 Wilcoxon rank sum).  
Parameter Pulmonary 
artery 







23/25 20/21 20/22 0.223 †  
 
Operative 26/27 20/20 20/21 0.607 † 
Time to peak  
BCW WI (ms) 
Non-
operative  
199.0 (44.3) 171.9 (54.0) 192.9 (43.5) 0.113 * 











































Table 7-5 Backward wave results 
Values are mean (SD) or median (IQR). BCW= backward compression wave. WI= wave intensity. 
†= Cochran test. *= one-way repeated measures ANOVA. §= Friedman’s test. Comparison 
between time-points paired t-test or Wilcoxon signed rank test. #= significant difference from pre-
op. ¥= significant difference from post-operative day 2 (POD2). Significant results (p<0.05) 





Figure 7-29 Operative and non-operative backward compression wave area  
Backward compression wave (BCW) area of the operative pulmonary artery (PA) (dark grey boxes) 
than non-operative (light grey boxes). Operative and non-operative PA BCW area was increased at 
post-operative day 2 (POD2) whereas only non-operative PA BCW area remains increased at 2-
months. The difference between operative and non-operative PA BCW area approaches 
significance at 2-months (p=0.063, Wilcoxon rank sum test). Wilcoxon signed rank test for 
comparisons of the same vessel between time-points. 
7.5.3.4 Wave reflection index 
Wave reflection index reveals that there was an increase in operative PA WRI on 
POD2 and at 2-months (p=0.001 and p=0.026 respectively, Wilcoxon), Table 7-6 
and Figure 7-30. Non-operative PA WRI was unchanged throughout the study. 
Operative PA WRI was greater than non-operative PA only on POD2 (p=0.003, 
Wilcoxon rank sum).  
Parameter Pulmonary 
artery 

















Table 7-6 Wave reflection index results 
Values are median (IQR). WRI= wave reflection index. §= Friedman’s test. Comparison between 
time-points Wilcoxon signed rank test. #= significant difference from pre-op. ¥= significant 





Figure 7-30 Operative and non-operative wave reflection index 
Wave reflection index (WRI) of the operative pulmonary artery (PA) (dark grey boxes) and non-
operative (light grey boxes). Operative PA WRI was increased at post-operative day 2 (POD2) and 
at 2-months. No significant non-operative PA changes. Wilcoxon signed rank test for comparisons 
between time-points and Wilcoxon rank sum test for comparison between vessels at same time-
point. 
7.5.3.5 Distance to reflection site 
The calculated distance to the apparent site of reflection in the operative PA was 
reduced from pre-op on POD2 and at 2-months (p<0.001, Wilcoxon for both). 
Operative PA distance to reflection site was similar to non-operative PA pre-
operatively (p=0.608) but less than the non-operative PA on POD2 and at 2-months 
(p<0.001, all Wilcoxon rank sum), Figure 7-31. 
Parameter Pulmonary 
artery 
Pre-op POD2 2-months p-value 
Distance to  


















Table 7-7 Reflection site distance results 
Values are median (IQR). Both Friedman’s test. Comparison between time-points Wilcoxon signed 
rank test. #= significant difference from pre-op. ¥= significant difference from post-operative day 2 
(POD2). Percentage of flow was calculated from sum of operative and non-operative vessel flow. 





Figure 7-31 Operative and non-operative distance to reflection site 
Distance to the reflection site of the operative pulmonary artery (PA) (dark grey boxes) than non-
operative (light grey boxes). The site of operative PA reflection was reduced at post-operative day 
2 (POD2) and at 2-months. There was no change in the distance to reflection site in the non-
operative PA. Note consistent distance to reflection site in pre-operative PAs and post-operative 
non-operative PAs. Wilcoxon signed rank test for comparisons between time-points and Wilcoxon 





7.5.4 Summary of main results 
Wave intensity analysis could be performed in 136/142 (95.8%) vessels imaged. A 
summary of the main findings are presented in Table 6-11 and in Figure 7-32.  
Parameter Pulmonary artery Pre-op POD2 2-months 
Wave speed (SOS) Non-operative  ­ - 
Operative  ¯ ¯ 
Operative vs non-operative = ¯ ¯ 
FCW area Non-operative  ­­ ­ 
Operative  ¯ ¯ 
Operative vs non-operative = ¯ ¯ 
FEW area Non-operative  ­ ­ 
Operative  - ¯ 
Operative vs non-operative = ¯ ¯ 
BCW area Non-operative  ­ ­ 
Operative  ­ - 
Operative vs non-operative = = = 
WRI  Non-operative  - - 
Operative  ­­ ­ 
Operative vs non-operative = ­ = 
Time to peak BCW Non-operative  - - 
Operative  ¯ ¯ 
Operative vs non-operative = ¯ ¯ 
Distance to reflection  
site 
Non-operative  - - 
Operative  ¯ ¯ 
Operative vs non-operative = ¯ ¯ 
Table 7-8 Summary of changes in blood flow and afterload 
SOS= sum of squares method. FCW= forward compression wave. FEW= forward compression 
wave. BCW= backward compression wave. WRI= wave reflection index. POD2= post-operative 
day 2.  
Comparisons are POD2 vs pre-op and 2-months vs pre-op. - = no change. ¯= less than pre-
operatively. ¯¯= less than pre-operatively and 2-months. ­= greater than pre-operatively ­= 
greater than pre-operatively and 2-months. 
Operative vs non-operative, no difference between measures (=). ¯= operative less than non-





A representative example of the WIA changes following lung resection is displayed 
in Figure 7-32. The WIA plots are displayed for the non-operative (top row) and 
operative PA (bottom row), pre-operatively (left column), on POD2 (middle 
column) and at 2-months (right column) for patient RV1. Net wave intensity is 
plotted by the black line with the forward compression wave area (FCW, blue), 
forward expansion wave area (FEW, green) and backward compression wave area 
(BCW, red) highlighted. As net wave intensity is the sum of the forward and 
backward waves the shaded areas are not bound by the limits of the black line. 
The results for the FCW, BCW and wave reflection index (WRI) are noted on each 
plot. Whilst the results may differ between time points in this example, only 
changes that are significant in analysis of all patients are described below.  
Pre-operatively the FCW area, BCW area and WRI are similar between the 
operative and non-operative PA. The timings of each wave are also similar 
between the vessels. 
On POD2 the FCW area and BCW area in the non-operative PA increases. Both 
increase by a similar ratio therefore WRI is unchanged. In the operative PA FCW 
area is reduced both compared to pre-operatively and the non-operative PA. Note 
the change in the range of the y-axis required in order to visibly display the plot. 
BCW area is increased from pre-operatively therefore WRI is increased. In spite of 
the greater BCW area in the non-operative PA, WRI is only increased in the 
operative PA because of the marked difference in FCW area between the vessels. 
The time to peak BCW is reduced in the operative PA, compared to pre-operatively 
and to the non-operative PA, secondary to a more proximal site of wave reflection. 
Time to peak FCW is marginally reduced whereas time to peak FEW is unchanged.  
At 2-months non-operative FCW area and BCW remain increased, again WRI is 
unchanged as both areas are increased by a similar ratio. Operative FCW area is 
still reduced although BCW area has returned to pre-operative levels. As the FCW 
is reduced WRI remains increased, although to a lesser extent. The time to peak 
BCW remains reduced with an unchanged distance to the site of reflection. Again, 






Figure 7-32 Example of change in wave intensity plots following lung resection 




Wave intensity analysis was successfully performed in 95.8% of pulmonary arteries 
imaged although QA loop wave speed could only be calculated in 76.5% of PAs. 
Post-operatively there is a decrease in FCW, a decrease in wave speed and an 
increase in wave reflection in the operative PA. The wave reflection in the 
operative PA resulted in an earlier BCW potentially from a proximal reflection 
site. Whilst there is an increase in FCW and BCW in the non-operative PA there is 
no increase in wave reflection index.  
7.6.1 Strengths and limitations 
7.6.1.1 Strengths 
This is the first human study to measure the sequential change in wave intensity 
analysis parameters of both pulmonary arteries following lung resection. Whilst 
previous studies have investigated global changes in the steady components of 
afterload (PVR and PAP), WIA allows the assessment of pulsatile afterload in each 
lung. Calculation of WRI allows direct comparison; between each lung in the 
patient at that time point, between time points, and against results from other 
pulmonary WIA studies of varying methodology.  
As WIA is a developing field there are steps in the methodology that vary between 
studies. There is no defined and standardised approach to either filtration of the 
measured data or wave speed calculation. Both may affect the results and 
therefore both parameters were investigated prior to performing WIA. Whilst a 
Savitzky-Golay filter is advised by Parker (who originally described WIA) and is 
used in many studies, its use is not universal and the most appropriate window 
size is dependent on the data collected. As detailed, 4 window sizes were 
compared for balance between maintenance of signal and filtration of noise prior 
to selection of the window size used. Additionally, two differing wave speed 
calculation methods were compared prior to selection of the method subsequently 
used for WIA. 




Although CMR has advantages over PAC (it is non-invasive and allows accurate 
imaging of the LPA and RPA), there are limitations in CMR based WIA compared to 
a PAC based method. PAC measures pressure directly whereas CMR uses area as a 
surrogate; whilst this technique is widely used in WIA, it does introduce a potential 
error secondary to motion artefact351, 358. As such, WIA was not performed in the 
MPA secondary to potential motion artefacts and there were potentially motion 
artifacts in 6/142 (4.2%) scans. 
The spatial and temporal resolution of the CMR data may be limited by the CMR 
protocol. High CMR spatio-temporal resolution requires long breath holds to limit 
motion artefact, patients requiring lung resection would likely be unable to 
complete this even pre-operatively425. Flow imaging was performed during free 
breathing, this can introduce motion artefacts secondary to respiratory movement 
and limit the spatial resolution of the PA wall and therefore area measurement. 
Additionally, the effective temporal resolution was limited to one thirtieth of the 
cardiac cycle, this can fail to detect short lived events such as a BCW or limit the 
accuracy of wave speed calculation, discussed further in Appendix 1. The CMR 
protocol was a pragmatic balance between data acquisition and patient 
experience. An overly long CMR scan time requiring multiple breath holds may 
have prevented completion of the protocol on post-operative scanning.  
7.6.2 Filter selection 
Selection of an appropriate window size for the Savitzky-Golay filter is imperative 
for accurate representation of the underlying data. Too small a window size fails 
to remove the underlying noise and too large a window size removes too much of 
the underlying features of the data426. Whilst selection of filter size based on user 
interpretation of the plots generated, as in this study, is common place427 there 
are numerous methods to calculate the most appropriate window size426, 428, 429. 
Romo-Cárdenas et al. proposed a method based on the Nyquist-Shannon theorem 
(a periodic signal must be sampled at least double the highest frequency of the 
signal). Based on this theorem they state that window size should be calculated 
based on the ‘lobes’ present in the underlying signal426, Equation 7-20. In the flow 
and area plots to which the filter is applied the underlying profile has four lobes 
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(systolic and diastolic peaks and the troughs between them) and 30 data points 
giving a calculated ideal window size of 7, the same as determined by visual 
inspection of the data.  
!"#$%&'( − *+,"(	.$/0+.	1$&2 = 	 0"%"	4+$/%1,+521	$/	0"%"	46+7$,2 
Equation 7-20 Savitzky-Golay window size calculation 
Results rounded to the nearest odd number 
7.6.3 Wave speed 
The wave speed results in this investigation are similar in magnitude to those seen 
in the control groups in the previous CMR based pulmonary artery WIA studies by 
Quail et al.351 and Schafer et al.377 although, in common with these studies, they 
are less than the pulmonary artery catheter work by Su et al.404-406. Of note, wave 
speed decreased post-operatively in the operative PA whereas in all of the above 
studies wave speed is increased in disease, often by at least double. There are 
two broad potential explanations for the reduction in wave speed in the operative 
PA. Either pulmonary vasculature does not stiffen following lung resection during 
the timeframe of this study (this may occur beyond 2-months) or the wave speed 
may be artificially reduced secondary to the influence of proximal wave reflection 
on wave speed calculation. Su et al. demonstrated that increased WRI is present 
in all grades of PAH whereas wave speed increases with increasing severity. They 
conclude that the development of increased WRI occurs early in PAH whilst wave 
speed increases over time with increasing disease severity405, this may 
subsequently occur over time in patients from this study. 
In a PAH population Su et al. also found that “many” of their patients did not have 
a linear segment in the PU loop in early systole although they do not quantify the 
percentage of patients in which this occurs404. Within this study 32/136 (23.5%) of 
scans did not have a distinct linear segment in early systole. There was continuum 
between the obviously non-linear early systolic segments and the perfectly linear 
segments therefore any distinction between non-linear and linear segments is 
subjective. The SOS method eliminates this distinction from interpretation430.  
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The lower agreement between QA loop and SOS wave speed calculation and the 
trend to an increased percentage of non-linear scans in PAs that had undergone 
resection compared to the non-resected PAs suggest that PA ligation and/or 
proximal wave reflection limits the utility of the QA loop in this population. The 
SOS method may however also be influenced by wave reflection and may cause an 
underestimation of wave speed. It is not possible to conclude which method is 
most accurate from this study, particularly following resection. Weir-McCall et al. 
demonstrated that SOS had superior accuracy to QA loop method in a healthy 
volunteer pulmonary artery catheter study431. The primary benefit of the SOS 
method was its ability to calculate wave speed in all cases and was therefore used 
for WIA. 
The impact of inaccuracy of wave speed calculation on WIA has been investigated 
by Qureshi et al.396. They demonstrated that, compared to modelled and loop 
methods, SOS wave speed may result in the creation of a small BCW occurring 
prior to the initial peak in the FCW although it otherwise had minimal effect on 
WIA interpretation396. To mitigate the potential source of error, detection of the 
peak backward wave was confined to occurring after the peak WI of the FCW in 
this investigation presented here. Whilst there were small BCWs or BEWs prior to 
the FCW peak they were not included in the analysis. 
Further discussion on the factors affecting the linear segment of the flow-area 
loop is presented in Appendix 1 page 336. 
7.6.4 Wave intensity results 
Analysis was possible in 136/142 (95.8%) of all scans performed. The six scans 
removed had marked diastolic increases in area with no corresponding change in 
flow within the vessels. These area increases were likely not to be physiological 
but due to motion artefact which also prevents performing WIA in the MPA351, 358. 
The forward travelling waves are determined by the RV, whereas the backward 
waves are determined by the vasculature in which the waves travel, as such 
changes in these waves can respectively be attributed to RV function or to the 
pulmonary vasculature. The relationship between changes in WIA parameters and 
RV function are investigated separately in Chapter 8.  
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Comparison of absolute WI values is only possible between studies which use the 
same methodologyfff, this limits comparison of absolute values to Quail et al.351. 
Given the marked change in FCW area between the operative and non-operative 
PAs on POD2 and at 2-months, this further limits comparison to the pre-operative 
values from this investigation. Median [IQR] FCW area in patients from our study 
(1.54x10-3cm5 [1.10, 2.49 x10-3cm5] was similar to that seen in patients with PAH 
or CTEPH in the study by Quail et al. (2x10-3cm5 [2x10-3cm5]) but less than their 
healthy control group (5x10-3cm5 [3x10-3cm5]). BCWs were present in 129/136 
(94.9%) of scans in our study, the BCW area (0.106x10-3cm5 [0.058, 0.163x10-3cm5]) 
was less than the patient group in Quail et al. (0.4x10-3cm5 [0.6x10-3cm5]) who 
found only BEWs in the control group. The differences between the control group 
of Quail et al. and the pre-operative values in our study may be explained by the 
difference in co-morbidity of patients and their age (67 years [IQR 59.0 – 74.0 
years] vs 47±3 years in Quail et al.) as FCW decreases with age381. 
7.6.4.1 Relationship between wave intensity parameters and cardiac output 
In the systemic circulation, FCW intensity has been shown to increase with 
increased inotropy whereas FEW is unchanged432, however, in the pulmonary 
circulation this relationship has not previously been demonstrated. Total FCW area 
(operative and non-operative PA combined) increases on POD2 with the increase 
in cardiac output (CO) and by 2-months total FCW area and CO are similar to pre-
operatively. Within-subject testing revealed moderate to strong associations 
between the increase total FCW area and the increased in CO and heart rate (HR), 
Table 7-9. Additionally, the average time to peak FCW (average of operative and 
non-operative PA) is negatively associated with CO and HR. There were only weak 
associations between the change in total FEW area and CO and between the 
change in average time to peak FEW and the change in HR. As such, the magnitude 
and timing of the FCW are greatly augmented by the CO and HR, whereas FEW is 
affected to a far lesser extent. This suggests that the changes in timing and 
magnitude of overall FCW on POD2 may reflect the changes in cardiac output and 
heart rate alone. 
 
fff Schafer et al. performed their analysis in a paediatric population and as such indexed the WI 
results to ejected stroke volume. The indexing and age differences prevent direct comparison of 
results.  
Chapter 7 294 
 
 294 
Analysis of covariance, within-subject 
Wave Measure  Cardiac output  Heart rate  
FCW Total Area r 0.611 0.521 
p <0.001 0.001 
Average time to peak r -0.398 -0.664 
p 0.013 <0.001 
FEW 
 
Total Area r 0.383 0.250 
p 0.017 0.131 
Average time to peak r 0.044 -0.334 
p 0.792 0.040 
Table 7-9 Pooled association between cardiac output, heart rate and forward compression 
waves  
FCW= forward compression wave. FEW= forward expansion wave. Analysis of covariance with 
patient as factor. Significant results (p<0.05) highlighted bold italics. 
Post-operatively, the percentage of the CO travelling in the non-operative PA 
increases on POD2 (66.3%±9.52%) and at 2-months (60.9%±11.4%). Similarly, the 
percentage of total FCW travelling in the non-operative PA increases post-
operatively from pre-op (51.4% ±14.2%) to POD2 (69.6%±15.8%) and 2-months 
(67.1%±15.9%) (p<0.001 ANOVA, p<0.001 paired t-test for comparisons between 
pre-op and POD2 and between pre-op and 2-months). The percentage of the total 
FEW travelling in the non-operative PA also increases post-operatively 
(46.0%±15.2% pre-op, 61.9%±17.5% on POD2 and 62.4%±17.4% at 2-months, 
p<0.001 ANOVA, p<0.001 paired t-tests for comparisons between pre-op and POD2 
and between pre-op and 2-months).  
7.6.4.2 Wave reflection results 
Measurement of the BCW area alone would imply that there is increased pulsatile 
afterload in both vessels on POD2 and only in the non-operative PA at 2-months. 
In the pulmonary vasculature the BCW is solely generated by the reflection of the 
incident FCW, it must therefore be measured relative to the FCW, as a wave 
reflection index. In the non-operative PA FCW area and BCW area both increase 
post-operatively although the relative increase is similar and therefore WRI is 
unchanged. In the operative PA FCW area is decreased at both post-op time points 
whilst BCW is increased on POD2 and is similar to pre-op at 2-months. When the 
BCW area is calculated relative to the FCW, it shows increased wave reflection 
occurs at both POD2 and at 2-months in the operative PA, therefore there is 
increased pulsatile afterload in the operative PA following lung resection.  
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Whilst the absolute values of waves calculated in WIA cannot be compared across 
studies of differing methodologies, this is possible with WRI as the numerical and 
unit differences between methodologies are cancelled out in WRI and it can be 
simply calculated from study results. Su et al. calculated median [IQR] WRI for 
each individual patient in the MPA and a branched PA, they demonstrated 
increased WRI (values for branched PA therefore similar to the investigation 
presented) in PAH (24.7% [18.9, 32.6%]) and CTEPH (31.8% [25.8, 36.6%]) vs control 
(6.36% [3.20, 9.09%]). There was no significant difference between the branched 
PA and MPA WRI values in any group405. Though Schäfer et al. and Quail et al. do 
not report WRI, indicative figures can be calculated form the averaged results. 
Schäfer et al. showed an MPA WRI of 36.3% in children with PAH vs 4.6% in 
control377 and Quail et al. demonstrated a WRI of 20% in the patient group and 0% 
in the control group as there were no BCWs351.  
The increase in WRI in our study is comparatively small compared to these results. 
Contrary to the disease processes in the studies detailed above, lung resection 
may produce a purely unilateral change in wave reflection. This may contribute 
to the increased percentage of blood flow through the non-operative PA as blood 
preferentially flows through the lung with least impedance to flow. If both lungs 
were affected equally, then WRI may be higher. As discussed in 2.3 page 84, there 
is evidence of reduced PVreserve on exercise following lung resection48, 49, 68. Any 
increase in the incident FCW in the operative PA with cardiac output increase may 
cause increased WRI and further disproportionately increase blood flow through 
the non-operative PA. As the non-operative PA carries a greater percentage of the 
cardiac output, both at rest and potentially with increases in cardiac output, 
afterload may rapidly increase even if the non-operative pulmonary vasculature 
is healthy. As such the unilateral increase in WRI in the operative PA may be an 
underestimation of the increase in pulsatile afterload. 
7.6.4.3 Distance to site of wave reflection 
The concept of a distinct physical site of wave reflection has been disputed by 
Davies et al.388. This is based on experimental data in the aorta in which the 
reflection site remained a constant distance from the point of measurement as it 
moved distally. If there was a true definitive point of reflection the distance to 
this point would decrease as the measurement point approaches388. Any site of 
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wave reflection distal to the subsequent bifurcation is affected by re-reflection 
of the returning wave as crosses the bifurcation in reverse. This concept has been 
demonstrated by Khir and Parker in a canine study measuring WIA in the ascending 
aorta. Complete occlusion of descending aorta at the diaphragm generated BCWs 
in the ascending aorta, whereas occlusion distal to the renal arteries did not 
generate a discernible BCW. The reflections from a distal site return through a 
greater number of bifurcations at which the returning BCW is re-reflected towards 
the peripheries therefore the energy of the returning BCW is progressively 
diminished433.  
Following lung resection, the site of reflection would logically occur at the 
bifurcation of the PA to the lobar pulmonary artery that has now been ligated. As 
such, the reflected wave would not be significantly affected by re-reflection prior 
to its measurement. In this investigation the apparent site of wave reflection was 
reduced post-operatively in the operative PA to a median of 2.87cm [2.03-
5.22cm], similar to Quail et al. (2-3cm)351. This distance is in keeping with the 
distance from the mid-point of the operative PA (RPA or LPA) to bifurcation to 
lobar pulmonary artery351, 396. Quail et al. do not interpret this reflection site a 
physical point of reflection but an “amalgamation of reflections” as the vascular 
remodelling of the patients with PAH occurs in the microvasculature351. The 
distance in the investigate presented here may however reflect an actual physical 
site of wave reflection, similar to that demonstrated by Khir and Parker433. As the 
post-operative reflected BCW in the operative PA is measured without significant 
(if any) re-reflection this may be the first demonstration of a physical reflection 
site in the pulmonary vasculature in man.  
7.7 Conclusion 
The main finding of this investigation is that there is evidence of increased 
pulsatile afterload in the operative PA following lung resection, measured by an 
increased wave reflection index. This increase is present on POD2 and persists to 
2-months post-op whilst there is no increase in WRI in the non-operative PA. The 
reflection appears to originate from a proximal site potentially correlating with 
the resected branch of the pulmonary artery.  
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Chapter 8 Mechanisms of right ventricular 
dysfunction following lung resection 
In this investigation, association is sought between conventional indices of 
afterload, wave intensity analysis and the changes in RV function demonstrated 
earlier in this thesis. Whilst this will result in multiple comparisons, only 
biologically plausible associations are tested, detailed below with further 
background throughout this thesis. As described by Hill in his seminal 1965 paper; 
any association does not imply causation and interpretation must be based on the 
strength, consistency, temporality and plausibility of the association and 
ultimately prospective experimentation434. Any consistent associations will 
therefore guide further studies into the mechanisms of RV dysfunction following 
lung resection, section 9.3 page 333. As Hill concludes,  
 “All scientific work is incomplete” 
 Hill 1965434. 
The specific rationale for the association testing performed is discussed below. 
8.1 Association testing and hypothesis 
The overarching hypothesis of this thesis is that right ventricular dysfunction 
occurs secondary to an increase in pulsatile afterload following lung resection. In 
Chapter 6 it is hypothesised that the altered distribution of cardiac output (CO) 
occurs secondary to an increase in operative PA pulsatile afterload and may 
therefore be a surrogate marker of afterload. To investigate the relationship 
between the indices of afterload, the altered distribution of cardiac output and 
right ventricular function the following comparisons were performed as below. 
8.1.1 Association between indices of afterload 
Hypotheses, 
• There is an association between the change in WRI and the change in 
PAAT/ET and PA distensibility 
• There shortening of PAAT is temporally related to the BCW. 
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In this thesis three separate indices of afterload are investigated; PAAT (and 
heart-rate corrected PAAT - PAAT/ET), PA distensibility and WRIggg. Association 
testing between WRI and conventional afterload indices (PAAT/ET and PA 
distensibility) are performed to investigate the agreement between different 
indices of pulsatile afterload. In testing the within-subject association between 
WRI and PAAT, heart rate must be considered as a potential confounding factor. 
Sanz et al advise the calculation of PAAT/ET to normalise PAAT to the duration of 
ejection to adjust for heart rate342 therefore PAAT/ET is used for all comparisons. 
Within-subject association testing is performed at all time points to assess if a 
change in WRI is associated with a change in PAAT/ET or PA distensibility. 
Between-subject associations are tested at individual time points to assess the 
associations between indices in each vessel at each time point, as discussed in 
1.2.6.4.2 page 77, the relationship between resistance and compliance may be 
altered by a proximal PA occlusion.  
As a reduction in PAAT is hypothesised to be caused by the arrival of a reflected 
BCW351, association testing was performed between the time of peak of the BCW 
and PAAT. Of note, for results of PAAT described in Chapter 6, the time to peak 
flow was measured from the start of the cardiac cycle, measured from CMR timing 
of the ECG, whereas the BCW was measured from the onset of the FCW. In order 
to remove this potential discrepancy, PAAT timing was calculated form the onset 
of the FCW for the temporal comparisons alone, whilst the comparisons of 
PAAT/ET with WRI are performed on the unadjusted values reported in Chapter 6.  
  
 
ggg The association between PAAT, PAAT/ET and distensibility is investigated in Chapter 6. It 
should be noted that these results are calculated from the same CMR images and therefore the 
same area and flow results. 
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Associations between indices of afterload and cardiac output 
distribution 
Hypothesis, 
• There is an association between the increase in non-operative PA 
percentage of CO and, 
a. the increase in pulsatile afterload in the operative PA 
b. the earlier arrival of and reduced distance to wave reflection 
The distribution of blood flow across a bifurcation is affected by the outflow 
pressure difference between the daughter vessels398. A unilateral increase in 
pulsatile afterload may result in an increase in the percentage of cardiac output 
(percentage.CO) travelling in the contralateral PA. Additionally, the arrival of an 
early BCW during systole may further decrease the forward flow of blood in that 
vessel and therefore may also decrease the percentage.CO travelling in that 
vessel. The within-subject associations between the post-operative changes in 
indices of pulsatile afterload in the operative and non-operative PAs and the post-
operative changes in non-operative PA percentage.CO are sought. As there is 
markedly different CO, heart rate and potentially different mechanisms of 
dysfunction between POD2 and 2-months, within-subject association testing is 
performed separately on the changes between pre-op and POD2 and from pre-op 
and 2-months. The association between the post-operative change in arrival of 
the BCW (distance to reflection site and time to the peak BCW) and the change in 
non-operative PA percentage.CO are also tested.  
Finally, the relationship between the altered distribution of CO and pulsatile 
afterload in the MPA is investigated by the association between the increase in 
non-operative PA percentage.CO and change pulsatile afterload in the MPA 
(PAAT/ET and PA distensibility). 
8.1.2 Associations between indices of afterload and right 
ventricular function 
Hypotheses, 
• Right ventricular dysfunction, measured by changes in RVEF and RV strain, 
is associated with the post-operative increase of,  
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a. pulsatile afterload in the operative and non-operative PAhhh  
b. percentage of CO travelling in the non-operative PA. 
8.1.2.1 Forward compression wave area 
Within-subject testing is performed to assess association between post-operative 
change in FCW area and the change in RV function (RVEF and strain). As the 
percentage of total FCW areaiii travelling in the non-operative PA increased post-
operatively, similar to the increase in non-operative PA percentage.CO, the 
uneven FCW area distribution may also reflect increased operative PA pulsatile 
afterload.  
8.1.2.2 Indices of afterload 
Within-subject testing between the change in WRI and the time to BCW and the 
change in RV function were performed for the operative and non-operative PAs. 
As demonstrated in Chapter 6, there were associations between the increase in 
pulsatile afterload (PAAT/ET and PA distensibility) in the non-operative PA and 
the change in RV function between pre-op and POD2. Although the changes in 
pulsatile afterload are predominately in the operative PA the redistribution of CO 
and an inability of the non-operative PA to accommodate the increased blood flow 
may lead to impaired RV function.  
8.1.2.3 Cardiac output distribution  
The increase in the non-operative PA percentage.CO may be a sign of increased 
operative afterload and may also suggest that the indices of afterload in the 
operative PA are an underestimation of the true increase in pulsatile afterload as 
blood preferentially flows down the path of least resistance (non-operative PA). 
It is therefore hypothesised that an increase in the non-operative PA 
percentage.CO may be associated with impaired RV function.  
 
hhh Association testing between RVEF and PAAT, PAAT/ET and distensibility are performed in 
Chapter 6.  
iii FCW area was chosen over FCW peak based on the work by Quail et al who demonstrated that 
the relative difference in FCW peak between healthy controls and patients with PAH was 
smaller than the relative difference in FCW area351. 




8.2.1 Association between indices of afterload  
8.2.1.1 Association between pulmonary artery acceleration time and wave 
reflection index 
All time point within-subject analysis showed a strong negative associations 
between PAAT/ET and WRI in the operative PA, Table 8-1 and Figure 8-1. There 
was a weak negative association between PAAT/ET and WRI in the non-operative 
PA. In each association an increase in WRI (increase in pulsatile afterload) was 
associated with a decrease in PAAT/ET (increase in pulsatile afterload). Individual 
time point association showed that on POD2 there was a moderate association 
between operative PA WRI and PAAT/ET, Figure 8-2, although there were no other 
significant associations.  
Analysis of covariance, within-subject 
Wave reflection index (%) 
   Operative PA  Non-operative PA 
PAAT/ET (%)  r -0.606 -0.354 
  p <0.001 0.023 
      
Individual time point analysis 
   Operative PA  Non-operative PA 
PAAT/ET (%) Pre-op r 0.185 -0.200 
p 0.356 § 0.339 § 
POD2 r -0.595 0.224 
p 0.005 § 0.329 * 
2-months r -0.179 -0.124 
p 0.436 * 0.592 * 
Table 8-1 Associations between pulmonary artery acceleration time and wave reflection 
index 
PAAT/ET= pulmonary artery acceleration time/ejection time. PA= pulmonary artery. POD2= post-
operative day 2. Analysis of covariance with patient as factor. *= Pearson’s correlation co-efficient. 
§= Spearman’s correlation co-efficient. Significant results (p<0.05) highlighted bold italics. 




Figure 8-1 All time point within-subject association between operative pulmonary artery 
acceleration time and wave reflection index  
Note strong negative associations between pulmonary artery acceleration time corrected for heart 
rate (PAAT/ET) and wave reflection index (WRI) in the operative pulmonary artery (OP.PA). A 
reduction in PAAT/ET is associated with an increase in wave reflection index. Analysis of 
covariance with patient as factor. Coloured dots represent each patient and lines depict parallel 
lines of association for each patient. 
  
Figure 8-2 Association between operative pulmonary artery acceleration time and wave 
reflection index on post-operative day two 
Note strong negative association between operative pulmonary artery (OP.PA) wave reflection 
index and pulmonary artery acceleration time corrected for heart rate (PAAT/ET). Spearman’s 
correlation coefficient. 
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There were consistent moderate to strong positive within-subject and individual 
time point associations between PAAT and the time to the peak backward 
compression wave in the operative and non-operative PAs except for on POD2 in 
the non-operative PA which approached significance (p=0.069), Table 8-2.  
Analysis of covariance, within-subject 
Time to peak backward compression wave (ms) 
   Operative PA  Non-operative PA 
Pulmonary artery acceleration time (ms) r 0.571 0.592 
p <0.001 <0.001 
     
Individual time point analysis 
   Operative PA  Non-operative PA 
Pulmonary artery 
acceleration time (ms) 
Pre-op r 0.603 0.613 
p 0.001 § 0.001 * 
POD2 r 0.662 0.414 
p 0.015 * 0.069 * 
2-months r 0.540 0.786 
p 0.014 § <0.001 * 
Table 8-2 Associations between pulmonary artery acceleration time and time to peak 
backward compression wave 
PAAT= pulmonary artery acceleration time. PA= pulmonary artery. POD2= post-operative day 2. 
Analysis of covariance with patient as factor. *= Pearson’s correlation co-efficient. §= Spearman’s 
correlation co-efficient. Significant results (p<0.05) highlighted bold italics. 
8.2.1.2 Association between pulmonary artery distensibility and wave 
reflection index 
There were no associations between WRI and PA distensibility on within-subject 
analysis or individual time point analysis in any vessel, Table 8-3.  
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Table 8-3 Association between pulmonary artery distensibility and wave reflection index  
PA= pulmonary artery. POD2= post-operative day 2. Analysis of covariance with patient as factor. 
*= Pearson’s correlation co-efficient. §= Spearman’s correlation co-efficient. Significant results 
(p<0.05) highlighted bold italics. 
8.2.2 Association between indices of afterload and cardiac output 
distribution 
8.2.2.1 Indices of afterload 
There were moderate to strong within-subject associations between the change 
in operative PA indices of afterload and the change in non-operative PA 
percentage.CO between pre-op and POD2 and between pre-op and 2-months, 
Table 8-4 and Figure 8-3. All associations consistently showed that an increase in 
operative pulsatile afterload was associated with an increase in the non-operative 
PA percentage.CO. The increase in non-operative percentage.CO was associated 
with a shortening in non-operative PAAT/ET on POD2 and an increased in WRI at 
2-months. These two associations suggest that increased non-operative PA 
percentage.CO was also associated with signs of increased pulsatile afterload 
(reduced PAAT/ET and increased WRI) in the non-operative PA suggesting that it 
may be unable to accommodate the increased blood flow without an increase in 
pulsatile afterload. 
Analysis of covariance, within-subject 
Wave reflection index (%) 
   Operative PA  Non-operative PA 
PA distensibility (%) r -0.191 0.020 
p 0.225 0.901 
  
Individual time point analysis 
   Operative PA  Non-operative PA 
PA distensibility (%) Pre-op r -0.239 0.058 
p 0.251 § 0.774 § 
POD2 r 0.088 0.429 
p 0.705 * 0.059 § 
2-months r -0.151 -0.013 
p 0.513 * 0.956 * 
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Analysis of covariance, within-subject   
Change between pre-op and POD2 
  Operative PA Non-operative PA 









in non-operative  
PA(%)  
r 0.728 -0.657 -0.504 0.046 -0.545 -0.365 
p <0.001 0.001 0.020 0.851 0.011 0.104 
        
Change between pre-op and 2-months 
  Operative PA Non-operative PA 









in non-operative  
PA(%)  
r 0.523 -0.434 -0.295 0.474 0.225 0.250 
p 0.010 0.038 0.171 0.035 0.303 0.249 
Table 8-4 Within-subject association between afterload results and the percentage of 
cardiac output in the non-operative pulmonary artery 
PA= pulmonary artery. Percentage of cardiac output (percentage.CO) calculated as value in non-
operative PA divided by the total in operative and non-operative PA, expressed as a percentage. 
POD2= post-operative day 2. WRI= wave reflection index. PAAT/ET= Pulmonary artery 
acceleration time/ejection time. Analysis of covariance with patient as factor. Significant results 
(p<0.05) highlighted bold italics. 




Figure 8-3 Within-subject association between changes in percentage cardiac output in non-
operative pulmonary artery and operative pulmonary artery afterload 
Within-subject association plots displaying the association between the change in percentage of 
cardiac output (percentage.CO) in non-operative pulmonary artery (NONOP.PA) with indices of 
operative pulmonary artery (OP.PA) afterload. Associations shown for wave reflection index (WRI, 
left column), rate corrected pulmonary artery acceleration time (PAAT/ET, centre column) and PA 
distensibility (right column). Top row is within-subject associations for change between pre-operative 
(pre-op) and post-operative day 2 (POD2), bottom row is within-subject associations for change 
between pre-op and 2-months post-operative. Note increased operative afterload is generally 
associated with increased non-operative percentage.CO. Analysis of covariance with patient as 
factor. Coloured dots represent each patient and lines depict parallel lines of association for each 
patient. 
There was a strong within-subject association between the change in non-
operative percentage.CO and the change in main PAAT/ET between pre-op and 
POD2, an increase in non-operative percentage.CO was associated with a 
shortening in PAAT/ET, Table 8-5 and Figure 8-4. This suggests that the increase 
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in non-operative PA percentage.CO was associated with increase pulsatile 
afterload in the MPA on POD2. There were no other associations between MPA 
indices of afterload and non-operative percentage.CO.  
Analysis of covariance, within-subject 
Change between pre-op and POD2 
  MPA 
  PAAT/ET (%) PA distensibility (%) 
Percentage.CO in non-operative PA(%) r -0.621 0.231 
p 0.003 0.426 
 
Change between pre-op and 2-months 
  MPA 
  PAAT/ET (%) PA distensibility (%) 
Percentage.CO in non-operative PA(%) r -0.035 -0.055 
p 0.874 0.839 
Table 8-5 Within-subject association between main pulmonary artery indices of pulsatile 
afterload and the percentage of cardiac output in the non-operative pulmonary artery 
PA= pulmonary artery. MPA= main PA. PAAT/ET= Pulmonary artery acceleration time/ejection 
time. Percentage of cardiac output (percentage.CO) calculated as value in non-operative PA 
divided by the total in operative and non-operative PA, expressed as a percentage. POD2= post-
operative day 2. Analysis of covariance with patient as factor. Significant results (p<0.05) 
highlighted bold italics. 
 
Figure 8-4 Within-subject association between changes in percentage cardiac output in non-
operative pulmonary artery and main pulmonary artery acceleration time 
Within-subject association plot displaying the association between the change in percentage 
cardiac output in non-operative pulmonary artery (NONOP.PA) and change in rate corrected 
pulmonary artery acceleration time (PAAT/ET) in the main pulmonary artery between pre-op and 
POD2. Note increased non-operative percentage.CO is associated with a reduction in PAAT/ET. 
Analysis of covariance with patient as factor. Coloured dots represent each patient and lines depict 
parallel lines of association for each patient. 
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8.2.2.2 Wave reflection site and timing 
There were moderate to strong within-subject associations in the operative PA 
between the change in distance to reflection site, the time to peak BCW and non-
operative PA percentage.CO between pre-op and both post-operative time points. 
In each comparison more proximal and earlier of wave reflection in the operative 
PA was associated with an increase in the percentage.CO in the non-operative PA, 
Figure 8-5. There were no significant associations between the distance to 
reflection site or time to peak BCW and cardiac output distribution in the non-
operative PA. 
Analysis of covariance, within-subject 
Change between pre-op and POD2 
  Operative PA Non-operative PA 
  Distance to 
reflection site 
(cm) 





Time to peak 
BCW (ms) 
Percentage.CO  
in non-operative  
PA(%) 
r -0.560 -0.653 0.463 -0.266 
p 0.010 0.002 0.061 0.302 
 
Change between pre-op and 2-months 
  Operative PA Non-operative PA 
  Distance to 
reflection site 
(cm) 





Time to peak 
BCW (ms) 
Percentage.CO  
in non-operative  
PA(%) 
r -0.671 -0.594 0.175 -0.313 
p 0.001 0.006 0.518 0.238 
Table 8-6 Within-subject association between distance to reflection site, time to peak 
backward compression wave and the percentage of cardiac output in the non-operative 
pulmonary artery 
PA= pulmonary artery. Percentage of cardiac output (percentage.CO) calculated as value in non-
operative PA divided by the total in operative and non-operative PA, expressed as a percentage. 
BCW= backward compression wave. POD2= post-operative day 2. Analysis of covariance with 
patient as factor. Significant results (p<0.05) highlighted bold italics. 




Figure 8-5 Within-subject association between percentage cardiac output in non-operative 
pulmonary artery and distance to operative pulmonary artery reflection site 
Within-subject association plots displaying the association between the change in percentage of 
cardiac output (percentage.CO) in non-operative pulmonary artery (NONOP.PA) and the distance 
to the reflection site in the operative pulmonary artery. Change between pre-operative (pre-op) and 
post-operative day 2 (pre-op and POD2, left plot) and between pre-op and 2-months (right plot). 
Note increased non-operative percentage.CO is associated with a reduction in the distance to site 
of reflection. Analysis of covariance with patient as factor. Coloured dots represent each patient 
and lines depict parallel lines of association for each patient. 
8.2.3 Associations between indices of afterload and right 
ventricular function 
8.2.3.1 Forward compression wave 
Between pre-op and POD2 there was a moderate negative within-subject 
association between the change in operative PA FCW area and the change in 
RVGLS.S (r=-0.545) whilst the association between the change in non-operative 
FCW area and the change in RVGLS.S also approached significance (r=0.453, 
p=0.068) although the direction of association was the opposite, Table 7-9. The 
association between the change in FCW area in the operative PA and the change 
in RVEF also approached a positive significance (p=0.051) between pre-op and 
POD2jjj. Similarly, between pre-op and 2-months, the association between the 
change in RVGLS and the change in operative FCW area was negative whereas the 
association between RVGLS and non-operative PA FCW area was positive, Figure 
 
jjj Strain is a negative value, therefore in impaired strain the numerical value of strain increases 
whereas in impaired RVEF the numerical value decreases, this results in opposing directs of 
association between a parameter that impairs RV function and strain or RVEF. For example if 
an increase in an index of afterload results in impaired RV function the association will be 
positive for strain and negative for RVEF.  
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8-6. Also, there were opposing directions of associations (or trends to association, 
p<0.062) for RVEF, RVGLS.FW and RVGLS.S. In each comparison, an increase in 
non-operative PA FCW area or a decrease in operative PA FCW area were 
associated with a decrease in RV function.  
Table 8-7 Within-subject associations between forward compression wave area and indices 
of right ventricular function 
FCW= forward compression wave. PA= pulmonary artery. RVEF= right ventricular ejection fraction. 
RVGLS= right ventricular global longitudinal strain. RVGLS.FW= free wall RVGLS. RVGLS.S= 
septal RVGLS. POD2= post-operative day 2. Analysis of covariance with patient as factor. 
Significant results (p<0.05) highlighted bold italics. 
Analysis of covariance, within-subject 
Change between pre-op and POD2 
  RVEF (%) RVGLS (%) RVGLS.FW 
(%) 
RVGLS.S (%) 




r 0.431 -0.364 -0.178 -0.545 
p 0.051 0.137 0.510 0.019 
Non-operative  
PA 
r -0.313 0.413 0.119 0.453 
p 0.179 0.099 0.673 0.068 
      
Change between pre-op and 2-months 
  RVEF (%) RVGLS (%) RVGLS.FW 
(%) 
RVGLS.S (%) 




r 0.416 -0.504 -0.450 -0.460 
p 0.060 0.028 0.053 0.047 
Non-operative  
PA 
r -0.507 0.596 0.568 0.450 
p 0.019 0.009 0.014 0.061 




Figure 8-6 Within-subject association between forward compression wave area and right 
ventricular global longitudinal strain, between pre-operative and 2-months  
Within-subject association plots between the change operative pulmonary artery (PA) forward 
compression wave area (FCW area) (left), the change in non-operative pulmonary artery FCW 
area (right) against right ventricular global longitudinal strain (RVGLS) between pre-op and 2-
months. Note negative association for operative PA and positive association in non-operative PA. 
Analysis of covariance with patient as factor. Coloured dots represent each patient and lines depict 
parallel lines of association for each patient. 
8.2.3.2 Indices of afterload 
8.2.3.2.1 Wave reflection index 
There was a moderate negative association between the change in operative PA 
WRI and the change in RVEF between pre-op and POD2 although there were no 
other associations between these time points, Table 8-8. Between pre-op and 2-
months, there were strong positive within-subject associations between the 
change in non-operative PA WRI and the changes in RVGLS, RVGLS.S and RVGLS.FW 
whilst the change in WRI in the operative PA had a moderate positive association 
with the change in RVGLS.FW and approached significance with the change in 
RVGLS (p=0.053), Figure 8-7. In each association an increase in WRI was associated 
with an impairment in RV strain.  
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Analysis of covariance, within-subject 
Change between pre-op and POD2 
  RVEF (%) RVGLS (%) RVGLS.FW (%) RVGLS.S (%) 
WRI (%)  Operative  
PA 
r -0.480 0.015 -0.174 0.224 
p 0.028 0.952 0.518 0.329 
Non-operative  
PA 
r -0.024 0.337 0.311 0.229 
p 0.920 0.186 0.124 0.378 
      
Change between pre-op and 2-months 
  RVEF (%) RVGLS (%) RVGLS.FW (%) RVGLS.S (%) 
WRI (%)  Operative  
PA 
r -0.070 0.450 0.487 0.282 
p 0.763 0.053 0.035 0.242 
Non-operative  
PA 
r -0.268 0.702 0.745 0.553 
p 0.240 0.001 <0.001 0.017 
Table 8-8 Within-subject associations between wave reflection index and indices of right 
ventricular function 
PA= pulmonary artery. WRI= wave reflection index. RVEF= right ventricular ejection fraction. 
RVGLS= right ventricular global longitudinal strain. RVGLS.FW= free wall RVGLS. RVGLS.S= 
septal RVGLS. POD2= post-operative day 2. Analysis of covariance with patient as factor. 
Significant results (p<0.05) highlighted bold italics. 




Figure 8-7 Within-subject association between the change in wave reflection index and the 
change in right ventricular longitudinal strain between pre-operative and 2-months 
Within-subject association plots displaying the association between the change in wave reflection 
index (WRI) and the change right ventricular longitudinal strain (RVGLS, top row) and free wall 
RVGLS (RVGLS.FW, bottom row) between pre-op and 2-months in the operative pulmonary artery 
(OP.PA, left column) and non-operative PA (NONOP.PA, right column). Note strong positive 
associations between the increase in pulsatile afterload (WRI) and impaired RV strain (less 
negative strain) in the non-operative PA. Analysis of covariance with patient as factor. Coloured 
dots represent each patient and lines depict parallel lines of association for each patient.  
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The within-subject associations between the change in PAAT/ET, PA distensibility 
and the change in RVEF are presented separately in section 6.4.5 page 210.  
There were no consistent associations between the change in operative or non-
operative PAAT/ET or PA distensibility and the change in RV strain except a 
moderate negative association between the change in operative PA distensibility 
and the change in RVGLS.S between pre-op and POD2 (r=-0.508, p=0.031, ANCOVA 
with patient as factor). In this association an increase in pulsatile afterload 
(reduction in PA distensibility) was associated with impaired RVGLS.S. There were 
no with-subject associations between PAAT/ET or PA distensibility in the MPA and 
RV function (p>0.059). 
8.2.3.2.2 Time to peak backward compression wave 
There were moderate positive within-subject association between the change in 
time to peak BCW and change in RVEF in the operative and non-operative PAs 
between pre-op and POD2, Table 8-9. When corrected for heart rate, (divided by 
ejection time similar to PAAT/ET) neither of the associations retained 
significance. There was however a moderate positive association between the 
change in time to peak BCW in the operative PA between pre-op and 2-months 
and the corresponding change in RVEF, this retained significance when corrected 
for heart rate. An early BCW in the operative PA was associated with a reduction 
in RVEF. There were no within-subject associations between the change in time 
to peak BCW (p>0.053) or to time to peak BCW/ET (p>0.077) and the change in RV 
strain. 
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Table 8-9 Within-subject associations between time to peak backward compression wave 
and indices of right ventricular function 
PA= pulmonary artery. BCW= backward compression wave. BCW/ET= BCW normalised for heart 
rate. RVEF= right ventricular ejection fraction. POD2= post-operative day 2. Analysis of covariance 
with patient as factor. Significant results (p<0.05) highlighted bold italics. 
8.2.3.3 Cardiac output distribution  
There were moderate and strong associations between the change in non-
operative PA percentage.CO and the change in RVEF between pre-op and both 
post-operative time points, Table 8-10. In each association, an increased non-
operative PA percentage.CO was associated with a decreased RVEF, Figure 8-8.  
Analysis of covariance, within-subject 
Change between pre-op and POD2 
  RVEF (%) RVGLS (%) RVGLS.FW (%) RVGLS.S (%) 
Percentage.CO  
in non-operative  
PA(%) 
r -0.545 0.367 -0.087 0.500 
p 0.011 0.134 0.748 0.035 
      
Change between pre-op and 2-months 
  RVEF (%) RVGLS (%) RVGLS.FW (%) RVGLS.S (%) 
Percentage.CO  
in non-operative  
PA(%) 
r -0.634 0.471 0.540 0.335 
p 0.002 0.042 0.017 0.161 
Table 8-10 Within-subject association between right ventricular function and the percentage 
of cardiac output in the non-operative pulmonary artery 
PA= pulmonary artery. Percentage of cardiac output (percentage.CO) calculated as value in non-
operative PA divided by the total in operative and non-operative PA, expressed as a percentage. 
RVEF= right ventricular ejection fraction. RVGLS= right ventricular global longitudinal strain. 
RVGLS.FW= free wall RVGLS. RVGLS.S= septal RVGLS. POD2= post-operative day 2. Analysis 
of covariance with patient as factor. Significant results (p<0.05) highlighted bold italics. 
Analysis of covariance, within-subject     
Change between pre-op and POD2     
 RVEF (%)   RVEF (%) 

















p 0.018 p 0.097 
        
Change between pre-op and 2-months     
 RVEF (%)   RVEF (%) 

















p 0.967 p 0.580 




Figure 8-8 Within-subject association between percentage cardiac output in non-operative 
pulmonary artery and right ventricular ejection fraction 
Within-subject association plots displaying the association between the change in percentage of 
cardiac output (percentage.CO) in non-operative pulmonary artery (NONOP.PA) and the change in 
right ventricular ejection fraction (RVEF). Comparison demonstrated are between pre-operative 
and post-operative day 2 (pre-op and POD2, left plot) and pre-op and 2-months (right plot). Note 
negative association in each comparison, i.e. increased percentage.CO in the non-operative PA is 
associated with reduced RVEF. Analysis of covariance with patient as factor. Coloured dots 
represent each patient and lines depict parallel lines of association for each patient. 
Within-subject testing showed differing changes in strain between pre.op and 
POD2 and between pre.op and 2months, Table 8-10 and Figure 8-9. Between pre-
op and POD2 there was a moderate positive within-subject association between 
the change in the non-operative PA percentage.CO and the change in RVGLS.S, an 
increase in the percentage of cardiac output travelling in the non-operative PA 
was associated with a reduction in RVGLS.S (less negative i.e. poorer RV function). 
There was no association between non-operative PA percentage.CO and RVGLS.FW 
or RVGLS at this point. Conversely, between pre-op and 2-months there was a 
moderate positive association between the change in non-operative PA 
percentage.CO and the change in RVGLS.FW and RVGLS with no association 
between non-operative PA percentage.CO and RVGLS.S at this point.  




Figure 8-9 Within-subject association between percentage cardiac output in non-operative 
pulmonary artery and right ventricular longitudinal strain 
Within-subject association plots displaying the association between the change in percentage of 
cardiac output (percentage.CO) in non-operative pulmonary artery (NONOP.PA) and the change in 
right ventricular longitudinal strain (RVGLS) in the free wall (RVGLS.FW, left side) and septum 
(RVGSL.S, right side).Top row is within-subject association between pre-operative (pre-op) and 
post-operative day 2 (POD2), bottom row is between pre-op and 2-months post-operative. Note 
positive association at pre-op and POD2 in RVGLS.S only whereas between pre-op and 2-months 
there is a positive association in RVGLS.FW only. Analysis of covariance with patient as factor. 
Coloured dots represent each patient and lines depict parallel lines of association for each patient. 
8.2.4 Summary of main results 
Increased indices of pulsatile afterload in the operative PA were associated with 
an increase in the non-operative PA percentage.CO, i.e. increased operative 
pulsatile afterload was associated with a diversion of blood towards the non-
operative PA, Table 8-11. The increase in non-operative PA percentage.CO was 
associated with increased non-operative afterload, increased PAAT/ET at POD2 
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and increased WRI at 2-months, suggesting that non-operative PA may not be able 
to accommodate the increase in post-operative blood flow.  
Summary of within-subject association testing  












reflection site (cm) 





Operative  + + + - - - - -  - -  - - - 
Non- 
operative  




Operative  + + - -  - - -  - -  
Non- 
operative  
+ +     
Table 8-11 Summary of associations between the change percentage of cardiac output in 
the non-operative pulmonary artery and indices of afterload 
+/+ +/+ + += weak/moderate/strong positive association. -/- -/- - - = weak/moderate/strong negative 
association. Blank= no association. Percentage of cardiac output (percentage.CO) calculated as 
value in non-operative PA divided by the total in operative and non-operative pulmonary artery, 
expressed as a percentage. POD2= post-operative day 2. WRI= wave reflection index. PAAT/ET= 
Pulmonary artery acceleration time/ejection time. BCW= backward compression wave. 
The within-subject associations between the change in indices of pulsatile 
afterload, non-operative PA percentage.CO and indices of RV function are 
summarised in Table 6-11. Between pre-op and POD2 there was a moderate 
association between increase in operative PA WRI and decrease in RVEF. There 
were also consistent associations between the increase in non-operative PA WRI 
and impaired RV strain between pre-op and 2-months, suggesting that if the non-
operative PA cannot accommodate the increased blood flow, then impaired RV 
strain develops. Additionally, between pre-op and 2-months there were consistent 
associations between non-operative PA percentage.CO and RV strain, in each 
association increased non-operative PA percentage.CO resulted in impaired RV 
strain. Finally, there was moderate and strong associations between the increase 
in non-operative percentage.CO and reduction in RVEF between pre-op and POD2 
and between pre-op and 2-months. 





Parameter Pulmonary artery RVEF RVGLS RVGLS.FW RVGLS.S 
Pre-op and  
POD2 
WRI Operative  - -     
Non-operative      
Time to peak  
BCW/ET 
Operative      
Non-operative      
PAAT/ET Operative      
Non-operative  +    
PA distensibility Operative  + +   - - 
Non-operative  + +    
Percentage.CO Non-operative  - -   + + 
       
Pre-op and  
2-months 
 
WRI Operative    + +  
Non-operative   + + + + + + + + 
Time to peak  
BCW/ET 
Operative  ++    
Non-operative      
PAAT/ET Operative      
Non-operative      
PA distensibility Operative      
Non-operative      
Percentage.CO Non-operative  - - - + + + +  
Table 8-12 Summary of changes in wave intensity analysis parameters, blood flow 
distribution and indices of right ventricular function 
+/+ +/+ + += weak/moderate/strong positive association. -/- -/- - - = weak/moderate/strong negative 
association. Blank= no association. BCW= Backward compression wave. RVEF= right ventricular 
ejection fraction. RVGLS= right ventricular global longitudinal strain. RVGLS.FW= free wall 
RVGLS. RVGLS.S= septal RVGLS. POD2= post-operative day 2. Percentage.CO= percentage of 
cardiac output. NB Impaired strain results in an increase in value whereas impaired RVEF results 
in a decrease in its value. The association are therefore in the opposite direction if both RVEF and 
strain are both impaired by the same factor. 
8.3 Discussion  
This is the first study to demonstrate the hypothesised association between 
increased afterload and RV dysfunction following lung resection. Post-operatively 
the increase in pulsatile afterload in the operative PA diverts blood flow through 
the non-operative PA resulting in increased non-operative percenage.CO and, if 
the non-operative PA is unable to accommodate the increased flow, increased 
non-operative pulsatile afterload. On POD2, reduced RVEF is associated with 
increased pulsatile afterload in both operative and non-operative PAs and the 
increase in non-operative PA percentage.CO whereas RVGLS is unchanged. At 2-
months, reduced RVEF is again associated with increased non-operative PA 
percentage.CO and impaired RVGLS has developed secondary to an increase in 
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non-operative PA WRI and PA percentage.CO. It is argued that these associations 
are ultimately caused by the increase in operative PA pulsatile afterload. 
8.3.1 Strengths and limitations 
This is the first study to assess the sequential change in both pulmonary artery 
wave intensity analysis and perform CMR assessment of RV function following a 
lung resection. The design of this study allows within-subject association testing 
between the change in WIA parameters and the change in RV function from pre-
operative into the immediate and medium term post-operative period following 
lung resection demonstrating, for the first time, the hypothesised associations 
between RV function and afterload.  
Additionally, this is the first study to perform paired investigations of PA WIA and 
RV strain in any population. As demonstrated in Chapter 5 there is a delayed 
reduction in RVGLS and RVGLS.FW by 2-months following lung resection. Within-
subject analysis allows association testing between measures of WIA and RV strain 
to describe the potential mechanisms of this delayed reduction in RVGLS and 
RVGLS.FW.  
Finally, as this study performs assessment of blood flow in the operative and non-
operative PAs, it not only allows assessment of unilateral afterload changes but 
also allows investigation of the distribution of the cardiac output between vessels. 
A unilateral increase in afterload will divert blood to the contralateral PA and so 
an increase in non-operative percentage.CO may be a composite measure of 
increased afterload and may result in impaired RV function, it may also be further 
influenced by afterload in the non-operative PA.  
A limitation of the investigations detailed in this chapter is that the association 
testing performed results in multiple comparisons. Only biologically plausible 
association tests are performed in order to limit the number of comparisons, 
although there remains a significant risk of type 1 error. To limit the impact of 
this risk the interpretation of the results is based on the strength, consistency, 
temporality and plausibility of the results as per Hill, detailed in the introduction 
of this chapter, page 297434. Ultimately the results of this investigation (and those 
detailed in Chapters 5, 6 and 7) are used to guide further investigations detailed 
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later in section 9.3, Appendix 2 and Appendix 3. As such the interpretation of the 
results of this thesis will be tested by prospective experimentation.  
8.3.2 Association between indices of afterload 
Wave intensity analysis predominately assesses the pulsatile components of 
afterload, in particular wave reflection151. All studies that have performed 
association testing between PVR and BCW or WRI have shown there is no 
relationship between these measures351, 377, 406; therefore WRI is described a 
measure of the components of afterload that are distinctly separate to PVR151.  
Quail et al demonstrated that the characteristic “notched” flow pattern seen in 
CTEPH353, discussed in 6.1.2 page 196, occurs when BCW intensity exceeds FCW 
intensity351. In the investigation presented in this chapter, there were moderate 
to strong associations between the time to peak BCW and PAAT in the operative 
and non-operative vessels. In the operative PA, the strong association between 
PAAT/ET and WRI suggests both indices change with increased wave reflection. 
The weak association observed in the non-operative PA, however, may be due to 
lower WRI in that vessel. As PAAT and therefore PAAT/ET are measured from the 
time to peak flow, they will still be measured even if there is not a significant 
BCW, as such PAAT/ET may only be reduced and associated with WRI in the 
presence of a BCW. This is also suggested in the individual time point associations, 
the only associations between PAAT/ET and WRI occurs on POD2 in the operative 
PA, when WRI is highest. 
There were no associations between WRI and PA distensibility. Similar to PVR, PA 
distensibility may represent a component of afterload distinctly separate to wave 
reflection, namely the compliance of vessels. No other study has compared PA 
distensibility and WRI.  
8.3.3 Associations between indices of afterload and cardiac 
output distribution 
As demonstrated in Chapter 6, the non-operative PA percentage.CO increases 
post-operatively. Whilst there is an obvious physiological requirement for an 
increase in CO distribution to the now larger (relative to operative) non-operative 
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lung, the factors that dictate this change in flow highlight the impact of post-
operative changes in the pulmonary arterial afterload.  
Boumpouli et al performed a computational model study of the factors that affect 
the distribution of blood flow at the bifurcation of the MPA398, discussed further 
in 7.2.4.6 page 249. Although their study is based on modelling patterns of PA flow 
following surgical repair of tetralogy of Fallot, the factors affecting distribution 
of CO are potentially universal. In their model, the percentage of cardiac output 
that travels in a daughter vessel is decreased when that vessel has a higher outflow 
pressure (unilateral increase in afterload), a smaller cross-sectional area, a longer 
distance to subsequent bifurcation or a higher angle of take-off from the MPA 
compared to the other daughter vessel. Following lung resection, increases in 
indices of pulsatile afterload in the operative PA are consistently associated with 
the increase of the percentage.CO in the contralateral non-operative PA, similar 
to the model by Boumpouli et al. Of note, their model only simulates non-pulsatile 
flow, therefore does not take into account either the magnitude or timing of wave 
reflection398. As demonstrated in Table 8-6, in this current study, there were 
moderate to strong negative associations between the changes in distance to and 
timing of wave reflection and non-operative percentage.CO. It is therefore argued 
that the change in distribution of CO following lung resection is secondary to 
increased pulsatile afterload, from a proximal reflection site, in the operative PA. 
The only prior consistent evidence of increased afterload following lung resection 
can be found in longer term follow-up (4 years) and exercise studies which reveal 
increases in PVR and MPAP49, 67, 68. Following lung resection, the non-operative PA 
may be able to accommodate this increase in blood flow at rest and therefore 
MPAP and PVR do not change. This ability may reduce over time or be insufficient 
with increased cardiac output during exercise. In the investigation presented 
here, there is evidence of both situationskkk. On POD2 there is an increase in 
overall CO from pre-op (21%), with a greater relative increase in non-operative PA 
 
kkk The association between increased operative PA pulsatile afterload and increased non-
operative PA percentage.CO is interpreted as the increased operative PA pulsatile afterload 
diverts blood flow through the non-operative PA, as per Boumpouli et al. whereas the 
association between increased non-operative PA pulsatile afterload and increased non-
operative PA percentage.CO is interpreted as the increased blood flow results in increased non-
operative PA pulsatile afterload, as the non-operative PA is unable to accommodate the 
increased blood flow. 
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CO (67%), and there is a reduction in PAAT/ET in the non-operative PA. At 2-
months the overall CO is similar to pre-op although non-operative PA WRI is 
increased with increased non-operative PA percentage.CO. Pulsatile afterload 
may therefore increase in the non-operative PA over time and on exercise 
following lung resection. 
Although MPA WIA could not be performed, there is evidence of increased wave 
reflection in the MPA in the setting of increased CO on POD2. The strong negative 
association between increased non-operative percentage.CO and main PAAT/ET 
suggests that an increase in operative PA pulsatile afterload results in wave 
reflection in the MPA (shortened PAAT/ET in the MPA). There are similar within-
subject associations between main PAAT/ET and the changes in operative PA; WRI 
(r=-0.614, p=0.003), distance to reflection site (r=0.616, p=0.003) and time to 
peak BCW (r=0.582, p=0.006, all ANCOVA with patient as factor) between pre-op 
and POD2. None of these associations is present between pre-op and 2-months. 
Similar to the associations between RVEF, BNP and non-operative indices of 
afterload between pre-op and POD2, 6.6.2 page 222, this may be a purely peri-
operative relationship or it may persist post-operatively were the patient 
challenged by an increase in CO. 
8.3.4 Associations between indices of afterload and right 
ventricular function  
8.3.4.1 Forward compression wave 
The FCW is generated by RV contraction. Quail et al show that FCW area is 
associated with RVEF (r=0.65, p=0.002) although they do not describe if the 
association is in their control group, patients with pulmonary hypertension or both 
groups combined351. Other studies have failed to replicate this finding. In a 
paediatric population, Schafer et al found no association between peak FCW and 
RVEF377 whilst Su et al did not find any association between FCW (area or peak) 
and RV fractional area change405, 406. Operative and non-operative within-subject 
associations are in opposing directions, decreased RVEF is associated with 
increased FCW area in the non-operative PA but it is associated with decreased 
FCW area in the operative PA. This may be due to the uneven distribution of CO 
following lung resection, discussed below.  
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8.3.4.2 Wave reflection index 
Previous studies investigating increased afterload following lung resection have 
measured PA pressures and/or PVR in the MPA, failing to show any increase at rest 
following resection48, 49, 58-69. These indices are incomplete measures of afterload 
and not only overlook the pulsatile components of afterload103 but may fail to 
detect a unilateral increase in afterload398. WIA overcomes both of these issues 
by assessment of pulsatile afterload (WRI) in the operative and non-operative PAs. 
In all of the WIA studies in the pulmonary system, detailed in 7.2.5 page 250, there 
is a shared hypothesis that an increase in wave reflection (measured by BCW area 
or WRI) is responsible for impaired RV function. Only Schafer et al have shown an 
association between BCW and RVEF (r=0.41, p=0.017)377, neither Quail et al351 or 
Su et al405, 406 replicated this finding. In the current study, there was a within-
subject association between the change in operative PA WRI and the change in 
RVEF between pre-op and POD2, suggesting that increased WRI impairs RVEF at 
this time point, although there was no association between the parameters 
between pre-op and 2-months. 
The consistent positive within-subject associations observed between the change 
in RV strain and the change in WRI between pre-op and 2-months suggest that 
increased WRI results in impaired RV strain. Interestingly, the associations are 
stronger for non-operative PA than for operative PA suggesting that it is an 
increase in pulsatile afterload in the non-operative PA, rather than the operative 
PA, that is associated in the development of impaired RV strain by 2-months. This 
is similar to the within-subject associations between the change in non-operative 
pulsatile afterload (PAAT/ET and distensibility) and the change in RVEF and BNP 
between pre-op and POD2, see 6.4.5 page 210.  
8.3.4.3 Cardiac output distribution  
The opposing within-subject associations between the change in RV function and 
changes in FCW area in the operative and non-operative PAs seem counter-
intuitive, as a decrease in RVEF is associated with both an increase and a decrease 
in FCW area in the non-operative and operative PA respectively. Additionally, the 
associations between indices of non-operative pulsatile afterload and RV function 
initially appear contrary to the hypothesised relationship between an increase in 
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pulsatile afterload in the operative and a decrease in RV function detailed in 
8.1.2. Both of these patterns can be explained by the post-operative change in 
distribution of CO between the operative and non-operative PAs. Similar to the 
change in cardiac output distribution, the percentage of the total FCW travelling 
in the non-operative PA increases post-operatively. The increases in the two 
indices are strongly associated (r=0.765, p<0.001, between all-time points, 
ANCOVA with patient as factor) and are mathematically linked, the FCW is 
calculated from the change in blood flow. Within-subject association testing 
reveals that there are moderate to strong associations between an increase in the 
non-operative PA percentage.CO and impairment of RV function post-operatively.  
This comparison reveals the potential mechanisms of reduced RVEF following lung 
resection demonstrated by McCall et al232 and detailed in Chapter 4. The 
consistent within-subject associations between the change in RVEF and the 
increase in pulsatile afterload in both the operative PA (WRI, distensibility), the 
non-operative PA (PAAT/ET and distensibility) and the increase in non-operative 
PA percentage.CO between pre-op and POD2 imply that the POD2 reduction in 
RVEF is predominately caused by an increase in pulsatile afterload.  
The reduction at 2-months is strongly associated with the increase in non-
operative PA percentage.CO which in turn is associated with operative PA pulsatile 
afterload. Whilst, unlike the reduction in RVEF between pre-op and POD2, there 
are no associations between the change in indices of operative PA pulsatile 
afterload and the change in RVEF between pre-op and 2-months this may be 
secondary to the overall decrease in and change in distribution of CO. At 2-months 
the operative PA shows a relatively modest increase in pulsatile afterload but a 
reduction in percentage.CO. Compared to POD2, there is lower operative PA wave 
reflection (increased PAAT/ET and reduced WRI) at 2-months although there is no 
change in the absolute value of cardiac output travelling in the operative PA. At 
a lower CO the redistribution of CO through the non-operative PA may mask the 
true increase in operative PA pulsatile afterload by conventional indices. As 
described by the concept of reduced PVreserve, detailed in 1.2.6.2 page 71, an 
increase in CO (similar to POD2) may unmask a further rapid increase in operative 
PA afterload which may then be associated with a reduction in RVEF.  
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The reduction in RVGLS at 2months may also contribute to reduced RVEF. As 
demonstrated in Chapter 5, RVGLS.S decreases on POD2 whereas there is a 
delayed reduction in RVGLS and RVGLS.FW at 2-months. Between pre-op and 2-
months there were moderate to strong positive within-subject associations 
between the change in non-operative PA WRI and the impairment of RVGLS and 
RVGLS.FW. There were similar associations between the increase in non-operative 
PA percentage.CO and impairment of RVGLS, RVGLS.FW and RVGLS.S. These 
associations suggest that the reduction in RV strain between pre-op and 2-months 
is caused by a chronic increase in both operative and non-operative pulsatile 
afterload. Individual time point association testing between RVGLS and WRI reveal 
a potential mechanism for the lack of change on POD2 and the delayed reduction, 
Figure 8-10. On POD2 there is a moderate negative association between RVGLS 
and WRI in the operative PA, increased WRI is associated with improved strain. At 
2-months, however, there are moderate to strong positive associations between 
WRI and RVGLS in the operative and non-operative PAs, increased WRI is 
associated with impaired strain. This implies that on POD2, the RV is able to 
increase RVGLS to compensate for increased pulsatile afterload, i.e. it maintains 
coupling, however by 2-months this process is exhausted and the RV is no longer 
able to compensate for the chronic increase in pulsatile afterload, particularly if 
the non-operative PA is unable to accommodate the increased CO. 
The changes in RVGLS secondary to increased pulsatile afterload may also 
contribute to the reduction in RVEF by 2-months. There is moderate negative 
within-subject association testing between change in RVEF and change in RVGLS.S 
(r=-0.462, p=0.040, ANCOVA with patient as factor) whilst the change in RVGLS 
approaches significance (r=-0.425, p=0.062, ANCOVA with patient as factor). 




Figure 8-10 Association between right ventricular global longitudinal strain and wave 
reflection index at individual time points 
Pre-operative (top row), post-operative day 2 (POD2, middle row) and 2-months post-operative 
(bottom row) individual time point association plots between wave reflection index (WRI) and right 
ventricular global longitudinal strain (RVGLS) in the operative PA (OP.PA, left column) and non-
operative PA (NONOP.PA, right column). Note positive associations pre-operatively in the non-
operative PA and in both the operative and non-operative PAs at 2-months, however on POD2 
there was a moderate negative association between RVGLS and operative PA WRI. WRI is 
associated with impaired strain pre-operatively and at 2-months post-operatively whereas it is 
associated with increased strain at POD2. *= Pearson’s correlation co-efficient. §= Spearman’s 
correlation co-efficient.  




This investigation demonstrates, for the first time, that an increase in afterload 
following lung resection is associated with impaired RV function. A post-operative 
increase in pulsatile afterload in the operative PA results in an increased 
percentage.CO being diverted through the non-operative PA. This increase is 
associated with reduced RVEF and impaired RVGLS/RVGLS.FW. Additionally, by 2-
months an increase in non-operative pulsatile afterload secondary to the 
increased percentage.CO appears to lead to the development of impaired RVGLS. 
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Chapter 9 Major Findings, Conclusions and 
Future Directions  
This thesis investigates the mechanisms of RV dysfunction following lung resection 
by assessing RV strain and afterload. The major findings of each chapter are 
detailed below.  
9.1 Chapter summaries and major findings  
9.1.1 Chapter 5  
This chapter details the methodology of strain assessment of RV function and its 
investigation following lung resection. Global RV longitudinal strain (RVGLS) is 
unchanged at POD2 but reduced at 2-months following lung resection. Septal 
RVGLS is reduced at post-operative day 2 (POD2) whereas free wall RVGLS has a 
delayed reduction at 2-months. At both post-operative time points impaired free 
wall RVGLS was associated with reduced RVEF. 
9.1.2 Chapter 6  
This investigation demonstrates, for the first time, an increase in pulsatile 
afterload following lung resection. Rate corrected pulmonary artery acceleration 
time (PAAT/ET) and PA distensibility are both increased in the pulmonary artery 
(PA) supplying the resected lung (operative PA). The distribution of cardiac output 
(CO) between the PAs is altered post-operatively with an increase in the 
percentage travelling in the non-operative PA. Whilst there is only a modest 
shortening of PAAT/ET in the non-operative PA it is the indices of afterload in the 
non-operative PA that are associated with the reduction in RVEF and increase in 
BNP on POD2. The altered distribution of cardiac output is hypothesised as a 
potential mechanism for the decrease in pulmonary vascular reserve (PVreserve) 
following lung resection, demonstrated in previous studies and explored further 
in Chapter 8.  
9.1.3 Chapter 7  
The first use of wave intensity analysis in a lung resection population is described 
in this chapter. It is a method of combining the changes in PA flow and cross-
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sectional area to measure the rate of transport of wave energy in the PAs allowing 
assessment of the magnitude, timing and direction of wave travel in the PAs. 
These waves can be classified by the direction of travel as either forwards (away 
from the heart) or backwards (reflected towards the heart) and by the effect of 
blood flow as either compression (increase flow of blood in direction of travel) or 
expansion (decreases flow of blood in direction of travel). An increase in the 
percentage of the forward compression wave that is reflected as a backward 
compression wave (wave reflection index) is a marker of increased pulsatile 
afterload. Similar to the distribution of CO, there was a post-operative increase 
in the forward compression wave energy in the non-operative PA and a decrease 
in the operative PA. Further evidence of a post-operative increase in pulsatile 
afterload was provided by the increase in operative PA wave reflection index on 
POD2 and at 2-months. The time to peak backward compression wave was reduced 
in the operative PA post-operatively, suggesting the presence of early wave 
reflection. 
9.1.4 Chapter 8  
Comparisons between the conventional measures of pulsatile afterload (PAAT/ET 
and PA distensibility), findings of wave intensity analysis and RV function (RVEF 
and RV strain) demonstrate, for the first time, consistent associations between a 
post-operative increase in afterload and impaired RV function following lung 
resection.  
Post-operatively the increase in pulsatile afterload and the reduction in time to 
peak wave reflection in the operative PA are consistently associated with the 
increase in the percentage of cardiac output travelling in the non-operative PA. 
On POD2, the reduction in RVEF is consistently associated with the altered 
distribution of cardiac output and the increased afterload in both the operative 
and non-operative PAs. At 2-months, the reduction in RVEF is strongly associated 
with the altered distribution of cardiac output and the reduction in time to peak 
wave reflection in the operative PA. The delayed reduction in RVGLS is 
consistently associated with the increase in wave reflection (particularly in the 
non-operative PA) and the altered distribution of cardiac output.  
A summary of the main findings in this thesis are presented in Figure 9-1. 




Figure 9-1 Summary of the changes in and within-subject associations between indices of 
right ventricular afterload and function following lung resection. 
Representative example of the changes in right ventricular (RV) afterload and function following 
lung resection, right upper lobectomy in this example (shaded area) and ligation corresponding 
pulmonary artery (PA, red line) in the operative PA (left side) with the anatomy of the non-operative 
PA unchanged (right side). Red arrows represent the within-subject associations between the 
change in indices between pre-op and the time-point of testing (p<0.05). Change in percentage 
cardiac output (CO) in the non-operative PA displayed on left side. ­= increase compared to pre-
operative, ­­= increase compared to pre-operative and 2-months. ¯= decrease compared to pre-
operative, ¯¯= decrease compared to pre-operative and 2-months. RVEF= RV ejection fraction. 
RVGLS= RV global longitudinal strain. Images created by the author. 




Lung resection is a relatively unique insult to the pulmonary vasculature as it is a 
predominately unilateral insult, as such the conventional approaches to measure 
RV afterload do not detect the significant changes in afterload that occur. As 
multiple previous studies have shown, there is no change in PAP or PVR in the 
immediate post-operative period although they increase over time and on 
exercise. These measures assess the resistance of the distal pulmonary 
vasculature and therefore overlook the marked changes in the proximal pulmonary 
arteries. Assessment of the pulsatile components of afterload reveals the widely 
hypothesised link between increase afterload and impaired RV function following 
lung resection. These results must however be interpreted relative to both the 
overall cardiac output and the distribution of cardiac output at that time.  
It is hypothesised that the increase in operative pulsatile afterload and reduction 
in time to peak wave reflection diverts cardiac output through the non-operative 
PA, overwhelming the non-operative PA ultimately impairing RV function. This is 
supported by the consistent associations; between operative PA pulsatile 
afterload and the time to peak wave reflection and non-operative PA cardiac 
output, between altered distribution of cardiac output and impaired RV function 
(RVEF and RVGLS) and between non-operative PA pulsatile afterload and impaired 
RVGLS.  
On POD2 the overall cardiac output is increased from pre-op and the distribution 
of cardiac output is also altered with 66% of the overall cardiac output traveling 
in the non-operative PA. Of note, the absolute value of cardiac output in the 
operative PA is decreased post-operatively potentially secondary to increased 
pulsatile afterload. On POD2 the non-operative PA is therefore required to 
accommodate a 67% relative increase in cardiac output (overall increase is 21%) 
and there is a modest increase in non-operative PA pulsatile afterload (PAAT/ET). 
The observed reduction in RVEF on POD2 is associated with increased pulsatile 
afterload in both the operative and non-operative PAs, and the altered 
distribution of CO. Additionally, the peri-operative increase in BNP observed on 
POD2 is strongly associated with the increase in non-operative PA pulsatile 
afterload. The POD2 reduction in RVEF and increase in BNP are therefore 
hypothesised to be caused by increased pulsatile afterload with the inability of 
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the non-operative PA to accommodate the increased cardiac output driving the 
reduction in RV function. 
At 2-months overall cardiac output has returned to baseline although the absolute 
operative PA cardiac output is unchanged from POD2 and there is a 39% to 61% 
split between the operative and non-operative PAs. There remains an increase in 
indices of pulsatile afterload in the operative PA compared to pre-op, although to 
a lesser degree than on POD2, and there is no change in pulsatile afterload in the 
non-operative PA compared to pre-op. The delayed reduction in RVGLS that occurs 
at 2-months, demonstrated in Chapter 5, is strongly associated with increased 
pulsatile afterload in the non-operative PA and moderately associated with the 
increase in non-operative PA percentage of cardiac output. It is therefore argued 
that the observed reduction in RVGLS is secondary to a chronic increase in 
pulsatile afterload, again it appears that it is the inability of the non-operative PA 
to accommodate the increased cardiac output that drives to the reduction in RV 
function.  
It is notable that there is no association between operative PA pulsatile afterload 
and RVEF at 2-months. This may, however, be masked by the redistribution of 
cardiac output to the non-operative PA. The measures of pulsatile afterload in the 
operative PA may be an underestimation as blood preferentially travels in the non-
operative PA and they may rapidly increase with an increase in cardiac output, 
similar to on POD2. As hypothesised in Chapter 6 the altered distribution of cardiac 
output may be the underlying mechanism of the decrease in pulmonary vascular 
reserve seen following lung resection. Ultimately, the altered distribution of 
cardiac output that contributes to the reduction in RVEF is deemed secondary to 
increase in operative PA pulsatile afterload and the earlier wave reflection. 
9.3 Future work 
The design and successful funding of two studies further investigating the 
mechanism of RV dysfunction following lung resection are detailed below.  
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9.3.1 Right ventricular contractile reserve following lung 
resection 
As detailed in 1.2.6.2 page 71, the rate of increase MPAP on exercise is greater 
following lung resection than pre-operatively, i.e. there is decreased pulmonary 
vascular reserve (PVreserve). A potential pathophysiological mechanism, proposed 
in 6.6.2.1 page 223, is suggested by the post-operative increase in pulsatile 
afterload and reduction of the percentage of the cardiac output in the operative 
PA. Whilst the non-operative pulmonary vasculature is anatomically unchanged 
the blood flow through it is greatly increased. On exercise both the operative and 
non-operative PA may be unable to accommodate the increase in cardiac output, 
as such RV function may be further impaired. 
Similar to PVreserve, RV contractile reserve (RVCreserve) can be assessed by the 
change in RVEF on exercise. Claessen et al demonstrated that in healthy subjects 
RVEF will increase on exercise (a normal RVCreserve) whereas in CTEPH the RV is 
unable to increase RVEF in response to exercise120. As detailed in 2.3.1.2 page 87, 
there is evidence for a reduction in RVCreserve following lung resection 
demonstrated in the studies by Okada et al48, 49 although the reliability of this 
results must be questioned as RVEF is estimated by a volumetric pulmonary artery 
catheter.  
The design of a pilot feasibility study to echocardiographically assess RVCreserve 
and PVreserve following lung resection is detailed in Appendix 2. The funding 
application (Appendix 2a), a letter confirming success in funding (2b), the study 
protocol (2c) and confirmation of ethical approval (2d) are all provided, this is all 
original work devised and written by the author of this thesis. This study has 
finished recruitment and data collection, completion of data analysis is awaited.  
9.3.2 Right ventricular inflammation after lung resection 
In this thesis evidence is presented that, following lung resection, an increase in 
afterload is associated with reduction in RVEF, RV strain and an increase in BNP. 
These associations have subtly different timings and associations between POD2 
and 2-months suggesting subtly different pathophysiological mechanisms. On 
POD2 there are strong associations between the increase in BNP and indices of 
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pulsatile afterload, particularly in the non-operative PA. This suggests that the 
acute increase in pulsatile afterload leads to BNP release secondary to myocardial 
stretch. Additionally, the transient increase in RVGLS strain (reflecting increased 
contractility) to compensate for increased pulsatile afterload seen on POD2 and 
the delayed reduction in RVGLS by 2-months, secondary to chronic afterload, 
suggests that initial compensatory mechanisms become exhausted.  
Rat models of pulmonary embolism (analogous lung resection) results in 
myocardial oedema and scarring in the RV134, 135, 321, discussed 1.2.3.4 page 55. 
The study design and results are comparable to lung resection as there is an acute 
increase in afterload secondary to PA occlusion that results in impaired RV 
contractility. The myocardial mechanisms of RV dysfunction may therefore be 
similar following lung resection. BNP and other biomarkers only give a signal that 
myocardial damage occurs, but it cannot relate it to a specific region of the heart, 
nor can it explain what happens to the myocardium following the insult. Cardiac 
magnetic resonance is a rapidly developing field, with intravenous contrast and 
specific weighting of imaging it is possible to determine the myocardial water 
content (oedema) and extra-cellular volume (scarring) of regions of the heart. 
This has predominately been performed in the larger, more muscular LV but 
collaborators within the University of Glasgow have developed techniques to 
perform this in the RV435. Such imaging could potentially be able to relate RV 
function, afterload and contractility to oedema and scarring within the RV itself.  
The design of the first CMR study to investigation peri-operative RV oedema and 
scarring is detailed in the successful grant application, included in the Appendix 
3, again this is all original work devised and written by the author of this thesis. 
Finally, the design of the study includes repeating the analysis performed within 
this thesis in the new cohort, thus the changes in pulsatile afterload, RV strain 
and RVEF can be compared to the changes in myocardial oedema and scarring. 
Recruitment is complete and the initial results demonstrate, for the first time, 
acute oedema (on POD2) with resultant scarring (at 2-months) in the right 
ventricle following lung resection, further analysis is currently underway to 
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Appendix 1 – Factors affecting the linear segment of the flow-area loop 
Appendix 1 Factors affecting the linear segment of 
the flow-area loop 
This section provides further discussion on the comparison of the two methods of 
wave speed calculation used in Chapter 7. Discussion focuses on potential causes 
of the non-linear segments. 
Appendix 1.1 Summary of results 
The sum of squares (SOS) and flow-area (QA) loop methods results are summarised 
in Table 7-2 page 277 and repeated in Table Appendix 1 1. It was not possible to 
perform the QA loop method in 32/136 (23.5%) scans as they had a marked 
curvature (non-linear segment) in early systole, example shown in Figure 7-25 
page 276, repeated here as Figure Appendix 1 1. There was a trend to an increase 
in non-linear scans in the PAs that had undergone surgical resection (POD2 and 2-
months operative PA (14/41 (34.1%)) compared to those that had not undergone 
resection (non-resected) (18/95, (18.9%)), (p=0.055, Chi-squared test).  
Pulmonary  
artery 
Method Pre-op POD2 2-months p-value 
Operative  SOS  
(m.s-1) 
1.38 (1.28, 1.53) 0.92 (0.73, 1.20) # 0.90 (0.75, 1.06) # <0.001 § 




1.63 (1.29, 1.89) 1.14 (0.85, 1.73) 1.09 (0.93, 1.73) 0.056 § 
n 27 20 21  
QA Linear 
(m.s-1) 
1.64 (1.34, 1.90) 1.34 (0.87, 1.78) 1.36 (1.03, 1.78) 0.165 § 
n 22 13 14  
Non- 
operative   
SOS  
(m.s-1) 
1.29 (1.06, 1.76) 1.60 (1.33, 1.97) # 1.26 (1.11, 1.74) ¥ 0.019 § 




1.45 (1.18, 1.88) 1.74 (1.41, 2.15) 1.47 (1.07, 1.85) 0.101 § 
n 25 21 22  
QA Linear 
(m.s-1) 
1.40 (1.13, 1.80) 1.66 (1.35, 2.00) 1.38 (0.97, 1.76) 0.067 § 
n 22 17 16  
Table Appendix 1 1 Comparison of wave speed by flow-area loop and sum of squares 
techniques 
Values are median (IQR). c= wave speed. SOS= sum of square method. QA loop= flow area loop 
method. QA Al= all scans including non-linear (n=136). QA linear= QA scans only with linear 
segment (n=104). All Friedman’s test. Comparison between time-points Wilcoxon signed rank test. 
#= significant difference from pre-op. ¥= significant difference from post-operative day 2 (POD2). 
Significant results (p<0.05) highlighted bold italics. 
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Figure Appendix 1 1 Flow-area loop example 
Example of flow – area (QA) loop method of wave speed calculation in left and right pulmonary 
arteries of same scan (MRIRAN 37, patient from study). Flow was plotted against area for the 
entire cardiac cycle. Wave speed was calculated from the gradient of the plot in early systole. Red 
circles represent starting time (time= 0ms) and finishing time (time corresponding with third phase 
of original imaging) from which wave speed was calculated (red gradient line). Note linear segment 
in early systole in left panel but curved (non-linear) in right. 
Appendix 1.2 Discussion 
There is no agreed method to calculate wave speed, particularly in the pulmonary 
circulation351. Three different methods have previously been used; loop 
methods351, 377, 431, the sum of squares (SOS)404-406, 431 and the foot-to-foot 
method431. Within each method, calculation is dependent on the modality used; 
pulmonary artery catheter (PAC) studies measure pressure and velocity/flow 
whereas CMR studies measure flow (Q) and area (A). Comparison between the QA 
methods have been performed in the pulmonary circulation by Quail et al351 and 
Weir McCall et al431. Quail et al first described the SOS method from QA data and 
advocated for confining measurement of the QA loop to the first three phases of 
CMR imaging. They compared the SOS method to the QA loop method and 
demonstrated minimal bias and good agreement between the measures351. Weir-
McCall et al performed a more comprehensive comparison between different QA 
based wave speed calculation (SOS, QA loop from either the entire linear segment 
or from the first 3 points as per Quail et al351) in a healthy volunteer study. They 
found that the SOS method had improved accuracy and precision compared to the 
QA loop methods. Of note, the accuracy of all methods were improved with higher 
temporal resolution431. 
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Wave reflection has been shown to impact wave speed calculation. In the presence 
of wave reflection, QA based methods tends to underestimate wave speed 
whereas pressure (P) and velocity (U) based calculations tend to overestimate 
wave speed351, 430, 436. Proximal reflection sites either reduce the duration of, or 
completely remove the early systolic linear section of the QA or PU loop, from 
which wave speed is calculated418. This may be of particular importance in the 
pulmonary circulation as the vessels are comparatively short and there are 
multiple proximal sites of bifurcation compared to the systemic arterial system404. 
Borlotti et al investigated the effect of proximity to a reflection site on the 
percentage difference between methods of wave speed calculation and the foot-
to-foot method (the gold standard) in a bench top simulation using silicone tubing 
and a piston pump. Compared to the foot-to-foot method, in the setting of a 
proximal wave reflection, they demonstrated a greater percentage difference in 
measures using the QA loop than when using the SOS methodlll416. In the results 
from this study a similar comparison between the percentage difference between 
SOS and QA loop methods (100*(SOS-QA)/SOS) demonstrates that the percentage 
error between the measures increases with increasing proximity of the site of 
reflectionmmm, but only in the linear scans of the non-resected PAs, Figure 
Appendix 1 2.  
 
lll SOS was calculated from pressure and velocity measurements in this example.  
mmm Note that the distance to reflection is calculated from the time difference between the FCW 
and BCW and the wave speed calculated by the SOS method. This measure does not use the 
QA loop results in its calculation.  
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Figure Appendix 1 2 Percentage difference between wave speed calculation methods and 
distance to reflection site 
Percentage difference between wave speed calculation by sum of squares (SOS) and flow – area 
(QA) loop (100*(SOS-QA)/SOS) plotted against distance to apparent reflection site. Circles 
represent scans with linear early systolic segments for QA calculation, red + represent the scans 
with non-linear early systolic segments. All tests Spearman’s correlation co-efficient with linear 
results in black (upper result) and non-linear result in red (lower result). Significant result 
highlighted in bold italics.  
Left plot represents non-resected pulmonary arteries (operative pulmonary artery before surgery 
(22 linear and 5 non-linear scans) and non-operative pulmonary artery at all time points (55 linear 
and 13 non-linear scans). Note the increasing percentage difference (QA>SOS) between methods 
with reducing distance to site of reflection in the linear non-resected scans. 
Right plot represents resected pulmonary arteries (post-operative operative PA scans (27 linear 
and 14 non-linear scans)). No association between distance to reflection site and percentage 
difference.  
Non-linear scans are similar to the linear scans in non-resected pulmonary arteries (left plot). In the 
resected pulmonary arteries, the non-linear scans predominately have a shorter distance to 
reflection site than the linear scans (right plot). 
If the proximity to the apparent site of reflection site is the major driver of 
curvature in the early systolic segment then it would be expected to 
predominately occur in the scans with a proximal reflection. Although a reduced 
distance to reflection site decreases the agreement between the SOS and QA loop 
methods in the non-resected PAs it does not seem to influence the linearity of the 
early systolic segment. In the resected PAs, however, the majority of the non-
linear scans occurred in PAs with a shorter distance to the reflection site, Figure 
Appendix 1 2 and Table Appendix 1 2. 
In the resected PAs, the vessels with a non-linear segment have a shorter distance 
to reflection site, pulmonary artery acceleration time (PAAT), time to peak BCW 
and time to onset BCW, Table Appendix 1 2. There is no difference in any of these 
factors between the linear and the non-linear scans in the non-resected PAs 
although the non-linear vessels have a larger WRI compared to the linear vessels. 
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Similar to Figure Appendix 1 2, this suggests that separate mechanisms are 
responsible for the non-linear QA loops in the resected and non-resected PAs.  
Measure Pulmonary 
arteries 
Linear Non-linear p-value 
(linear vs 
non-linear) 
WRI (%) Resected 
n=41 
7.5 (3.2, 11.3) 
n=27 





4.3 (2.3, 7.2) 
n=77 
7.8 (3.9, 12. 3) 
n=18 
0.045 




Resected 3.76 (2.53, 5.74) 1.81 (1.34, 2.43) 0.002 
Non-resected 7.09 (4.89, 9.89) ‡ 7.87 (5.82, 10.97) ‡ 0.540 
    
PAAT (ms) Resected 135.1 (118.1, 158.6) 102.0 (86.0, 116.5) 0.001 
Non-resected 152.1 (27.9) ‡ 146.1 (26.9) ‡ 0.073 
    
Time to peak BCW 
(ms) 
Resected 158.0 (142.1, 171.6) 91.5 (85.5, 113.1) <0.001 
Non-resected 189.2 (48.2) ‡ 180.7 (57.6) ‡ 0.571 
    
Onset of BCW (ms) Resected 94.0 (79.0, 105.0) 53.5 (44.3, 61.8) 0.003 
Non-resected 111.8 (90.0, 130.1) ‡ 110.9 (75.3, 140.8) ‡ 0.936 
    
Time of 3rd phase 
(ms) 
Resected 80.9 (13.4) 77.2 (8.8) 0.288 
Non-resected 85.8 (15.7) 83.6 (13.0) 0.555 
    
PAAT - 3rd phase 
(ms) 
Resected 52.0 (42.8, 67.3) 23.3 (16.8, 28.9) 0.001 
Non-resected 68.4 (17.8) ‡ 57.9 (24.2) ‡ 0.107 
    
Time to peak BCW 
- 3rd phase (ms) 
Resected 73.8 (61.1, 95.6) 14.1 (7.8, 30.7) <0.001 
Non-resected 103.4 (44.2) ‡ 100.2 (57.6) ‡ 0.834 
    
Onset of BCW - 3rd 
phase (ms) 
Resected 12.8 (-2.1, 23.3) -26.6 (-36.6, -13.8) 0.002 
Non-resected 27.7 (4.9, 48.5) 40.7 (-13.9, 58.4) ‡ 0.498 
Table Appendix 1 2  Comparison of the difference in afterload and timing parameters for 
flow – area loop with and without a linear segment 
WRI= wave reflection index. PAAT= pulmonary artery acceleration time. BCW= backward 
compression wave. Time of 3rd phase= the final time that wave speed was calculated from, NB it is 
one tenth of the duration of the cardiac cycle and so is also representative of difference in heart 
rate between groups. ‡= significantly different to resected pulmonary artery. Significant results 
(p<0.05) highlighted in bold italics.  
Calculation of wave speed from the QA loop must be performed prior to wave 
reflection351, 431. In the study presented, the QA loop method was performed on 
the data from the first 3 time points of the cardiac cycle, similar to Quail et al351. 
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The time to the 3rd phase (and therefore heart ratennn) is similar between the 
linear and non-linear scans and between the resected and non-resected PAs. The 
time difference from the time of the 3rd phase to PAAT, to the time to peak BCW 
and to the time to onset BCW are all lower in the non-linear resected PAs than all 
other vessels. Additionally, the median difference between the time of the 3rd 
phase to the onset of the BCW is negative. This demonstrates that the onset of 
the BCW and therefore wave reflection occurs prior to the 3rd phase thus the non-
linear section of the QA loop contains wave reflection in the resected PAs.  
Quail et al were able to calculate wave speed by the QA loop method from all 
scans. This is potentially due to the difference in temporal resolution of the CMR 
imaging between studies. They achieved a temporal resolution of 10.5ms and the 
QA loop was measured during the first 31.5ms of the cardiac cycle, prior to the 
time to peak BCW (76ms) and PAAT (67ms)351. Similarly, Weir-McCall et al achieved 
a temporal resolution of 7-12ms in their study comparing methods of wave speed 
calculation during a 4-minute free breathing sequence431. Whilst the accuracy of 
all methods improved with a higher temporal resolution the SOS method had 
superior intra- and inter-observer reproducibility than QA loop methods 
throughout431. A greater temporal resolution may detect the presence of a linear 
segment of the QA loop in a greater percentage of the resected PAs. 
In the non-resected PAs, the only significant difference between the linear and 
non-linear QA loops is an increase in WRI in the non-linear vessels. The timing of 
the reflected wave is not different between groups and as such a greater temporal 
resolution may be of limited benefit. An alternative explanation for the non-linear 
QA loops in the non-resected PAs may be subtle motion or reporting artefacts. As 
discussed in Chapters 6 and 7 there appears to be a continuum between marked 
to minor diastolic motion artefacts. This has also been reported by other authors 
in pulmonary artery CMR studies351, 358, 431. WIA studies performed with a PAC 
measure PA pressure instead of area and therefore do not have the potential 
motion and reporting artefacts, also they have a greater temporal resolution than 
CMR (5ms)404. In a PAC study, Su et al however found that “many” of the patients 
 
nnn On CMR imaging the cardiac cycle is divided into 30 phases irrespective of heart rate. The 3rd 
phase is therefore equal to 1/10th of the duration of the cardiac cycle and heart rate is equitable 
to 6/(time to 3rd phase (in seconds)). 
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in their pulmonary WIA study did not have a linear segment404-406. Instead, they 
relied on the SOS method (with pressure and velocity) to calculate wave speed. A 
non-linear segment may therefore be present irrespective of modality. 
Finally, the foot-to-foot method has be utilised in the pulmonary circulation to 
measure wave speed between the MPA and RPA/LPA. This approach assumes a 
constant wave speed from the measurement point in the MPA to the measurement 
point in the RPA and LPA however, the calculated wave speed was lower in the 
RPA than the LPA431. Whilst it is feasible to perform CMR imaging at two separate 
points in the RPA/LPA, the short distance between the points could introduce 
significant error in wave speed calculation and would also double the required 
scan time for that component of analysis.  
Appendix 1.3 Conclusion 
The cause(s) of a non-linear segment in early systole are likely multifactorial and 
different in resected and non-resected PAs. In the resected PAs, the non-linear 
segments are caused by a proximal site of wave reflection that results in the early 
arrival of a BCW. In the non-resected PAs, the non-linear scans have a greater WRI 
although there is no difference in the timing of wave reflection between linear 
and non-linear QA loops. In the pulmonary circulation the presence of non-linear 
segments in loop-based wave speed calculation may occur irrespective of the 
method of assessment, therefore the SOS method is potentially superior.  
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Appendix 2 Right ventricular contractile reserve 
following lung resection 
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Email address:  
Title of project: Assessment of RV contractile reserve on exercise following lung resection – a pilot study 





The Royal College of Anaesthetists 
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A description and justification of the proposed project (not more than 500 words): 
Explanatory Notes 
Please note that applications for research, travel and education grants will be assessed against three criteria:  
1. Appropriateness and importance at local, national and international level 
2. Methodology 
3.  Timescale and justification of funding 




Lung cancer is the leading cause of cancer death in the UK. Surgical resection offers the best chance of cure; 
rates are increasing with older and sicker patients now undergoing resection. Unfortunately, morbidity 
following lung resection remains high. Many patients experience long term dyspnoea and decreased 
functional capacity, this is poorly associated with the change in lung function[1] and may be influenced by 




Our group has previously investigated changes in cardiac function at rest following lobectomy with 
echocardiography and cardiac magnetic resonance (CMR) imaging, demonstrating decreased right 
ventricular ejection fraction (RVEF) but unchanged left ventricular ejection fraction following surgery[3] 
(Figure 1). Delta RVEF (POD2 from pre-op) was associated with potential cardiac inflammation (delta BNP, 
r=0.47, p=0.03).  
 
Although long recognised as a potential cause of decreased exercise capacity following lung resection, RV 
function on exercise has undergone very little investigation. Using volumetric pulmonary artery catheters to 
measure RVEF (a technique the accuracy of which has since been challenged[4]), Okada et al showed that 
three weeks following lobectomy RVEF was decreased at rest and further decreased on exercise in parallel 
with a marked increase in pulmonary artery pressure and pulmonary vascular resistance. Echocardiographic 
assessment of RV function is challenging due to its complex shape and retrosternal position but surrogate 
markers of tricuspid annular plane systolic excursion (TAPSE), tricuspid S wave velocity and RV longitudinal 
strain (RVLS) have all been shown to associate with RVEF measured by CMR[6]. In our previous study TAPSE 
correlated best with RVEF (r=0.35, p<0.01) but showed no significant change between time points.  
 
In pulmonary hypertension, the concept of RV contractile reserve is increasingly recognised as an important 
determinant of exercise capacity and outcome[6]. We hypothesise that following lung resection patients may 
exhibit similar physiology. The subtle changes in RVEF we have previously observed at rest may manifest as 
reduced RV contractile reserve on exercise in the face of well documented afterload increase. 
 
Methodology 





The Royal College of Anaesthetists 





Primary endpoint  
• RV contractile reserve measured as the change in RV function (delta TAPSE) on exercise relative to 
rest determined pre and 2-months post-operatively. 
 
Secondary endpoints  
• Change in contractility (delta RVLS) on exercise. 
• Change in afterload (est. pulmonary artery pressure and acceleration time) on exercise. 
• Change in markers of cardiac inflammation (BNP, CK-MB, troponin and myoglobin).  
 
Study design 
Pilot observational cohort study of patients undergoing video-assisted thoracoscopic lobectomy. With 
informed consent and ethical approval, five patients will undergo exercise echocardiography pre-operatively 
and two months post-operatively. The echocardiography protocol will assess RV and LV function, afterload 
and contractility at rest and on a fixed workload at submaximal exercise. 
 
Timescale and funding justification  
 
Grant funds will cover the echocardiography scanning and blood samples analysis costs. A draft protocol has 
been prepared and we aim to complete the study in nine months from funding decision.  
 
This study will help inform a larger clinical study examining the functional impact of post-operative RV 
dysfunction. Ameliorating perioperative RV injury may be a novel therapeutic target and lead to improved 
patient outcomes following lung resection. 
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Detailed breakdown of costs: 
Exercise echocardiography (£150) x 2 visits x 5 patients = £1500 
Exercise echocardiography will be performed by band 7, British Society of Echocardiography accredited 
cardiac physiologists according to a standardised protocol and will be dual reported post processing by 
blinded observers using EchoPAC software. 
Cardiac biomarkers (£470 for 25 tests), 5 tests x 5 patients = £470 
Alere Triage ProfilER SOB Panel – Testing pre-operatively, post-operatively, POD1, POD2 and 2 months. 
Total = £1970 
Patient recruitment, sampling, data collection and analysis will be performed by a full time Clinical 
Anaesthetics Research Fellow (applicant), salaried by the University of Glasgow until August 2017. 
Details of other funding that has been applied for or received from other sources: 
Nil  





How to apply 
Please attach an electronic copy of your curriculum vitae to this form and submit both documents as a 
SINGLE pdf file using the document upload box on the NIAA website here. 
A signed copy should also be sent to:  Pamela Hines, NIAA Coordinator, Royal College of Anaesthetists, 
Churchill House, 35 Red Lion Square, London, WC1R 4SG. 
The deadline for all applications is 5.00 pm on Friday, 2 September 2016. 
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Thank you for your application for a RCoA Research, Education & Travel grant. I 
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agreed to offer funding of £1,970 from the Ernest Leach Research Fund for your project 
entitled, Assessment of RV contractile reserve on exercise following lung resection 
– a pilot study. 
Reimbursement will be made with a direct payment, on submission of receipts 
and invoices from you. 
The College will expect you to complete a short report on the project and its findings. 
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Assessment of right ventricular contractile reserve on 
exercise following lung resection – a pilot study 






1. Lay abstract (300) 
Introduction 
Lung cancer is the second most common cancer in the UK and is the leading cause of 
cancer related death. Where appropriate, surgery (lung resection) to remove the tumour 
and the surrounding lung provides the best chance of cure. Post-operatively patients may 
however suffer long-term shortness of breath greatly limiting their day-to-day function. 
This shortness of breath is not solely caused by the decrease in lung function but also from 
a decrease in the performance of the heart. Although the surgery does not directly involve 
the heart it is thought that it is indirectly damaged by the surgery. 
Background 
In a previous study our research group showed that the function of the right side of the 
heart (the part of the heart that pumps blood to the lungs) is decreased following lung 
resection. There is also evidence that patients with poor right heart function before 
surgery have more complications after surgery. Investigation of its ability to increase its 
function on exercise (contractile reserve) can detect decreased right heart function when 
not apparent at rest. Assessment of the contractile reserve of the right heart has not been 
reliably performed following lung resection. 
Methods 
We will perform ultrasound scans of the heart (echocardiography) before and two months 
after lung resection of seven patients. During the scans we will assess the function of the 
right heart at rest and on exercise (cycling). Will we perform various methods of assessing 
right heart function to determine which is most reliably performed. 
Aims 
The aim of the research is to assess the ability of exercise echocardiography as a method 
of assessing contractile reserve following lung resection. This will guide further studies 
investigating both right heart function following surgery and whether poor right heart 
function on exercise before surgery can detect patients at risk of complications.  
 








Lung cancer is the leading cause of cancer death in the UK and has the highest regional 
incidence within Greater Glasgow and Clyde[1, 2]. Where appropriate, surgical resection 
offers the best chance of cure. Resection rates have risen markedly over the last ten 
years[3] with a particular increase in elderly patients [4].  
Morbidity following lung resection remains high with many patients experiencing long 
term dyspnoea resulting in decreased functional/exercise capacity[5-7]. This decrease in 
capacity is poorly associated with the change in lung function[8] although it may be 
influenced by cardiac limitation[7, 9]. Guidelines published in 2013 regarding the selection 
of patients for lung resection concluded that the causes of long term dyspnoea, “remain 
largely unknown.”[10] Nonetheless, The British Thoracic Society now advocate: 
“Offer[ing] surgical resection to patients at moderate to high risk of post-
operative shortness of breath if they are aware of and accept the risks of dyspnoea and 
associated complications.”[11] 
Patients prioritise exercise capacity following lung cancer surgery; patient and public 
involvement between the (Glasgow) Victoria Infirmary Lung Cancer Support Group and our 
research group highlighted the challenges faced following ‘successful’ lung resection. 
Second only to “being alive and cancer free” exercise capacity was the main priority of 
post-operative patients although they experienced significant impairment of functional 
capacity. Our research also shows that post-operative patients experience a marked 
increase in problems with ‘mobility’ and ‘self-care’ as evidenced by changes in these 
domains of the EQ-5D quality of life score[12]. 
2.2 Right ventricular and pulmonary vascular response to lung 
resection 
Right ventricular function at rest has been shown to decrease following lung resection. 
Our research group has conducted the only sequential cardiac magnetic resonance (CMR) 
study assessing RV function following lung resectiona. We demonstrated a decrease in right 
ventricular ejection fraction (RVEF)b following lobectomy at day two (POD2) and two 
months post-op (Figure 1)[13]. In our cohort, RVEF on POD2 was associated with length of 
high dependency stay (p<0.05, r=-0.61). Others have shown that peri-operative decrease 
in RV function is associated with both early and late post-operative complications[14, 15]. 
In another study impaired RV function intra-operatively identified patients in whom late 
cardio-respiratory symptoms would develop[16], suggesting peri-operative RV dysfunction 
may have an impact long into the post-operative period.  
 
a  'The Pulmonary Vascular / Right Ventricular Response to Lung Resection'. ClinicalTrials.gov identifier 
- NCT01892800. https://clinicaltrials.gov/show/NCT01892800 
b  We recognise that assessment of RV function is more complex than measurement of RVEF alone, 
which is dependent on loading conditions. During analysis we also plan to investigate other parameters of 
RV function and interpret changes in RVEF in the context of indices of preload, contractility and afterload.  







Figure 1 Right ventricular ejection fraction (A) decreases from pre-op levels by post-operative day 2 
(POD2), (absolute decrease of 4.9%, relative decrease of 9.7%) and remains low two months.  Left 
ventricular ejection fraction (B) was unchanged throughout study. Error bars 95% confidence 
intervals. All paired t-tests. McCall et al[13]. 
Right ventricular function on exercise following lung resection has only been 
investigated by one research group[17, 18]. In the two studies patients performed 
submaximal exercise with RVEF calculated from volumetric pulmonary artery catheters 
(PAC). RVEF did not change from rest on exercise pre-operatively but decreased on 
exercise at three weeks post-op[18]. In a follow-up study Okada et al. demonstrated that 
patients with a decrease in RVEF on exercise pre-op experienced more complications, a 
greater post-operative drop in RVEF and a longer hospital stay[17]. The reliability of 
derived values of RV volumes and RVEF by PACs has subsequently been shown to be poor, 
thus limiting the validity of these results[19][20]. Although questions exist of their validity 
these results imply that not only does RV dysfunction on exercise occur following lung 
resection but also that its presence pre-operatively may identify patients at risk of 
complications. 
Increased afterload is the most intuitive explanation for reduced RVEF. Intra-operatively 
afterload, measured by pulmonary vascular resistance (PVR), increases on institution of 
one-lung ventilation and again on pulmonary artery (PA) clamping[21, 22]. This acute 
increase returns to baseline however by 24-48 hours post-operatively [18, 22-24] yet RVEF 
remains depressed at 2 months post-op[13]. We suggest this discord between hypothesis 
and evidence may exist because PVR fails to assess the full complexity of RV afterload. 
PVR only assesses resistance to steady flow ignoring the resistance to pulsatile flow that 
is responsible for up to half the hydraulic work of the RV[25]. In our previous study we 
demonstrated increases in pulsatile components of afterload at rest with; increased wave 
reflection, decreased pulmonary artery acceleration time and distensibility. Increased 
afterload on exercise however has been demonstrated following lung resection; Okada et 
al observed that as RVEF fell on exercise there was a marked increase in PVR and PA 
pressure (Figure 2)[18].  
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Figure 2 Relative change of cardiovascular parameters on exercise before and after lung resection. 
RVEF, heart rate (HR), PVR index (PVRI) and mean pulmonary artery pressure (mPAP) on exercise all 
worsen by three weeks post-op. # p<0.05 paired t-test. Adapted from Okada et al 1994[18]. 
Biomarker evidence of myocardial injury has also been demonstrated following lung 
resection by our group. Patients with a decreased functional capacity post-operatively 
have elevated peri-operative B-type natriuretic peptide (BNP) levels, a marker of 
myocardial stretch, further relating post-operative functional limitation to cardiac 
dysfunction[26].  
2.3 Right ventricular and pulmonary vascular response to 
exercise 
There is growing appreciation of the importance of assessing the ability of the RV and 
pulmonary vascular system to maintain/augment its’ function in response to exercise[27]. 
This ability to accommodate changes occurring on exercise is termed ‘reserve’. Decrease 
in both right ventricular contractile reserve (RVCreserve) and pulmonary vascular reserve 
(PVreserve) have been demonstrated in patients with pulmonary hypertension (PAH). 
Right ventricular contractile reserve is defined by Haddad et al as;  
  “the extent of increase or change in ventricular function that occurs during 
exercise or pharmacological stress”[28] 
Patients with decreased RVCreserve are not able to increase RV function on 
exercise/stress (Figure 3)[29]. Assessment of RVCreserve can identify RV dysfunction 
which is not apparent at rest, is associated with a decrease in functional ability and is 
predictive of survival in this patients with PAH[30-33].  
Pulmonary vascular reserve describes the ability of the pulmonary vascular system to 
cope with an increase in cardiac output. As cardiac output increases there is a linear 
increase in PA pressure (Figure 3)[29]. The slope of this linear relationship is the 
PVreserve[29, 34]. Healthy patients have a gradient of 1-2mmHg/l/min whilst 
>3mmHg/l/min is suggestive of decreased PVreserve[34].  







Figure 3. RVCreserve (A) and PVreserve (B) in healthy subjects, patients with chronic thrombo-
embolic pulmonary hypertension (CTEPH) and CTEPH patients who have undergone pulmonary 
endarterectomy (post-PEA). A, healthy subjects and post-PEA have similar RVEF at rest but on 
exercise post-PEA are unable to increase RVEF. B, gradient of mPAP vs cardiac output increasing from 
control (1mmHg/L/min) to post-PEA (4.7mmHg/L/min) and CTEPH (6.7mmHg/L/min) with decreasing 
pulmonary vascular reserve. Adapted from Claessen et al[29]. 
 
2.3.1 Methods of assessing reserve 
Assessment of the RV is challenging, even at rest, due to its retrosternal position, complex 
irregular shape and marked load dependence[35]. Assessment RVCreserve relies on 
accurate and reproducible assessment of regional or global RV function whilst PVreserve 
requires repeated measurement of pulmonary artery pressure[36]. 
Cardiac MRI is the gold standard for assessing RV volume/function[35] although cannot 
measure PA pressures thus preventing conventional PVreserve measurement.  
Pulmonary artery catheters reliably assess pressures and flow although volumetric 
measurements have never reliably been validated against other measures[19] preventing 
RVCreserve measurement.  
Echocardiographic imaging of the entire RV is challenging and is further complicated 
following lung resection by a potential shift in the position of the heart and 
hyperinflation[37]. Regional RV assessment and estimated systolic PAP have however been 
shown to agree with CMR and PAC measurements in pulmonary hypertension by Claessen 
et al[36].  
2.4 Hypothesis and research question 
In this pilot study we aim to assess the feasibility of echocardiographic assessment of 
RVC/PV-reserve pre- and post-operatively in patients undergoing lung resection. 
Echocardiographic assessment of the RV is challenging at rest and potentially further 
complicated by both lung resection and exercise. Not only will we assess the technical 
feasibility of exercise echocardiography but also the patients’ experiences of it with 
patient satisfaction questionnaires.  
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We hypothesise that the subtle decrease in RVEF and increase in afterload observed we 
have observed at rest will manifest as markedly decreased right ventricular contractile 
and pulmonary vascular reserve on exercise. Additionally, the detection of subtle RV 
dysfunction pre-op could allow identification of patients at high risk of severe post-op RV 
dysfunction.  
We aim to answer the following questions: 
1) Is exercise echocardiographic assessment of RVC/PV-reserve following lung resection  
a) feasible? 
b) acceptable to patients? 
2) Does RVC/PV-reserve change following lung resection? 
3) Are any observed changes related to the changes in markers of cardiac inflammation 
(BNP, CK-MB, troponin I, D-dimer and myoglobin)? 
4) Are any observed changes related to self-reported functional status?  
 
If the technique proves feasible in this patient group, the results of this pilot study will 
be used to enable power analysis in the design of a larger observational study to 
investigate our hypotheses further. 
3. Study plan 
3.1 Study design 
Feasibility pilot study to assess the utility of exercise echocardiography following lung 
resection. Prospective observational cohort study of 7 patients presenting for video-
assisted thoracoscopic surgery (VATS) lobectomy of primary lung cancer. 
3.2 Setting 
Golden Jubilee National Hospital / West of Scotland Heart and Lung Centre – a NHS tertiary 
referral cardiothoracic surgical centre (single centre).  
3.3 Study summary 
The purpose of the study is to assess both the feasibility and patient satisfaction of 
exercise echocardiography in measurement of RVC/PV-reserve following lung resection.  
Patients presenting for VATS lobectomy for suspected lung cancer will undergo exercise 
echocardiographic assessment pre-operatively and two months post-operatively. 
Echocardiography will assess RV/LV function and flow/pressure in the main pulmonary 
artery. This will be performed both at rest and on two-stage cycle-ergometric exercise at 
set workloads. Contemporaneous blood testing of cardiac biomarkers will also be tested 
(Table 1).  
Recruitment will be limited to patients undergoing anatomical lobectomy with VATS. 
Surgical technique will be standardised to a single surgeon. Anaesthetic technique will be 
standardised for analgesia provision, use of vasopressors/inotropes, blood transfusion and 
peri-operative fluid management (Appendix 1). Such standardisation reflects the normal 
practice of the surgeon/anaesthetist involved. 











POD 1 POD 2 POD 3 POD 4 2 Months 
Consent 




      
Self-reported functional status 
• METS, MRC dyspnoea score, NYHA 
grade and EQ-5D 
X       X 
Exercise echocardiography 
• Standardised protocol (appendix 
2) 
• Patient satisfaction 
questionnaires (appendix 5) 
 
 X      X 
Biomarkers: 
• Myocardial dysfunction (BNP, CK-







































4. Objectives and outcome measures 
4.1 Primary outcome measures 
The primary outcome of the study is to determine if exercise echocardiographic 
assessment of RVC/PV-reserve is feasible following lung resection and if so which 
parameter is most reliably imaged. We will assess both image acquisition and 
patient satisfaction of the procedure. Image acquisition will be assessed by the 
quality of imaging achieved at rest, on light and on moderate exercise in patients 
pre-operatively and two months post-operatively (appendix 2). Image quality will 
be graded at time of scanning by echocardiography technician and then by two 
blinded observers during post-processing echo analysis.  
Patient satisfaction questionnaires will examine the patients’ experience of 
exercise echocardiography (appendix 5), allowing us to assess whether this 
technique would be acceptable to patients in a subsequent larger observational 
study. 
4.2 Rationale for primary outcome 
4.2.1 Methods of assessing reserve 
Echocardiographic imaging of the entire RV is challenging and therefore relies 
upon the use of regional assessment as a surrogate of global RV function, 
summarised below (Figure 4). We will assess the feasibility of obtaining each of 
the following measures. 
• Systolic (S’) wave velocity is a load dependent measure of RV contractility 
derived from tissue doppler imaging of the RV free wall[38].  
• Tricuspid annular plane systolic excursion (TAPSE) measures the 
longitudinal shortening of the RV on contraction. TAPSE is highly load 
dependent[38] although it is frequently used in PAH and RVCreserve 
assessment[33, 39]. 
• RV fractional area change (RVFAC) is obtained from a long axis of the RV 
following measurement of the cross-sectional area of the RV at end systole 
(RVESA) and end diastole (RVEDA)[39]. Its accuracy is limited by the 
assumption that the RV is concentric although Claessen et al. showed a 
strong correlation with RVEF on exercise[36]. RVFAC (%) = (RVEDA-
RVESA)/RVEDA. 
• Eccentricity index is a measure of concentricity of the LV that can detect 
pressure/volume overload of the RV[40]. As RV pressure/volume increases 
it flattens the interventricular septum causing deformation of the LV thus 
increasing its eccentricity. 
• Systolic pulmonary artery pressure can be estimated from the maximal 
velocity of the tricuspid regurgitant jet[32]. Significant improvement in the 
ability to detect the jet can be obtained with the administration of agitated 
colloid[36].  








Figure 4. Echocardiographic assessment of RVCreserve of a pulmonary hypertension patient 
at rest (left) and on exercise (right). i) S wave velocity, ii) TAPSE, and iii) LV eccentricity 
index (EI). Note increases in S’ wave velocity and TAPSE on exercise with a deterioration in 
EI with flattening of the interventricular septum indicating RV pressure/volume overload.  
Adapted from Aleida et al.[39] 
   
Exercise capacity assessment following lobectomy by other authors  have 
demonstrated a maximal workload achievable of 67-99 Watts[6, 8, 41-43]. A fixed 
two stage exercise protocol of 25W and 50W, as per Blumberg et al, will negate 
the need for maximal exercise capacity assessment and allow comparison of 
similar workloads pre- and post-operative[31].  
 
4.2.2 Method of assessing patient satisfaction 
Lung resection rates are increasing, especially in older patients[4]. These patients 
tend to have more comorbidities, including cardiac, respiratory and 
musculoskeletal disorders. The physical ability of patients to complete the 
exercise component of the study is essential for the test. We will assess patients’ 
experience of the procedure and of the exercise programme and their ability to 











Patients’ feedback of the technique will guide further work and potentially pre-
operative testing. If the technique of exercise echocardiography is useful in this 
setting and can detect patients at risk of RV dysfunction post-operatively the 
procedure may be incorporated into pre-operative testing. It is imperative that 
we develop a protocol that is acceptable to patients.  
4.3 Secondary outcomes 
4.3.1 Outcome measures 
1) Does RVC/PV-reserve change following lung resection? 
2) Are any observed changes related to the changes in markers of cardiac 
inflammation (BNP, CK-MB, troponin I, D-dimer and myoglobin)? 
3) Are any observed changes related to self-reported functional status? 
4.3.2 Rationale for secondary outcomes 
The study is not powered to detect changes in the secondary outcomes described. 
The following analysis will be used to power a larger observational cohort study 
to investigate the hypotheses described. 
1) Does RVC/PV-reserve change following lung resection? 
Right ventricular contractile reserve will be assessed by the change in measures 
of RV function from rest to exercise (D) pre-operatively to post-operatively. Due 
to pilot nature of this study we will assess changes in TAPSE, S’ and RVFAC.  
Pulmonary vascular reserve will be assessed by gradient of systolic/mean PAP 
against CO pre-operatively vs post-operatively[29] 
 
2) Are any observed changes in RV/PV Reserve related to the changes in markers 
of cardiac inflammation (BNP, CK-MB, troponin I, D-dimer and myoglobin)?  
B-type natriuretic peptide (BNP): is a hormone secreted by cardiac myocytes in 
response to mechanical stretch. In our previous study patients with elevated pre-
operative BNP had lower functional capacity post-operatively [26]. In this previous 
study BNP was highest on POD2 (the last day of testing) and so, in the proposed 
study BNP will be assayed at further time-points in order to delineate the timing 
of the post-operative peak in plasma BNP (Table 1). Plasma BNP may have value 
as a peri-operative marker of RV dysfunction and may be related to RVCreserve in 
this patient population. 
 
3) Are any observed changes related to self-reported functional status? 
Functional status will be assessed subjectively by written questionnaires pre-
operatively and two months post-operatively (Table 1). Scoring will be performed 
with the New York Heart Association (NYHA) classification[44], WHO performance 






status classification[45], MRC Breathlessness Scale[46] and health related quality 
of life scoring by EQ-5D questionnaire[12]. 
5. Selection and withdrawal of study subjects 
5.1 Inclusion criteria 
1) Provision of informed consent   
2) Age >16 years   
3) Planned elective lung resection by VATS lobectomy   
5.2 Exclusion criteria 
Subjects fulfilling any of the criteria below will be excluded from the study:  
1) Pregnancy   
2) On-going participation in any investigational research which could undermine 
the  scientific basis of the study   
3) Wedge, segmental or sub-lobar lung resection   
4) Pneumonectomy   
5) Isolated right middle lobectomy   
6) Contraindication to exercise echocardiography, as per British Society of 
Echocardiography guidelines[47] 
a) Acute coronary syndrome 
b) Left ventricular failure with symptoms at rest  
c) Recent history (within the last week) of life threatening arrhythmias 
d) Severe dynamic or fixed left ventricular outflow tract obstruction  
e) Severe systemic hypertension (systolic blood pressure >220mmHg and/or 
diastolic blood pressure >120mmHg) 
f) Recent pulmonary embolism or infarction 
g) Thrombophlebitis or active deep vein thrombosis 
h) Known hypokalaemia 
i) Active endocarditis, myocarditis, or pericarditis. 
5.3 Rationale for inclusion/exclusion criteria 
Lobectomy is the most common lung resection performed[2]. Although 
pneumonectomy will cause greater physiological disruption they represent less 
than 6% of lung resections nationally potentially limiting the application of study 
results. VATS resection rates have rapidly increased in recent years and now 
account for 70% of resections within the Golden Jubilee National Hospital (the 
largest thoracic surgical unit in the UK). Lesser resections (including isolated right 
middle lobectomy) have been excluded as the lesser physiological disruption may 
be hypothesised to be inadequate to significantly influence RV function and/or 
impair imaging.  
Many of the contraindications for exercise echocardiography are contraindications 
for surgery, and as such we don’t anticipate exclusion of many patients based on 
these criteria.  






5.4 Withdrawal and exclusions 
A patient may request withdrawal from the study at any time without it affecting 
their clinical care. The patient will not have to give a reason for their decision to 
withdraw. 
6. Study conduct 
6.1 Recruitment 
Patients will be identified from the waiting list of patients presenting to GJNH for 
lung resection by consultation between Dr Shelley (chief investigator), Dr Glass 
(principal investigator) and Mr Kirk (lead surgeon). Potentially eligible patients 
will be approached by either Mr Kirk (lead surgeon) or Dr Stevens (anaesthetist), 
provided with a patient information leaflet and given a verbal outline of the study 
when attending the combined anaesthetic and surgical pre-assessment clinic 
(generally occurring 3 days prior to admission). Mr Kirk and Dr Stevens are part of 
the patients direct clinical care team. It is hoped Dr Glass or a designated member 
of the research team will be able to attend this clinic on the majority of occasions 
for the purpose of an introduction. 
Patients will then be advised that Dr Glass or a designated member of the research 
team will come to see them once admitted prior to their operation, to discuss the 
study further, to answer any questions that they may have about the study and if 
appropriate obtain informed consent. 
6.2 Consent  
Written informed consent will be obtained, following a face-to-face discussion 
about the study (where patients are given the opportunity to ask questions) by a 
member of the study team.  
6.3 Data collection  
Data collection involves: 
• Baseline demographic data  
• Self-report of exercise tolerance 
• Exercise echocardiography 
• Laboratory sampling 
• Intra-operative data  
• Post-operative clinical data  
6.3.1 Baseline demographic data  
Case note review and routine pre-operative investigations:  
• Indication for resection, tumour staging (if applicable) 
• Chemo- / Radio- therapy received (if any) 






• Alcohol consumption – units per week 
• Smoking history – current and pack years, time since abstinence if 
applicable 
• Pulmonary function test results: 
- Forced expiratory volume in 1 second (FEV1) 
- Forced vital capacity (FVC) 
- FEV1/FVC ratio (%) 
- Diffusing lung capacity for carbon monoxide (DLCO) 
• Co morbidities 
- As defined by the definitions of Thoracoscore (The Thoracic Surgery 
Scoring  System) 
- Smoking addiction 
- History of cancer 
- COPD 
- Arterial hypertension 
- Heart disease 
- Diabetes mellitus 
- Peripheral vascular disease  
- Obesity 
- Alcoholism   
• American Society of Anesthesiologists (ASA) grade   
• Medication history (including over the counter medication)   
• Height and body weight   
6.3.2 Self-report of functional status   
Self-report of functional status will be by completion of a written questionnaire 
(Appendix 6) encompassing the New York Heart Association (NYHA) 
classification[44], WHO performance status classification[45], MRC Breathlessness 
Scale[46] and health related quality of life scoring by EQ-5D questionnaire[12]. 
6.3.3 Echocardiographic imaging 
Exercise testing will be performed on a GE eBike EL Ergometer (Freiburg, 
Germany) at rest and on two fixed workloads. Echocardiography image acquisition 
will be undertaken on a Vivid E9 cardiovascular ultrasound (GE Healthcare, 
Freiburg, Germany) by band 7, British Society of Echocardiography accredited 
cardiac physiologists according to a standardised protocol (Appendix 2). Post 
processing will be dual reported by blinded observers using EchoPAC software (GE 
Healthcare) and 4D RV-Function analysis software (TomTec Imaging Systems) 
according to a standardised protocol (Appendix 3). Echo image quality will be 
graded at time of scanning and then by the two blinded observers on post-
processing analysis (Appendix 4). 
6.3.4 Laboratory sampling 
Blood sampling: Just prior to induction of anaesthesia a baseline 3ml EDTA blood 
sample will be collected. A further 3 ml sample will be taken on immediately post-
operatively, on post-operative days 1, 2, 3, 4 and on follow up at 2 months. Where 






possible blood samples will be taken from a radial arterial cannula (routine for 
surgeries such as this) or collected along with any bloods required for their normal 
clinical care to avoid unnecessary venepuncture. 
Biomarkers of myocardial dysfunction (BNP, CK-MB, troponin I, D-dimer and 
myoglobin) will be analysed using the Alere Triage® ProfilER SOBTM Panel system 
(Alere Ltd. Stockport, UK). Quality control measures will be undertaken as per the 
manufacture’s guidelines. All samples taken for the study will be analysed within 
6hours of collection (as per manufacture guidelines) and subsequently disposed 
of. 
6.3.5 Intra- / Peri-operative data 
• Anaesthetic techniques / drugs administered 
• Regional anaesthetic technique utilised (and success of technique) 
• Duration of surgery / anaesthetic 
• During the period of one lung ventilation (OLV) 
- Duration of OLV 
- Tidal volume, minute volume, PEEP, inspiratory plateau and peak 
airway pressure 
- Fraction of inspired oxygen (FiO2), 
- Need for continuous positive airway pressure (CPAP) / insufflation of 
operative lung to avoid hypoxia 
• Surgery performed (lobectomy / pneumonectomy, operative side) 
• Estimated blood loss 
• Intravenous fluids and volume delivered 
6.3.6 Post-operative clinical data 
• Routinely sampled arterial blood gas analyses (ABGs) – (PaO2, PaCO2, 
[H+], [HCO3-], lactate, base excess) immediately postoperatively and at 
approximately 6 hourly intervals until HDU discharge postoperatively 
• Intravenous fluids administered in first 24 hours 
• Duration of HDU / hospital stay 
• Formal chest radiology reports 
• Incidence of new-onset atrial fibrillation 
• Need for vasopressor / inotrope administration 
• Need for high flow nasal continuous positive airways pressure / non-
invasive ventilation 
• Need for ICU admission / positive pressure ventilation 
• In-hospital mortality 






7. Data Management 
7.1 Data collection 
Patient data will be collected manually on case report forms (CRFs) by one of the 
investigators, or an appropriately trained research nurse.  
7.2 Database 
Anonymised patient data will be stored on a password protected university 
computer. A patient identifier list will be kept in a locked cabinet within the 
Anaesthetic Department at Golden Jubilee National Hospital. 
7.3 Archiving 
Study data will be archived for five years after the completion of the trial. It will 
be stored within locked filing cabinets within the Department of Anaesthesia, 
Golden Jubilee National Hospital. 
8. Statistical Analysis 
8.1 Statistical Methods 
8.1.1 Primary outcome 
Feasibility of exercise echocardiography will be assessed by the quality of images 
achieved and patient satisfaction of procedure at each stage of exercise and visit 
(Appendices 4 & 5). No formal statistical testing will be performed on this 
information. 
8.2.2 Secondary outcomesc 
• Paired secondary outcomes. Data will be assessed for normality and 
comparison will be made using a paired t-test or Wilcoxon signed ranks test 
as appropriate. 
• Association between secondary outcomes. Exploratory analyses seeking to 
examine the mechanism of decreased reserve will be undertaken. 
Association between RVC/PV-reserve, self-reported functional status and 
cardiac biomarkers will be assessed with Pearson correlation coefficient or 
its nonparametric alternative, Spearman’s rank correlation coefficient, as 
appropriate. 
 
cIt is acknowledged that our study lacks power to detect changes in RVC/PV-reserve and its potential 
association with cardiac biomarkers and functional status. Such comparisons must be reviewed as 
exploratory analyses and will require further confirmation. 






9. Study Organisation 
9.1 Sponsor 
This study will be sponsored by the National Waiting Times Centre Board (Golden 
Jubilee National Hospital). 
9.2 Administration 
All routine clinical and non-clinical co-ordination of the study will be the 
responsibility of the principal investigator (AG). The chief investigator (BS) will 
assume responsibility for the overall management and conduct of the trial. 
9.3 Indemnity 
The NHS research indemnity scheme will apply. 
9.4 Monitoring 
This study will be sponsored by the National Waiting Times Centre Board (Golden 
Jubilee National Hospital). As such, the Research and Development department 
undertake to monitor this research in line with the Research Governance 
Framework for Health and Community Care (Scotland). 
10. Ethics and regulatory approval 
The study will be conducted in accordance with the ethical principles that have 
their origin in the Declaration of Helsinki. The study will be submitted to the West 
of Scotland Research Ethics Committee for approval. 
11. Projected study timetable  
We aim to commence recruitment in April 2017, and recruit one patient a week. 
Factoring time for patient refusal, holidays and unforeseen issues we propose to 
have completed this study by the end of September 2017.  
12. Protocol amendments 
Any substantial amendments to the final protocol will be clearly documented and 
forwarded to the Research Ethics Committee for approval prior to implementation 
via the IRAS process of Notification of Substantial Amendment.  
13. Publication 
The results of the study will be reported first to study collaborators.  






Subsequently, we plan to communicate our results by reporting them to the funder 
and presentation at national meetings with publication in appropriate peer 
reviewed journals. 
At the end of the study, all subjects will be thanked in writing for their 
participation in the study and provided with a short summary of the trial findings. 
Further details about the trial results and final report will be available on request. 
14. Ethics and regulatory approval 
The study will be conducted in accordance with the ethical principles that have 
their origin in the Declaration of Helsinki. The study will be submitted to the West 
of Scotland Research Ethics Committee for approval. 






APPENDIX ONE: Protocol for peri-operative management of study subjects 
It is not the intention of this study to alter patient management. This protocol is 
intended to document and establish uniformity in the intra-operative and post-
operative anaesthetic and surgical management of study patients and reflects the 
standard practice of the clinicians involved. 
Intra-operative anaesthetic management 
Premedication: Benzodiazepine or none 
Intravenous access + arterial line under local anaesthetic. 
Thoracic epidural pre-induction or paravertebral catheters intra-operatively. 
Induction: Propofol. 
Muscle relaxation: any. 
Lung isolation: Double-lumen endo-tracheal tube. 
Ventilation: Lung protective protocol. Target parameters: TV <8mls/kg, PEEP 0-
10cmH2O, Pmax limited to <30cmH2O, FiO2 titrated to maintain SaO2 92%-98%. 
Generally permissive approach to hypercapnia. 
Central venous cannulation (internal-jugular or subclavian) once anaesthetised. 
Maintenance: Inhalational anaesthetic agent ± Remifentanil 
Fluid management: Generally restrictive approach. Target <1000ml intra-
operative fluid unless exceptional losses. 
Intra-operative hypotension: Colloid boluses as appropriate. Ephedrine / 
metaraminol boluses. Rarely metaraminol / noradrenaline by infusion. Use of 
dobutamine in exceptional circumstances (must be recorded on CRF). 
Surgical management: 
Video-assisted thoracoscopic surgery (VATS) lobectomy with standard approach 
with anatomically appropriate lymph node clearance.  
Post-operative care: 
Analgesia: Regular Paracetamol, NSAID if tolerated.  
Paravertebral catheter: Bupivicaine 0.125%, initial rate 15ml/hr. 20ml 0.25% top-
up as required. 
Fluid management:  Maintenance fluid at 1ml/kg/hr up to 70 mls/hr until 
adequate oral intake. Fluid restriction to less than 2000ml/24 hours unless 
exceptional drain losses. 
Atrial fibrillation: ECG to confirm. Mg+ & K+ replacement in first instance. IV 
Amiodarone as first line therapy in cases of new-onset atrial fibrillation unless 
contraindicated. (Patients not in sinus rhythm pre-operatively will be excluded 
from the study). 
Blood transfusion: Concentrated red cell replacement if Hb<8.0g/dL. 










Imaging will be performed at rest, on constant workload of 25 W and then 50W. 
 
2D  
• 4CH (including RA) Required high frame rate– ideally one extra cineloop with 
reduced sector dimensions (just RV) with high temporal and spatial resolution 
• PARASTERNAL SAX  
o AV LEVEL (RVOT, PV, PA) 
o MV level (optional for pure RV assessment) 
o Papillary muscle level 




o PV  
o TV  
• PW  
o RVOT  
o TV inflow 
• TDI (colour and/or PW) 
o RV FREE WALL  
o TV annulus (inc diastolic)  
 
M MODE (Vivid scans could be obtained off line from 2D scans) 
• TV annulus at RV free wall (TAPSE)  
• RVOT  
• IVC (respirations) 
 










APPENDIX THREE: Protocol for Echocardiographic post-processing 
 
Indices of RV preload, contractility, afterload and diastolic dysfunction to be derived from 
echocardiography during post-processing. This will be collect from images obtained from 
rest and both stages of exercise. As scientific reviewers often request specific 
supplementary data, we intend to collect data on all of the indices below. We have 
highlighted those we intend to focus on during our analysis. 
 
Component Parameter Technique 
Geometric Chamber 
dimensions 
RV dimensions, RVOT diameters, PA 
diameter and RV area measured per BSE 
guidelines. 
Preload Estimated RAP Derived from IVC collapse. 
Contractility Fractional area 
change 
RV end diastolic / systolic areas measured 
in 4 chamber view per BSE guidelines. 
RVFAC (%) = (RVEDA – RVESA)/RVEDA 




Derived from apical 4 chamber view. M 
mode cursor positioned on lateral portion of 
the tricuspid annulus. 
Contractility S’ wave velocity  
 
Derived from TDI of RV free wall at the level 





Derived from Tissue Doppler Imaging (TDI) 
of RV free wall at the level of TV annulus. 
MPI=(IVCT+IVRT)/ET 
IVCT – isovolumetric contraction time, ET – 
ejection time. 
Contractility RV outflow tract 
shortening fraction 
(RVOT-SF) 
M mode, parasternal short axis view at 
base. RVOT diameters (D) measured at end 
systole (ES) and diastole (ED) 
RVOT-SF (%) = (EDRVOTD-
ESRVOTD)/EDRVOTD 
Contractility Peak systolic strain 
and strain rate 
 
Derived from apical 4 chamber view. Peak 
longitudinal systolic strain assessed globally 





Tissue Doppler derived, in basal segment of 
RV free wall. Ratio between maximal 
systolic velocity and time to maximum 
systolic velocity. 
Contractility  RVEF3DE   Derived from 3D-Echocardiography (3DE). 
Afterload Estimated PA 
systolic pressure 
 
Tricuspid Regurgitant Jet (TRJ) velocity 
(Bernoulli equation)  
Where TRJ not obtainable attempt will be 
made to estimate mean PA pressure from 
pulmonary regurgitant jet velocity or RV 
outflow tract acceleration time. 
  






Afterload Eccentricity index Measure of anterior-posterior : medial-lateral 
dimension of LV from short axis image at 
mid papillary level. 
Afterload Pulse wave 
Doppler of RVOT 
Pulmonary artery acceleration time. Shape 
of flow velocity envelope in RVOT 




relaxation time  
(IVRT) 
Time from pulmonary valve closure to 
tricuspid valve opening. Derived from TDI of 
ventricular free wall. 
Diastolic 
dysfunction 
Tricuspid valve E/e’ E/e’ ratio measured by tissue Doppler 
imaging. E – tricuspid flow early diastolic 
velocity, e’ peak early diastolic velocity of 











APPENDIX FOUR: Echocardiography case report form 
 
 
Exercise Echo ID number in this study: EXEC |__|__| 
Reviewer initials:      |__|__| 
 
Parameter Result Image Quality 
Exercise level Rest Low Mod Rest Low Mod 
Fractional area  
change 
      
TAPSE 
 
      
S’ wave velocity 
 
      
Estimated PA  
systolic pressure 
      
Eccentricity index 
 
      
Image Quality 
Good 
Poor but interpretable 













APPENDIX FIVE: Patient satisfaction questionnaire 
 
RV Exercise Echocardiography Questionnaire 
 
 
Patient ID number in this study: RVEX |__|__| 
 
 
Pre-op q    2 months q 
 
Can you rate how well informed you were 
about the exercise echocardiography? 
□ Very uninformed  
□ Somewhat uninformed  
□ Well informed  
□ Very well informed 
How difficult was it for you to undergo the 
echocardiography at rest? 




□ Very easy 
How difficult was it for you to perform the 
low intensity exercise? 




□ Very easy 
 
How difficult was it for you to undergo the 
echocardiography scanning on low intensity 
exercise? 




□ Very easy 
 
How difficult was it for you to perform the 
moderate intensity exercise? 




□ Very easy 
□  
 
How difficult was it for you to undergo the 
echocardiography scanning at moderate 
intensity exercise? 




□ Very easy 
 
Would you undertake exercise 
echocardiography again? 



















APPENDIX SIX: Self-reporting functional status questionnaire 
 
Right ventricular contractile reserve following lung resection  








Pre-op q    2 months q 
 
 
We would like to ask you some questions about how your health / symptoms effect 
your day to day life. Please read the instructions and tick the appropriate box. 
Though, some of the scoring systems overlap it is important that you answer each 
one individually. This should take no longer than 10 minutes. 
 




World Health Organization Performance status: 
Please tick the ONE box that best describes you: 
Fully active, able to carry on all pre-disease performance without 
restriction 
q 
Restricted in physically strenuous activity but ambulatory (able to walk) 
and able to carry out work of a light or sedentary nature, e.g., light 
house work, office work 
q 
Ambulatory (able to walk) and capable of all self-care but unable to 
carry out any work activities. Up and about more than 50% of waking 
hours 
q 
Capable of only limited self-care, confined to bed or chair more than 
50% of waking  hours 
q 
Completely disabled. Cannot carry on any self-care. Totally confined to 










MRC Breathlessness Scale: 
Please tick the ONE box that best describes you:  
No breathlessness except with strenuous exercise q 
Breathless when walking up an incline or hurrying on the level q 
Walks slower than most people on the level, or stops after 15 minutes of 
walking on the level 
q 
Stops after a few minutes of walking on the level q 
Breathless with minimal activity such as getting dressed, to breathless 
to leave the house 
q 
 
New York Heart Association classification: 
Please tick the ONE box that best describes you:  
No symptoms and no limitation in ordinary physical activity, e.g. 
shortness of breath when walking, climbing stairs etc. 
q 
Mild symptoms (mild shortness of breath and/or angina) and slight 
limitation during ordinary activity. 
q 
Marked limitation in activity due to symptoms, even during less-than-
ordinary activity, e.g. walking short distances (20–100 m). 
q 
Severe limitations. Experiences symptoms even while at rest. Mostly 
bedbound. 
q 






Quality of Life 
Under each heading, please tick the ONE box that best describes your health 
TODAY  
MOBILITY 
I have no problems in walking about      q 
I have slight problems in walking about      q 
I have moderate problems in walking about     q 
I have severe problems in walking about     q 
I am unable to walk about        q 
 
SELF-CARE 
I have no problems washing or dressing myself    q 
I have slight problems washing or dressing myself    q 
I have moderate problems washing or dressing myself   q 
I have severe problems washing or dressing myself    q 
I am unable to wash or dress myself      q 
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities     q 
I have slight problems doing my usual activities    q 
I have moderate problems doing my usual activities    q 
I have severe problems doing my usual activities    q 




PAIN / DISCOMFORT 
I have no pain or discomfort       q 
I have slight pain or discomfort       q 
I have moderate pain or discomfort      q 
I have severe pain or discomfort       q 
I have extreme pain or discomfort      q 
 
ANXIETY / DEPRESSION 
I am not anxious or depressed       q 
I am slightly anxious or depressed      q 
I am moderately anxious or depressed      q 
I am severely anxious or depressed      q 
I am extremely anxious or depressed      q 
  






• We would like to know how good or bad your health is  
TODAY. 
• This scale is numbered from 0 to 100. 
• 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
• Mark an X on the scale to indicate how your health is 
TODAY.  
• Now, please write the number you marked on the 
scale in the box below.  



























The best health        
 you can imagine 
 
The worst health        
 you can imagine 
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East of England - Cambridge Central Research Ethics Committee 






11 April 2017 
 
Dr Ben Shelley 





Dear Dr Shelley 
 
Study title: Assessment of right ventricular contractile reserve on 
exercise following lung resection – a pilot study 
REC reference: 17/EE/0134 
IRAS project ID: 218001 
 
Thank you for your letter of 31/03/2017 responding to the Proportionate Review  
Sub-Committee’s request for changes to the documentation for the above study. 
 
The revised documentation has been reviewed and approved by the sub-committee. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date 
of this favourable opinion letter. The expectation is that this information will be published for all 
studies that receive an ethical opinion but should you wish to provide a substitute contact point, 
wish to make a request to defer, or require further information, please contact please contact 
hra.studyregistration@nhs.net outlining the reasons for your request. 
Under very limited circumstances (e.g. for student research which has received an 
unfavourable opinion), it may be possible to grant an exemption to the publication of the study. 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised. 
 
Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 





Management permission must be obtained from each host organisation prior to the start of the 
study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given permission 
for the research to proceed (except where explicitly specified otherwise).  
Guidance on applying for HRA Approval (England)/ NHS permission for research is available in 
the Integrated Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.  
 
Where a NHS organisation s role in the study is limited to identifying and referring potential 
participants to research sites (“participant identification centre ), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations.  
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database. This should be before the first participant is recruited but no 
later than 6 weeks after recruitment of the first participant. 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details as part of 
the annual progress reporting process. 
  
To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory. 
  
If a sponsor wishes to request a deferral for study registration within the required timeframe, 
they should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will 
be registered, however, in exceptional circumstances non registration may be permissible with 
prior agreement from the HRA. Guidance on where to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 








The documents reviewed and approved by the Committee are: 
 
Document   Version   Date   
GP/consultant information sheets or letters [GP letter]  1  06 March 2017  
Letter from sponsor [Ernest Leech Sponsor Letter]      
Non-validated questionnaire [Pt satisfaction exercise 
echocardiography]  
1  06 March 2017  
Participant consent form [Consent Form]  1  06 March 2017  
Participant information sheet (PIS) [Patient Info Sheet]  2  28 March 2017  
REC Application Form [REC_Form_10032017]    10 March 2017  
Research protocol or project proposal [Assessment of RV 
contractile reserve on exercise following lung resection protocol]  
1  07 March 2017  
Summary CV for Chief Investigator (CI) [CV Shelley]    13 March 2017  
Summary CV for supervisor (student research) [CV - Adam Glass]    22 February 2017  
Validated questionnaire [Self reported functional status]    06 March 2017  
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 




The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 




You are invited to give your view of the service that you have received from the Research Ethics 
Service and the application procedure.  If you wish to make your views known please use the 
feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance  
 
We are pleased to welcome researchers and R & D staff at our RES Committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
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17/EE/0134 Please quote this number on all correspondence 
With the Committee’s best wishes for the success of this project. 
Yours sincerely 
Revd Dr Derek Fraser 
Chair 
Email: NRESCommittee.EastofEngland-CambridgeCentral@nhs.net 
Enclosures:  “After ethical review – guidance for researchers  
Copy to: Dr Adam Glass 
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NATIONAL INSTITUTE FOR ACADEMIC ANAESTHESIA 
ACTACC FUNDED PROJECT GRANT – up to £15,000 
 
Name of Applicant:  Dr Ben Shelley ................................................................................................... . 
 
Email address:  b.shelley@clinmed.gla.ac.uk͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͙͘ 
 
Position and Department:  Consultant in Cardiothoracic Anaesthesia and Intensive Care,  
Golden Jubilee National Hospital 
 
Department in which the Project will be conducted (if different) ........................................................  
 
Head of Department: Academic -  Professor John Kinsella, NHS ʹ  Dr Jacqueline Church........................   
 
Names and appointments of any collaborators: 
  
Co-Investigator: Dr Adam Glass 
Clinical Research Fellow 
Golden Jubilee National Hospital 
Beardmore Street 
Clydebank G81 4HX 
Tel: 0141 9515000 
E-mail: aglass01@doctors.org 
 
Co-Investigator: Dr Philip McCall 
Postgraduate Research Student 
Academic Unit of Anaesthesia 
Level 4, Walton Building 
Glasgow Royal Infirmary  
84 Castle Street 
Glasgow G4 OSF 
Tel: 0141 2114625 
E-mail: philipmccall@nhs.net 
 
Co-Investigator: Professor John Kinsella 
Professor and Head of Academic Unit of 
Anaesthesia 
Level 4, Walton Building 
Glasgow Royal Infirmary  
84 Castle Street 
Glasgow G4 OSF 
Tel: 0141 2114625 
E-Mail: john.kinsella@glasgow.ac.uk 
 
Co-investigator & Lead Surgeon: Mr Alan Kirk 
Consultant Cardiothoracic Surgeon 
Golden Jubilee National Hospital 
Beardmore Street 
Clydebank G81 4HX 
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Co-investigator & Lead Cardiologist: 
 
Prof Colin Berry 
Consultant Cardiologist 
Golden Jubilee National Hospital 
Beardmore Street 
Clydebank G81 4HX 
Tel: 0141 9515000 
E-mail: Colin.berry@glasgow.ac.uk 
 
Co-investigator & MRI Physicist  Dr Aleksandra Radjenovic 
Senior Lecturer in MRI   
Institute of Cardiovascular & Medical Sciences   
BHF Glasgow Cardiovascular Research Centre   
University of Glasgow 
126 University Place 
Glasgow, G12 8TA 
Tel: +44 (0)141 330 3006  
Email: Aleksandra.Radjenovic@Glasgow.ac.uk   
 
 
Title of proposed research:   Right ventricular inflammation after lung resection. 
 ........................................................................................................................................................  
 ........................................................................................................................................................  
 
 
Abstract of proposed research (up to 200 words): 
 
Lung cancer is the leading cause of cancer death within the UK. Surgical resection offers the best 
chance of cure but is associated with long-term dyspnoea and poor functional capacity. This is 
poorly associated with changes in respiratory function and maybe influenced by cardiac limitation.  
 
Our research group have demonstrated that right ventricular (RV) function deteriorates following 
lung resection; a phenomenon widely believed to occur secondarily to increased afterload. In animal 
models acute increases in RV afterload stimulate neutrophil/macrophage infiltration leading to 
inflammation and fibrosis. Chronic increases in afterload lead to RV hypertrophy, paradoxical 
septal movement and RV failure. Our previous study also demonstrated increased afterload and 
paradoxical septal movement following lung resection. 
 
We hypothesise that abrupt afterload changes occurring intra-operatively and early post-operatively 
trigger an acute inflammatory RV injury, which is sustained long into the post-operative period by 
altered flow dynamics within the pulmonary vasculature.  
 
Fifteen patients will undergo sequential cardiac magnetic resonance with T1 mapping, a non-
invasive method of assessing myocardial inflammation/fibrosis. We will assess the presence of 
post-operative RV inflammation and its association to post-operative RV dysfunction. Peri-
operative RV protection may provide a therapeutic opportunity, preventing RV dysfunction and 
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Lung cancer is the second most common cancer in the UK and is the leading cause of cancer related 
death. Where appropriate, surgery to remove the tumour and the surrounding lung (lung resection) 
provides the best chance of cure. Frequently patients are either current or ex-smokers with related 
lung or heart problems which increase the risks associated with surgery. Following surgery patients 
may suffer long term shortness of breath, greatly limiting their day-to-day function and lowering 
quality of life. This shortness of breath is not solely caused by the removal of part of the lung but 
also from a decrease in the performance of the heart. Although the surgery does not directly involve 
the heart it is thought that the damage is caused indirectly by the surgery and by the removal of part 
of the lung. 
 
Function of the heart following lung resection 
 
In a previous study our research group showed that the function of the right side of the heart (the 
right heart) is decreased following lung resection. The decrease in right heart (the part that supplies 
blood to the lungs) function was associated with a prolonged stay in the high dependency unit and 
blood markers indicating damage to the heart. The process by which the damage occurs is poorly 
understood, but it is thought that an increase in the forces preventing the right heart pumping blood 
(resistance) is to blame. The decrease in function in the right heart may be caused during surgery by 
the diminished blood supply to the cancerous lung and, post operatively, as lung resection can cause 
a long term increase in resistance.  
 
Diseases that cause an increase in resistance to the right heart have been shown to cause damage to 
different parts of the right heart. An acute increase in resistance can cause inflammation, thinning 
and scarring whilst a long term increase in resistance causes the right heart to thicken. We believe 
that the potential damage during the operation will cause permanent damage to the right heart and 
contribute to shortness of breath and functional limitation. 
 
To investigate the potential inflammation/scarring and the function of the heart we will image the 
heart with specialised MRI scans. We have used this technique in our previous study with over 80% 




The aim of the research is to determine whether damage occurs in the right heart during and 
following lung resection and, if so, does it result in scarring. We will compare the function of the 
right heart before, during and after surgery to determine if the inflammation causes the decrease in 
right heart function following lung resection. We anticipate that the study will increase our 
understanding of how the right heart may be damaged by lung resection. We believe this will guide 
further studies aiming to prevent such damage, ultimately limiting the disabling breathlessness and 
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TITLE 
Right ventricular inflammation after lung resection. 
 
AIMS 
1) To assess the feasibility of T1-mapping cardiac magnetic resonance (CMR) 
investigation of right ventricular (RV) inflammation following lung resection. 
2) To determine if inflammation of the RV is present following lung resection. 
3) To determine if inflammation observed in the early post-operative period leads to 
subsequent RV fibrosis. 
4) To investigate if inflammation/fibrosis is linked to: 
a) RV function. 




Lung cancer is the leading cause of cancer death in the UK and has the highest regional 
incidence within Greater Glasgow and Clyde[1, 2]. Where appropriate surgical resection is the first 
choice treatment; resection rates have risen markedly over the last ten years[3] with a particular 
increase in elderly patients [4].  
 
Morbidity following lung resection remains high with patients experiencing long term dyspnoea 
and decreased functional capacity [5, 6]. This decrease in functional capacity is poorly associated 
with the change in lung function[7] and may be influenced by cardiac limitation[8].  
 
Patients prioritise exercise capacity following lung cancer surgery; patient and public 
involvement between the (Glasgow) Victoria Infirmary Lung Cancer Support Group and our 
e ea ch g  hgh gh ed he cha e ge  faced f g cce f  g e ec . Sec d  
to being alive and cancer free  exercise capacity was the main priority of post-operative patients 
although they experienced significant impairment of functional capacity. Our research also shows 
that post-operative a e  e e e ce a a ed c ea e  b e  h b  a d self-
ca e . 
 
Right ventricular function following lung resection 
 
Right ventricular function has been shown to decrease following lung resection. Our research group 
has conducted the only sequential CMR study assessing RV function following lung resectiona. We 
demonstrated a decrease in right ventricular ejection fraction (RVEF)b following lobectomy at day 
two (POD2) and two months post-op (Figure 1)[9]. A peri-operative decrease in RV function is 
associated with early and late post-operative complications[10, 11]. In our cohort, RVEF on POD2 
                                                                 
a  2012 ACTA Project Grant - 'The Pulmonary Vascular / Right Ventricular Response to Lung Resection'. 
ClinicalTrials.gov identifier - NCT01892800. https://clinicaltrials.gov/show/NCT01892800 
b  We recognise that assessment of RV function is more complex than measurement of RVEF alone, which is 
dependent on loading conditions. During analysis we also plan to investigate other parameters of RV function and 
interpret changes in RVEF in the context of indices of preload, contractility (strain) and afterload.   
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was associated with length of HDU stay (p<0.05, r=-0.61). In one study impaired RV function intra-
operatively identified patients in whom late cardio-respiratory symptoms would develop[12], 
suggesting peri-operative RV dysfunction may have an impact long into the post-operative period.  
 
The most intuitive explanation for reduced RVEF is increased afterload. Intra-operatively PVR 
increases on institution of one-lung ventilation and at PA clamping[13, 14], but this acute increase 
returns to baseline 24-48 hours post-operatively [14-17] yet RVEF remains depressed at 2 months. 
Studies using PAP or PVR to assess afterload may not however reflect the full complexity of RV 
afterload. PVR assesses resistance to steady flow but ignores resistance to pulsatile flow that is 
responsible for up to half the hydraulic work of the RV[18]. In our previous study we demonstrated 
increases in pulsatile components of afterload following lobectomy with decreased pulmonary 
artery acceleration time (PAAT) (Figure 2) and distensibility. Estimated PA systolic pressure was 
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We hypothesise that the well documented abrupt changes in afterload occurring intra-operatively 
and in the early post-operative period trigger an acute inflammatory RV injury, which is sustained 
long into the post-operative period by altered flow dynamics and c ea ed a e  af e ad. 
Perioperative RV protection may therefore provide a therapeutic opportunity, preventing RV 
dysfunction and ameliorating disabling decreases in functional capacity post-operatively.  
 
Mechanisms of RV damage secondary to increased afterload 
 
Insights from Pulmonary embolism: RV dysfunction in PE, a syndrome of acutely increased 
afterload potentially analogous to lung resection, primarily affects the RV free wall and base, 
sparing the apex. Increased afterload leads to acute RV dilatation, leftward movement of the 
interventricular septum (IVS), reduced LV filling and LV dysfunction[19-21]. Following PE 
however the  degree  of  RV  dysfunction exhibited is not accounted for by the effects of increased 
RV afterload or RV ischaemia alone[22]. 
 
Evidence from rat models of PE demonstrate an inflammatory response occurring within the RV 
resulting in decreased contractile function with thinning and scarring of the RV outflow tract[22-
25]. Eighteen hours following PE basal segments of the RV show neutrophil/macrophage 
infiltration[23]. After the initial insult, a secondary macrophage wave occurs which is associated 
with histological scar formation[24]. Similar RV neutrophil/macrophage infiltration has been seen 
in human autopsy following fatal PE[26]. 
 
Insights from Pulmonary hypertension (PH): In PH the RV is subjected to a gradual increase in 
afterload leading to RV remodelling and hypertrophy[22]. The RV becomes more concentric with 
flattening the IVS[27]. Similar to PE, leftward movement of the IVS causes LV dysfunction 
through reduced diastolic filling and LV end-diastolic volumes[20, 27]. As has been observed 
following lung resection, in patients with PH exercise causes a further decrease in RVEF with RV 
dilatation further impairing the LV[15, 28]. This bowing of the IVS can be measured by the 
eccentricity index (EI), a measure of the deformation of the normally concentric LV[20]. EI is 
strongly associated with CMR evidence of fibrosis at the ventricular insertion points (VIPs) (Figure 
5) which in turn is associated with increased disease severity and RV dysfunction[29-31]. It has 
been hypothesised that shear stresses from abnormal IVS movement cause fibrosis at VIPs[29].  
 
In our previous study diastolic EI at POD2 and 2 months was significantly associated with RVEF 
(Figure 3), HDU length of stay and global strain. Decreased RVEF following resection is associated 
with abnormal septal movement and we hypothesise that fibrosis will be present at the VIPs. 
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Assessment of the right ventricle 
 
Cardiac magnetic resonance (CMR) is non-ionising, non-invasive and is the gold standard for RV 
assessment[32]. In our previous study CMR was well tolerated by patients at all time points with 




Ventricular function and afterload: CMR can accurately assess ventricular volumes throughout the 
cardiac cycle allowing ejection fraction calculation. Velocity encoded flow sequences allow 
measurement of flow, velocity and area changes of the pulmonary arteries[32] and evaluation of 
afterload[33, 34]. RV contractility can be assessed post-processing with feature tracking strain 
analysis[35].  
 
Tissue characterisation: T1-mapping is a quantitative method of assessing the magnetic properties 
f a e ba ed   e a a  e. Ta  e  a  def e T1 e a a  e a  a measure of how 
fast the nuclear spin magnetization returns to its equilibrium state after a radiofrequency (RF) 
pulse [36]. Following the RF pulse the magnetisation is measured with sequential imaging 
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allowing construction of the T1 recovery curve and therefore T1 from its decay constant (Figure 
5)[36-38]. Tissues of different cellular composition and water content will recover at different 
rates[39]. Native T1 (without contrast) has been shown to increase with oedema and fibrosis[40]. 
Administration of intravenous contrast (gadolinium) allows calculation of extra-cellular volume 
(ECV) from T1 values of blood and myocardium pre- and post-contrast. ECV is associated with 
increased myocardial fibrosis[41] and is predictive of all-cause mortality in cardiomyopathy[42]. In 
PH, increased T1 and ECV have been demonstrated at the VIP and are associated with both RV 
function and disease severity[30, 43, 44]. Collaborators in our institution have demonstrated that 
RV free wall T1 is increased in PH by imaging in systole[45].  
 
Cardiac biomarkers: Troponin and BNP have been shown to increase with acute PE [46-48]. 
Troponin I is associated with RV dysfunction, adverse outcome and greater segmental 
obstruction[46, 47] whilst BNP of greater than 100pg/ml is associated with increased mortality[48]. 
In our study pre-op to POD2 change in BNP was associated with a decrease in RVEF (p=0.03, 





We hypothesise that RV inflammation contributes to the decrement in RV function observed after 
lung resection and will be revealed by T1 mapping of inflammation/fibrosis.  
 
 
In exploring this hypothesis we seek to address the following questions: 
 
1) Can RV inflammation be assessed by T1 mapping CMR following lung resection? 
2) Is increased T1 (inflammation) present in the RV immediately following lung resection? 
3) Does early post-operative inflammation lead to the subsequent development of RV 
fibrosis? 
4) Is oedema/fibrosis associated with changes in  
a) RV function? 






































Prospective observational cohort study of 15 patients presenting for video-assisted thoracoscopic 




Golden Jubilee National Hospital / West of Scotland Heart and Lung Centre ± a NHS tertiary 




Patients presenting for VATS lobectomy will undergo CMR assessment of ventricular function, 
oedema and fibrosis pre-operatively, on POD2 and two months post-operatively. CMR will assess 
oedema and fibrosis of the ventricles with T1-mapping pre- and post- contrast (gadolinium). 
RV/LV function, dimensions, strain and flow in the pulmonary arteries (main, left and right) will 
also be assessed. Contemporaneous blood testing of biomarkers of myocardial dysfunction will be 
performed (Table 1). 
 
Surgical technique will be standardised to a single surgeon. Anaesthetic technique will be 
standardised for maintenance, analgesia, vasopressors/inotropes, blood transfusion and fluid 
management. Such standardisation reflects the normal practice of the individual(s) involved.  
 
Objective and outcome measures 
 
Primary outcome  
 
1) Can RV inflammation be assessed by T1 mapping CMR following lung resection? 
Whilst T1 mapping is common practice in the LV its use in the RV is less established. Though all 
clinical papers investigating RV T1 have been in PH patients with hypertrophied ventricles, T1 in 
VIPs[30, 44] and in RV free wall have been successfully measured in healthy controls[50]. Whilst 
we hypothesise we shall observe changes in the RV post-op, these changes are likely to be modest 
compared to established PH and our pre-op scans will be of relatively healthy hearts. As such, we 




1) Is increased T1 (inflammation) present in the RV following lung resection? 
2) Does inflammation lead to RV fibrosis? 
3) Is oedema/scarring associated with changes in 
a) RV function? 
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Spruijt et al and Reiter et al found similar effect size differences between native T1 at RVIPs 
in PH vs controls (T1 values differ between studies due to different field strengths): 
 
x Spruijt et al- PH 1060r70ms vs controls 957r27ms, effect size 1.37[30]. 
x Reiter et al- PH 1298r78ms vs controls 1193r31ms, effect size 1.25[44]. 
Myocardial infarction (MI) causes a greater difference in native T1 between infarcted 
myocardium and remote zone (myocardium not directly affected by the infract): 
 
x Carrick et al (collaborators in our institution)- Infarct 1097r52ms vs remote zone 
961r25ms effect size 2.36[51]. 
We hypothesise that the observed difference (effect size) in native T1 observed post-
operatively will be modest in comparison to PH or MI. Due to the pilot nature of this study, 
we have no indicative value from which to calculate power, however as a guide, the effect 
size for the change in RVEF seen in our previous study was 0.9. 
 
Based on a 2-sided, paired t-test with a significance level of 5% and power of 80%, 12 
patients would be required to demonstrate an effect size of 0.9. In our previous study 22/27 
(81%) patients completed POD2 scanning. Assuming a minimal sample size of 12 patients, 




Primary outcome: Will be assessed through dual reporting of the CMR images and testing 
intra-/inter-observer variability, previously shown to be exceptionally low (rIC = 0.96)[44].  
 
Secondary outcomes: Paired secondary outcomes will be assessed for normality and 
comparison will be made using a paired t-test or Wilcoxon signed ranks test as appropriate. 
Re ea ed ea e  ANOVA  F ed a  e  a  a a e  be ed  a e  
differences between variables repeated over time. Association will be sought between 
evidence of inflammation/oedema and parameters of RV function and cardiac biomarkers 
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B: A list of the resources which will be required and which will be provided by the Host 
Institution. 
 
This study is being coordinated by the Academic Unit of Anaesthesia, Pain and Critical Care 
Medicine at the University of Glasgow who will provide general infrastructure, office space, 
secretarial support, computing facilities (including statistical software), secure file storage 
and technical support. BS is a research affiliate, AG is employed by the unit as a clinical 
research fellow and JK is head of unit. 
 
Clinical studies will take place in the West of Scotland Heart and Lung Centre / Golden 
Jubilee National Hospital (GJNH), Clydebank. GJNH is a modern tertiary referral 
cardiothoracic surgical centre equipped to a high standard with appropriate theatre, critical 
care, laboratory and radiology facilities. Facilities specifically available at GJNH for the 
conduct of this study include: office space and computing facilities, on-site Research and 
De e e  Se ce, he Bea d e Hea h Sc e ce  Re ea ch Ce e (NHS Sc a d s new 
clinical skills and research centre offering consulting rooms and research laboratory facilities) 
and electronic patient data recording throughout all theatre and critical care areas.  
 
Feasibility: Lung cancer rates in Glasgow are the highest in the UK. Recent audit data has 
revealed that GJNH is the largest thoracic surgical unit in the UK performing in excess of 500 
resections for primary lung cancer each year. Within our last study we recruited 27 
lobectomy patients within one year with 27/43 patients approached enrolling. In this study, 
we propose to recruit just 15 of this population over a period of 6 months. We feel the shorter 
timeframe is appropriate as 70% of lung resections carried out within the hospital are by 
VATS. Target recruitment will be one patient per week with sufficient flexibility to allow for 




Cardiovascular Magnetic Resonance will be performed within an existing NHS facility (West 
of Scotland Heart and Lung Centre / Golden Jubilee National Hospital) by NHS staff. 
Dedicated research time is available at a non-commercial cost per scan. All appropriate 
software is available for post-processing. Our collaborators and CMR technicians are 
experienced in performing T1 mapping, have helped developed imaging protocols/methods 
and have published in this field. 
 
Estimated running costs: 
 
The principal applicant (BS) will be employed for the duration of the project by the National 
Health Service Scotland. AG will be employed by the University of Glasgow as is JK, CB 
and AR. Co-investigator AK is employed by the National Health Service Scotland. Support 
for NHS staff costs (1-2 hours per week for the duration of the project) is covered by NHS 
Sc a d Re ea ch a d De e e  de  he e  f NHS Sc a d  NHS ( e ea ch) 
Support Costs policy.  
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AG is employed as a clinical research fellow based at the Golden Jubilee National Hospital 
and will undertake the day-to-day running of the study. It will form the bulk of his research 
 f   d a . The d  a d e   be c ded  h  MD e ed Mecha  
f gh  e c a  d f c  f g g e ec  hich he is currently undertaking 
with the University of Glasgow. 
 
No additional costs are anticipated over and above those for which application is made. 
 
Ethics Committee approval: 
 
Research Ethics Committees now require evidence of successful peer review. We will 
therefore seek approval from the West of Scotland REC once we have funding. The 
applicants are familiar with ethics procedures. We anticipate no problems obtaining approval. 
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Direct costs – staff: Nil 
 
Other direct costs – additional investigations: 














Cardiac magnetic resonance 
imaging 
CMR scanning will be carried 
out at GJNH. Dedicated 
research time is available at a 
non-commercial cost per scan.  
225 3 - 675 10125 
Measurement of biomarkers 
Blood samples for (Troponin 
I, BNP, CK-MB, d-Dimer and 
myoglobin) measurement will 
be analysed using the Alere 
Triage® PROFILER SOB 
Panel system (Alere Ltd. 
Stockport, UK). Hardware is 
being provided on loan by 
Alere Ltd - application is 
made for the cost of 
consumables only. £470 for 
25 tests. (Appendix 2) 
18.8 5 - 94 1410 
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Control panel for 
biomarkers 
Alere controls panels 
required. £191 per 25 tests.  




   
12108 
 














250 - 1 - 250 
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Name of Applicant. Dr Ben Shelley.........................................................................................................  
 








    £ 
(i) Salary 
(ii) Emplo er  con rib ion  in re pec  of perann a ion and  
 national insurance (where applicable) 
 
    _________ 
Total staff costs   0 

























Con in ed  
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(a) Materials and consumables  £ 
 
Measurement of biomarkers ʹ  consumables from Alere 
 Blood tests   1410 







(b) Animals   £ 
 
  Purchase 











(c) Other expenses  £ 
 
Cardiac magnetic resonance imaging  10125 




    _________ 
TOTAL GRANT REQUESTED  £12358 
    _________ 
 
(Requests for purchase of equipment must be accompanied by three competitive quotations 
for pricing or where restricted supplier this must be stated.) 
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YOU MAY BE RECEIVING THIS MAIL IN COPY FOR INFORMATION ONLY 
 
Dear Dr. Glass: 
 
The NIAA grants committee met yesterday to consider your application for ACTACC funding. I am delighted to be 
able to inform you that your application was recommended for support in full. However ACTACC had insufficient 
funds to cover the award in full so the difference was made up by AAGBI/Anaesthesia as follows; I hope that you 
will approve. ACTACC-£7,700; AAGBI/Anaesthesia-£4,658; Total as in application £12,358 
 
This e.mail is a formal notification of funding for which we would request an acceptance e.mail (cc to ACTACC and 
AAGBI). Please note that if we do not hear from you within two weeks of the date of this award notification then the 
award will be withdrawn. 
 
For your information I attach a copy of your peer review. 
 
Please find below a copy of the peer review associated with your application and note that the abstracts from your 
application will posted onto the NIAA (and partner). Please have a look it and let me know if there are any (small) 
changes that you may wish to make. 
 
In order to claim the funding you (or your finance office) will need to contact ACTACC/AAGBI directly and for your 
information I copy the relevant details below. There may be some additional conditions (e.g., the need for 
interim/final reports) that the project funder will provide. 
 
All funding queries (and especially finance office claims) should be directed to ACTACC/AAGBI and NOT NIAA. 
 
Contact for ACTACC: John.Kendall@lhch.nhs.uk 
Contact for AAGBI: secretariat@aagbi.org 
 
Successful applicants should contact their CLRN as soon as the award is made and work with them to obtain NIHR 
portfolio approval and support. 
 
To find out which NIAA grants are recognised for inclusion on the NIHR portfolio click here: 
http://www.niaa.org.uk/article.php?newsid=877 
 




On behalf of NIAA and its funding partners I would like to congratulate you on the quality of your application and 
look forward to seeing your results published. 
 




Prof. David Lambert 
Grants Officer, NIAA e-grants 
dgl3@leicester.ac.uk 
 
Reviewer(s)' Comments to Applicant: 
Reviewer: 1 
 
Comments to the Applicant 
This is a well written and clearly set out pilot project to detect whether inflammation occurs in the the RV following 
lobectomy/pneumonectomy. 
 
The technique of T1 mapping is well established in assessment of the LV, both for detection of oedema and and 
quantification of extracellular volume, (a surrogate of interstitial fibrosis).  
The major weakness of the application is the sptial resolution of current t1 mapping sequences is low and given that 
the RV wall is very thin, this inevitably means that partial volume errors (inclusion of blood pool and epicardial fat in 
quantitative voxels) will significantly affect the results.  
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Comments to the Applicant 
MAJOR POINTS: 
1. Authors’ primary question whether RV inflammation can be assessed by T1 mapping CMR following lung 
resection is clearly limited by the expectation of only modest information in non-hypertrophied right 
ventricles.  Which strategies will be pursued if T1 mapping does not show anything?  
2. Authors need to make clear how T1-mapping can distinguish myocardial fibrosis from myocardial 
inflammation.  Edema may be part of both, therefore a tissue-based analysis would be essential.  Have authors 




1. Will left heart disease have been sufficiently excluded, e.g. by echo and preoperative coronary 
catheterization?  Some right heart compromise may be the result of increased left ventricular filling pressures after 
surgical stress. 





Comments to the Applicant 
1) The proposal is generally presented.  It has a reasonable hypothesis and has clear questions for 
investigation.    However, the units of measurement for the primary outcome (effect size) and the quantifications of 
multiple sites of measurement of inflammation and fibrosis aren't clear enough.   The investigators should explain 
how they aggregate these data, given that they relate to the main outcomes. 
 
2) The project is simple and deliverable. 
 
3)  The applicant has a relevant track record. 
 
4)  The costs are mainly for the scans.  Other administrative costs are small. 
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